1	Ultrastructural	_	JJ	JJ	_	2	amod	_	_
2	localization	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	5	case	_	_
4	carcinoembryonic	_	JJ	JJ	_	5	amod	_	_
5	antigen	_	NN	NN	_	2	nmod	_	_
7	CEA	_	NNP	NNP	_	2	appos	_	_
9	on	_	IN	IN	_	11	case	_	_
10	ultrathin	_	NN	NN	_	11	compound	_	_
11	cryosections	_	NNS	NNS	_	2	nmod	_	_
12	of	_	IN	IN	_	14	case	_	_
13	human	_	JJ	JJ	_	14	amod	_	_
14	tumours	_	NNS	NNS	_	11	nmod	_	_

1	A	_	DT	DT	_	6	det	_	_
2	new	_	JJ	JJ	_	6	amod	_	_
4	more	_	RBR	RBR	_	5	advmod	_	_
5	direct	_	JJ	JJ	_	6	amod	_	_
6	method	_	NN	NN	_	17	nsubjpass	_	_
7	for	_	IN	IN	_	9	case	_	_
8	reliable	_	JJ	JJ	_	9	amod	_	_
9	localization	_	NN	NN	_	6	nmod	_	_
10	of	_	IN	IN	_	11	case	_	_
11	CEA	_	NNP	NNP	_	9	nmod	_	_
12	on	_	IN	IN	_	14	case	_	_
13	human	_	JJ	JJ	_	14	amod	_	_
14	tumours	_	NNS	NNS	_	11	nmod	_	_
15	has	_	VBZ	VBZ	_	17	aux	_	_
16	been	_	VBN	VBN	_	17	auxpass	_	_
17	applied	_	VBN	VBN	_	0	root	_	_
18	at	_	IN	IN	_	21	case	_	_
19	the	_	DT	DT	_	21	det	_	_
20	ultrastructural	_	JJ	JJ	_	21	amod	_	_
21	level	_	NN	NN	_	17	nmod	_	_

1	Freshly	_	RB	RB	_	2	advmod	_	_
2	prepared	_	JJ	JJ	_	4	amod	_	_
3	biopsy	_	JJ	JJ	_	4	amod	_	_
4	material	_	NN	NN	_	27	nsubjpass	_	_
5	from	_	IN	IN	_	6	case	_	_
6	breast_and_gastric_tumours	_	NNS	NNS	_	4	nmod	_	_
8	as	_	RB	RB	_	4	cc	_	_
9	well	_	RB	RB	_	8	mwe	_	_
10	as	_	IN	IN	_	8	mwe	_	_
11	xenografted	_	JJ	JJ	_	12	amod	_	_
12	colon_tumours	_	NNS	NNS	_	4	conj	_	_
13	from	_	IN	IN	_	14	case	_	_
14	mice	_	NNS	NNS	_	12	nmod	_	_
16	and	_	CC	CC	_	4	cc	_	_
17	a	_	DT	DT	_	20	det	_	_
18	colon_tumour	_	NN	NN	_	20	compound	_	_
19	cell	_	NN	NN	_	20	compound	_	_
20	line	_	NN	NN	_	4	conj	_	_
22	LS_174_T	_	NNP	NNP	_	20	appos	_	_
25	were	_	VBD	VBD	_	27	auxpass	_	_
26	briefly	_	RB	RB	_	27	advmod	_	_
27	fixed	_	VBN	VBN	_	0	root	_	_
28	in	_	IN	IN	_	29	case	_	_
29	glutaraldehyde	_	NN	NN	_	27	nmod	_	_
30	and	_	CC	CC	_	27	cc	_	_
31	frozen	_	VBN	VBN	_	27	conj	_	_
32	in	_	IN	IN	_	34	case	_	_
33	liquid	_	JJ	JJ	_	34	amod	_	_
34	propane	_	NN	NN	_	31	nmod	_	_

1	Ultrathin	_	NN	NN	_	2	compound	_	_
2	cryosections	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	labelled	_	VBN	VBN	_	0	root	_	_
5	with	_	IN	IN	_	8	case	_	_
6	monospecific	_	JJ	JJ	_	8	amod	_	_
7	CEA	_	NNP	NNP	_	8	compound	_	_
8	antibodies	_	NNS	NNS	_	4	nmod	_	_
9	by	_	IN	IN	_	10	mark	_	_
10	applying	_	VBG	VBG	_	4	advcl	_	_
11	gold-coupled	_	JJ	JJ	_	13	amod	_	_
12	second	_	JJ	JJ	_	13	amod	_	_
13	antibodies	_	NNS	NNS	_	10	dobj	_	_

1	Variations	_	NNS	NNS	_	7	nsubjpass	_	_
2	in	_	IN	IN	_	5	case	_	_
3	the	_	DT	DT	_	5	det	_	_
4	labelling	_	JJ	JJ	_	5	amod	_	_
5	patterns	_	NNS	NNS	_	1	nmod	_	_
6	were	_	VBD	VBD	_	7	auxpass	_	_
7	found	_	VBN	VBN	_	0	root	_	_
8	when	_	WRB	WRB	_	9	advmod	_	_
9	comparing	_	VBG	VBG	_	7	advcl	_	_
10	breast	_	NN	NN	_	9	dobj	_	_
12	colon	_	NN	NN	_	10	conj	_	_
14	and	_	CC	CC	_	10	cc	_	_
15	gastric_cancers	_	NN	NN	_	10	conj	_	_

1	Apart	_	RB	RB	_	3	advmod	_	_
2	from	_	IN	IN	_	3	case	_	_
3	breast_tumours	_	NNS	NNS	_	8	nmod	_	_
5	all	_	DT	DT	_	7	det	_	_
6	other	_	JJ	JJ	_	7	amod	_	_
7	samples	_	NNS	NNS	_	8	nsubj	_	_
8	reveal	_	VBP	VBP	_	0	root	_	_
9	significant	_	JJ	JJ	_	10	amod	_	_
10	extracellular	_	NN	NN	_	11	nsubj	_	_
11	CEA	_	VBP	VBP	_	8	ccomp	_	_
12	positivity	_	RB	RB	_	11	advmod	_	_
13	on	_	IN	IN	_	16	case	_	_
14	the	_	DT	DT	_	16	det	_	_
15	cell	_	NN	NN	_	16	compound	_	_
16	membrane	_	NN	NN	_	11	nmod	_	_

1	Intracellular	_	NNP	NNP	_	2	compound	_	_
2	localization	_	NNP	NNP	_	5	nsubjpass	_	_
3	has	_	VBZ	VBZ	_	5	aux	_	_
4	been	_	VBN	VBN	_	5	auxpass	_	_
5	found	_	VBN	VBN	_	0	root	_	_
6	on	_	IN	IN	_	9	case	_	_
7	the	_	DT	DT	_	9	det	_	_
8	endoplasmic	_	JJ	JJ	_	9	amod	_	_
9	reticulum	_	NN	NN	_	5	nmod	_	_
11	nuclear	_	JJ	JJ	_	12	amod	_	_
12	membrane	_	NNS	NNS	_	9	appos	_	_
14	and	_	CC	CC	_	9	cc	_	_
16	in	_	IN	IN	_	17	case	_	_
17	breast_tumours	_	NNS	NNS	_	9	dep	_	_
19	on	_	IN	IN	_	22	case	_	_
20	electron	_	JJ	JJ	_	22	amod	_	_
21	dense	_	JJ	JJ	_	22	amod	_	_
22	bodies	_	NNS	NNS	_	9	conj	_	_

1	These	_	DT	DT	_	2	det	_	_
2	investigations	_	NNS	NNS	_	3	nsubj	_	_
3	confirm	_	VBP	VBP	_	0	root	_	_
4	our	_	PRP$	PRP$	_	7	nmod:poss	_	_
5	previous	_	JJ	JJ	_	7	amod	_	_
6	experimental	_	JJ	JJ	_	7	amod	_	_
7	results	_	NNS	NNS	_	3	dobj	_	_
8	using	_	VBG	VBG	_	7	acl	_	_
9	preembedding	_	VBG	VBG	_	8	advcl	_	_
10	labelling	_	VBG	VBG	_	9	advcl	_	_
11	techniques	_	NNS	NNS	_	10	dobj	_	_
12	before	_	IN	IN	_	14	case	_	_
13	Epon	_	NNP	NNP	_	14	compound	_	_
14	inclusion	_	NN	NN	_	10	nmod	_	_

1	Protein	_	NNP	NNP	_	2	nsubj	_	_
2	kinase	_	VBD	VBD	_	0	root	_	_
3	C	_	NNP	NNP	_	4	compound	_	_
4	desensitization	_	NN	NN	_	2	dobj	_	_
5	by	_	IN	IN	_	6	case	_	_
6	phorbol_esters	_	NNS	NNS	_	2	nmod	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	its	_	PRP$	PRP$	_	9	nmod:poss	_	_
9	impact	_	NN	NN	_	6	conj	_	_
10	on	_	IN	IN	_	11	case	_	_
11	growth	_	NN	NN	_	2	nmod	_	_
12	of	_	IN	IN	_	15	case	_	_
13	human	_	JJ	JJ	_	15	amod	_	_
14	breast_cancer	_	NN	NN	_	15	compound	_	_
15	cells	_	NNS	NNS	_	11	nmod	_	_

1	Active	_	JJ	JJ	_	2	amod	_	_
2	phorbol_esters	_	NNS	NNS	_	10	nsubj	_	_
3	such	_	JJ	JJ	_	6	case	_	_
4	as	_	IN	IN	_	3	mwe	_	_
5	TPA	_	NNP	NNP	_	6	compound	_	_
6	_	_	NNP	NNP	_	2	nmod	_	_
8	12-0-tetra-decanoylphorbol-13-acetate	_	JJ	JJ	_	6	dep	_	_
10	inhibited	_	VBD	VBD	_	0	root	_	_
11	growth	_	NN	NN	_	10	dobj	_	_
12	of	_	IN	IN	_	14	case	_	_
13	mammary_carcinoma	_	NN	NN	_	14	compound	_	_
14	cells	_	NNS	NNS	_	11	nmod	_	_
16	MCF-7	_	NN	NN	_	27	dep	_	_
17	greater	_	JJR	JJR	_	19	dep	_	_
18	than	_	IN	IN	_	19	dep	_	_
19	BT-20	_	JJ	JJ	_	16	amod	_	_
20	greater	_	JJR	JJR	_	22	dep	_	_
21	than	_	IN	IN	_	22	dep	_	_
22	MDA-MB-231	_	JJ	JJ	_	16	amod	_	_
23	greater	_	JJR	JJR	_	25	advmod	_	_
24	than	_	IN	IN	_	25	advmod	_	_
25	=	_	CD	CD	_	26	nummod	_	_
26	ZR-75-1	_	NN	NN	_	27	nmod:npmod	_	_
27	greater	_	JJR	JJR	_	14	dep	_	_
28	than	_	IN	IN	_	29	case	_	_
29	HBL-100	_	NN	NN	_	27	nmod	_	_
31	with	_	IN	IN	_	33	case	_	_
32	the	_	DT	DT	_	33	det	_	_
33	exception	_	NN	NN	_	14	nmod	_	_
34	of	_	IN	IN	_	36	case	_	_
35	T-47-D	_	NN	NN	_	36	compound	_	_
36	cells	_	NNS	NNS	_	33	nmod	_	_
37	presumably	_	RB	RB	_	39	advmod	_	_
38	by	_	IN	IN	_	39	mark	_	_
39	interacting	_	VBG	VBG	_	10	advcl	_	_
40	with	_	IN	IN	_	43	case	_	_
41	the	_	DT	DT	_	43	det	_	_
42	phospholipid/Ca2	_	JJ	JJ	_	43	amod	_	_
43	+	_	NN	NN	_	39	nmod	_	_
45	dependent	_	JJ	JJ	_	47	amod	_	_
46	protein	_	NN	NN	_	47	compound	_	_
47	kinase	_	NN	NN	_	43	dep	_	_
49	PKC	_	NNP	NNP	_	43	appos	_	_

1	The	_	DT	DT	_	4	det	_	_
2	nonresponsive	_	JJ	JJ	_	4	amod	_	_
3	T-47-D	_	NN	NN	_	4	compound	_	_
4	cells	_	NNS	NNS	_	5	nsubj	_	_
5	exhibited	_	VBD	VBD	_	0	root	_	_
6	the	_	DT	DT	_	9	det	_	_
7	lowest	_	JJS	JJS	_	9	amod	_	_
8	PKC	_	NN	NN	_	9	compound	_	_
9	activity	_	NN	NN	_	5	dobj	_	_

1	A	_	DT	DT	_	8	det	_	_
2	rapid	_	JJ	JJ	_	8	amod	_	_
4	30	_	CD	CD	_	5	compound	_	_
5	min	_	CD	CD	_	8	dep	_	_
7	TPA-dependent	_	JJ	JJ	_	8	amod	_	_
8	translocation	_	NN	NN	_	15	nsubjpass	_	_
9	of	_	IN	IN	_	11	case	_	_
10	cytosolic	_	JJ	JJ	_	11	amod	_	_
11	PKC	_	NNP	NNP	_	8	nmod	_	_
12	to	_	TO	TO	_	13	case	_	_
13	membranes	_	NNS	NNS	_	8	nmod	_	_
14	was	_	VBD	VBD	_	15	auxpass	_	_
15	found	_	VBN	VBN	_	0	root	_	_
16	in	_	IN	IN	_	20	case	_	_
17	the	_	DT	DT	_	20	det	_	_
18	five	_	CD	CD	_	20	nummod	_	_
19	TPA-sensitive	_	JJ	JJ	_	20	amod	_	_
20	cell	_	NN	NN	_	15	nmod	_	_
21	without	_	IN	IN	_	22	mark	_	_
22	affecting	_	VBG	VBG	_	15	advcl	_	_
23	cell	_	NN	NN	_	24	compound	_	_
24	growth	_	NN	NN	_	22	dobj	_	_

1	However	_	RB	RB	_	9	advmod	_	_
3	TPA-treatment	_	NNP	NNP	_	9	nsubj	_	_
4	of	_	IN	IN	_	8	case	_	_
5	more	_	JJR	JJR	_	7	advmod	_	_
6	than	_	IN	IN	_	5	mwe	_	_
7	10	_	CD	CD	_	8	nummod	_	_
8	hours	_	NNS	NNS	_	3	nmod	_	_
9	inhibited	_	VBD	VBD	_	0	root	_	_
10	reversibly	_	RB	RB	_	9	advmod	_	_
11	the	_	DT	DT	_	12	det	_	_
12	growth	_	NN	NN	_	9	dobj	_	_
13	of	_	IN	IN	_	15	case	_	_
14	TPA-responsive	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	12	nmod	_	_

1	This	_	DT	DT	_	2	det	_	_
2	effect	_	NN	NN	_	3	nsubj	_	_
3	coincided	_	VBD	VBD	_	0	root	_	_
4	with	_	IN	IN	_	7	case	_	_
5	the	_	DT	DT	_	7	det	_	_
6	complete	_	JJ	JJ	_	7	amod	_	_
7	loss	_	NN	NN	_	3	nmod	_	_
8	of	_	IN	IN	_	11	case	_	_
9	cellular	_	JJ	JJ	_	11	amod	_	_
10	PKC	_	NNP	NNP	_	11	compound	_	_
11	activity	_	NN	NN	_	7	nmod	_	_
12	due	_	JJ	JJ	_	15	case	_	_
13	to	_	TO	TO	_	12	mwe	_	_
14	the	_	DT	DT	_	15	det	_	_
15	proteolysis	_	NNS	NNS	_	3	nmod	_	_
16	of	_	IN	IN	_	21	case	_	_
17	the	_	DT	DT	_	21	det	_	_
18	translocated	_	JJ	JJ	_	19	amod	_	_
19	membrane-bound	_	JJ	JJ	_	21	amod	_	_
20	PKC	_	NNP	NNP	_	21	compound	_	_
21	holoenzyme	_	NN	NN	_	15	nmod	_	_
23	75K	_	CD	CD	_	21	appos	_	_
25	into	_	IN	IN	_	30	case	_	_
26	60K	_	CD	CD	_	30	compound	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	50K	_	CD	CD	_	26	conj	_	_
29	PKC	_	NNP	NNP	_	30	compound	_	_
30	fragments	_	NNS	NNS	_	3	nmod	_	_

1	Resumption	_	NNP	NNP	_	9	nsubjpass	_	_
2	of	_	IN	IN	_	4	case	_	_
3	cell	_	NN	NN	_	4	compound	_	_
4	growth	_	NN	NN	_	1	nmod	_	_
5	after	_	IN	IN	_	6	case	_	_
6	TPA-removal	_	NNP	NNP	_	4	nmod	_	_
7	was	_	VBD	VBD	_	9	auxpass	_	_
8	closely	_	RB	RB	_	9	advmod	_	_
9	related	_	VBN	VBN	_	0	root	_	_
10	to	_	TO	TO	_	29	mark	_	_
11	the	_	DT	DT	_	13	det	_	_
12	specific	_	JJ	JJ	_	13	amod	_	_
13	reappearance	_	NN	NN	_	29	nsubj	_	_
14	of	_	IN	IN	_	18	case	_	_
15	the	_	DT	DT	_	18	det	_	_
16	PKC	_	NNP	NNP	_	18	compound	_	_
17	holoenzyme	_	NN	NN	_	18	compound	_	_
18	activity	_	NN	NN	_	13	nmod	_	_
20	75K	_	CD	CD	_	18	appos	_	_
22	in	_	IN	IN	_	28	case	_	_
23	the	_	DT	DT	_	28	det	_	_
24	TPA-responsive	_	JJ	JJ	_	28	amod	_	_
25	human	_	JJ	JJ	_	28	amod	_	_
26	mammary_tumor	_	NN	NN	_	28	compound	_	_
27	cell	_	NN	NN	_	28	compound	_	_
28	lines	_	NNS	NNS	_	18	nmod	_	_
29	suggesting	_	VBG	VBG	_	9	advcl	_	_
30	an	_	DT	DT	_	31	det	_	_
31	involvement	_	NN	NN	_	29	dobj	_	_
32	of	_	IN	IN	_	33	case	_	_
33	PKC	_	NNP	NNP	_	31	nmod	_	_
34	in	_	IN	IN	_	36	case	_	_
35	growth	_	NN	NN	_	36	compound	_	_
36	regulation	_	NN	NN	_	29	nmod	_	_

1	Evaluation	_	NNP	NNP	_	15	nsubj	_	_
2	of	_	IN	IN	_	4	case	_	_
3	the	_	DT	DT	_	4	det	_	_
4	toxicity	_	NN	NN	_	1	nmod	_	_
5	of	_	IN	IN	_	6	case	_	_
6	Rh	_	NNP	NNP	_	4	nmod	_	_
8	III	_	NNP	NNP	_	6	appos	_	_
10	and	_	CC	CC	_	6	cc	_	_
11	Pt	_	NNP	NNP	_	6	conj	_	_
13	II	_	NNP	NNP	_	6	appos	_	_
15	complexes	_	VBZ	VBZ	_	0	root	_	_
16	against	_	IN	IN	_	19	case	_	_
17	Trypanosoma_cruzi	_	NNP	NNP	_	19	compound	_	_
18	culture	_	NN	NN	_	19	compound	_	_
19	forms	_	NNS	NNS	_	15	nmod	_	_

1	In	_	IN	IN	_	4	case	_	_
2	the	_	DT	DT	_	4	det	_	_
3	present	_	JJ	JJ	_	4	amod	_	_
4	study	_	NN	NN	_	27	nmod	_	_
5	the	_	DT	DT	_	6	det	_	_
6	activity	_	NN	NN	_	27	nsubjpass	_	_
7	of	_	IN	IN	_	9	case	_	_
8	15	_	CD	CD	_	9	nummod	_	_
9	complexes	_	NNS	NNS	_	6	nmod	_	_
10	of	_	IN	IN	_	11	case	_	_
11	Rh	_	NNP	NNP	_	9	nmod	_	_
13	III	_	NNP	NNP	_	11	appos	_	_
15	and	_	CC	CC	_	9	cc	_	_
16	19	_	CD	CD	_	9	conj	_	_
17	of	_	IN	IN	_	18	case	_	_
18	Pt	_	NNP	NNP	_	16	nmod	_	_
20	II	_	NNP	NNP	_	18	appos	_	_
22	against	_	IN	IN	_	25	case	_	_
23	Trypanosoma_cruzi	_	NNP	NNP	_	25	compound	_	_
24	epimastigote	_	NN	NN	_	25	compound	_	_
25	forms	_	NNS	NNS	_	18	nmod	_	_
26	was	_	VBD	VBD	_	27	auxpass	_	_
27	investigated	_	VBN	VBN	_	0	root	_	_

1	The	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	obtained	_	VBD	VBD	_	0	root	_	_
4	show	_	NN	NN	_	3	dobj	_	_
5	that	_	IN	IN	_	18	mark	_	_
6	complexes	_	NNS	NNS	_	18	nsubj	_	_
7	of	_	IN	IN	_	8	case	_	_
8	Rh	_	NNP	NNP	_	6	nmod	_	_
10	III	_	NNP	NNP	_	8	appos	_	_
12	with	_	IN	IN	_	16	case	_	_
13	the	_	DT	DT	_	16	det	_	_
14	highest	_	JJS	JJS	_	16	amod	_	_
15	antitumoural	_	JJ	JJ	_	16	amod	_	_
16	activity	_	NN	NN	_	8	nmod	_	_
17	also	_	RB	RB	_	18	advmod	_	_
18	appear	_	VBP	VBP	_	3	ccomp	_	_
19	to	_	TO	TO	_	22	mark	_	_
20	be	_	VB	VB	_	22	cop	_	_
21	more	_	RBR	RBR	_	22	advmod	_	_
22	effective	_	JJ	JJ	_	18	xcomp	_	_
23	against	_	IN	IN	_	25	case	_	_
24	cultured	_	JJ	JJ	_	25	amod	_	_
25	epimastigotes	_	NNS	NNS	_	22	nmod	_	_

1	Thus	_	RB	RB	_	40	advmod	_	_
3	complexes	_	NNS	NNS	_	40	nsubj	_	_
4	-LSB-	_	NNP	NNP	_	5	compound	_	_
5	Rh	_	NNP	NNP	_	12	dobj	_	_
7	L	_	NNP	NNP	_	5	appos	_	_
9	4X2	_	CD	CD	_	10	compound	_	_
10	-RSB-	_	CD	CD	_	12	dep	_	_
11	+	_	JJ	JJ	_	12	dep	_	_
12	X	_	NN	NN	_	3	dep	_	_
14	where	_	WRB	WRB	_	18	advmod	_	_
15	L	_	NNP	NNP	_	18	nsubj	_	_
16	is	_	VBZ	VBZ	_	18	cop	_	_
17	a	_	DT	DT	_	18	det	_	_
18	derivative	_	NN	NN	_	12	ccomp	_	_
19	of	_	IN	IN	_	23	case	_	_
20	thiazole	_	JJ	JJ	_	23	amod	_	_
21	present	_	JJ	JJ	_	23	amod	_	_
22	high	_	JJ	JJ	_	23	amod	_	_
23	activity	_	NN	NN	_	18	nmod	_	_
24	against	_	IN	IN	_	26	case	_	_
25	the	_	DT	DT	_	26	det	_	_
26	parasite	_	NN	NN	_	23	nmod	_	_
28	and	_	CC	CC	_	18	cc	_	_
29	were	_	VBD	VBD	_	32	cop	_	_
30	even	_	RB	RB	_	32	advmod	_	_
31	more	_	RBR	RBR	_	32	advmod	_	_
32	active	_	JJ	JJ	_	18	conj	_	_
33	when	_	WRB	WRB	_	34	advmod	_	_
34	Cl	_	VBN	VBN	_	32	ccomp	_	_
37	X	_	NNP	NNP	_	3	appos	_	_
39	was	_	VBD	VBD	_	40	cop	_	_
40	present	_	JJ	JJ	_	0	root	_	_
41	in	_	IN	IN	_	43	case	_	_
42	their	_	PRP$	PRP$	_	43	nmod:poss	_	_
43	structure	_	NN	NN	_	40	nmod	_	_

1	Complexes	_	JJ	JJ	_	10	amod	_	_
2	cis-Pt	_	JJ	JJ	_	10	amod	_	_
4	L	_	NNP	NNP	_	10	appos	_	_
6	m	_	NN	NN	_	10	compound	_	_
8	X	_	NNP	NNP	_	10	appos	_	_
10	n	_	NNS	NNS	_	46	nsubj	_	_
11	that	_	IN	IN	_	13	mark	_	_
12	present	_	RB	RB	_	13	advmod	_	_
13	1,2-diamminecyclohexane	_	JJ	JJ	_	10	dep	_	_
15	DDH	_	NNP	NNP	_	10	appos	_	_
17	in	_	IN	IN	_	19	case	_	_
18	their	_	PRP$	PRP$	_	19	nmod:poss	_	_
19	molecule	_	NN	NN	_	10	nmod	_	_
21	e.g.	_	VBG	VBG	_	46	advcl	_	_
22	cis-Pt	_	JJ	JJ	_	26	amod	_	_
24	DDH	_	NNP	NNP	_	26	appos	_	_
26	Cl2	_	NN	NN	_	21	dobj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	cis-Pt	_	NN	NN	_	26	conj	_	_
30	DDH	_	NNP	NNP	_	28	appos	_	_
33	metafluorobenzoic	_	JJ	JJ	_	28	dep	_	_
35	2	_	CD	CD	_	26	dep	_	_
36	of	_	IN	IN	_	41	case	_	_
37	high	_	JJ	JJ	_	41	amod	_	_
38	and	_	CC	CC	_	37	cc	_	_
39	moderate	_	JJ	JJ	_	37	conj	_	_
40	antitumoural	_	JJ	JJ	_	41	amod	_	_
41	activity	_	NN	NN	_	35	nmod	_	_
43	respectively	_	RB	RB	_	46	advmod	_	_
45	have	_	VBP	VBP	_	46	aux	_	_
46	shown	_	VBN	VBN	_	0	root	_	_
47	greater	_	JJR	JJR	_	48	amod	_	_
48	effectiveness	_	NN	NN	_	46	dobj	_	_
49	than	_	IN	IN	_	54	case	_	_
50	cis-Pt	_	JJ	JJ	_	54	amod	_	_
52	NH3	_	NNP	NNP	_	54	appos	_	_
54	2Cl2	_	NN	NN	_	46	nmod	_	_
56	DDP	_	NNP	NNP	_	54	appos	_	_

1	The	_	DT	DT	_	2	det	_	_
2	effect	_	NN	NN	_	24	nsubj	_	_
3	produced	_	VBN	VBN	_	2	acl	_	_
4	by	_	IN	IN	_	10	case	_	_
5	cis-Pt	_	JJ	JJ	_	10	amod	_	_
7	pentamidine	_	NN	NN	_	10	compound	_	_
9	Cl2	_	JJ	JJ	_	10	amod	_	_
10	complex	_	NN	NN	_	3	nmod	_	_
12	obtained	_	VBN	VBN	_	10	acl	_	_
13	in	_	IN	IN	_	12	advcl	_	_
14	order	_	NN	NN	_	13	mwe	_	_
15	to	_	TO	TO	_	16	mark	_	_
16	enforce	_	VB	VB	_	12	xcomp	_	_
17	the	_	DT	DT	_	18	det	_	_
18	action	_	NN	NN	_	16	dobj	_	_
19	of	_	IN	IN	_	20	case	_	_
20	pentamidine	_	NN	NN	_	18	nmod	_	_
22	was	_	VBD	VBD	_	24	cop	_	_
23	considerably	_	RB	RB	_	24	advmod	_	_
24	high	_	JJ	JJ	_	0	root	_	_

1	On	_	IN	IN	_	4	case	_	_
2	the	_	DT	DT	_	4	det	_	_
3	other	_	JJ	JJ	_	4	amod	_	_
4	hand	_	NN	NN	_	11	nmod	_	_
6	no	_	DT	DT	_	8	neg	_	_
7	positive	_	JJ	JJ	_	8	amod	_	_
8	correlation	_	NN	NN	_	11	nsubjpass	_	_
9	can	_	MD	MD	_	11	aux	_	_
10	be	_	VB	VB	_	11	auxpass	_	_
11	established	_	VBN	VBN	_	0	root	_	_
12	between	_	IN	IN	_	15	case	_	_
13	the	_	DT	DT	_	15	det	_	_
14	antitumour	_	NN	NN	_	15	compound	_	_
15	effects	_	NNS	NNS	_	11	nmod	_	_
16	of	_	IN	IN	_	22	case	_	_
17	the	_	DT	DT	_	22	det	_	_
18	Pt	_	NNP	NNP	_	22	compound	_	_
20	II	_	NNP	NNP	_	22	appos	_	_
22	complexes	_	NNS	NNS	_	15	nmod	_	_
23	and	_	CC	CC	_	15	cc	_	_
24	its	_	PRP$	PRP$	_	26	nmod:poss	_	_
25	antitrypanosomic	_	JJ	JJ	_	26	amod	_	_
26	activity	_	NN	NN	_	15	conj	_	_

1	A	_	DT	DT	_	3	det	_	_
2	specific	_	JJ	JJ	_	3	amod	_	_
3	antibody	_	NN	NN	_	0	root	_	_
4	to	_	TO	TO	_	9	case	_	_
5	a	_	DT	DT	_	9	det	_	_
6	new	_	JJ	JJ	_	9	amod	_	_
7	peptide	_	JJ	JJ	_	9	amod	_	_
8	growth	_	NN	NN	_	9	compound	_	_
9	factor	_	NN	NN	_	3	nmod	_	_
10	from	_	IN	IN	_	12	case	_	_
11	human	_	JJ	JJ	_	12	amod	_	_
12	placenta	_	NN	NN	_	9	nmod	_	_
14	immunocytochemical	_	JJ	JJ	_	15	amod	_	_
15	studies	_	NNS	NNS	_	3	dep	_	_
16	on	_	IN	IN	_	18	case	_	_
17	its	_	PRP$	PRP$	_	18	nmod:poss	_	_
18	location	_	NN	NN	_	15	nmod	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	biosynthesis	_	NNS	NNS	_	18	conj	_	_

1	Recently	_	RB	RB	_	4	advmod	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	isolated	_	VBD	VBD	_	0	root	_	_
5	a	_	DT	DT	_	9	det	_	_
6	new	_	JJ	JJ	_	9	amod	_	_
7	peptide	_	JJ	JJ	_	9	amod	_	_
8	growth	_	NN	NN	_	9	compound	_	_
9	factor	_	NN	NN	_	4	dobj	_	_
10	of	_	IN	IN	_	11	case	_	_
11	Mr	_	NNP	NNP	_	9	nmod	_	_
12	34	_	CD	CD	_	13	compound	_	_
13	000	_	CD	CD	_	4	nmod	_	_
14	from	_	IN	IN	_	13	case	_	_
15	synctial	_	JJ	JJ	_	16	amod	_	_
16	membranes	_	NNS	NNS	_	13	dep	_	_
17	of	_	IN	IN	_	19	case	_	_
18	human	_	JJ	JJ	_	19	amod	_	_
19	placenta	_	NN	NN	_	16	nmod	_	_

1	In	_	IN	IN	_	5	case	_	_
2	its	_	PRP$	PRP$	_	5	nmod:poss	_	_
3	polypeptide	_	JJ	JJ	_	5	amod	_	_
4	molecular	_	JJ	JJ	_	5	amod	_	_
5	weight	_	NN	NN	_	16	nmod	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	receptor	_	NN	NN	_	9	compound	_	_
8	binding	_	VBG	VBG	_	9	amod	_	_
9	specificity	_	NN	NN	_	5	conj	_	_
10	it	_	PRP	PRP	_	16	nsubj	_	_
11	is	_	VBZ	VBZ	_	16	cop	_	_
12	unlike	_	IN	IN	_	16	case	_	_
13	several	_	JJ	JJ	_	16	amod	_	_
14	known	_	VBN	VBN	_	16	amod	_	_
15	growth	_	NN	NN	_	16	compound	_	_
16	factors	_	NNS	NNS	_	0	root	_	_

1	In	_	IN	IN	_	3	case	_	_
2	this	_	DT	DT	_	3	det	_	_
3	paper	_	NN	NN	_	5	nmod	_	_
4	we	_	PRP	PRP	_	5	nsubj	_	_
5	described	_	VBD	VBD	_	0	root	_	_
6	immunocytochemical	_	JJ	JJ	_	7	amod	_	_
7	studies	_	NNS	NNS	_	5	dobj	_	_
8	on	_	IN	IN	_	11	case	_	_
9	its	_	PRP$	PRP$	_	11	nmod:poss	_	_
10	cellular	_	JJ	JJ	_	11	amod	_	_
11	location	_	NN	NN	_	5	nmod	_	_
12	and	_	CC	CC	_	5	cc	_	_
13	biosynthesis	_	VBZ	VBZ	_	5	conj	_	_

1	A	_	DT	DT	_	3	det	_	_
2	rabbit	_	NN	NN	_	3	compound	_	_
3	antiserum	_	NN	NN	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	raised	_	VBN	VBN	_	0	root	_	_
6	against	_	IN	IN	_	9	case	_	_
7	a	_	DT	DT	_	9	det	_	_
8	homogeneous	_	JJ	JJ	_	9	amod	_	_
9	preparation	_	NN	NN	_	5	nmod	_	_
10	of	_	IN	IN	_	13	case	_	_
11	the	_	DT	DT	_	13	det	_	_
12	placental	_	JJ	JJ	_	13	amod	_	_
13	peptide	_	NN	NN	_	9	nmod	_	_

1	The	_	DT	DT	_	2	det	_	_
2	specificity	_	NN	NN	_	7	nsubjpass	_	_
3	of	_	IN	IN	_	5	case	_	_
4	the	_	DT	DT	_	5	det	_	_
5	antibody	_	NN	NN	_	2	nmod	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	established	_	VBN	VBN	_	0	root	_	_
8	by	_	IN	IN	_	12	case	_	_
9	immunoprecipitation	_	NN	NN	_	12	compound	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	immunoblot	_	NN	NN	_	9	conj	_	_
12	analyses	_	NNS	NNS	_	7	nmod	_	_

1	The	_	DT	DT	_	2	det	_	_
2	antibody	_	NN	NN	_	3	nsubj	_	_
3	recognized	_	VBD	VBD	_	0	root	_	_
4	both	_	PDT	PDT	_	6	cc:preconj	_	_
5	the	_	DT	DT	_	6	det	_	_
6	native	_	JJ	JJ	_	13	nsubj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	denatured	_	JJ	JJ	_	9	amod	_	_
9	34-kilodalton	_	NNS	NNS	_	6	conj	_	_
11	kDa	_	NN	NN	_	6	appos	_	_
13	peptide	_	JJ	JJ	_	3	xcomp	_	_
14	but	_	CC	CC	_	3	cc	_	_
15	showed	_	VBD	VBD	_	3	conj	_	_
16	no	_	RB	RB	_	17	neg	_	_
17	binding	_	JJ	JJ	_	15	xcomp	_	_
18	to	_	TO	TO	_	20	case	_	_
19	a	_	DT	DT	_	20	det	_	_
20	variety	_	NN	NN	_	17	nmod	_	_
21	of	_	IN	IN	_	24	case	_	_
22	other	_	JJ	JJ	_	24	amod	_	_
23	growth	_	NN	NN	_	24	compound	_	_
24	factors	_	NNS	NNS	_	20	nmod	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	hormones	_	NNS	NNS	_	24	conj	_	_
27	tested	_	VBN	VBN	_	24	acl	_	_

1	The	_	DT	DT	_	2	det	_	_
2	antibody	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	used	_	VBN	VBN	_	0	root	_	_
5	to	_	TO	TO	_	6	mark	_	_
6	investigate	_	VB	VB	_	4	xcomp	_	_
7	the	_	DT	DT	_	8	det	_	_
8	genesis	_	NN	NN	_	6	dobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	location	_	NN	NN	_	8	conj	_	_
11	of	_	IN	IN	_	15	case	_	_
12	the	_	DT	DT	_	15	det	_	_
13	34-kDa	_	JJ	JJ	_	15	amod	_	_
14	membranous	_	NNS	NNS	_	15	compound	_	_
15	mitogen	_	NN	NN	_	8	nmod	_	_

1	Immunoperoxidase	_	JJ	JJ	_	2	amod	_	_
2	staining	_	NN	NN	_	7	nsubj	_	_
3	of	_	IN	IN	_	6	case	_	_
4	placental	_	JJ	JJ	_	6	amod	_	_
5	tissue	_	NN	NN	_	6	compound	_	_
6	slices	_	NNS	NNS	_	2	nmod	_	_
7	revealed	_	VBD	VBD	_	0	root	_	_
8	a	_	DT	DT	_	10	det	_	_
9	restricted	_	VBN	VBN	_	10	amod	_	_
10	localization	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	13	case	_	_
12	the	_	DT	DT	_	13	det	_	_
13	antigen	_	NN	NN	_	10	nmod	_	_
14	in	_	IN	IN	_	25	case	_	_
15	the	_	DT	DT	_	25	det	_	_
16	cytoplasmic	_	JJ	JJ	_	17	amod	_	_
17	organelles	_	NNS	NNS	_	25	compound	_	_
18	of	_	IN	IN	_	19	case	_	_
19	cytotrophoblasts	_	NNS	NNS	_	17	nmod	_	_
20	and	_	CC	CC	_	17	cc	_	_
21	in	_	IN	IN	_	23	case	_	_
22	the	_	DT	DT	_	23	det	_	_
23	brush	_	NN	NN	_	17	conj	_	_
24	border	_	NN	NN	_	25	compound	_	_
25	membranes	_	NNS	NNS	_	13	nmod	_	_
26	of	_	IN	IN	_	27	case	_	_
27	syncytiotrophoblasts	_	NNS	NNS	_	10	nmod	_	_

1	No	_	DT	DT	_	4	neg	_	_
2	other	_	JJ	JJ	_	4	amod	_	_
3	placental	_	JJ	JJ	_	4	amod	_	_
4	structures	_	NNS	NNS	_	5	nsubj	_	_
5	contained	_	VBD	VBD	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	antigen	_	NN	NN	_	5	dobj	_	_

1	A	_	DT	DT	_	4	det	_	_
2	developmentally	_	JJ	JJ	_	4	amod	_	_
3	regulated	_	JJ	JJ	_	4	amod	_	_
4	appearance	_	NN	NN	_	9	nsubjpass	_	_
5	of	_	IN	IN	_	7	case	_	_
6	the	_	DT	DT	_	7	det	_	_
7	mitogen	_	NN	NN	_	4	nmod	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	suggested	_	VBN	VBN	_	0	root	_	_
10	by	_	IN	IN	_	12	case	_	_
11	the	_	DT	DT	_	12	det	_	_
12	fact	_	NN	NN	_	9	nmod	_	_
13	that	_	IN	IN	_	18	mark	_	_
14	first	_	JJ	JJ	_	16	amod	_	_
15	trimester	_	NN	NN	_	16	compound	_	_
16	placenta	_	NN	NN	_	18	nsubj	_	_
17	consistently	_	RB	RB	_	18	advmod	_	_
18	stained	_	VBD	VBD	_	9	ccomp	_	_
19	far	_	RB	RB	_	21	advmod	_	_
20	more	_	RBR	RBR	_	21	advmod	_	_
21	strongly	_	RB	RB	_	18	advmod	_	_
22	than	_	IN	IN	_	24	case	_	_
23	term	_	NN	NN	_	24	compound	_	_
24	placenta	_	NN	NN	_	18	nmod	_	_

1	These	_	DT	DT	_	2	det	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	the	_	DT	DT	_	8	det	_	_
6	34-kDa	_	JJ	JJ	_	8	amod	_	_
7	mitogenic	_	JJ	JJ	_	8	amod	_	_
8	protein	_	NN	NN	_	9	nsubj	_	_
9	originates	_	VBZ	VBZ	_	3	ccomp	_	_
10	in	_	IN	IN	_	11	case	_	_
11	placenta	_	NN	NN	_	9	nmod	_	_
12	from	_	IN	IN	_	15	case	_	_
13	embryo-derived	_	JJ	JJ	_	15	amod	_	_
14	cellular	_	JJ	JJ	_	15	amod	_	_
15	structures	_	NNS	NNS	_	9	nmod	_	_
16	and	_	CC	CC	_	9	cc	_	_
17	suggest	_	VBP	VBP	_	9	conj	_	_
18	that	_	IN	IN	_	25	mark	_	_
19	in	_	IN	IN	_	22	case	_	_
20	its	_	PRP$	PRP$	_	22	nmod:poss	_	_
21	strategic	_	JJ	JJ	_	22	amod	_	_
22	location	_	NN	NN	_	25	nmod	_	_
23	it	_	PRP	PRP	_	25	nsubj	_	_
24	may	_	MD	MD	_	25	aux	_	_
25	influence	_	VB	VB	_	17	ccomp	_	_
26	trophoblastic	_	JJ	JJ	_	27	amod	_	_
27	growth	_	NN	NN	_	25	dobj	_	_
28	in	_	IN	IN	_	31	case	_	_
29	an	_	DT	DT	_	31	det	_	_
30	autocrine	_	JJ	JJ	_	31	amod	_	_
31	manner	_	NN	NN	_	25	nmod	_	_

1	In	_	IN	IN	_	3	case	_	_
2	other	_	JJ	JJ	_	3	amod	_	_
3	studies	_	NNS	NNS	_	5	nmod	_	_
4	we	_	PRP	PRP	_	5	nsubj	_	_
5	investigated	_	VBD	VBD	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	presence	_	NN	NN	_	5	dobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	biosynthesis	_	NNS	NNS	_	7	conj	_	_
10	of	_	IN	IN	_	13	case	_	_
11	the	_	DT	DT	_	13	det	_	_
12	34-kDa	_	JJ	JJ	_	13	amod	_	_
13	peptide	_	NN	NN	_	7	nmod	_	_
14	in	_	IN	IN	_	19	case	_	_
15	the	_	DT	DT	_	19	det	_	_
16	A431	_	NNP	NNP	_	19	compound	_	_
17	vulval_carcinoma	_	NN	NN	_	19	compound	_	_
18	cell	_	NN	NN	_	19	compound	_	_
19	line	_	NN	NN	_	5	nmod	_	_
21	which	_	WDT	WDT	_	23	nsubjpass	_	_
22	was	_	VBD	VBD	_	23	auxpass	_	_
23	shown	_	VBN	VBN	_	19	acl:relcl	_	_
24	earlier	_	RBR	RBR	_	23	advmod	_	_
25	to	_	TO	TO	_	26	mark	_	_
26	contain	_	VB	VB	_	23	xcomp	_	_
27	a	_	DT	DT	_	31	det	_	_
28	membrane-associated	_	JJ	JJ	_	31	amod	_	_
29	34-kDa	_	JJ	JJ	_	31	amod	_	_
30	growth	_	NN	NN	_	31	compound	_	_
31	factor	_	NN	NN	_	26	dobj	_	_

1	The	_	DT	DT	_	2	det	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	23	mark	_	_
5	this	_	DT	DT	_	7	det	_	_
6	cell	_	NN	NN	_	7	compound	_	_
7	line	_	NN	NN	_	23	nsubj	_	_
9	as	_	RB	RB	_	7	cc	_	_
10	well	_	RB	RB	_	9	mwe	_	_
11	as	_	IN	IN	_	9	mwe	_	_
12	some	_	DT	DT	_	15	det	_	_
13	other	_	JJ	JJ	_	15	amod	_	_
14	human	_	JJ	JJ	_	15	amod	_	_
15	carcinomas	_	NNS	NNS	_	7	conj	_	_
16	of	_	IN	IN	_	20	case	_	_
17	breast	_	NN	NN	_	20	compound	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	bladder	_	NN	NN	_	17	conj	_	_
20	origin	_	NN	NN	_	15	nmod	_	_
22	actively	_	RB	RB	_	23	advmod	_	_
23	expresses	_	VBZ	VBZ	_	3	ccomp	_	_
24	this	_	DT	DT	_	25	det	_	_
25	peptide	_	NN	NN	_	23	dobj	_	_

2	ABSTRACT	_	NNP	NNP	_	4	compound	_	_
3	TRUNCATED	_	NNP	NNP	_	4	compound	_	_
4	AT	_	NNP	NNP	_	9	dep	_	_
5	250	_	CD	CD	_	6	nummod	_	_
6	WORDS	_	NNS	NNS	_	4	dep	_	_
8	Cell	_	JJ	JJ	_	9	amod	_	_
9	kinetic	_	NN	NN	_	0	root	_	_
10	studies	_	NNS	NNS	_	9	dep	_	_
11	of	_	IN	IN	_	13	case	_	_
12	the	_	DT	DT	_	13	det	_	_
13	effect	_	NN	NN	_	10	nmod	_	_
14	of	_	IN	IN	_	17	case	_	_
15	a	_	DT	DT	_	17	det	_	_
16	combined	_	VBN	VBN	_	17	amod	_	_
17	therapy	_	NN	NN	_	13	nmod	_	_
18	with	_	IN	IN	_	19	case	_	_
19	1-beta_D-arabinofuranosylcytosine	_	JJ	JJ	_	17	nmod	_	_
21	Ara-C	_	NNP	NNP	_	19	appos	_	_
23	and	_	CC	CC	_	19	cc	_	_
24	X-irradiation	_	NNP	NNP	_	19	conj	_	_
25	on	_	IN	IN	_	29	case	_	_
26	the	_	DT	DT	_	29	det	_	_
27	L1210	_	NNP	NNP	_	29	compound	_	_
28	ascites	_	NNS	NNS	_	29	compound	_	_
29	tumour	_	NN	NN	_	24	nmod	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	studied	_	VBD	VBD	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	effect	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	7	case	_	_
6	combined	_	VBN	VBN	_	7	amod	_	_
7	therapy	_	NN	NN	_	4	nmod	_	_
8	with	_	IN	IN	_	9	case	_	_
9	X-ray	_	NN	NN	_	7	nmod	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	1-beta-D-arabinofuranosylcytosine	_	NN	NN	_	9	conj	_	_
13	Ara-C	_	NNP	NNP	_	9	appos	_	_
16	firstly	_	RB	RB	_	35	advmod	_	_
17	the	_	DT	DT	_	18	det	_	_
18	effect	_	NN	NN	_	35	nsubjpass	_	_
19	of	_	IN	IN	_	21	case	_	_
20	whole-body	_	JJ	JJ	_	21	amod	_	_
21	X-irradiation	_	NN	NN	_	18	nmod	_	_
22	alone	_	JJ	JJ	_	35	advmod	_	_
23	on	_	IN	IN	_	25	case	_	_
24	the	_	DT	DT	_	25	det	_	_
25	proliferation	_	NN	NN	_	22	nmod	_	_
26	of	_	IN	IN	_	30	case	_	_
27	the	_	DT	DT	_	30	det	_	_
28	L1210	_	NNP	NNP	_	30	compound	_	_
29	ascites	_	NNS	NNS	_	30	compound	_	_
30	tumour	_	NN	NN	_	25	nmod	_	_
31	of	_	IN	IN	_	33	case	_	_
32	the	_	DT	DT	_	33	det	_	_
33	mouse	_	NN	NN	_	30	nmod	_	_
34	was	_	VBD	VBD	_	35	auxpass	_	_
35	studied	_	VBN	VBN	_	2	parataxis	_	_
36	by	_	IN	IN	_	43	case	_	_
37	autoradiographic	_	JJ	JJ	_	43	amod	_	_
38	and	_	CC	CC	_	37	cc	_	_
39	cytofluorometric	_	JJ	JJ	_	37	conj	_	_
41	FCM	_	NNP	NNP	_	43	appos	_	_
43	methods	_	NNS	NNS	_	35	nmod	_	_

1	The	_	DT	DT	_	3	det	_	_
2	effect	_	NN	NN	_	3	compound	_	_
3	X-irradiation	_	NN	NN	_	11	nsubj	_	_
4	with	_	IN	IN	_	6	case	_	_
5	4	_	CD	CD	_	6	nummod	_	_
6	Gy	_	NNS	NNS	_	3	nmod	_	_
7	was	_	VBD	VBD	_	11	cop	_	_
8	mainly	_	RB	RB	_	11	advmod	_	_
9	a	_	DT	DT	_	11	det	_	_
10	cytostatic	_	JJ	JJ	_	11	amod	_	_
11	one	_	NN	NN	_	0	root	_	_
12	leading	_	VBG	VBG	_	11	acl	_	_
13	to	_	TO	TO	_	16	case	_	_
14	an	_	DT	DT	_	16	det	_	_
15	altered	_	JJ	JJ	_	16	amod	_	_
16	distribution	_	NN	NN	_	12	nmod	_	_
17	of	_	IN	IN	_	19	case	_	_
18	the	_	DT	DT	_	19	det	_	_
19	cells	_	NNS	NNS	_	16	nmod	_	_
20	throughout	_	IN	IN	_	22	case	_	_
21	the	_	DT	DT	_	22	det	_	_
22	cycle	_	NN	NN	_	12	nmod	_	_
23	due	_	JJ	JJ	_	22	amod	_	_
24	to	_	TO	TO	_	25	case	_	_
25	radiation	_	NN	NN	_	23	nmod	_	_
26	induced	_	VBN	VBN	_	25	acl	_	_
27	mitotic	_	JJ	JJ	_	28	amod	_	_
28	delay	_	NN	NN	_	26	dobj	_	_

1	The	_	DT	DT	_	3	det	_	_
2	cytocidal	_	JJ	JJ	_	3	amod	_	_
3	effect	_	NN	NN	_	5	nsubj	_	_
4	is	_	VBZ	VBZ	_	5	cop	_	_
5	negligible	_	JJ	JJ	_	0	root	_	_

1	As	_	IN	IN	_	3	mark	_	_
2	is	_	VBZ	VBZ	_	3	auxpass	_	_
3	known	_	VBN	VBN	_	22	advcl	_	_
4	from	_	IN	IN	_	6	case	_	_
5	previous	_	JJ	JJ	_	6	amod	_	_
6	studies	_	NNS	NNS	_	3	nmod	_	_
8	Fietkau	_	NNP	NNP	_	6	appos	_	_
10	Friede	_	NNP	NNP	_	12	compound	_	_
11	_	_	NNP	NNP	_	12	compound	_	_
12	Maurer-Schultze	_	NNP	NNP	_	8	dep	_	_
14	1984	_	CD	CD	_	8	dep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	effect	_	NN	NN	_	22	nsubj	_	_
18	of	_	IN	IN	_	21	case	_	_
19	200	_	CD	CD	_	21	nummod	_	_
20	mg/kg	_	JJ	JJ	_	21	amod	_	_
21	Ara-C	_	NNS	NNS	_	17	nmod	_	_
22	consists	_	VBZ	VBZ	_	0	root	_	_
23	of	_	IN	IN	_	25	case	_	_
24	an	_	DT	DT	_	25	det	_	_
25	inhibition	_	NN	NN	_	22	nmod	_	_
26	of	_	IN	IN	_	28	case	_	_
27	DNA	_	NN	NN	_	28	compound	_	_
28	synthesis	_	NN	NN	_	25	nmod	_	_
29	and	_	CC	CC	_	25	cc	_	_
30	of	_	IN	IN	_	31	mark	_	_
31	killing	_	VBG	VBG	_	25	conj	_	_
32	a	_	DT	DT	_	34	det	_	_
33	considerable	_	JJ	JJ	_	34	amod	_	_
34	portion	_	NN	NN	_	31	dobj	_	_
35	of	_	IN	IN	_	39	case	_	_
36	the	_	DT	DT	_	39	det	_	_
37	L	_	JJ	JJ	_	39	amod	_	_
38	1210	_	CD	CD	_	39	nummod	_	_
39	cells	_	NNS	NNS	_	34	nmod	_	_
41	predominantly	_	RB	RB	_	34	advmod	_	_
42	of	_	IN	IN	_	45	case	_	_
43	S	_	NNP	NNP	_	45	compound	_	_
44	phase	_	NN	NN	_	45	compound	_	_
45	cells	_	NNS	NNS	_	34	nmod	_	_

1	With	_	IN	IN	_	2	case	_	_
2	respect	_	NN	NN	_	32	nmod	_	_
3	to	_	TO	TO	_	5	case	_	_
4	the	_	DT	DT	_	5	det	_	_
5	importance	_	NN	NN	_	2	nmod	_	_
6	for	_	IN	IN	_	9	case	_	_
7	potential	_	JJ	JJ	_	9	amod	_	_
8	therapeutic	_	JJ	JJ	_	9	amod	_	_
9	regimens	_	NNS	NNS	_	5	nmod	_	_
11	the	_	DT	DT	_	12	det	_	_
12	influence	_	NN	NN	_	32	nsubjpass	_	_
13	of	_	IN	IN	_	15	case	_	_
14	the	_	DT	DT	_	15	det	_	_
15	sequence	_	NN	NN	_	12	nmod	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	the	_	DT	DT	_	19	det	_	_
18	time	_	NN	NN	_	19	compound	_	_
19	interval	_	NN	NN	_	15	conj	_	_
20	between	_	IN	IN	_	24	case	_	_
21	the	_	DT	DT	_	24	det	_	_
22	two	_	CD	CD	_	24	nummod	_	_
23	therapeutic	_	JJ	JJ	_	24	amod	_	_
24	steps	_	NNS	NNS	_	19	nmod	_	_
25	on	_	IN	IN	_	27	case	_	_
26	the	_	DT	DT	_	27	det	_	_
27	survival	_	NN	NN	_	24	nmod	_	_
28	of	_	IN	IN	_	30	case	_	_
29	tumour-bearing	_	JJ	JJ	_	30	amod	_	_
30	mice	_	NNS	NNS	_	27	nmod	_	_
31	was	_	VBD	VBD	_	32	auxpass	_	_
32	studied	_	VBN	VBN	_	0	root	_	_

1	Most	_	JJS	JJS	_	3	amod	_	_
2	combination	_	NN	NN	_	3	compound	_	_
3	therapies	_	NNS	NNS	_	5	nsubj	_	_
4	significantly	_	RB	RB	_	5	advmod	_	_
5	increase	_	VB	VB	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	survival	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	10	case	_	_
9	tumour-bearing	_	JJ	JJ	_	10	amod	_	_
10	mice	_	NNS	NNS	_	7	nmod	_	_
11	compared	_	VBN	VBN	_	16	case	_	_
12	to	_	TO	TO	_	16	case	_	_
13	the	_	DT	DT	_	16	det	_	_
14	single	_	JJ	JJ	_	16	amod	_	_
15	therapeutic	_	JJ	JJ	_	16	amod	_	_
16	steps	_	NNS	NNS	_	5	advcl	_	_
18	however	_	RB	RB	_	29	advmod	_	_
20	no	_	DT	DT	_	22	neg	_	_
21	significant	_	JJ	JJ	_	22	amod	_	_
22	differences	_	NNS	NNS	_	29	nsubjpass	_	_
23	between	_	IN	IN	_	27	case	_	_
24	the	_	DT	DT	_	27	det	_	_
25	various	_	JJ	JJ	_	27	amod	_	_
26	combined	_	JJ	JJ	_	27	amod	_	_
27	therapies	_	NNS	NNS	_	22	nmod	_	_
28	were	_	VBD	VBD	_	29	auxpass	_	_
29	found	_	VBN	VBN	_	5	parataxis	_	_

1	Whole-body	_	NNP	NNP	_	2	compound	_	_
2	X-irradiation	_	NNP	NNP	_	17	nsubj	_	_
3	with	_	IN	IN	_	5	case	_	_
4	4	_	CD	CD	_	5	nummod	_	_
5	Gy	_	NNS	NNS	_	2	nmod	_	_
6	followed	_	VBN	VBN	_	5	acl	_	_
7	by	_	IN	IN	_	9	case	_	_
8	the	_	DT	DT	_	9	det	_	_
9	application	_	NN	NN	_	6	nmod	_	_
10	of	_	IN	IN	_	11	case	_	_
11	200	_	CD	CD	_	9	nmod	_	_
12	mg/kg	_	VBG	VBG	_	6	xcomp	_	_
13	Ara-C	_	JJ	JJ	_	15	amod	_	_
14	10	_	CD	CD	_	13	dep	_	_
15	hr	_	NN	NN	_	12	dobj	_	_
16	later	_	RB	RB	_	17	advmod	_	_
17	resulted	_	VBD	VBD	_	0	root	_	_
18	in	_	IN	IN	_	21	case	_	_
19	the	_	DT	DT	_	21	det	_	_
20	greatest	_	JJS	JJS	_	21	amod	_	_
21	increase	_	NN	NN	_	17	nmod	_	_
22	of	_	IN	IN	_	26	case	_	_
23	the	_	DT	DT	_	26	det	_	_
24	mean	_	JJ	JJ	_	26	amod	_	_
25	survival	_	NN	NN	_	26	compound	_	_
26	time	_	NN	NN	_	21	nmod	_	_
27	of	_	IN	IN	_	28	case	_	_
28	tumour-bearing_animals	_	NNS	NNS	_	26	nmod	_	_
30	from	_	IN	IN	_	34	case	_	_
31	13.2	_	CD	CD	_	33	compound	_	_
32	to	_	TO	TO	_	33	dep	_	_
33	17.4	_	CD	CD	_	34	nummod	_	_
34	days	_	NNS	NNS	_	17	nmod	_	_

1	It	_	PRP	PRP	_	3	nsubjpass	_	_
2	was	_	VBD	VBD	_	3	auxpass	_	_
3	shown	_	VBN	VBN	_	0	root	_	_
4	that	_	IN	IN	_	16	mark	_	_
5	apart	_	RB	RB	_	9	advmod	_	_
6	from	_	IN	IN	_	9	case	_	_
7	the	_	DT	DT	_	9	det	_	_
8	cytocidal	_	JJ	JJ	_	9	amod	_	_
9	effect	_	NN	NN	_	16	advcl	_	_
10	on	_	IN	IN	_	12	case	_	_
11	S-phase	_	JJ	JJ	_	12	amod	_	_
12	cells	_	NNS	NNS	_	9	nmod	_	_
14	Ara-C	_	NNP	NNP	_	16	nsubj	_	_
15	also	_	RB	RB	_	16	advmod	_	_
16	kills	_	VBZ	VBZ	_	3	ccomp	_	_
17	cells	_	NNS	NNS	_	19	nsubj	_	_
18	sublethally	_	RB	RB	_	19	advmod	_	_
19	damaged	_	JJ	JJ	_	16	xcomp	_	_
20	by	_	IN	IN	_	23	case	_	_
21	a	_	DT	DT	_	23	det	_	_
22	preceding	_	VBG	VBG	_	23	amod	_	_
23	X-irradiation	_	NN	NN	_	19	nmod	_	_

1	Ribosomal	_	NNP	NNP	_	2	compound	_	_
2	RNA	_	NNP	NNP	_	0	root	_	_
3	on	_	IN	IN	_	5	case	_	_
4	the	_	DT	DT	_	5	det	_	_
5	surfaces	_	NNS	NNS	_	2	nmod	_	_
6	of	_	IN	IN	_	10	case	_	_
7	nonleukemic	_	JJ	JJ	_	10	amod	_	_
8	mouse	_	NN	NN	_	10	compound	_	_
9	ascites_tumor	_	NN	NN	_	10	compound	_	_
10	cells	_	NNS	NNS	_	2	nmod	_	_

1	RNAs	_	NNS	NNS	_	18	nsubjpass	_	_
2	on	_	IN	IN	_	5	case	_	_
3	the	_	DT	DT	_	5	det	_	_
4	cell	_	NN	NN	_	5	compound	_	_
5	surfaces	_	NNS	NNS	_	1	nmod	_	_
6	of	_	IN	IN	_	8	case	_	_
7	two	_	CD	CD	_	8	nummod	_	_
8	nonleukemic	_	NN	NN	_	5	nmod	_	_
9	and	_	CC	CC	_	5	cc	_	_
10	two	_	CD	CD	_	12	nummod	_	_
11	leukemic	_	JJ	JJ	_	12	amod	_	_
12	strains	_	NNS	NNS	_	5	conj	_	_
13	of	_	IN	IN	_	16	case	_	_
14	mouse	_	NN	NN	_	16	compound	_	_
15	ascites_tumor	_	NN	NN	_	16	compound	_	_
16	cells	_	NNS	NNS	_	12	nmod	_	_
17	were	_	VBD	VBD	_	18	auxpass	_	_
18	studied	_	VBN	VBN	_	0	root	_	_
19	by	_	IN	IN	_	20	mark	_	_
20	fractionating	_	VBG	VBG	_	18	nmod	_	_
21	the	_	DT	DT	_	22	det	_	_
22	RNAs	_	NNPS	NNPS	_	23	nsubj	_	_
23	released	_	VBN	VBN	_	20	dep	_	_
24	from	_	IN	IN	_	27	case	_	_
25	the	_	DT	DT	_	27	det	_	_
26	cell	_	NN	NN	_	27	compound	_	_
27	surface	_	NN	NN	_	23	nmod	_	_
28	by	_	IN	IN	_	31	case	_	_
29	gentle	_	JJ	JJ	_	31	amod	_	_
30	pronase	_	NN	NN	_	31	compound	_	_
31	treatment	_	NN	NN	_	23	nmod	_	_
32	after	_	IN	IN	_	36	case	_	_
33	sucrose	_	JJ	JJ	_	36	amod	_	_
34	density	_	NN	NN	_	36	compound	_	_
35	gradient	_	NN	NN	_	36	compound	_	_
36	centrifugation	_	NN	NN	_	23	nmod	_	_
38	by	_	IN	IN	_	41	case	_	_
39	indirect	_	JJ	JJ	_	41	amod	_	_
40	membrane	_	JJ	JJ	_	41	amod	_	_
41	immunofluorescence	_	NN	NN	_	20	conj	_	_
42	that	_	WDT	WDT	_	43	nsubj	_	_
43	used	_	VBD	VBD	_	41	acl:relcl	_	_
44	anti-RNA	_	JJ	JJ	_	45	amod	_	_
45	antibody	_	NN	NN	_	43	dobj	_	_
46	and	_	CC	CC	_	20	cc	_	_
47	by	_	IN	IN	_	49	case	_	_
48	cell	_	NN	NN	_	49	compound	_	_
49	electrophoresis	_	NNS	NNS	_	20	conj	_	_

1	RNA	_	NNP	NNP	_	3	nsubjpass	_	_
2	was	_	VBD	VBD	_	3	auxpass	_	_
3	extracted	_	VBN	VBN	_	0	root	_	_
4	from	_	IN	IN	_	7	case	_	_
5	the	_	DT	DT	_	7	det	_	_
6	cell	_	NN	NN	_	7	compound	_	_
7	supernatants	_	NNS	NNS	_	3	nmod	_	_
8	of	_	IN	IN	_	9	case	_	_
9	Ehrlich_ascites_tumor	_	NNP	NNP	_	7	nmod	_	_
10	and	_	CC	CC	_	7	cc	_	_
11	sarcoma_180	_	JJ	JJ	_	12	amod	_	_
12	cells	_	NNS	NNS	_	7	conj	_	_
14	nonleukemic	_	JJ	JJ	_	12	dep	_	_
16	that	_	WDT	WDT	_	19	nsubjpass	_	_
17	had	_	VBD	VBD	_	19	aux	_	_
18	been	_	VBN	VBN	_	19	auxpass	_	_
19	treated	_	VBN	VBN	_	12	acl:relcl	_	_
20	or	_	CC	CC	_	19	cc	_	_
21	not	_	RB	RB	_	22	neg	_	_
22	treated	_	VBN	VBN	_	19	conj	_	_
23	with	_	IN	IN	_	24	case	_	_
24	pronase	_	NN	NN	_	22	nmod	_	_
26	1	_	CD	CD	_	27	nummod	_	_
27	microgram/ml	_	NN	NN	_	24	dep	_	_
29	37	_	CD	CD	_	30	nummod	_	_
30	degrees	_	NNS	NNS	_	27	appos	_	_
31	C	_	NNP	NNP	_	30	appos	_	_
33	20	_	CD	CD	_	34	nummod	_	_
34	min	_	NN	NN	_	27	appos	_	_
36	followed	_	VBN	VBN	_	24	acl	_	_
37	by	_	IN	IN	_	41	case	_	_
38	sucrose	_	JJ	JJ	_	41	amod	_	_
39	density	_	NN	NN	_	41	compound	_	_
40	gradient	_	NN	NN	_	41	compound	_	_
41	centrifugation	_	NN	NN	_	36	nmod	_	_

1	It	_	PRP	PRP	_	4	nsubjpass	_	_
2	was	_	VBD	VBD	_	4	auxpass	_	_
3	clearly	_	RB	RB	_	4	advmod	_	_
4	demonstrated	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	24	mark	_	_
6	the	_	DT	DT	_	7	det	_	_
7	amounts	_	NNS	NNS	_	24	nsubj	_	_
8	of	_	IN	IN	_	10	case	_	_
9	ribosomal	_	NNP	NNP	_	10	compound	_	_
10	RNA	_	NNP	NNP	_	7	nmod	_	_
12	18S	_	CD	CD	_	10	dep	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	28S	_	CD	CD	_	12	conj	_	_
16	released	_	VBN	VBN	_	10	acl	_	_
17	after	_	IN	IN	_	19	case	_	_
18	pronase	_	JJ	JJ	_	19	amod	_	_
19	treatment	_	NN	NN	_	16	nmod	_	_
20	were	_	VBD	VBD	_	24	cop	_	_
21	approximately	_	RB	RB	_	22	advmod	_	_
22	80	_	CD	CD	_	23	nummod	_	_
23	%	_	NN	NN	_	24	nmod:npmod	_	_
24	greater	_	JJR	JJR	_	4	ccomp	_	_
25	than	_	IN	IN	_	26	case	_	_
26	that	_	DT	DT	_	24	nmod	_	_
27	of	_	IN	IN	_	29	case	_	_
28	nonpronase-treated	_	JJ	JJ	_	29	amod	_	_
29	cells	_	NNS	NNS	_	26	nmod	_	_

1	Ehrlich_ascites_tumor	_	JJ	JJ	_	2	amod	_	_
2	cells	_	NNS	NNS	_	22	nsubj	_	_
3	that	_	WDT	WDT	_	6	nsubjpass	_	_
4	had	_	VBD	VBD	_	6	aux	_	_
5	been	_	VBN	VBN	_	6	auxpass	_	_
6	treated	_	VBN	VBN	_	2	acl:relcl	_	_
7	with	_	IN	IN	_	8	case	_	_
8	actinomycin_D	_	NN	NN	_	6	nmod	_	_
10	100	_	CD	CD	_	13	nummod	_	_
11	micrograms/kg	_	JJ	JJ	_	13	amod	_	_
12	body	_	NN	NN	_	13	compound	_	_
13	weight	_	NN	NN	_	8	dep	_	_
14	of	_	IN	IN	_	15	case	_	_
15	mouse	_	NN	NN	_	13	nmod	_	_
17	16	_	CD	CD	_	18	nummod	_	_
18	h	_	NN	NN	_	15	appos	_	_
20	in	_	IN	IN	_	21	case	_	_
21	vivo	_	NN	NN	_	8	nmod	_	_
22	released	_	VBD	VBD	_	0	root	_	_
23	an	_	DT	DT	_	24	det	_	_
24	amount	_	NN	NN	_	22	dobj	_	_
25	of	_	IN	IN	_	27	case	_	_
26	ribosomal	_	JJ	JJ	_	27	amod	_	_
27	RNA	_	NNP	NNP	_	24	nmod	_	_
28	after	_	IN	IN	_	30	case	_	_
29	pronase	_	JJ	JJ	_	30	amod	_	_
30	treatment	_	NN	NN	_	22	nmod	_	_
31	only	_	RB	RB	_	32	advmod	_	_
32	20	_	CD	CD	_	33	nummod	_	_
33	%	_	NN	NN	_	34	nmod:npmod	_	_
34	greater	_	JJR	JJR	_	37	advmod	_	_
35	than	_	IN	IN	_	37	case	_	_
36	the	_	DT	DT	_	37	det	_	_
37	value	_	NN	NN	_	22	nmod	_	_
38	for	_	IN	IN	_	40	case	_	_
39	untreated	_	JJ	JJ	_	40	amod	_	_
40	cells	_	NNS	NNS	_	37	nmod	_	_

1	Actinomycin_D	_	JJ	JJ	_	2	amod	_	_
2	treatment	_	NN	NN	_	4	nsubj	_	_
3	greatly	_	RB	RB	_	4	advmod	_	_
4	reduced	_	VBD	VBD	_	0	root	_	_
5	both	_	PDT	PDT	_	8	det:predet	_	_
6	the	_	DT	DT	_	8	det	_	_
7	cell	_	NN	NN	_	8	compound	_	_
8	surface	_	NN	NN	_	4	iobj	_	_
9	negative	_	JJ	JJ	_	10	amod	_	_
10	charge	_	NN	NN	_	4	dobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	the	_	DT	DT	_	15	det	_	_
13	cell	_	NN	NN	_	15	compound	_	_
14	surface	_	NN	NN	_	15	compound	_	_
15	immunofluorescence	_	NN	NN	_	10	conj	_	_
16	when	_	WRB	WRB	_	21	advmod	_	_
17	rabbit	_	NN	NN	_	19	compound	_	_
18	anti-RNA	_	NN	NN	_	19	compound	_	_
19	antibody	_	NN	NN	_	21	nsubjpass	_	_
20	was	_	VBD	VBD	_	21	auxpass	_	_
21	used	_	VBN	VBN	_	15	acl:relcl	_	_

1	Under	_	IN	IN	_	5	case	_	_
2	the	_	DT	DT	_	5	det	_	_
3	same	_	JJ	JJ	_	5	amod	_	_
4	experimental	_	JJ	JJ	_	5	amod	_	_
5	conditions	_	NNS	NNS	_	13	nmod	_	_
6	with	_	IN	IN	_	7	case	_	_
7	actinomycin_D	_	NN	NN	_	5	nmod	_	_
9	only	_	RB	RB	_	12	advmod	_	_
10	ribosomal	_	JJ	JJ	_	12	amod	_	_
11	RNA	_	NNP	NNP	_	12	compound	_	_
12	synthesis	_	NNP	NNP	_	13	nsubj	_	_
13	showed	_	VBD	VBD	_	0	root	_	_
14	preferential	_	JJ	JJ	_	15	amod	_	_
15	inhibition	_	NN	NN	_	13	dobj	_	_
17	not	_	RB	RB	_	19	neg	_	_
18	the	_	DT	DT	_	19	det	_	_
19	syntheses	_	NNS	NNS	_	15	appos	_	_
20	of	_	IN	IN	_	24	case	_	_
21	poly	_	JJ	JJ	_	24	amod	_	_
22	A-containing	_	NNP	NNP	_	24	compound	_	_
23	messenger	_	NN	NN	_	24	compound	_	_
24	RNA	_	NNS	NNS	_	19	nmod	_	_
26	4S	_	CD	CD	_	24	conj	_	_
27	or	_	CC	CC	_	24	cc	_	_
28	other	_	JJ	JJ	_	30	amod	_	_
29	small-size	_	JJ	JJ	_	30	amod	_	_
30	RNAs	_	NNS	NNS	_	24	conj	_	_

1	In	_	IN	IN	_	2	case	_	_
2	contrast	_	NN	NN	_	11	nmod	_	_
4	L1210	_	NN	NN	_	7	compound	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	C1498	_	NN	NN	_	4	conj	_	_
7	cells	_	NNS	NNS	_	11	nsubj	_	_
9	leukemic	_	JJ	JJ	_	7	dep	_	_
11	showed	_	VBD	VBD	_	0	root	_	_
12	no	_	DT	DT	_	13	neg	_	_
13	change	_	NN	NN	_	11	dobj	_	_
14	in	_	IN	IN	_	16	case	_	_
15	the	_	DT	DT	_	16	det	_	_
16	amounts	_	NNS	NNS	_	11	nmod	_	_
17	of	_	IN	IN	_	19	case	_	_
18	ribosomal	_	NNP	NNP	_	19	compound	_	_
19	RNA	_	NNP	NNP	_	16	nmod	_	_
20	released	_	VBN	VBN	_	19	acl	_	_
21	after	_	IN	IN	_	23	case	_	_
22	pronase	_	JJ	JJ	_	23	amod	_	_
23	treatment	_	NN	NN	_	20	nmod	_	_

1	L1210	_	NNP	NNP	_	2	compound	_	_
2	cells	_	NNS	NNS	_	4	nsubj	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	showed	_	VBD	VBD	_	0	root	_	_
5	no	_	DT	DT	_	6	neg	_	_
6	change	_	NN	NN	_	4	dobj	_	_
7	in	_	IN	IN	_	11	case	_	_
8	the	_	DT	DT	_	11	det	_	_
9	surface	_	NN	NN	_	11	compound	_	_
10	negative	_	JJ	JJ	_	11	amod	_	_
11	charge	_	NN	NN	_	4	nmod	_	_
12	after	_	IN	IN	_	14	mark	_	_
13	being	_	VBG	VBG	_	14	auxpass	_	_
14	treated	_	VBN	VBN	_	4	advcl	_	_
15	with	_	IN	IN	_	16	case	_	_
16	actinomycin_D	_	NN	NN	_	14	nmod	_	_

2	ABSTRACT	_	NNP	NNP	_	4	compound	_	_
3	TRUNCATED	_	NNP	NNP	_	4	compound	_	_
4	AT	_	NNP	NNP	_	8	nsubj	_	_
5	250	_	CD	CD	_	6	nummod	_	_
6	WORDS	_	NNS	NNS	_	4	dep	_	_
8	-LSB-	_	VBZ	VBZ	_	0	root	_	_
9	130	_	CD	CD	_	11	nummod	_	_
10	retinal	_	JJ	JJ	_	11	amod	_	_
11	detachments	_	NNS	NNS	_	8	dobj	_	_
12	treated	_	VBN	VBN	_	11	acl	_	_
13	by	_	IN	IN	_	15	case	_	_
14	internal	_	JJ	JJ	_	15	amod	_	_
15	plugging	_	NNS	NNS	_	12	nmod	_	_
16	with	_	IN	IN	_	20	case	_	_
17	an	_	DT	DT	_	20	det	_	_
18	expansive	_	JJ	JJ	_	20	amod	_	_
19	gas	_	NN	NN	_	20	compound	_	_
20	-RSB-	_	NN	NN	_	12	nmod	_	_

1	-LSB-	_	NNP	NNP	_	12	nsubj	_	_
2	In	_	IN	IN	_	4	case	_	_
3	vitro	_	JJ	JJ	_	4	amod	_	_
4	study	_	NN	NN	_	12	nmod	_	_
5	of	_	IN	IN	_	8	case	_	_
6	the	_	DT	DT	_	8	det	_	_
7	antipeptic	_	JJ	JJ	_	8	amod	_	_
8	activity	_	NN	NN	_	4	nmod	_	_
9	of	_	IN	IN	_	11	case	_	_
10	antacid	_	NN	NN	_	11	compound	_	_
11	preparations	_	NNS	NNS	_	8	nmod	_	_
12	-RSB-	_	VBZ	VBZ	_	0	root	_	_

1	Silicone	_	VB	VB	_	0	root	_	_
2	oil	_	NN	NN	_	1	dobj	_	_
3	in	_	IN	IN	_	5	case	_	_
4	the	_	DT	DT	_	5	det	_	_
5	anterior_chamber_of_the_eye	_	NN	NN	_	1	nmod	_	_

1	An	_	DT	DT	_	3	det	_	_
2	anguished	_	JJ	JJ	_	3	amod	_	_
3	adolescent	_	NN	NN	_	0	root	_	_

1	Genomic	_	JJ	JJ	_	2	amod	_	_
2	organization	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	8	case	_	_
4	the	_	DT	DT	_	8	det	_	_
5	human	_	JJ	JJ	_	8	amod	_	_
6	oestrogen	_	NN	NN	_	8	compound	_	_
7	receptor	_	NN	NN	_	8	compound	_	_
8	gene	_	NN	NN	_	2	nmod	_	_

1	The	_	DT	DT	_	3	det	_	_
2	oestrogen	_	NN	NN	_	3	compound	_	_
3	receptor	_	NN	NN	_	11	nsubj	_	_
5	ER	_	NNP	NNP	_	3	appos	_	_
7	is	_	VBZ	VBZ	_	11	cop	_	_
8	a	_	DT	DT	_	11	det	_	_
9	ligand-activated	_	JJ	JJ	_	11	amod	_	_
10	transcription	_	NN	NN	_	11	compound	_	_
11	factor	_	NN	NN	_	0	root	_	_
12	composed	_	VBN	VBN	_	11	acl	_	_
13	of	_	IN	IN	_	15	case	_	_
14	several	_	JJ	JJ	_	15	amod	_	_
15	domains	_	NNS	NNS	_	12	nmod	_	_
16	important	_	JJ	JJ	_	15	amod	_	_
17	for	_	IN	IN	_	18	case	_	_
18	hormone	_	NN	NN	_	16	nmod	_	_
19	binding	_	VBG	VBG	_	18	amod	_	_
21	DNA	_	NNP	NNP	_	22	compound	_	_
22	binding	_	NNP	NNP	_	18	conj	_	_
23	and	_	CC	CC	_	18	cc	_	_
24	activation	_	NN	NN	_	18	conj	_	_
25	of	_	IN	IN	_	26	case	_	_
26	transcription	_	NN	NN	_	24	nmod	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	show	_	VBP	VBP	_	0	root	_	_
3	here	_	RB	RB	_	2	advmod	_	_
4	that	_	IN	IN	_	13	mark	_	_
5	the	_	DT	DT	_	8	det	_	_
6	human	_	JJ	JJ	_	8	amod	_	_
7	ER	_	NNP	NNP	_	8	compound	_	_
8	gene	_	NN	NN	_	13	nsubj	_	_
9	is	_	VBZ	VBZ	_	13	cop	_	_
10	greater	_	JJR	JJR	_	12	advmod	_	_
11	than	_	IN	IN	_	12	advmod	_	_
12	140	_	CD	CD	_	13	nummod	_	_
13	kb	_	NN	NN	_	2	ccomp	_	_
14	in	_	IN	IN	_	15	case	_	_
15	length	_	NN	NN	_	13	nmod	_	_
17	split	_	VBN	VBN	_	13	acl	_	_
18	into	_	IN	IN	_	20	case	_	_
19	eight	_	CD	CD	_	20	nummod	_	_
20	exons	_	NNS	NNS	_	17	nmod	_	_
21	and	_	CC	CC	_	13	cc	_	_
22	that	_	IN	IN	_	31	mark	_	_
23	the	_	DT	DT	_	24	det	_	_
24	positions	_	NNS	NNS	_	31	nsubj	_	_
25	of	_	IN	IN	_	27	case	_	_
26	these	_	DT	DT	_	27	det	_	_
27	introns	_	NNS	NNS	_	24	nmod	_	_
28	have	_	VBP	VBP	_	31	aux	_	_
29	been	_	VBN	VBN	_	31	cop	_	_
30	highly	_	RB	RB	_	31	advmod	_	_
31	conserved	_	JJ	JJ	_	13	conj	_	_
32	when	_	WRB	WRB	_	33	advmod	_	_
33	compared	_	VBN	VBN	_	31	advcl	_	_
34	with	_	IN	IN	_	37	case	_	_
35	the	_	DT	DT	_	37	det	_	_
36	chicken	_	NN	NN	_	37	compound	_	_
37	progesterone_receptor	_	NN	NN	_	33	nmod	_	_
38	and	_	CC	CC	_	31	cc	_	_
39	are	_	VBP	VBP	_	41	cop	_	_
40	remarkably	_	RB	RB	_	41	advmod	_	_
41	similar	_	JJ	JJ	_	31	conj	_	_
42	to	_	TO	TO	_	43	case	_	_
43	those	_	DT	DT	_	41	nmod	_	_
44	of	_	IN	IN	_	45	case	_	_
45	one	_	CD	CD	_	43	nmod	_	_
46	of	_	IN	IN	_	50	case	_	_
47	the	_	DT	DT	_	50	det	_	_
48	chicken	_	NN	NN	_	50	compound	_	_
49	thyroid	_	NN	NN	_	50	compound	_	_
50	hormone	_	NN	NN	_	45	nmod	_	_
51	receptor	_	NN	NN	_	52	compound	_	_
52	genes	_	NNS	NNS	_	31	dobj	_	_

1	The	_	DT	DT	_	4	det	_	_
2	N-terminal	_	NNP	NNP	_	4	compound	_	_
3	A/B	_	NNP	NNP	_	4	compound	_	_
4	region	_	NN	NN	_	23	nsubj	_	_
6	which	_	WDT	WDT	_	9	nsubjpass	_	_
7	is	_	VBZ	VBZ	_	9	auxpass	_	_
8	not	_	RB	RB	_	9	neg	_	_
9	conserved	_	VBN	VBN	_	4	acl:relcl	_	_
10	between	_	IN	IN	_	13	case	_	_
11	the	_	DT	DT	_	13	det	_	_
12	different	_	JJ	JJ	_	13	amod	_	_
13	members	_	NNS	NNS	_	9	nmod	_	_
14	of	_	IN	IN	_	18	case	_	_
15	the	_	DT	DT	_	18	det	_	_
16	nuclear	_	JJ	JJ	_	18	amod	_	_
17	receptor	_	NN	NN	_	18	compound	_	_
18	family	_	NN	NN	_	13	nmod	_	_
20	is	_	VBZ	VBZ	_	23	cop	_	_
21	almost	_	RB	RB	_	23	advmod	_	_
22	entirely	_	RB	RB	_	23	advmod	_	_
23	encoded	_	JJ	JJ	_	0	root	_	_
24	within	_	IN	IN	_	27	case	_	_
25	a	_	DT	DT	_	27	det	_	_
26	single	_	JJ	JJ	_	27	amod	_	_
27	exon	_	NN	NN	_	23	nmod	_	_

1	Notably	_	RB	RB	_	16	advmod	_	_
2	each	_	DT	DT	_	16	nsubjpass	_	_
3	of	_	IN	IN	_	8	case	_	_
4	the	_	DT	DT	_	8	det	_	_
5	putative	_	JJ	JJ	_	8	amod	_	_
7	zinc	_	NN	NN	_	8	compound	_	_
8	fingers	_	NNS	NNS	_	2	nmod	_	_
10	of	_	IN	IN	_	14	case	_	_
11	the	_	DT	DT	_	14	det	_	_
12	receptor	_	NN	NN	_	14	compound	_	_
13	DNA-binding	_	NN	NN	_	14	compound	_	_
14	domain	_	NN	NN	_	8	nmod	_	_
15	is	_	VBZ	VBZ	_	16	auxpass	_	_
16	encoded	_	VBN	VBN	_	0	root	_	_
17	separately	_	RB	RB	_	16	advmod	_	_
19	and	_	CC	CC	_	16	cc	_	_
20	the	_	DT	DT	_	22	det	_	_
21	hormone-binding	_	JJ	JJ	_	22	amod	_	_
22	domain	_	NN	NN	_	24	nsubjpass	_	_
23	is	_	VBZ	VBZ	_	24	auxpass	_	_
24	assembled	_	VBN	VBN	_	16	conj	_	_
25	from	_	IN	IN	_	27	case	_	_
26	five	_	CD	CD	_	27	nummod	_	_
27	exons	_	NNS	NNS	_	24	nmod	_	_

1	In	_	IN	IN	_	2	case	_	_
2	addition	_	NN	NN	_	5	nmod	_	_
4	we	_	PRP	PRP	_	5	nsubj	_	_
5	find	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	17	mark	_	_
7	the	_	DT	DT	_	16	det	_	_
8	ER	_	NNP	NNP	_	16	compound	_	_
9	isolated	_	JJ	JJ	_	16	amod	_	_
10	from	_	IN	IN	_	14	case	_	_
11	the	_	DT	DT	_	14	det	_	_
12	human	_	JJ	JJ	_	14	amod	_	_
13	breast_cancer	_	NN	NN	_	14	compound	_	_
14	cell	_	NN	NN	_	9	nmod	_	_
15	line	_	NN	NN	_	16	compound	_	_
16	MCF-7	_	NN	NN	_	17	nsubj	_	_
17	contains	_	VBZ	VBZ	_	5	ccomp	_	_
18	a	_	DT	DT	_	23	det	_	_
19	Gly-400	_	NN	NN	_	23	compound	_	_
21	Val	_	NNP	NNP	_	23	compound	_	_
22	mutation	_	NNP	NNP	_	23	compound	_	_
23	present	_	NN	NN	_	17	dobj	_	_
24	in	_	IN	IN	_	27	case	_	_
25	the	_	DT	DT	_	27	det	_	_
26	hormone-binding	_	JJ	JJ	_	27	amod	_	_
27	domain	_	NN	NN	_	17	nmod	_	_

1	Efficient	_	JJ	JJ	_	3	amod	_	_
2	one-step	_	JJ	JJ	_	3	amod	_	_
3	selection	_	NN	NN	_	7	nsubj	_	_
4	of	_	IN	IN	_	6	case	_	_
5	hepatoma	_	NN	NN	_	6	compound	_	_
6	cell	_	NN	NN	_	3	nmod	_	_
7	variants	_	VBZ	VBZ	_	0	root	_	_
8	of	_	IN	IN	_	10	case	_	_
9	a	_	DT	DT	_	10	det	_	_
10	variety	_	NN	NN	_	7	nmod	_	_
11	of	_	IN	IN	_	12	case	_	_
12	phenotypes	_	NNS	NNS	_	10	nmod	_	_
13	by	_	IN	IN	_	14	case	_	_
14	use	_	NN	NN	_	7	nmod	_	_
15	of	_	IN	IN	_	16	case	_	_
16	aflatoxin_B1	_	CD	CD	_	14	nmod	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	developed	_	VBN	VBN	_	0	root	_	_
4	a	_	DT	DT	_	5	det	_	_
5	method	_	NN	NN	_	3	dobj	_	_
6	to	_	TO	TO	_	7	mark	_	_
7	select	_	VB	VB	_	5	acl	_	_
8	for	_	IN	IN	_	11	case	_	_
9	rat	_	NN	NN	_	11	compound	_	_
10	hepatoma	_	NN	NN	_	11	compound	_	_
11	cells	_	NNS	NNS	_	7	nmod	_	_
12	that	_	WDT	WDT	_	13	nsubj	_	_
13	fail	_	VBP	VBP	_	11	acl:relcl	_	_
14	to	_	TO	TO	_	15	mark	_	_
15	express	_	VB	VB	_	13	xcomp	_	_
16	hepatocyte-specific	_	JJ	JJ	_	17	amod	_	_
17	functions	_	NNS	NNS	_	15	dobj	_	_

1	Well-differentiated	_	JJ	JJ	_	2	amod	_	_
2	cells	_	NNS	NNS	_	3	nsubj	_	_
3	descended	_	VBD	VBD	_	0	root	_	_
4	from	_	IN	IN	_	15	case	_	_
5	the	_	DT	DT	_	15	det	_	_
6	H4IIEC3	_	CD	CD	_	7	compound	_	_
7	hepatoma	_	CD	CD	_	8	nummod	_	_
8	line	_	NN	NN	_	9	nmod:npmod	_	_
9	express	_	JJ	JJ	_	15	amod	_	_
10	aldrin	_	NN	NN	_	15	compound	_	_
11	epoxidase	_	NN	NN	_	15	compound	_	_
13	AE	_	NNP	NNP	_	15	appos	_	_
15	activity	_	NN	NN	_	3	nmod	_	_
17	an	_	DT	DT	_	18	det	_	_
18	indicator	_	NN	NN	_	15	appos	_	_
19	of	_	IN	IN	_	22	case	_	_
20	the	_	DT	DT	_	22	det	_	_
21	liver-specific	_	JJ	JJ	_	22	amod	_	_
22	forms	_	NNS	NNS	_	18	nmod	_	_
23	of	_	IN	IN	_	25	case	_	_
24	cytochromes	_	JJ	JJ	_	25	amod	_	_
25	P450	_	NN	NN	_	22	nmod	_	_
26	and	_	CC	CC	_	3	cc	_	_
28	concurrently	_	RB	RB	_	31	advmod	_	_
30	are	_	VBP	VBP	_	31	cop	_	_
31	able	_	JJ	JJ	_	3	conj	_	_
32	to	_	TO	TO	_	33	mark	_	_
33	activate	_	VBG	VBG	_	31	advcl	_	_
34	the	_	DT	DT	_	36	det	_	_
35	procarcinogen	_	NN	NN	_	36	compound	_	_
36	aflatoxin_B1	_	NN	NN	_	33	dobj	_	_
38	AFB1	_	NNP	NNP	_	36	appos	_	_
40	into	_	IN	IN	_	43	case	_	_
41	highly	_	RB	RB	_	42	advmod	_	_
42	toxic	_	JJ	JJ	_	43	amod	_	_
43	metabolites	_	NNS	NNS	_	33	nmod	_	_

1	Thus	_	RB	RB	_	8	advmod	_	_
3	differentiated	_	JJ	JJ	_	5	amod	_	_
4	hepatoma	_	NN	NN	_	5	compound	_	_
5	cells	_	NNS	NNS	_	8	nsubj	_	_
6	are	_	VBP	VBP	_	8	cop	_	_
7	highly	_	RB	RB	_	8	advmod	_	_
8	sensitive	_	JJ	JJ	_	0	root	_	_
9	to	_	TO	TO	_	10	case	_	_
10	AFB1	_	NNP	NNP	_	8	nmod	_	_
12	while	_	IN	IN	_	24	mark	_	_
13	dedifferentiated	_	JJ	JJ	_	14	amod	_	_
14	derivatives	_	NNS	NNS	_	24	nsubj	_	_
16	which	_	WDT	WDT	_	17	nsubj	_	_
17	fail	_	VBP	VBP	_	14	acl:relcl	_	_
18	to	_	TO	TO	_	19	mark	_	_
19	express	_	VB	VB	_	17	xcomp	_	_
20	AE	_	NNP	NNP	_	21	compound	_	_
21	activity	_	NN	NN	_	19	dobj	_	_
23	are	_	VBP	VBP	_	24	cop	_	_
24	resistant	_	JJ	JJ	_	8	advcl	_	_

1	Exposure	_	JJ	JJ	_	13	dep	_	_
2	of	_	IN	IN	_	5	case	_	_
3	differentiated	_	JJ	JJ	_	5	amod	_	_
4	Fao	_	NNP	NNP	_	5	compound	_	_
5	cells	_	NNS	NNS	_	1	nmod	_	_
6	to	_	TO	TO	_	9	case	_	_
7	10	_	CD	CD	_	9	nummod	_	_
8	microM	_	NN	NN	_	9	compound	_	_
9	AFB1	_	NN	NN	_	1	nmod	_	_
10	for	_	IN	IN	_	12	case	_	_
11	24	_	CD	CD	_	12	nummod	_	_
12	h	_	NN	NN	_	9	nmod	_	_
13	permits	_	VBZ	VBZ	_	0	root	_	_
14	the	_	DT	DT	_	15	det	_	_
15	isolation	_	NN	NN	_	13	dobj	_	_
17	at	_	IN	IN	_	19	case	_	_
18	a	_	DT	DT	_	19	det	_	_
19	frequency	_	NN	NN	_	22	nmod	_	_
20	of	_	IN	IN	_	21	case	_	_
21	5	_	CD	CD	_	19	nmod	_	_
22	x	_	SYM	SYM	_	15	acl:relcl	_	_
23	10	_	CD	CD	_	13	nsubj	_	_
25	-5	_	CD	CD	_	23	appos	_	_
28	of	_	IN	IN	_	30	case	_	_
29	resistant	_	WP$	WP$	_	30	nmod:poss	_	_
30	colonies	_	NNS	NNS	_	34	nmod	_	_
31	that	_	DT	DT	_	32	det	_	_
32	exhibit	_	NN	NN	_	34	nsubj	_	_
33	strongly	_	RB	RB	_	34	advmod	_	_
34	reduced	_	VBD	VBD	_	23	acl:relcl	_	_
35	AE	_	NNP	NNP	_	36	compound	_	_
36	activity	_	NN	NN	_	34	dobj	_	_

1	Strikingly	_	RB	RB	_	8	advmod	_	_
3	various	_	JJ	JJ	_	5	amod	_	_
4	morphological	_	JJ	JJ	_	5	amod	_	_
5	types	_	NNS	NNS	_	8	nsubj	_	_
6	can	_	MD	MD	_	8	aux	_	_
7	be	_	VB	VB	_	8	cop	_	_
8	observed	_	JJ	JJ	_	0	root	_	_

1	In	_	IN	IN	_	5	case	_	_
2	more	_	JJR	JJR	_	4	advmod	_	_
3	than	_	IN	IN	_	2	mwe	_	_
4	90	_	CD	CD	_	5	nummod	_	_
5	%	_	NN	NN	_	13	nmod	_	_
6	of	_	IN	IN	_	8	case	_	_
7	the	_	DT	DT	_	8	det	_	_
8	colonies	_	NNS	NNS	_	5	nmod	_	_
10	cells	_	NNS	NNS	_	13	nsubj	_	_
11	are	_	VBP	VBP	_	13	cop	_	_
12	morphologically	_	RB	RB	_	13	advmod	_	_
13	similar	_	JJ	JJ	_	0	root	_	_
14	to	_	TO	TO	_	18	case	_	_
15	the	_	DT	DT	_	18	det	_	_
16	original	_	JJ	JJ	_	18	amod	_	_
17	differentiated	_	JJ	JJ	_	18	amod	_	_
18	cells	_	NNS	NNS	_	13	nmod	_	_
19	and	_	CC	CC	_	13	cc	_	_
20	accumulate	_	VBP	VBP	_	13	conj	_	_
21	all	_	DT	DT	_	23	det	_	_
22	liver-specific	_	JJ	JJ	_	23	amod	_	_
23	mRNAs	_	NNS	NNS	_	20	dobj	_	_
24	examined	_	VBN	VBN	_	23	acl	_	_
25	in	_	IN	IN	_	26	case	_	_
26	amounts	_	NNS	NNS	_	24	nmod	_	_
27	comparable	_	JJ	JJ	_	26	amod	_	_
28	to	_	TO	TO	_	30	case	_	_
29	Fao	_	NNP	NNP	_	30	compound	_	_
30	cells	_	NNS	NNS	_	27	nmod	_	_

1	Moreover	_	RB	RB	_	5	advmod	_	_
3	they	_	PRP	PRP	_	5	nsubj	_	_
4	are	_	VBP	VBP	_	5	cop	_	_
5	able	_	JJ	JJ	_	0	root	_	_
6	to	_	TO	TO	_	7	mark	_	_
7	carry	_	VB	VB	_	5	xcomp	_	_
8	out	_	RP	RP	_	7	compound:prt	_	_
9	gluconeogenesis	_	NNS	NNS	_	7	dobj	_	_
11	as	_	IN	IN	_	12	mark	_	_
12	judged	_	VBN	VBN	_	9	dep	_	_
13	by	_	IN	IN	_	15	case	_	_
14	their	_	PRP$	PRP$	_	15	nmod:poss	_	_
15	capacity	_	NN	NN	_	12	nmod	_	_
16	to	_	TO	TO	_	17	mark	_	_
17	grow	_	VB	VB	_	15	acl	_	_
18	in	_	IN	IN	_	20	case	_	_
19	glucose-free	_	JJ	JJ	_	20	amod	_	_
20	medium	_	NN	NN	_	17	nmod	_	_

1	For	_	IN	IN	_	4	case	_	_
2	a	_	DT	DT	_	4	det	_	_
3	minor	_	JJ	JJ	_	4	amod	_	_
4	fraction	_	NN	NN	_	10	nmod	_	_
5	of	_	IN	IN	_	6	case	_	_
6	colonies	_	NNS	NNS	_	4	nmod	_	_
8	the	_	DT	DT	_	9	det	_	_
9	cells	_	NNS	NNS	_	10	nsubj	_	_
10	exhibit	_	VB	VB	_	0	root	_	_
11	nonhepatic	_	JJ	JJ	_	12	amod	_	_
12	morphology	_	NN	NN	_	10	dobj	_	_

1	These	_	DT	DT	_	2	det	_	_
2	cells	_	NNS	NNS	_	3	nsubj	_	_
3	fail	_	VBP	VBP	_	0	root	_	_
4	to	_	TO	TO	_	5	mark	_	_
5	express	_	VB	VB	_	3	xcomp	_	_
6	three	_	CD	CD	_	5	dobj	_	_
7	or	_	CC	CC	_	6	cc	_	_
8	more	_	JJR	JJR	_	6	conj	_	_
9	of	_	IN	IN	_	12	case	_	_
10	the	_	DT	DT	_	12	det	_	_
11	liver	_	NN	NN	_	12	compound	_	_
12	functions	_	NNS	NNS	_	6	nmod	_	_
13	and	_	CC	CC	_	3	cc	_	_
14	are	_	VBP	VBP	_	16	cop	_	_
15	not	_	RB	RB	_	16	neg	_	_
16	able	_	JJ	JJ	_	3	conj	_	_
17	to	_	TO	TO	_	18	mark	_	_
18	proliferate	_	VB	VB	_	16	xcomp	_	_
19	in	_	IN	IN	_	21	case	_	_
20	glucose-free	_	JJ	JJ	_	21	amod	_	_
21	medium	_	NN	NN	_	18	nmod	_	_

1	Our	_	PRP$	PRP$	_	2	nmod:poss	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	use	_	NN	NN	_	9	nsubj	_	_
7	of	_	IN	IN	_	8	case	_	_
8	AFB1	_	NNP	NNP	_	6	nmod	_	_
9	constitutes	_	VBZ	VBZ	_	3	ccomp	_	_
10	a	_	DT	DT	_	16	det	_	_
11	simple	_	JJ	JJ	_	16	amod	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	efficient	_	JJ	JJ	_	11	conj	_	_
14	single-step	_	JJ	JJ	_	16	amod	_	_
15	selective	_	JJ	JJ	_	16	amod	_	_
16	method	_	NN	NN	_	9	dobj	_	_
17	for	_	IN	IN	_	18	mark	_	_
18	obtaining	_	VBG	VBG	_	16	acl	_	_
19	variant_hepatoma	_	NN	NN	_	20	compound	_	_
20	cells	_	NNS	NNS	_	18	dobj	_	_
21	of	_	IN	IN	_	24	case	_	_
22	a	_	DT	DT	_	24	det	_	_
23	wide	_	JJ	JJ	_	24	amod	_	_
24	variety	_	NN	NN	_	20	nmod	_	_
25	of	_	IN	IN	_	26	case	_	_
26	phenotypes	_	NNS	NNS	_	24	nmod	_	_

1	The	_	DT	DT	_	5	det	_	_
2	marmoset	_	JJ	JJ	_	5	amod	_	_
3	B-lymphoblastoid	_	JJ	JJ	_	5	amod	_	_
4	cell	_	NN	NN	_	5	compound	_	_
5	line	_	NN	NN	_	9	nsubj	_	_
7	B95-8	_	NNP	NNP	_	5	appos	_	_
9	produces	_	VBZ	VBZ	_	0	root	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	responds	_	VBZ	VBZ	_	9	conj	_	_
12	to	_	TO	TO	_	14	case	_	_
13	B-cell	_	JJ	JJ	_	14	amod	_	_
14	growth	_	NN	NN	_	9	nmod	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	differentiation	_	NN	NN	_	17	compound	_	_
17	factors	_	NNS	NNS	_	14	conj	_	_
19	role	_	NN	NN	_	14	dep	_	_
20	of	_	IN	IN	_	22	case	_	_
21	shed	_	NNP	NNP	_	22	compound	_	_
22	CD23	_	NNP	NNP	_	19	nmod	_	_
24	sCD23	_	NNP	NNP	_	22	appos	_	_

1	The	_	DT	DT	_	5	det	_	_
2	EBV-producing	_	JJ	JJ	_	5	amod	_	_
3	marmoset	_	JJ	JJ	_	5	amod	_	_
4	B-cell	_	NN	NN	_	5	compound	_	_
5	line	_	NN	NN	_	27	nsubjpass	_	_
7	B95-8	_	NNP	NNP	_	5	appos	_	_
10	commonly	_	RB	RB	_	11	advmod	_	_
11	used	_	VBN	VBN	_	5	acl	_	_
12	as	_	IN	IN	_	14	case	_	_
13	a	_	DT	DT	_	14	det	_	_
14	source	_	NN	NN	_	11	nmod	_	_
15	of	_	IN	IN	_	16	case	_	_
16	EBV	_	NNP	NNP	_	14	nmod	_	_
17	for	_	IN	IN	_	18	case	_	_
18	stimulation	_	NN	NN	_	11	nmod	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	transformation	_	NN	NN	_	18	conj	_	_
21	of	_	IN	IN	_	24	case	_	_
22	human	_	JJ	JJ	_	24	amod	_	_
23	B	_	NNP	NNP	_	24	compound	_	_
24	cells	_	NNS	NNS	_	18	nmod	_	_
26	was	_	VBD	VBD	_	27	auxpass	_	_
27	shown	_	VBN	VBN	_	0	root	_	_
28	to	_	TO	TO	_	29	mark	_	_
29	proliferate	_	VB	VB	_	27	xcomp	_	_
30	in	_	IN	IN	_	31	case	_	_
31	response	_	NN	NN	_	29	nmod	_	_
32	to	_	TO	TO	_	33	case	_	_
33	supernatants	_	NNS	NNS	_	29	nmod	_	_
34	containing	_	VBG	VBG	_	33	acl	_	_
35	human	_	JJ	JJ	_	38	amod	_	_
36	B-cell	_	NNP	NNP	_	38	compound	_	_
37	growth	_	NN	NN	_	38	compound	_	_
38	factors	_	NNS	NNS	_	34	dobj	_	_
40	BCGF	_	NNP	NNP	_	38	appos	_	_
42	derived	_	VBN	VBN	_	38	acl	_	_
43	from	_	IN	IN	_	46	case	_	_
44	PHA-activated	_	JJ	JJ	_	46	amod	_	_
45	T	_	NNP	NNP	_	46	compound	_	_
46	cells	_	NNS	NNS	_	42	nmod	_	_
47	or	_	CC	CC	_	46	cc	_	_
48	the	_	DT	DT	_	51	det	_	_
49	KG-la	_	JJ	JJ	_	51	amod	_	_
50	cell	_	NN	NN	_	51	compound	_	_
51	line	_	NN	NN	_	46	conj	_	_
53	and	_	CC	CC	_	46	cc	_	_
54	to	_	TO	TO	_	60	case	_	_
55	a	_	DT	DT	_	60	det	_	_
56	commercial	_	JJ	JJ	_	60	amod	_	_
57	low	_	JJ	JJ	_	60	amod	_	_
58	molecular	_	JJ	JJ	_	60	amod	_	_
59	weight	_	NN	NN	_	60	compound	_	_
60	BCGF	_	NN	NN	_	46	conj	_	_
62	BCGFlow	_	NNP	NNP	_	60	appos	_	_
65	but	_	CC	CC	_	66	cc	_	_
66	not	_	RB	RB	_	33	cc	_	_
67	to	_	TO	TO	_	68	case	_	_
68	recombinant_human_IL-4	_	JJ	JJ	_	33	conj	_	_
70	rhIL-4	_	JJ	JJ	_	68	dep	_	_

1	In	_	IN	IN	_	3	case	_	_
2	this	_	DT	DT	_	3	det	_	_
3	respect	_	NN	NN	_	6	nmod	_	_
5	B95-8	_	NNP	NNP	_	6	nsubj	_	_
6	responded	_	VBD	VBD	_	0	root	_	_
7	in	_	IN	IN	_	11	case	_	_
8	much	_	RB	RB	_	11	advmod	_	_
9	the	_	DT	DT	_	11	det	_	_
10	same	_	JJ	JJ	_	11	amod	_	_
11	way	_	NN	NN	_	6	nmod	_	_
12	as	_	IN	IN	_	17	case	_	_
13	human	_	JJ	JJ	_	17	amod	_	_
14	EBV-transformed	_	JJ	JJ	_	17	amod	_	_
15	lymphoblastoid	_	JJ	JJ	_	17	amod	_	_
16	cell	_	NN	NN	_	17	compound	_	_
17	lines	_	NNS	NNS	_	11	nmod	_	_
19	LCL	_	NNP	NNP	_	17	appos	_	_

1	In	_	IN	IN	_	2	case	_	_
2	contrast	_	NN	NN	_	7	nmod	_	_
4	B95-8	_	NNP	NNP	_	7	nsubj	_	_
5	did	_	VBD	VBD	_	7	aux	_	_
6	not	_	RB	RB	_	7	neg	_	_
7	secrete	_	VB	VB	_	0	root	_	_
8	immunoglobulin	_	NN	NN	_	7	dobj	_	_
9	in	_	IN	IN	_	10	case	_	_
10	response	_	NN	NN	_	7	nmod	_	_
11	to	_	TO	TO	_	12	case	_	_
12	B-cell_differentiation_factor	_	NNP	NNP	_	10	nmod	_	_
14	BCDF	_	NNP	NNP	_	12	appos	_	_
16	containing	_	VBG	VBG	_	10	dep	_	_
17	supernatants	_	NNS	NNS	_	16	dobj	_	_
18	from	_	IN	IN	_	22	case	_	_
19	the	_	DT	DT	_	22	det	_	_
20	KG-la	_	JJ	JJ	_	22	amod	_	_
21	cell	_	NN	NN	_	22	compound	_	_
22	line	_	NN	NN	_	16	nmod	_	_
24	nor	_	CC	CC	_	16	cc	_	_
25	to	_	TO	TO	_	26	case	_	_
26	BCGFlow	_	NNP	NNP	_	16	conj	_	_
28	or	_	CC	CC	_	10	cc	_	_
29	IL-6	_	NN	NN	_	10	conj	_	_
30	obtained	_	VBN	VBN	_	29	acl	_	_
31	from	_	IN	IN	_	36	case	_	_
32	the	_	DT	DT	_	36	det	_	_
33	T24	_	NNP	NNP	_	36	compound	_	_
34	bladder_carcinoma	_	NN	NN	_	36	compound	_	_
35	cell	_	NN	NN	_	36	compound	_	_
36	line	_	NN	NN	_	30	nmod	_	_
38	whereas	_	IN	IN	_	42	mark	_	_
39	significant	_	JJ	JJ	_	40	amod	_	_
40	responses	_	NNS	NNS	_	42	nsubjpass	_	_
41	were	_	VBD	VBD	_	42	auxpass	_	_
42	obtained	_	VBN	VBN	_	30	advcl	_	_
43	with	_	IN	IN	_	46	case	_	_
44	human	_	JJ	JJ	_	46	amod	_	_
45	EBV-transformed	_	JJ	JJ	_	46	amod	_	_
46	LCL	_	NN	NN	_	42	nmod	_	_

1	Both	_	DT	DT	_	2	det	_	_
2	B95-8	_	NN	NN	_	8	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	control	_	NN	NN	_	7	compound	_	_
5	EBV-transformed	_	JJ	JJ	_	7	amod	_	_
6	human	_	JJ	JJ	_	7	amod	_	_
7	LCL	_	NN	NN	_	2	conj	_	_
8	secreted	_	VBD	VBD	_	0	root	_	_
9	BCGF	_	NNP	NNP	_	12	nsubj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	BCDF	_	NNP	NNP	_	9	conj	_	_
12	detected	_	VBD	VBD	_	8	ccomp	_	_
13	with	_	IN	IN	_	15	case	_	_
14	the	_	DT	DT	_	15	det	_	_
15	indicator	_	NN	NN	_	12	nmod	_	_
16	B-cell	_	JJ	JJ	_	18	amod	_	_
17	lines	_	NNS	NNS	_	18	compound	_	_
18	CESS	_	NNS	NNS	_	12	dobj	_	_
20	L4	_	NNP	NNP	_	18	conj	_	_
22	and	_	CC	CC	_	18	cc	_	_
23	HFB1	_	NNP	NNP	_	18	conj	_	_
25	but	_	CC	CC	_	26	cc	_	_
26	only	_	RB	RB	_	18	cc	_	_
27	the	_	DT	DT	_	29	det	_	_
28	human	_	JJ	JJ	_	29	amod	_	_
29	LCL	_	NN	NN	_	18	conj	_	_
30	secreted	_	VBN	VBN	_	29	acl	_	_
31	BCGF	_	NNP	NNP	_	32	compound	_	_
32	detectable	_	NNP	NNP	_	30	dobj	_	_
33	in	_	IN	IN	_	35	case	_	_
34	co-stimulation	_	JJ	JJ	_	35	amod	_	_
35	assays	_	NNS	NNS	_	32	nmod	_	_
36	with	_	IN	IN	_	40	case	_	_
37	TPA-activated	_	JJ	JJ	_	40	amod	_	_
38	tonsillar	_	NN	NN	_	40	compound	_	_
39	B	_	NN	NN	_	40	compound	_	_
40	cells	_	NNS	NNS	_	30	nmod	_	_

1	Unlike	_	IN	IN	_	3	case	_	_
2	EBV-transformed	_	NNP	NNP	_	3	compound	_	_
3	LCL	_	NNP	NNP	_	8	nmod	_	_
5	B95-8	_	NNP	NNP	_	8	nsubj	_	_
6	did	_	VBD	VBD	_	8	aux	_	_
7	not	_	RB	RB	_	8	neg	_	_
8	express	_	VB	VB	_	0	root	_	_
9	detectable	_	JJ	JJ	_	11	amod	_	_
10	surface	_	NN	NN	_	11	compound	_	_
11	CD23	_	NN	NN	_	8	dobj	_	_
13	and	_	CC	CC	_	8	cc	_	_
14	did	_	VBD	VBD	_	16	aux	_	_
15	not	_	RB	RB	_	16	neg	_	_
16	release	_	VB	VB	_	8	conj	_	_
17	into	_	IN	IN	_	20	case	_	_
18	the	_	DT	DT	_	20	det	_	_
19	culture	_	NN	NN	_	20	compound	_	_
20	medium	_	NN	NN	_	16	nmod	_	_
21	soluble	_	JJ	JJ	_	22	amod	_	_
22	CD23	_	NN	NN	_	16	dobj	_	_
24	sCD23	_	NNP	NNP	_	22	appos	_	_
26	recognized	_	VBN	VBN	_	22	acl	_	_
27	by	_	IN	IN	_	29	case	_	_
28	an	_	DT	DT	_	29	det	_	_
29	EIA	_	NNP	NNP	_	26	nmod	_	_
30	for	_	IN	IN	_	33	case	_	_
31	the	_	DT	DT	_	33	det	_	_
32	human	_	JJ	JJ	_	33	amod	_	_
33	molecule	_	NN	NN	_	29	nmod	_	_

1	Although	_	IN	IN	_	3	mark	_	_
2	not	_	RB	RB	_	3	neg	_	_
3	releasing	_	VBG	VBG	_	9	advcl	_	_
4	detectable	_	JJ	JJ	_	5	amod	_	_
5	sCD23	_	NNS	NNS	_	3	dobj	_	_
7	B95-8	_	NN	NN	_	8	compound	_	_
8	cells	_	NNS	NNS	_	9	nsubj	_	_
9	did	_	VBD	VBD	_	0	root	_	_
10	proliferate	_	NNS	NNS	_	9	dobj	_	_
11	in	_	IN	IN	_	12	case	_	_
12	response	_	NN	NN	_	9	nmod	_	_
13	to	_	TO	TO	_	16	case	_	_
14	purified	_	JJ	JJ	_	16	amod	_	_
15	human	_	JJ	JJ	_	16	amod	_	_
16	sCD23	_	NNS	NNS	_	9	nmod	_	_
18	and	_	CC	CC	_	9	cc	_	_
19	were	_	VBD	VBD	_	20	auxpass	_	_
20	found	_	VBN	VBN	_	9	conj	_	_
21	to	_	TO	TO	_	26	mark	_	_
22	be	_	VB	VB	_	26	cop	_	_
23	1000	_	CD	CD	_	24	nummod	_	_
24	times	_	NNS	NNS	_	26	dep	_	_
25	more	_	RBR	RBR	_	26	advmod	_	_
26	sensitive	_	JJ	JJ	_	20	xcomp	_	_
27	in	_	IN	IN	_	29	case	_	_
28	this	_	DT	DT	_	29	det	_	_
29	assay	_	NN	NN	_	26	nmod	_	_
30	than	_	IN	IN	_	32	case	_	_
31	EBV-transformed	_	NNP	NNP	_	32	compound	_	_
32	LCL	_	NNP	NNP	_	29	nmod	_	_

1	This	_	DT	DT	_	3	nsubj	_	_
2	may	_	MD	MD	_	3	aux	_	_
3	provide	_	VB	VB	_	0	root	_	_
4	a	_	DT	DT	_	5	det	_	_
5	basis	_	NN	NN	_	3	dobj	_	_
6	for	_	IN	IN	_	9	case	_	_
7	a	_	DT	DT	_	9	det	_	_
8	sensitive	_	JJ	JJ	_	9	amod	_	_
9	bioassay	_	NN	NN	_	3	nmod	_	_
10	for	_	IN	IN	_	11	case	_	_
11	sCD23	_	CD	CD	_	9	nmod	_	_

1	Unlike	_	IN	IN	_	3	case	_	_
2	EBV-transformed	_	NNP	NNP	_	3	compound	_	_
3	LCL	_	NNP	NNP	_	6	nmod	_	_
5	it	_	PRP	PRP	_	6	nsubj	_	_
6	seems	_	VBZ	VBZ	_	0	root	_	_
7	that	_	IN	IN	_	14	mark	_	_
8	in	_	IN	IN	_	9	dep	_	_
9	vitro	_	NN	NN	_	10	amod	_	_
10	proliferation	_	NN	NN	_	14	nsubj	_	_
11	of	_	IN	IN	_	12	case	_	_
12	B95-8	_	NN	NN	_	10	nmod	_	_
13	may	_	MD	MD	_	14	aux	_	_
14	involve	_	VB	VB	_	6	ccomp	_	_
15	an	_	DT	DT	_	17	det	_	_
16	autocrine	_	JJ	JJ	_	17	amod	_	_
17	loop	_	NN	NN	_	14	dobj	_	_
18	which	_	WDT	WDT	_	21	nsubj	_	_
19	does	_	VBZ	VBZ	_	21	aux	_	_
20	not	_	RB	RB	_	21	neg	_	_
21	depend	_	VB	VB	_	17	acl:relcl	_	_
22	on	_	IN	IN	_	23	case	_	_
23	CD23	_	NNP	NNP	_	21	nmod	_	_

1	Accuracy	_	NNP	NNP	_	11	nsubj	_	_
2	of	_	IN	IN	_	7	case	_	_
3	a	_	DT	DT	_	7	det	_	_
4	central	_	JJ	JJ	_	7	amod	_	_
5	mass	_	JJ	JJ	_	7	amod	_	_
6	spectrometer	_	NN	NN	_	7	compound	_	_
7	system	_	NN	NN	_	1	nmod	_	_
8	at	_	IN	IN	_	10	case	_	_
9	high	_	JJ	JJ	_	10	amod	_	_
10	respiratory	_	NN	NN	_	7	nmod	_	_
11	frequencies	_	VBZ	VBZ	_	0	root	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	shown	_	VBN	VBN	_	0	root	_	_
4	that	_	DT	DT	_	3	dobj	_	_
5	in	_	IN	IN	_	7	case	_	_
6	a	_	DT	DT	_	7	det	_	_
7	laboratory	_	NN	NN	_	4	nmod	_	_
8	setting	_	VBG	VBG	_	7	acl	_	_
9	the	_	DT	DT	_	11	det	_	_
10	long	_	JJ	JJ	_	11	amod	_	_
11	lengths	_	NNS	NNS	_	8	dobj	_	_
12	of	_	IN	IN	_	13	mark	_	_
13	sampling	_	VBG	VBG	_	11	acl	_	_
14	catheters	_	NNS	NNS	_	15	nsubj	_	_
15	necessary	_	JJ	JJ	_	13	xcomp	_	_
16	to	_	TO	TO	_	17	mark	_	_
17	access	_	VB	VB	_	15	xcomp	_	_
18	a	_	DT	DT	_	21	det	_	_
19	central	_	JJ	JJ	_	21	amod	_	_
20	mass	_	NN	NN	_	21	compound	_	_
21	spectrometer	_	NN	NN	_	22	nsubj	_	_
22	restrict	_	VB	VB	_	17	ccomp	_	_
23	the	_	DT	DT	_	25	det	_	_
24	high-frequency	_	JJ	JJ	_	25	amod	_	_
25	response	_	NN	NN	_	22	dobj	_	_
26	of	_	IN	IN	_	28	case	_	_
27	the	_	DT	DT	_	28	det	_	_
28	system	_	NN	NN	_	25	nmod	_	_

1	Reported	_	NNP	NNP	_	5	nsubj	_	_
2	here	_	RB	RB	_	5	advmod	_	_
3	are	_	VBP	VBP	_	5	cop	_	_
4	the	_	DT	DT	_	5	det	_	_
5	results	_	NNS	NNS	_	0	root	_	_
6	from	_	IN	IN	_	12	case	_	_
7	a	_	DT	DT	_	12	det	_	_
8	clinically	_	RB	RB	_	9	advmod	_	_
9	operating	_	VBG	VBG	_	12	amod	_	_
10	Perkin-Elmer	_	NNP	NNP	_	12	compound	_	_
11	Advantage	_	NNP	NNP	_	12	compound	_	_
12	system	_	NN	NN	_	5	nmod	_	_

1	The	_	DT	DT	_	3	det	_	_
2	sampling	_	VBG	VBG	_	3	amod	_	_
3	catheter	_	NN	NN	_	4	nsubj	_	_
4	was	_	VBD	VBD	_	0	root	_	_
5	50	_	CD	CD	_	6	nummod	_	_
6	meters	_	NNS	NNS	_	7	nmod:npmod	_	_
7	long	_	RB	RB	_	4	advmod	_	_
8	and	_	CC	CC	_	4	cc	_	_
9	the	_	DT	DT	_	11	det	_	_
10	sampling	_	VBG	VBG	_	11	amod	_	_
11	flow	_	NN	NN	_	14	nsubj	_	_
12	was	_	VBD	VBD	_	14	cop	_	_
13	240	_	CD	CD	_	14	nummod	_	_
14	ml/min	_	NN	NN	_	4	conj	_	_

1	Rapid	_	NNP	NNP	_	2	compound	_	_
2	changes	_	NNS	NNS	_	7	nsubjpass	_	_
3	in	_	IN	IN	_	5	case	_	_
4	carbon_dioxide	_	JJ	JJ	_	5	amod	_	_
5	concentration	_	NN	NN	_	2	nmod	_	_
6	were	_	VBD	VBD	_	7	auxpass	_	_
7	created	_	VBN	VBN	_	0	root	_	_
8	by	_	IN	IN	_	13	case	_	_
9	an	_	DT	DT	_	13	det	_	_
10	electronically	_	RB	RB	_	11	advmod	_	_
11	operated	_	VBN	VBN	_	13	amod	_	_
12	solenoid	_	JJ	JJ	_	13	amod	_	_
13	valve	_	NN	NN	_	7	nmod	_	_
14	switching	_	VBG	VBG	_	13	acl	_	_
15	between	_	IN	IN	_	16	advmod	_	_
16	6.94	_	CD	CD	_	17	dep	_	_
17	%	_	NN	NN	_	18	dep	_	_
18	CO2	_	NN	NN	_	14	dobj	_	_
19	in	_	IN	IN	_	24	case	_	_
20	50	_	CD	CD	_	21	compound	_	_
21	%	_	NN	NN	_	24	amod	_	_
22	O2	_	NNP	NNP	_	24	compound	_	_
23	balance	_	NN	NN	_	24	compound	_	_
24	N2	_	NNS	NNS	_	14	nmod	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	100	_	CD	CD	_	27	compound	_	_
27	%	_	NN	NN	_	28	amod	_	_
28	O2	_	NN	NN	_	24	conj	_	_

1	The	_	DT	DT	_	2	det	_	_
2	frequency	_	NN	NN	_	8	nsubjpass	_	_
3	of	_	IN	IN	_	6	case	_	_
4	this	_	DT	DT	_	6	det	_	_
5	simulated	_	JJ	JJ	_	6	amod	_	_
6	breathing	_	NN	NN	_	2	nmod	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	varied	_	VBN	VBN	_	0	root	_	_
9	between	_	IN	IN	_	10	amod	_	_
10	10	_	CD	CD	_	13	nummod	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	100	_	CD	CD	_	10	conj	_	_
13	breaths/min	_	NNS	NNS	_	8	dobj	_	_
14	with	_	IN	IN	_	16	case	_	_
15	the	_	DT	DT	_	16	det	_	_
16	ratio	_	NN	NN	_	8	nmod	_	_
17	of	_	IN	IN	_	18	case	_	_
18	inspiration	_	NN	NN	_	16	nmod	_	_
19	to	_	TO	TO	_	20	case	_	_
20	expiration	_	NN	NN	_	8	nmod	_	_
21	fixed	_	VBN	VBN	_	20	acl	_	_
22	at	_	IN	IN	_	23	case	_	_
23	1:2	_	CD	CD	_	21	nmod	_	_

1	Data	_	NNP	NNP	_	3	nsubjpass	_	_
2	were	_	VBD	VBD	_	3	auxpass	_	_
3	taken	_	VBN	VBN	_	0	root	_	_
4	from	_	IN	IN	_	6	case	_	_
5	the	_	DT	DT	_	6	det	_	_
6	terminal	_	NN	NN	_	3	nmod	_	_
7	in	_	IN	IN	_	10	case	_	_
8	the	_	DT	DT	_	10	det	_	_
9	operating	_	VBG	VBG	_	10	amod	_	_
10	room	_	NN	NN	_	6	nmod	_	_

1	Errors	_	RB	RB	_	10	advmod	_	_
2	greater	_	JJR	JJR	_	4	advmod	_	_
3	than	_	IN	IN	_	4	advmod	_	_
4	5	_	CD	CD	_	5	nummod	_	_
5	%	_	NN	NN	_	10	nsubj	_	_
6	of	_	IN	IN	_	9	case	_	_
7	the	_	DT	DT	_	9	det	_	_
8	true	_	JJ	JJ	_	9	amod	_	_
9	value	_	NN	NN	_	5	nmod	_	_
10	occurred	_	VBD	VBD	_	0	root	_	_
11	at	_	IN	IN	_	13	case	_	_
12	35	_	CD	CD	_	13	nummod	_	_
13	breaths/min	_	NN	NN	_	10	nmod	_	_
14	for	_	IN	IN	_	18	case	_	_
15	the	_	DT	DT	_	18	det	_	_
16	indicated	_	VBN	VBN	_	18	amod	_	_
17	inspired	_	JJ	JJ	_	18	amod	_	_
18	concentration	_	NN	NN	_	10	nmod	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	73	_	CD	CD	_	21	nummod	_	_
21	breaths/min	_	NN	NN	_	18	conj	_	_
22	for	_	IN	IN	_	26	case	_	_
23	the	_	DT	DT	_	26	det	_	_
24	indicated	_	JJ	JJ	_	26	amod	_	_
25	expired	_	VBN	VBN	_	26	amod	_	_
26	concentration	_	NN	NN	_	21	nmod	_	_

1	For	_	IN	IN	_	3	case	_	_
2	critical	_	JJ	JJ	_	3	amod	_	_
3	situations	_	NNS	NNS	_	20	nmod	_	_
4	in	_	IN	IN	_	5	case	_	_
5	which	_	WDT	WDT	_	8	nmod	_	_
6	respiratory	_	JJ	JJ	_	7	amod	_	_
7	frequencies	_	NNS	NNS	_	8	nsubj	_	_
8	exceed	_	VBP	VBP	_	3	acl:relcl	_	_
9	40	_	CD	CD	_	10	nummod	_	_
10	breaths/min	_	NN	NN	_	8	dobj	_	_
12	a	_	DT	DT	_	16	det	_	_
13	centrally	_	RB	RB	_	14	advmod	_	_
14	located	_	VBN	VBN	_	16	amod	_	_
15	mass	_	NN	NN	_	16	compound	_	_
16	spectrometer	_	NN	NN	_	20	nsubj	_	_
17	may	_	MD	MD	_	20	aux	_	_
18	not	_	RB	RB	_	20	neg	_	_
19	be	_	VB	VB	_	20	cop	_	_
20	adequate	_	JJ	JJ	_	0	root	_	_
21	for	_	IN	IN	_	22	mark	_	_
22	measuring	_	VBG	VBG	_	20	advcl	_	_
23	CO2	_	NNP	NNP	_	22	dobj	_	_
24	because	_	RB	RB	_	26	case	_	_
25	of	_	IN	IN	_	24	mwe	_	_
26	errors	_	NNS	NNS	_	23	nmod	_	_
27	introduced	_	VBN	VBN	_	26	acl	_	_
28	by	_	IN	IN	_	32	case	_	_
29	the	_	DT	DT	_	32	det	_	_
30	long	_	JJ	JJ	_	32	amod	_	_
31	sampling	_	JJ	JJ	_	32	amod	_	_
32	catheters	_	NNS	NNS	_	27	nmod	_	_

1	-LSB-	_	NNP	NNP	_	4	compound	_	_
2	The	_	NNP	NNP	_	4	compound	_	_
3	German	_	NNP	NNP	_	4	compound	_	_
4	Society	_	NNP	NNP	_	11	nsubj	_	_
5	of	_	IN	IN	_	10	case	_	_
6	Pediatric	_	NNP	NNP	_	10	compound	_	_
7	Oncology	_	NNP	NNP	_	10	compound	_	_
8	Cooperative	_	NNP	NNP	_	10	compound	_	_
9	Ewing_Sarcoma	_	NNP	NNP	_	10	compound	_	_
10	Studies	_	NNPS	NNPS	_	4	nmod	_	_
11	CESS	_	VBZ	VBZ	_	0	root	_	_
12	81/86	_	CD	CD	_	11	dobj	_	_
14	report	_	NN	NN	_	18	nsubj	_	_
15	after	_	IN	IN	_	17	case	_	_
16	6 1/2	_	CD	CD	_	17	nummod	_	_
17	years	_	NNS	NNS	_	14	nmod	_	_
18	-RSB-	_	VBZ	VBZ	_	11	parataxis	_	_

1	The	_	DT	DT	_	4	det	_	_
2	GPO	_	NNP	NNP	_	4	compound	_	_
3	Cooperative	_	NNP	NNP	_	4	compound	_	_
4	Ewing	_	NNP	NNP	_	7	nmod:poss	_	_
5	's	_	POS	POS	_	4	case	_	_
6	Sarcoma	_	NNP	NNP	_	7	compound	_	_
7	Study	_	NNP	NNP	_	41	nsubj	_	_
9	CESS	_	NNP	NNP	_	7	dep	_	_
10	81	_	CD	CD	_	9	nummod	_	_
11	with	_	IN	IN	_	13	case	_	_
12	10	_	CD	CD	_	13	nummod	_	_
13	months	_	NNS	NNS	_	9	nmod	_	_
14	four-drug	_	JJ	JJ	_	16	amod	_	_
15	combination	_	NN	NN	_	16	compound	_	_
16	chemotherapy	_	NN	NN	_	13	dep	_	_
18	vincristine	_	NN	NN	_	16	dep	_	_
20	actinomycin_D	_	NN	NN	_	18	conj	_	_
22	cyclophosphamide	_	NN	NN	_	18	conj	_	_
24	and	_	CC	CC	_	18	cc	_	_
25	adriamycin	_	NN	NN	_	18	conj	_	_
26	=	_	SYM	SYM	_	27	dep	_	_
27	VACA	_	NNP	NNP	_	18	acl:relcl	_	_
29	and	_	CC	CC	_	7	cc	_	_
30	local	_	JJ	JJ	_	31	amod	_	_
31	control	_	NN	NN	_	7	conj	_	_
32	with	_	IN	IN	_	35	case	_	_
33	surgery	_	NN	NN	_	35	compound	_	_
34	and/or	_	NN	NN	_	35	compound	_	_
35	radiation	_	NN	NN	_	31	nmod	_	_
37	following	_	VBG	VBG	_	38	case	_	_
38	week	_	NN	NN	_	7	nmod	_	_
39	18	_	CD	CD	_	38	nummod	_	_
41	resulted	_	VBD	VBD	_	0	root	_	_
42	in	_	IN	IN	_	47	case	_	_
43	a	_	DT	DT	_	47	det	_	_
44	Kaplan-Meier	_	JJ	JJ	_	47	amod	_	_
45	estimated	_	JJ	JJ	_	47	amod	_	_
46	disease-free	_	JJ	JJ	_	47	amod	_	_
47	survival	_	NN	NN	_	41	nmod	_	_
48	of	_	IN	IN	_	50	case	_	_
49	51	_	CD	CD	_	50	nummod	_	_
50	%	_	NN	NN	_	47	nmod	_	_
51	after	_	IN	IN	_	53	case	_	_
52	6 1/2	_	CD	CD	_	53	nummod	_	_
53	years	_	NNS	NNS	_	41	nmod	_	_
55	51/93	_	CD	CD	_	56	nummod	_	_
56	patients	_	NNS	NNS	_	57	nmod:npmod	_	_
57	disease-free	_	JJ	JJ	_	53	dep	_	_

1	Tumor	_	JJ	JJ	_	2	amod	_	_
2	volume	_	NN	NN	_	10	nsubjpass	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	histological	_	NN	NN	_	5	compound	_	_
5	response	_	NN	NN	_	2	conj	_	_
6	to	_	TO	TO	_	8	case	_	_
7	primary	_	JJ	JJ	_	8	amod	_	_
8	chemotherapy	_	NN	NN	_	2	nmod	_	_
9	were	_	VBD	VBD	_	10	auxpass	_	_
10	identified	_	VBN	VBN	_	0	root	_	_
11	as	_	IN	IN	_	15	case	_	_
12	most	_	RBS	RBS	_	15	advmod	_	_
13	significant	_	JJ	JJ	_	15	amod	_	_
14	prognostic	_	JJ	JJ	_	15	amod	_	_
15	factors	_	NNS	NNS	_	10	nmod	_	_

1	As	_	IN	IN	_	3	case	_	_
2	a	_	DT	DT	_	3	det	_	_
3	consequence	_	NN	NN	_	10	nmod	_	_
5	the	_	DT	DT	_	8	det	_	_
6	CESS	_	NNP	NNP	_	8	compound	_	_
7	86	_	CD	CD	_	8	nummod	_	_
8	regimen	_	NN	NN	_	10	nsubj	_	_
9	was	_	VBD	VBD	_	10	cop	_	_
10	stratified	_	JJ	JJ	_	0	root	_	_
11	according	_	VBG	VBG	_	13	case	_	_
12	to	_	TO	TO	_	11	mwe	_	_
13	risk	_	NN	NN	_	10	nmod	_	_
14	of	_	IN	IN	_	15	case	_	_
15	relapse	_	NN	NN	_	13	nmod	_	_

1	Standard	_	NNP	NNP	_	3	compound	_	_
2	risk	_	NN	NN	_	3	compound	_	_
3	patients	_	NNS	NNS	_	14	nsubjpass	_	_
5	extremity_tumors	_	NNS	NNS	_	3	dep	_	_
6	less	_	JJR	JJR	_	8	advmod	_	_
7	than	_	IN	IN	_	6	mwe	_	_
8	100	_	CD	CD	_	5	dep	_	_
9	ml	_	NN	NN	_	11	compound	_	_
10	tumor	_	NN	NN	_	11	compound	_	_
11	volume	_	NN	NN	_	8	dep	_	_
13	were	_	VBD	VBD	_	14	auxpass	_	_
14	continued	_	VBN	VBN	_	0	root	_	_
15	on	_	IN	IN	_	17	case	_	_
16	VACA	_	NNP	NNP	_	17	compound	_	_
17	chemotherapy	_	NN	NN	_	14	nmod	_	_

1	In	_	IN	IN	_	4	case	_	_
2	high	_	JJ	JJ	_	4	amod	_	_
3	risk	_	NN	NN	_	4	compound	_	_
4	patients	_	NNS	NNS	_	26	nmod	_	_
6	extremity_tumors	_	NNS	NNS	_	4	dep	_	_
7	greater	_	JJR	JJR	_	9	advmod	_	_
8	than	_	IN	IN	_	9	advmod	_	_
9	100	_	CD	CD	_	11	nummod	_	_
10	ml	_	NN	NN	_	11	compound	_	_
11	tumor_volume	_	NN	NN	_	6	dep	_	_
13	_	_	JJ	JJ	_	14	amod	_	_
14	central_tumors	_	NNS	NNS	_	11	appos	_	_
17	cyclophosphamide	_	NN	NN	_	26	nsubjpass	_	_
18	in	_	IN	IN	_	20	case	_	_
19	conventional	_	JJ	JJ	_	20	amod	_	_
20	dose	_	NN	NN	_	17	nmod	_	_
22	1200	_	CD	CD	_	23	nummod	_	_
23	mg/m2/course	_	NNS	NNS	_	20	appos	_	_
25	was	_	VBD	VBD	_	26	auxpass	_	_
26	replaced	_	VBN	VBN	_	0	root	_	_
27	by	_	IN	IN	_	29	case	_	_
28	high	_	JJ	JJ	_	29	amod	_	_
29	doses	_	NNS	NNS	_	26	nmod	_	_
30	of	_	IN	IN	_	31	case	_	_
31	ifosfamide	_	NN	NN	_	29	nmod	_	_
33	6	_	CD	CD	_	34	nummod	_	_
34	g/m2/course	_	NNS	NNS	_	31	appos	_	_
36	with	_	IN	IN	_	38	case	_	_
37	mesna	_	NN	NN	_	38	compound	_	_
38	uroprotection	_	NN	NN	_	26	nmod	_	_
40	VAIA	_	NNP	NNP	_	38	appos	_	_

1	Local	_	JJ	JJ	_	2	amod	_	_
2	control	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	obtained	_	VBN	VBN	_	0	root	_	_
5	following	_	VBG	VBG	_	6	case	_	_
6	week	_	NN	NN	_	4	nmod	_	_
7	9	_	CD	CD	_	6	nummod	_	_

1	Patients	_	NNS	NNS	_	5	nsubjpass	_	_
2	with	_	IN	IN	_	3	case	_	_
3	radiation	_	NN	NN	_	1	nmod	_	_
4	were	_	VBD	VBD	_	5	auxpass	_	_
5	randomised	_	VBN	VBN	_	0	root	_	_
6	for	_	IN	IN	_	8	case	_	_
7	conventional	_	JJ	JJ	_	8	amod	_	_
8	fractionation	_	NN	NN	_	5	nmod	_	_
9	or	_	CC	CC	_	8	cc	_	_
10	accelerated	_	VBN	VBN	_	12	amod	_	_
11	split-course	_	JJ	JJ	_	12	amod	_	_
12	hyperfractionation	_	NN	NN	_	8	conj	_	_

1	The	_	DT	DT	_	2	det	_	_
2	study	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	piloted	_	VBN	VBN	_	0	root	_	_
5	from	_	IN	IN	_	6	case	_	_
6	February	_	NNP	NNP	_	4	nmod	_	_
7	to	_	TO	TO	_	8	case	_	_
8	December	_	NNP	NNP	_	4	nmod	_	_
9	1985	_	CD	CD	_	8	nummod	_	_
11	27/37	_	CD	CD	_	12	nummod	_	_
12	patients	_	NNS	NNS	_	14	nsubj	_	_
13	were	_	VBD	VBD	_	14	cop	_	_
14	disease-free	_	JJ	JJ	_	4	parataxis	_	_
15	on	_	IN	IN	_	16	case	_	_
16	October	_	NNP	NNP	_	14	nmod	_	_
17	1	_	CD	CD	_	16	nummod	_	_
19	1987	_	CD	CD	_	16	nummod	_	_

1	The	_	DT	DT	_	3	det	_	_
2	ongoing	_	JJ	JJ	_	3	amod	_	_
3	trial	_	NN	NN	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	started	_	VBN	VBN	_	0	root	_	_
6	on	_	IN	IN	_	7	case	_	_
7	January	_	NNP	NNP	_	5	nmod	_	_
8	1	_	CD	CD	_	7	nummod	_	_
10	1986	_	CD	CD	_	7	nummod	_	_

1	On	_	IN	IN	_	2	case	_	_
2	October	_	NNP	NNP	_	0	root	_	_
3	1	_	CD	CD	_	2	nummod	_	_
5	1987	_	CD	CD	_	2	nummod	_	_

1	63/66	_	CD	CD	_	2	nummod	_	_
2	patients	_	NNS	NNS	_	4	nsubj	_	_
3	were	_	VBD	VBD	_	4	cop	_	_
4	disease-free	_	JJ	JJ	_	0	root	_	_

1	In	_	IN	IN	_	2	case	_	_
2	patients	_	NNS	NNS	_	18	nmod	_	_
3	with	_	IN	IN	_	5	case	_	_
4	large	_	JJ	JJ	_	5	amod	_	_
5	primaries	_	NNS	NNS	_	2	nmod	_	_
7	according	_	VBG	VBG	_	11	case	_	_
8	to	_	TO	TO	_	7	mwe	_	_
9	Kaplan-Meier	_	JJ	JJ	_	11	amod	_	_
10	life-table	_	JJ	JJ	_	11	amod	_	_
11	analysis	_	NN	NN	_	18	nmod	_	_
13	the	_	DT	DT	_	15	det	_	_
14	disease-free	_	JJ	JJ	_	15	amod	_	_
15	survival	_	NN	NN	_	18	nsubj	_	_
16	was	_	VBD	VBD	_	18	cop	_	_
17	significantly	_	RB	RB	_	18	advmod	_	_
18	better	_	JJR	JJR	_	0	root	_	_
19	in	_	IN	IN	_	20	case	_	_
20	patients	_	NNS	NNS	_	18	nmod	_	_
21	receiving	_	VBG	VBG	_	20	acl	_	_
22	VAIA	_	NNP	NNP	_	21	dobj	_	_
23	chemotherapy	_	RB	RB	_	21	advmod	_	_
25	compared	_	VBN	VBN	_	30	case	_	_
26	to	_	TO	TO	_	30	case	_	_
27	the	_	DT	DT	_	30	det	_	_
28	previous	_	JJ	JJ	_	30	amod	_	_
29	VACA	_	NNP	NNP	_	30	compound	_	_
30	regimen	_	NN	NN	_	18	advcl	_	_

1	The	_	DT	DT	_	2	det	_	_
2	toxicity	_	NN	NN	_	9	nsubj	_	_
3	of	_	IN	IN	_	7	case	_	_
4	both	_	DT	DT	_	7	det	_	_
5	combination	_	NN	NN	_	7	compound	_	_
6	chemotherapy	_	NN	NN	_	7	compound	_	_
7	regimens	_	NN	NN	_	2	nmod	_	_
8	was	_	VBD	VBD	_	9	cop	_	_
9	comparable	_	JJ	JJ	_	0	root	_	_

1	Cell	_	JJ	JJ	_	3	amod	_	_
2	type-specific	_	JJ	JJ	_	3	amod	_	_
3	variability	_	NN	NN	_	7	nsubj	_	_
4	of	_	IN	IN	_	5	case	_	_
5	bacitracin	_	NN	NN	_	3	nmod	_	_
6	's	_	VBZ	VBZ	_	7	cop	_	_
7	effects	_	NNS	NNS	_	0	root	_	_
8	on	_	IN	IN	_	9	case	_	_
9	insulin	_	NN	NN	_	7	nmod	_	_
10	binding	_	VBG	VBG	_	9	amod	_	_
11	and	_	CC	CC	_	9	cc	_	_
12	intracellular	_	NN	NN	_	13	compound	_	_
13	accumulation	_	NN	NN	_	9	conj	_	_

1	Bacitracin	_	NNP	NNP	_	3	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	3	auxpass	_	_
3	known	_	VBN	VBN	_	0	root	_	_
4	to	_	TO	TO	_	5	mark	_	_
5	inhibit	_	VB	VB	_	3	xcomp	_	_
6	proteolytic	_	JJ	JJ	_	7	amod	_	_
7	degradation	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	9	case	_	_
9	insulin	_	NN	NN	_	7	nmod	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	several	_	JJ	JJ	_	14	amod	_	_
12	other	_	JJ	JJ	_	14	amod	_	_
13	peptide	_	NN	NN	_	14	compound	_	_
14	hormones	_	NNS	NNS	_	9	conj	_	_

1	Previous	_	JJ	JJ	_	2	amod	_	_
2	work	_	NN	NN	_	7	nsubj	_	_
3	with	_	IN	IN	_	6	case	_	_
4	isolated	_	VBN	VBN	_	6	amod	_	_
5	rat	_	NN	NN	_	6	compound	_	_
6	adipocytes	_	NNS	NNS	_	2	nmod	_	_
7	showed	_	VBD	VBD	_	0	root	_	_
8	that	_	IN	IN	_	10	mark	_	_
9	bacitracin	_	NN	NN	_	10	nsubj	_	_
10	blocked	_	VBD	VBD	_	7	ccomp	_	_
11	insulin	_	NN	NN	_	12	compound	_	_
12	degradation	_	NN	NN	_	10	dobj	_	_
13	by	_	IN	IN	_	16	case	_	_
14	the	_	DT	DT	_	16	det	_	_
15	plasma	_	NN	NN	_	16	compound	_	_
16	membrane	_	NN	NN	_	10	nmod	_	_
17	and	_	CC	CC	_	10	cc	_	_
19	even	_	RB	RB	_	22	advmod	_	_
20	in	_	IN	IN	_	22	case	_	_
21	the	_	DT	DT	_	22	det	_	_
22	absence	_	NN	NN	_	10	dep	_	_
23	of	_	IN	IN	_	26	case	_	_
24	detectable	_	JJ	JJ	_	26	amod	_	_
25	insulin	_	NN	NN	_	26	compound	_	_
26	degradation	_	NN	NN	_	22	nmod	_	_
28	bacitracin	_	VBN	VBN	_	10	conj	_	_
29	increased	_	VBN	VBN	_	30	amod	_	_
30	insulin	_	NN	NN	_	28	dobj	_	_
31	binding	_	VBG	VBG	_	30	amod	_	_
32	by	_	IN	IN	_	33	mark	_	_
33	decreasing	_	VBG	VBG	_	30	acl	_	_
34	the	_	DT	DT	_	35	det	_	_
35	rate	_	NN	NN	_	33	dobj	_	_
36	of	_	IN	IN	_	38	case	_	_
37	insulin	_	NN	NN	_	38	compound	_	_
38	dissociation	_	NN	NN	_	35	nmod	_	_

1	The	_	DT	DT	_	3	det	_	_
2	present	_	JJ	JJ	_	3	amod	_	_
3	study	_	NN	NN	_	4	nsubj	_	_
4	examined	_	VBD	VBD	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	effects	_	NNS	NNS	_	4	dobj	_	_
7	of	_	IN	IN	_	8	case	_	_
8	bacitracin	_	NN	NN	_	6	nmod	_	_
9	on	_	IN	IN	_	10	case	_	_
10	insulin	_	NN	NN	_	4	nmod	_	_
11	binding	_	JJ	JJ	_	10	amod	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	degradation	_	JJ	JJ	_	11	conj	_	_
14	and	_	CC	CC	_	10	cc	_	_
15	on	_	IN	IN	_	16	case	_	_
16	levels	_	NNS	NNS	_	10	conj	_	_
17	of	_	IN	IN	_	19	case	_	_
18	intracellular	_	NN	NN	_	19	compound	_	_
19	insulin	_	NN	NN	_	16	nmod	_	_
20	in	_	IN	IN	_	22	case	_	_
21	a	_	DT	DT	_	22	det	_	_
22	variety	_	NN	NN	_	4	nmod	_	_
23	of	_	IN	IN	_	25	case	_	_
24	cell	_	NN	NN	_	25	compound	_	_
25	types	_	NNS	NNS	_	22	nmod	_	_

1	Bacitracin	_	NNP	NNP	_	2	nsubj	_	_
2	inhibited	_	VBD	VBD	_	0	root	_	_
3	insulin	_	NN	NN	_	4	compound	_	_
4	degradation	_	NN	NN	_	2	dobj	_	_
5	in	_	IN	IN	_	8	case	_	_
6	all	_	DT	DT	_	8	det	_	_
7	cell	_	NN	NN	_	8	compound	_	_
8	types	_	NNS	NNS	_	2	nmod	_	_

1	Maximal	_	JJ	JJ	_	2	amod	_	_
2	inhibition	_	NN	NN	_	3	nsubj	_	_
3	varied	_	VBD	VBD	_	0	root	_	_
4	from	_	IN	IN	_	6	case	_	_
5	70	_	CD	CD	_	6	nummod	_	_
6	%	_	NN	NN	_	3	nmod	_	_
8	H4IIEC3_hepatoma	_	JJ	JJ	_	9	amod	_	_
9	cells	_	NNS	NNS	_	6	appos	_	_
11	to	_	TO	TO	_	13	case	_	_
12	95	_	CD	CD	_	13	nummod	_	_
13	%	_	NN	NN	_	3	nmod	_	_
15	rat	_	NN	NN	_	16	compound	_	_
16	adipocytes	_	NNS	NNS	_	13	appos	_	_
19	concentrations	_	NNS	NNS	_	23	nsubj	_	_
20	giving	_	VBG	VBG	_	19	acl	_	_
21	half-maximal	_	JJ	JJ	_	22	amod	_	_
22	inhibition	_	NN	NN	_	20	dobj	_	_
23	varied	_	VBD	VBD	_	3	parataxis	_	_
24	from	_	IN	IN	_	26	case	_	_
25	25	_	CD	CD	_	26	nummod	_	_
26	microM	_	NN	NN	_	23	nmod	_	_
28	3T3-A31	_	CD	CD	_	29	nummod	_	_
29	fibroblasts	_	NNS	NNS	_	26	appos	_	_
31	to	_	TO	TO	_	33	case	_	_
32	250	_	CD	CD	_	33	nummod	_	_
33	microM	_	NN	NN	_	23	nmod	_	_
35	H4IIEC3	_	NNP	NNP	_	33	appos	_	_

1	Dose-response	_	JJ	JJ	_	2	amod	_	_
2	curves	_	NNS	NNS	_	3	nsubj	_	_
3	showed	_	VBD	VBD	_	0	root	_	_
4	three	_	CD	CD	_	6	nummod	_	_
5	distinctive	_	JJ	JJ	_	6	amod	_	_
6	effects	_	NNS	NNS	_	3	dobj	_	_
7	on	_	IN	IN	_	8	case	_	_
8	insulin	_	NN	NN	_	6	nmod	_	_
9	binding	_	VBG	VBG	_	8	amod	_	_
11	dose-dependent	_	JJ	JJ	_	12	amod	_	_
12	stimulation	_	NN	NN	_	6	conj	_	_
14	rat	_	NN	NN	_	15	compound	_	_
15	adipocytes	_	NNS	NNS	_	12	appos	_	_
18	a	_	DT	DT	_	20	det	_	_
19	biphasic	_	JJ	JJ	_	20	amod	_	_
20	curve	_	NN	NN	_	12	appos	_	_
21	with	_	IN	IN	_	23	case	_	_
22	slight	_	JJ	JJ	_	23	amod	_	_
23	stimulation	_	NN	NN	_	20	nmod	_	_
24	at	_	IN	IN	_	26	case	_	_
25	low	_	JJ	JJ	_	26	amod	_	_
26	doses	_	NNS	NNS	_	23	nmod	_	_
27	and	_	CC	CC	_	23	cc	_	_
28	inhibition	_	NN	NN	_	23	conj	_	_
29	at	_	IN	IN	_	30	case	_	_
30	concentrations	_	NNS	NNS	_	28	nmod	_	_
31	greater	_	JJR	JJR	_	33	advmod	_	_
32	than	_	IN	IN	_	33	advmod	_	_
33	50	_	CD	CD	_	34	nummod	_	_
34	microM	_	NN	NN	_	30	dep	_	_
36	human	_	JJ	JJ	_	37	amod	_	_
37	fibroblasts	_	NNS	NNS	_	30	dep	_	_
39	H4IIEC3	_	NNP	NNP	_	37	conj	_	_
41	and	_	CC	CC	_	37	cc	_	_
42	3T3-L1	_	CD	CD	_	43	nummod	_	_
43	adipocytes	_	NNS	NNS	_	37	conj	_	_
46	or	_	CC	CC	_	6	cc	_	_
47	dose-dependent	_	JJ	JJ	_	48	amod	_	_
48	inhibition	_	NN	NN	_	6	conj	_	_
49	of	_	IN	IN	_	50	case	_	_
50	binding	_	VBG	VBG	_	48	nmod	_	_
52	3T3-L1	_	CD	CD	_	53	nummod	_	_
53	preadipocytes	_	NNS	NNS	_	50	dep	_	_
54	and	_	CC	CC	_	53	cc	_	_
55	3T3-A31	_	CD	CD	_	56	nummod	_	_
56	fibroblasts	_	NNS	NNS	_	53	conj	_	_

1	The	_	DT	DT	_	3	det	_	_
2	intracellular	_	NN	NN	_	3	compound	_	_
3	accumulation	_	NN	NN	_	10	nsubjpass	_	_
4	of	_	IN	IN	_	7	case	_	_
5	insulin	_	NN	NN	_	7	compound	_	_
6	rat	_	NN	NN	_	7	compound	_	_
7	adipocytes	_	NNS	NNS	_	3	nmod	_	_
8	was	_	VBD	VBD	_	10	auxpass	_	_
9	not	_	RB	RB	_	10	neg	_	_
10	affected	_	VBN	VBN	_	0	root	_	_
11	by	_	IN	IN	_	12	case	_	_
12	bacitracin	_	NN	NN	_	10	nmod	_	_
13	but	_	CC	CC	_	10	cc	_	_
14	was	_	VBD	VBD	_	15	auxpass	_	_
15	decreased	_	VBN	VBN	_	10	conj	_	_
16	in	_	IN	IN	_	20	case	_	_
17	all	_	DT	DT	_	20	det	_	_
18	other	_	JJ	JJ	_	20	amod	_	_
19	cell	_	NN	NN	_	20	compound	_	_
20	types	_	NNS	NNS	_	15	nmod	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	illustrated	_	VBD	VBD	_	0	root	_	_
4	type-specific	_	JJ	JJ	_	3	xcomp	_	_
5	variability	_	RB	RB	_	4	advmod	_	_
6	in	_	IN	IN	_	8	case	_	_
7	the	_	DT	DT	_	8	det	_	_
8	effects	_	NNS	NNS	_	4	nmod	_	_
9	of	_	IN	IN	_	10	case	_	_
10	bacitracin	_	NN	NN	_	8	nmod	_	_
11	on	_	IN	IN	_	13	case	_	_
12	insulin	_	NN	NN	_	13	compound	_	_
13	processing	_	NN	NN	_	4	nmod	_	_
14	resulting	_	VBG	VBG	_	13	acl	_	_
15	from	_	IN	IN	_	17	case	_	_
16	cellular	_	JJ	JJ	_	17	amod	_	_
17	heterogeneity	_	NN	NN	_	14	nmod	_	_
18	either	_	CC	CC	_	21	cc:preconj	_	_
19	in	_	IN	IN	_	21	case	_	_
20	processing	_	NN	NN	_	21	compound	_	_
21	insulin	_	NN	NN	_	3	nmod	_	_
22	or	_	CC	CC	_	21	cc	_	_
23	in	_	IN	IN	_	24	case	_	_
24	response	_	NN	NN	_	21	conj	_	_
25	to	_	TO	TO	_	26	case	_	_
26	bacitracin	_	NN	NN	_	3	nmod	_	_
28	or	_	CC	CC	_	26	cc	_	_
29	both	_	DT	DT	_	26	conj	_	_
31	and	_	CC	CC	_	3	cc	_	_
32	suggest	_	VBP	VBP	_	3	conj	_	_
33	that	_	IN	IN	_	45	mark	_	_
34	insulin	_	NN	NN	_	36	compound	_	_
35	binding	_	JJ	JJ	_	36	amod	_	_
36	studies	_	NNS	NNS	_	45	nsubjpass	_	_
37	performed	_	VBN	VBN	_	36	acl	_	_
38	in	_	IN	IN	_	40	case	_	_
39	the	_	DT	DT	_	40	det	_	_
40	presence	_	NN	NN	_	37	nmod	_	_
41	of	_	IN	IN	_	42	case	_	_
42	bacitracin	_	NN	NN	_	40	nmod	_	_
43	can	_	MD	MD	_	45	aux	_	_
44	be	_	VB	VB	_	45	auxpass	_	_
45	biased	_	VBN	VBN	_	32	ccomp	_	_

1	Persistence	_	NNP	NNP	_	4	nsubj	_	_
2	of	_	IN	IN	_	3	case	_	_
3	polymicrobial	_	NN	NN	_	1	nmod	_	_
4	abscesses	_	VBZ	VBZ	_	0	root	_	_
5	in	_	IN	IN	_	10	case	_	_
6	the	_	DT	DT	_	10	det	_	_
7	poorly	_	RB	RB	_	8	advmod	_	_
8	controlled	_	VBN	VBN	_	10	amod	_	_
9	diabetic	_	JJ	JJ	_	10	amod	_	_
10	host	_	NN	NN	_	4	nmod	_	_

1	Polymicrobial_infections	_	NNS	NNS	_	4	nsubjpass	_	_
2	are	_	VBP	VBP	_	4	auxpass	_	_
3	frequently	_	RB	RB	_	4	advmod	_	_
4	found	_	VBN	VBN	_	0	root	_	_
5	in	_	IN	IN	_	8	case	_	_
6	soft	_	JJ	JJ	_	8	amod	_	_
7	tissue	_	NN	NN	_	8	compound	_	_
8	infections	_	NNS	NNS	_	4	nmod	_	_
9	of	_	IN	IN	_	12	case	_	_
10	the	_	DT	DT	_	12	det	_	_
11	lower	_	JJR	JJR	_	12	amod	_	_
12	extremities	_	NNS	NNS	_	8	nmod	_	_
13	in	_	IN	IN	_	15	case	_	_
14	diabetic	_	JJ	JJ	_	15	amod	_	_
15	patients	_	NNS	NNS	_	4	nmod	_	_

1	The	_	DT	DT	_	3	det	_	_
2	relative	_	JJ	JJ	_	3	amod	_	_
3	susceptibility	_	NN	NN	_	26	nsubjpass	_	_
4	to	_	TO	TO	_	6	mark	_	_
5	and	_	CC	CC	_	6	cc	_	_
6	persistence	_	NN	NN	_	3	acl	_	_
7	of	_	IN	IN	_	17	mark	_	_
8	soft	_	JJ	JJ	_	11	amod	_	_
9	tissue	_	NN	NN	_	11	compound	_	_
10	polymicrobial	_	NN	NN	_	11	compound	_	_
11	infections	_	NNS	NNS	_	17	nsubj	_	_
12	of	_	IN	IN	_	16	case	_	_
13	diabetic	_	JJ	JJ	_	16	amod	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	nondiabetic	_	JJ	JJ	_	13	conj	_	_
16	mice	_	NNS	NNS	_	11	nmod	_	_
17	using	_	VBG	VBG	_	6	advcl	_	_
18	bacteria	_	NNS	NNS	_	17	dobj	_	_
19	commonly	_	RB	RB	_	20	advmod	_	_
20	found	_	VBN	VBN	_	18	acl	_	_
21	in	_	IN	IN	_	24	case	_	_
22	clinical	_	JJ	JJ	_	24	amod	_	_
23	foot	_	NN	NN	_	24	compound	_	_
24	infections	_	NNS	NNS	_	20	nmod	_	_
25	were	_	VBD	VBD	_	26	auxpass	_	_
26	studied	_	VBN	VBN	_	0	root	_	_

1	Subcutaneous	_	JJ	JJ	_	2	amod	_	_
2	abscesses	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	induced	_	VBN	VBN	_	0	root	_	_
5	in	_	IN	IN	_	7	case	_	_
6	three	_	CD	CD	_	7	nummod	_	_
7	groups	_	NNS	NNS	_	4	nmod	_	_
8	of	_	IN	IN	_	12	case	_	_
9	diabetic	_	JJ	JJ	_	12	amod	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	nondiabetic	_	JJ	JJ	_	9	conj	_	_
12	mice	_	NNS	NNS	_	7	nmod	_	_
13	using	_	VBG	VBG	_	12	acl	_	_
16	1	_	LS	LS	_	19	dep	_	_
18	E.	_	NNP	NNP	_	19	nsubj	_	_
19	_	_	VBZ	VBZ	_	4	parataxis	_	_
20	coli	_	NNS	NNS	_	19	dobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	enterococcus	_	NNS	NNS	_	20	conj	_	_
25	2	_	CD	CD	_	27	appos	_	_
27	enterococcus	_	NNS	NNS	_	20	conj	_	_
28	and	_	CC	CC	_	20	cc	_	_
29	Bacteroides_fragilis	_	NNP	NNP	_	20	conj	_	_
31	B.	_	NNP	NNP	_	32	compound	_	_
32	_	_	NNP	NNP	_	33	nsubj	_	_
33	fragilis	_	VBZ	VBZ	_	29	dep	_	_
36	and	_	CC	CC	_	19	cc	_	_
38	3	_	LS	LS	_	46	dep	_	_
40	E.	_	NNP	NNP	_	42	compound	_	_
41	_	_	NNP	NNP	_	42	compound	_	_
42	coli	_	NNP	NNP	_	46	nsubj	_	_
43	and	_	CC	CC	_	42	cc	_	_
44	B.	_	NNP	NNP	_	45	compound	_	_
45	_	_	NNP	NNP	_	42	conj	_	_
46	fragilis	_	VBZ	VBZ	_	19	conj	_	_

1	Abscesses	_	NNS	NNS	_	3	nsubjpass	_	_
2	were	_	VBD	VBD	_	3	auxpass	_	_
3	removed	_	VBN	VBN	_	0	root	_	_
4	at	_	IN	IN	_	8	case	_	_
5	1	_	CD	CD	_	8	nummod	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	2	_	CD	CD	_	5	conj	_	_
8	wk	_	NN	NN	_	3	nmod	_	_
9	for	_	IN	IN	_	12	case	_	_
10	total	_	JJ	JJ	_	12	amod	_	_
11	colony	_	NN	NN	_	12	compound	_	_
12	counts	_	NNS	NNS	_	8	nmod	_	_

1	At	_	IN	IN	_	3	case	_	_
2	1	_	CD	CD	_	3	nummod	_	_
3	wk	_	NN	NN	_	6	nmod	_	_
5	there	_	EX	EX	_	6	expl	_	_
6	was	_	VBD	VBD	_	0	root	_	_
7	a	_	DT	DT	_	11	det	_	_
8	significantly	_	RB	RB	_	9	advmod	_	_
9	greater	_	JJR	JJR	_	11	amod	_	_
10	bacterial	_	JJ	JJ	_	11	amod	_	_
11	growth	_	NN	NN	_	6	nsubj	_	_
12	in	_	IN	IN	_	14	case	_	_
13	the	_	DT	DT	_	14	det	_	_
14	abscesses	_	NNS	NNS	_	11	nmod	_	_
15	of	_	IN	IN	_	18	case	_	_
16	the	_	DT	DT	_	18	det	_	_
17	diabetic	_	JJ	JJ	_	18	amod	_	_
18	mice	_	NNS	NNS	_	14	nmod	_	_
19	compared	_	VBN	VBN	_	23	case	_	_
20	with	_	IN	IN	_	23	case	_	_
21	the	_	DT	DT	_	23	det	_	_
22	nondiabetic	_	JJ	JJ	_	23	amod	_	_
23	mice	_	NNS	NNS	_	6	advcl	_	_
24	only	_	RB	RB	_	28	advmod	_	_
25	in	_	IN	IN	_	27	case	_	_
26	the	_	DT	DT	_	27	det	_	_
27	group	_	NN	NN	_	24	nmod	_	_
28	injected	_	VBN	VBN	_	23	acl	_	_
29	with	_	IN	IN	_	30	case	_	_
30	enterococcus	_	NNS	NNS	_	28	nmod	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	B.	_	NNP	NNP	_	34	compound	_	_
33	_	_	NNP	NNP	_	34	compound	_	_
34	fragilis	_	NNS	NNS	_	30	conj	_	_

1	There	_	EX	EX	_	2	expl	_	_
2	were	_	VBD	VBD	_	0	root	_	_
3	significantly	_	RB	RB	_	4	advmod	_	_
4	higher	_	JJR	JJR	_	6	amod	_	_
5	colony	_	NN	NN	_	6	compound	_	_
6	counts	_	NNS	NNS	_	2	nsubj	_	_
7	in	_	IN	IN	_	9	case	_	_
8	the	_	DT	DT	_	9	det	_	_
9	diabetic	_	NN	NN	_	6	nmod	_	_
10	compared	_	VBN	VBN	_	14	case	_	_
11	with	_	IN	IN	_	14	case	_	_
12	the	_	DT	DT	_	14	det	_	_
13	nondiabetic	_	JJ	JJ	_	14	amod	_	_
14	mice	_	NNS	NNS	_	9	acl	_	_
15	in	_	IN	IN	_	18	case	_	_
16	all	_	DT	DT	_	18	det	_	_
17	three	_	CD	CD	_	18	nummod	_	_
18	groups	_	NNS	NNS	_	14	nmod	_	_
19	at	_	IN	IN	_	21	case	_	_
20	2	_	CD	CD	_	21	nummod	_	_
21	wk	_	NN	NN	_	18	nmod	_	_
22	after	_	IN	IN	_	23	case	_	_
23	injection	_	NN	NN	_	21	nmod	_	_
24	of	_	IN	IN	_	26	case	_	_
25	the	_	DT	DT	_	26	det	_	_
26	bacteria	_	NNS	NNS	_	23	nmod	_	_

1	Two	_	CD	CD	_	2	nummod	_	_
2	weeks	_	NNS	NNS	_	10	dep	_	_
3	after	_	IN	IN	_	10	mark	_	_
4	injection	_	NN	NN	_	10	nsubj	_	_
5	of	_	IN	IN	_	6	case	_	_
6	inocula	_	NN	NN	_	4	nmod	_	_
7	containing	_	VBG	VBG	_	6	acl	_	_
8	B.	_	NNP	NNP	_	9	compound	_	_
9	_	_	NNP	NNP	_	7	dobj	_	_
10	fragilis	_	VBZ	VBZ	_	26	advcl	_	_
12	both	_	DT	DT	_	14	dep	_	_
13	in	_	IN	IN	_	14	case	_	_
14	combination	_	NN	NN	_	10	nmod	_	_
15	with	_	IN	IN	_	18	case	_	_
16	E.	_	NNP	NNP	_	18	compound	_	_
17	_	_	NNP	NNP	_	18	compound	_	_
18	coli	_	NNS	NNS	_	10	nmod	_	_
19	or	_	CC	CC	_	18	cc	_	_
20	enterococcus	_	NNS	NNS	_	18	conj	_	_
22	all	_	DT	DT	_	24	det	_	_
23	nondiabetic	_	JJ	JJ	_	24	amod	_	_
24	mice	_	NNS	NNS	_	26	nsubj	_	_
25	had	_	VBD	VBD	_	26	aux	_	_
26	eradicated	_	VBN	VBN	_	0	root	_	_
27	B.	_	NNP	NNP	_	29	compound	_	_
28	_	_	NNP	NNP	_	29	compound	_	_
29	fragilis	_	NNS	NNS	_	26	dobj	_	_
30	from	_	IN	IN	_	32	case	_	_
31	the	_	DT	DT	_	32	det	_	_
32	abscesses	_	NNS	NNS	_	26	nmod	_	_
34	but	_	CC	CC	_	26	cc	_	_
35	significant	_	JJ	JJ	_	36	amod	_	_
36	numbers	_	NNS	NNS	_	41	nsubj	_	_
37	of	_	IN	IN	_	40	case	_	_
38	B.	_	NNP	NNP	_	40	compound	_	_
39	_	_	NNP	NNP	_	40	compound	_	_
40	fragilis	_	NNS	NNS	_	36	nmod	_	_
41	persisted	_	VBD	VBD	_	26	conj	_	_
42	in	_	IN	IN	_	44	case	_	_
43	the	_	DT	DT	_	44	det	_	_
44	abscesses	_	NNS	NNS	_	41	nmod	_	_
45	of	_	IN	IN	_	48	case	_	_
46	the	_	DT	DT	_	48	det	_	_
47	diabetic	_	JJ	JJ	_	48	amod	_	_
48	mice	_	NNS	NNS	_	44	nmod	_	_

1	In	_	IN	IN	_	4	case	_	_
2	the	_	DT	DT	_	4	det	_	_
3	diabetic	_	JJ	JJ	_	4	amod	_	_
4	mice	_	NNS	NNS	_	12	nmod	_	_
6	the	_	DT	DT	_	7	det	_	_
7	presence	_	NN	NN	_	12	nsubj	_	_
8	of	_	IN	IN	_	9	case	_	_
9	enterococci	_	NNS	NNS	_	7	nmod	_	_
10	was	_	VBD	VBD	_	12	cop	_	_
11	more	_	RBR	RBR	_	12	advmod	_	_
12	synergistic	_	JJ	JJ	_	0	root	_	_
13	for	_	IN	IN	_	14	case	_	_
14	growth	_	NN	NN	_	12	nmod	_	_
15	of	_	IN	IN	_	18	case	_	_
16	B.	_	NNP	NNP	_	18	compound	_	_
17	_	_	NNP	NNP	_	18	compound	_	_
18	fragilis	_	NNS	NNS	_	14	nmod	_	_
19	than	_	IN	IN	_	22	mark	_	_
20	was	_	VBD	VBD	_	22	cop	_	_
21	the	_	DT	DT	_	22	det	_	_
22	presence	_	NN	NN	_	12	ccomp	_	_
23	of	_	IN	IN	_	26	case	_	_
24	E.	_	NNP	NNP	_	26	compound	_	_
25	_	_	NNP	NNP	_	26	compound	_	_
26	coli	_	NNS	NNS	_	22	nmod	_	_

1	These	_	DT	DT	_	2	det	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	12	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	bacteria	_	NNS	NNS	_	12	nsubj	_	_
7	of	_	IN	IN	_	11	case	_	_
8	polymicrobial	_	JJ	JJ	_	11	amod	_	_
9	soft	_	JJ	JJ	_	11	amod	_	_
10	tissue	_	NN	NN	_	11	compound	_	_
11	infections	_	NNS	NNS	_	6	nmod	_	_
12	persist	_	VBP	VBP	_	3	ccomp	_	_
13	for	_	IN	IN	_	16	case	_	_
14	a	_	DT	DT	_	16	det	_	_
15	longer	_	JJR	JJR	_	16	amod	_	_
16	period	_	NN	NN	_	12	nmod	_	_
17	of	_	IN	IN	_	18	case	_	_
18	time	_	NN	NN	_	16	nmod	_	_
19	in	_	IN	IN	_	21	case	_	_
20	the	_	DT	DT	_	21	det	_	_
21	diabetic	_	NN	NN	_	12	nmod	_	_
22	compared	_	VBN	VBN	_	26	case	_	_
23	with	_	IN	IN	_	26	case	_	_
24	the	_	DT	DT	_	26	det	_	_
25	nondiabetic	_	JJ	JJ	_	26	amod	_	_
26	host	_	NN	NN	_	21	acl	_	_

1	In	_	IN	IN	_	2	case	_	_
2	addition	_	NN	NN	_	8	nmod	_	_
4	B.	_	NNP	NNP	_	6	compound	_	_
5	_	_	NNP	NNP	_	6	compound	_	_
6	fragilis	_	NNS	NNS	_	8	nsubj	_	_
7	has	_	VBZ	VBZ	_	8	aux	_	_
8	increased	_	VBN	VBN	_	0	root	_	_
9	pathogenicity	_	RB	RB	_	8	advmod	_	_
10	in	_	IN	IN	_	12	case	_	_
11	the	_	DT	DT	_	12	det	_	_
12	diabetic	_	NN	NN	_	8	nmod	_	_
13	compared	_	VBN	VBN	_	17	case	_	_
14	with	_	IN	IN	_	17	case	_	_
15	the	_	DT	DT	_	17	det	_	_
16	nondiabetic	_	JJ	JJ	_	17	amod	_	_
17	host	_	NN	NN	_	12	acl	_	_
19	particularly	_	RB	RB	_	22	advmod	_	_
20	in	_	IN	IN	_	22	case	_	_
21	the	_	DT	DT	_	22	det	_	_
22	presence	_	NN	NN	_	8	nmod	_	_
23	of	_	IN	IN	_	24	case	_	_
24	enterococci	_	NNS	NNS	_	22	nmod	_	_

1	-LSB-	_	NNP	NNP	_	2	compound	_	_
2	Chlamydia_trachomatis	_	NNP	NNP	_	3	nsubj	_	_
3	infection	_	VBD	VBD	_	0	root	_	_
4	in	_	IN	IN	_	6	case	_	_
5	a	_	DT	DT	_	6	det	_	_
6	patient	_	NN	NN	_	3	nmod	_	_
7	with	_	IN	IN	_	10	case	_	_
8	condylomata	_	NN	NN	_	10	compound	_	_
9	acuminata	_	NN	NN	_	10	compound	_	_
10	-RSB-	_	NNS	NNS	_	3	nmod	_	_

1	Chlamydia_trachomatis_cervical_infection	_	NNP	NNP	_	3	nsubjpass	_	_
2	was	_	VBD	VBD	_	3	auxpass	_	_
3	observed	_	VBN	VBN	_	0	root	_	_
4	in	_	IN	IN	_	7	case	_	_
5	a	_	DT	DT	_	7	det	_	_
6	19-year-old	_	JJ	JJ	_	7	amod	_	_
7	woman	_	NN	NN	_	3	nmod	_	_
8	with	_	IN	IN	_	9	case	_	_
9	genital_condylomata_acuminata	_	NN	NN	_	7	nmod	_	_

1	To	_	TO	TO	_	2	mark	_	_
2	isolate	_	VB	VB	_	14	advcl	_	_
3	C.trachomatis	_	NNS	NNS	_	2	dobj	_	_
5	cycloheximide-treated	_	JJ	JJ	_	7	amod	_	_
6	McCoy	_	NNP	NNP	_	7	compound	_	_
7	cells	_	NNS	NNS	_	14	nsubjpass	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	a	_	DT	DT	_	12	det	_	_
10	culture-independent	_	JJ	JJ	_	12	amod	_	_
11	monoclonal	_	JJ	JJ	_	12	amod	_	_
12	antibody	_	NN	NN	_	7	conj	_	_
13	were	_	VBD	VBD	_	14	auxpass	_	_
14	used	_	VBN	VBN	_	0	root	_	_

1	In	_	IN	IN	_	2	case	_	_
2	addition	_	NN	NN	_	9	nmod	_	_
4	a	_	DT	DT	_	7	det	_	_
5	single-antigen	_	JJ	JJ	_	7	amod	_	_
6	immunofluorescence	_	NN	NN	_	7	compound	_	_
7	test	_	NN	NN	_	9	nsubjpass	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	made	_	VBN	VBN	_	0	root	_	_
10	to	_	TO	TO	_	11	mark	_	_
11	determine	_	VB	VB	_	9	xcomp	_	_
12	the	_	DT	DT	_	15	det	_	_
13	chlamydia	_	JJ	JJ	_	15	amod	_	_
14	antibody	_	NN	NN	_	15	compound	_	_
15	titer	_	NN	NN	_	11	dobj	_	_

1	Condylomata	_	NNP	NNP	_	2	compound	_	_
2	acuminata	_	NNP	NNP	_	4	nsubjpass	_	_
3	are	_	VBP	VBP	_	4	auxpass	_	_
4	induced	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	7	case	_	_
6	human	_	JJ	JJ	_	7	amod	_	_
7	papillomaviruses	_	NNS	NNS	_	4	nmod	_	_
9	HPV	_	NNP	NNP	_	7	appos	_	_
12	predominantly	_	RB	RB	_	13	advmod	_	_
13	types	_	NNS	NNS	_	7	appos	_	_
14	6	_	CD	CD	_	13	nummod	_	_
15	and	_	CC	CC	_	13	cc	_	_
16	11	_	CD	CD	_	13	conj	_	_

1	This	_	DT	DT	_	2	det	_	_
2	case	_	NN	NN	_	3	nsubj	_	_
3	shows	_	VBZ	VBZ	_	0	root	_	_
4	that	_	IN	IN	_	12	mark	_	_
5	simultaneous	_	JJ	JJ	_	7	amod	_	_
6	genital	_	JJ	JJ	_	7	amod	_	_
7	infection	_	NN	NN	_	12	nsubj	_	_
8	of	_	IN	IN	_	9	case	_	_
9	C.trachomatis	_	NNP	NNP	_	7	nmod	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	HPV	_	NNP	NNP	_	9	conj	_	_
12	requires	_	VBZ	VBZ	_	3	ccomp	_	_
13	special	_	JJ	JJ	_	14	amod	_	_
14	attention	_	NN	NN	_	12	dobj	_	_

1	Immune	_	NNP	NNP	_	3	compound	_	_
2	response	_	NN	NN	_	3	compound	_	_
3	potential	_	NN	NN	_	0	root	_	_
4	of	_	IN	IN	_	8	case	_	_
5	mast	_	JJ	JJ	_	8	amod	_	_
6	cell-deficient	_	JJ	JJ	_	8	amod	_	_
7	W/Wv	_	NNP	NNP	_	8	compound	_	_
8	mice	_	NNS	NNS	_	3	nmod	_	_

1	Immune	_	NNP	NNP	_	2	compound	_	_
2	responses	_	NNS	NNS	_	29	nsubjpass	_	_
3	of	_	IN	IN	_	7	case	_	_
4	mast	_	JJ	JJ	_	7	amod	_	_
5	cell-deficient	_	JJ	JJ	_	7	amod	_	_
6	WBB6F1-W/Wv	_	NN	NN	_	7	compound	_	_
7	mice	_	NNS	NNS	_	2	nmod	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	their	_	PRP$	PRP$	_	12	nmod:poss	_	_
10	mast	_	JJ	JJ	_	12	amod	_	_
11	cell-sufficient	_	JJ	JJ	_	12	amod	_	_
12	littermates	_	NNS	NNS	_	7	conj	_	_
14	LM	_	NNP	NNP	_	2	dep	_	_
16	WBB6F1-W	_	NNP	NNP	_	18	compound	_	_
17	/	_	NNP	NNP	_	18	compound	_	_
18	+	_	NNP	NNP	_	14	dep	_	_
20	Wv	_	NNP	NNP	_	26	compound	_	_
22	+	_	JJ	JJ	_	26	dep	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	+	_	JJ	JJ	_	22	conj	_	_
26	+	_	NNP	NNP	_	18	appos	_	_
28	were	_	VBD	VBD	_	29	auxpass	_	_
29	compared	_	VBN	VBN	_	0	root	_	_

1	After	_	IN	IN	_	5	case	_	_
2	a	_	DT	DT	_	5	det	_	_
3	single	_	JJ	JJ	_	5	amod	_	_
4	intravenous	_	JJ	JJ	_	5	amod	_	_
5	injection	_	NN	NN	_	28	nmod	_	_
6	of	_	IN	IN	_	8	case	_	_
7	sheep	_	NN	NN	_	8	compound	_	_
8	erythrocytes	_	NNS	NNS	_	5	nmod	_	_
10	SE	_	NNP	NNP	_	8	appos	_	_
13	polyvinylpyrrolidone_or_bacterial_lipopolysaccharide	_	RB	RB	_	28	advmod	_	_
15	the	_	DT	DT	_	23	det	_	_
16	antigen-specific	_	JJ	JJ	_	17	amod	_	_
17	IgM	_	JJ	JJ	_	23	amod	_	_
18	plaque-forming	_	JJ	JJ	_	23	amod	_	_
19	cell	_	NN	NN	_	23	compound	_	_
21	PFC	_	NNP	NNP	_	23	appos	_	_
23	response	_	NN	NN	_	28	nsubj	_	_
24	of	_	IN	IN	_	26	case	_	_
25	W/Wv	_	NNP	NNP	_	26	compound	_	_
26	mice	_	NNS	NNS	_	23	nmod	_	_
27	was	_	VBD	VBD	_	28	cop	_	_
28	similar	_	JJ	JJ	_	0	root	_	_
29	to	_	TO	TO	_	31	case	_	_
30	or	_	CC	CC	_	31	cc	_	_
31	greater	_	JJR	JJR	_	28	nmod	_	_
32	than	_	IN	IN	_	34	case	_	_
33	the	_	DT	DT	_	34	det	_	_
34	response	_	NN	NN	_	28	nmod	_	_
35	of	_	IN	IN	_	37	case	_	_
36	LM	_	NNP	NNP	_	37	compound	_	_
37	mice	_	NNS	NNS	_	34	nmod	_	_

1	When	_	WRB	WRB	_	13	advmod	_	_
2	both	_	DT	DT	_	6	det	_	_
3	primary	_	JJ	JJ	_	6	amod	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	secondary	_	JJ	JJ	_	3	conj	_	_
6	injections	_	NNS	NNS	_	13	nsubjpass	_	_
7	of	_	IN	IN	_	8	case	_	_
8	SE	_	NNP	NNP	_	6	nmod	_	_
9	or	_	CC	CC	_	8	cc	_	_
10	chicken	_	NN	NN	_	11	compound	_	_
11	gamma-globulin	_	NN	NN	_	8	conj	_	_
12	were	_	VBD	VBD	_	13	auxpass	_	_
13	given	_	VBN	VBN	_	29	advcl	_	_
14	to	_	TO	TO	_	15	case	_	_
15	mice	_	NNS	NNS	_	13	nmod	_	_
16	and	_	CC	CC	_	13	cc	_	_
17	antigen-specific	_	JJ	JJ	_	20	amod	_	_
18	IgG	_	NNP	NNP	_	20	compound	_	_
19	PFC	_	NNP	NNP	_	20	compound	_	_
20	responses	_	NNS	NNS	_	21	nsubj	_	_
21	quantified	_	VBN	VBN	_	13	conj	_	_
23	the	_	DT	DT	_	24	det	_	_
24	response	_	NN	NN	_	29	nsubj	_	_
25	of	_	IN	IN	_	26	case	_	_
26	W/Wv	_	NNP	NNP	_	24	nmod	_	_
27	again	_	RB	RB	_	29	advmod	_	_
28	was	_	VBD	VBD	_	29	cop	_	_
29	similar	_	JJ	JJ	_	0	root	_	_
30	to	_	TO	TO	_	32	case	_	_
31	or	_	CC	CC	_	32	cc	_	_
32	greater	_	JJR	JJR	_	29	nmod	_	_
33	than	_	IN	IN	_	34	case	_	_
34	that	_	DT	DT	_	29	nmod	_	_
35	of	_	IN	IN	_	37	case	_	_
36	LM	_	NNP	NNP	_	37	compound	_	_
37	mice	_	NNS	NNS	_	34	nmod	_	_

1	Serum	_	JJ	JJ	_	2	amod	_	_
2	titers	_	NNS	NNS	_	7	nsubj	_	_
3	of	_	IN	IN	_	5	case	_	_
4	antigen-specific	_	JJ	JJ	_	5	amod	_	_
5	IgE	_	NNP	NNP	_	2	nmod	_	_
6	were	_	VBD	VBD	_	7	cop	_	_
7	higher	_	JJR	JJR	_	0	root	_	_
8	in	_	IN	IN	_	9	case	_	_
9	W/Wv	_	NNP	NNP	_	7	nmod	_	_
10	than	_	IN	IN	_	13	case	_	_
11	in	_	IN	IN	_	13	case	_	_
12	LM	_	NNP	NNP	_	13	compound	_	_
13	mice	_	NNS	NNS	_	7	nmod	_	_
14	after	_	IN	IN	_	15	case	_	_
15	injections	_	NNS	NNS	_	7	nmod	_	_
16	of	_	IN	IN	_	17	case	_	_
17	ovalbumin	_	NN	NN	_	15	nmod	_	_
18	in	_	IN	IN	_	19	case	_	_
19	alum	_	NN	NN	_	17	nmod	_	_
20	or	_	CC	CC	_	17	cc	_	_
21	infections	_	NNS	NNS	_	17	conj	_	_
22	of	_	IN	IN	_	24	case	_	_
23	Nippostrongylus	_	NNP	NNP	_	24	compound	_	_
24	brasiliensis	_	NNS	NNS	_	21	nmod	_	_

1	Ovalbumin-sensitized	_	NNP	NNP	_	2	compound	_	_
2	W/Wv	_	NNP	NNP	_	6	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	LM	_	NNP	NNP	_	5	compound	_	_
5	mice	_	NNS	NNS	_	2	conj	_	_
6	developed	_	VBD	VBD	_	0	root	_	_
7	active	_	JJ	JJ	_	8	amod	_	_
8	systemic_anaphylaxis	_	NNS	NNS	_	6	dobj	_	_
9	after	_	IN	IN	_	11	case	_	_
10	ovalbumin	_	NN	NN	_	11	compound	_	_
11	challenge	_	NN	NN	_	6	nmod	_	_

1	The	_	DT	DT	_	2	det	_	_
2	ability	_	NN	NN	_	17	nsubjpass	_	_
3	of	_	IN	IN	_	5	case	_	_
4	W/Wv	_	NNP	NNP	_	5	compound	_	_
5	mice	_	NNS	NNS	_	2	nmod	_	_
6	to	_	TO	TO	_	8	mark	_	_
7	be	_	VB	VB	_	8	auxpass	_	_
8	sensitized	_	VBN	VBN	_	5	acl	_	_
9	for	_	IN	IN	_	8	nmod	_	_
10	and	_	CC	CC	_	8	cc	_	_
11	elicit_contact_sensitivity	_	VB	VB	_	8	conj	_	_
13	CS	_	NNP	NNP	_	15	appos	_	_
15	reactions	_	NNS	NNS	_	11	dobj	_	_
16	was	_	VBD	VBD	_	17	auxpass	_	_
17	studied	_	VBN	VBN	_	0	root	_	_
18	using	_	VBG	VBG	_	17	ccomp	_	_
19	picryl_chloride	_	NN	NN	_	18	dobj	_	_
20	or	_	CC	CC	_	19	cc	_	_
21	dinitrofluorobenzene	_	NN	NN	_	19	conj	_	_
22	as	_	IN	IN	_	26	case	_	_
23	sensitizing	_	NN	NN	_	26	compound	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	challenge	_	NN	NN	_	23	conj	_	_
26	agents	_	NNS	NNS	_	18	nmod	_	_
27	and	_	CC	CC	_	18	cc	_	_
28	quantifying	_	VBG	VBG	_	18	conj	_	_
29	24-hour	_	JJ	JJ	_	30	amod	_	_
30	reactions	_	NNS	NNS	_	28	dobj	_	_
31	by	_	IN	IN	_	32	case	_	_
32	change	_	NN	NN	_	28	nmod	_	_
33	in	_	IN	IN	_	35	case	_	_
34	ear	_	NN	NN	_	35	compound	_	_
35	thickness	_	NN	NN	_	32	nmod	_	_

1	SE	_	NNP	NNP	_	8	nsubjpass	_	_
2	or	_	CC	CC	_	1	cc	_	_
3	methylated	_	JJ	JJ	_	6	amod	_	_
4	bovine	_	JJ	JJ	_	6	amod	_	_
5	serum	_	NN	NN	_	6	compound	_	_
6	albumin	_	NN	NN	_	1	conj	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	used	_	VBN	VBN	_	0	root	_	_
9	to	_	TO	TO	_	10	mark	_	_
10	sensitize	_	VB	VB	_	8	xcomp	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	challenge	_	VB	VB	_	10	conj	_	_
13	mice	_	NNS	NNS	_	10	dobj	_	_
14	for	_	IN	IN	_	19	case	_	_
15	delayed-type_hypersensitivity	_	JJ	JJ	_	19	amod	_	_
17	DTH	_	NNP	NNP	_	19	appos	_	_
19	reactions	_	NNS	NNS	_	13	nmod	_	_
20	which	_	WDT	WDT	_	22	nsubjpass	_	_
21	were	_	VBD	VBD	_	22	auxpass	_	_
22	quantified	_	VBN	VBN	_	13	acl:relcl	_	_
23	at	_	IN	IN	_	25	case	_	_
24	24	_	CD	CD	_	25	nummod	_	_
25	h	_	NN	NN	_	22	nmod	_	_
26	by	_	IN	IN	_	27	case	_	_
27	change	_	NN	NN	_	22	nmod	_	_
28	in	_	IN	IN	_	30	case	_	_
29	foot	_	NN	NN	_	30	compound	_	_
30	pad	_	NN	NN	_	27	nmod	_	_
31	or	_	CC	CC	_	30	cc	_	_
32	ear	_	NN	NN	_	33	compound	_	_
33	thickness	_	NN	NN	_	30	conj	_	_

1	CS	_	NNP	NNP	_	4	compound	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	DTH	_	NNP	NNP	_	1	conj	_	_
4	reactions	_	NNS	NNS	_	11	nsubj	_	_
5	of	_	IN	IN	_	9	case	_	_
6	W/Wv	_	NNP	NNP	_	9	compound	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	LM	_	NNP	NNP	_	6	conj	_	_
9	mice	_	NNS	NNS	_	4	nmod	_	_
10	were	_	VBD	VBD	_	11	cop	_	_
11	similar	_	JJ	JJ	_	0	root	_	_

1	No	_	DT	DT	_	2	neg	_	_
2	evidence	_	NN	NN	_	9	nsubjpass	_	_
3	of	_	IN	IN	_	4	case	_	_
4	immune_deficiency	_	NN	NN	_	2	nmod	_	_
5	of	_	IN	IN	_	7	case	_	_
6	W/Wv	_	NNP	NNP	_	7	compound	_	_
7	mice	_	NNS	NNS	_	4	nmod	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	found	_	VBN	VBN	_	0	root	_	_

1	Modulation	_	NNP	NNP	_	0	root	_	_
2	of	_	IN	IN	_	4	case	_	_
3	actin-bundling	_	JJ	JJ	_	4	amod	_	_
4	activity	_	NN	NN	_	1	nmod	_	_
5	of	_	IN	IN	_	7	case	_	_
6	55-kDa	_	JJ	JJ	_	7	amod	_	_
7	protein	_	NN	NN	_	1	nmod	_	_
8	by	_	IN	IN	_	10	case	_	_
9	multiple	_	JJ	JJ	_	10	amod	_	_
10	isoforms	_	NNS	NNS	_	1	nmod	_	_
11	of	_	IN	IN	_	12	case	_	_
12	tropomyosin	_	NN	NN	_	10	nmod	_	_

1	Cultured	_	JJ	JJ	_	3	amod	_	_
2	rat	_	NN	NN	_	3	compound	_	_
3	cells	_	NNS	NNS	_	4	nsubj	_	_
4	contain	_	VBP	VBP	_	0	root	_	_
5	five	_	CD	CD	_	6	nummod	_	_
6	isoforms	_	NNS	NNS	_	4	dobj	_	_
7	of	_	IN	IN	_	8	case	_	_
8	tropomyosin	_	NN	NN	_	6	nmod	_	_
10	Matsumura	_	NNP	NNP	_	16	compound	_	_
12	F.	_	NNP	NNP	_	16	appos	_	_
14	Yamashiro-Matsumura	_	NNP	NNP	_	16	appos	_	_
16	S.	_	NNP	NNP	_	8	conj	_	_
18	and	_	CC	CC	_	8	cc	_	_
19	Lin	_	NNP	NNP	_	8	conj	_	_
21	J.J.-C	_	RB	RB	_	8	advmod	_	_

2	1983	_	NNP	NNP	_	0	root	_	_
4	J.	_	NNP	NNP	_	5	compound	_	_
5	Biol	_	NNP	NNP	_	2	dep	_	_

1	Chem	_	FW	FW	_	0	root	_	_

1	258	_	NNP	NNP	_	3	nsubj	_	_
3	6636-6644	_	VBZ	VBZ	_	0	root	_	_

1	To	_	TO	TO	_	2	mark	_	_
2	explore	_	VB	VB	_	20	advcl	_	_
3	the	_	DT	DT	_	4	det	_	_
4	roles	_	NNS	NNS	_	2	dobj	_	_
5	of	_	IN	IN	_	9	case	_	_
6	the	_	DT	DT	_	9	det	_	_
7	multiple	_	JJ	JJ	_	9	amod	_	_
8	tropomyosin	_	NN	NN	_	9	compound	_	_
9	isoforms	_	NNS	NNS	_	4	nmod	_	_
10	in	_	IN	IN	_	13	case	_	_
11	the	_	DT	DT	_	13	det	_	_
12	microfilament	_	JJ	JJ	_	13	amod	_	_
13	organization	_	NN	NN	_	2	nmod	_	_
14	of	_	IN	IN	_	16	case	_	_
15	cultured	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	13	nmod	_	_
18	we	_	PRP	PRP	_	20	nsubj	_	_
19	have	_	VBP	VBP	_	20	aux	_	_
20	examined	_	VBN	VBN	_	0	root	_	_
21	effects	_	NNS	NNS	_	20	dobj	_	_
22	of	_	IN	IN	_	23	case	_	_
23	tropomyosins	_	NNS	NNS	_	21	nmod	_	_
24	on	_	IN	IN	_	27	case	_	_
25	the	_	DT	DT	_	27	det	_	_
26	bundling	_	VBG	VBG	_	27	amod	_	_
27	activity	_	NN	NN	_	20	nmod	_	_
28	of	_	IN	IN	_	31	case	_	_
29	the	_	DT	DT	_	31	det	_	_
30	55-kDa	_	JJ	JJ	_	31	amod	_	_
31	protein	_	NN	NN	_	27	nmod	_	_
32	recently	_	RB	RB	_	33	advmod	_	_
33	purified	_	VBN	VBN	_	31	acl	_	_
34	from	_	IN	IN	_	36	case	_	_
35	HeLa	_	NNP	NNP	_	36	compound	_	_
36	cells	_	NNS	NNS	_	33	nmod	_	_
38	Yamashiro-Matsumura	_	NNP	NNP	_	36	dep	_	_
40	S.	_	NNP	NNP	_	38	dep	_	_
42	and	_	CC	CC	_	36	cc	_	_
43	Matsumura	_	NNP	NNP	_	45	compound	_	_
45	F.	_	NNP	NNP	_	36	conj	_	_
47	1985	_	CD	CD	_	45	appos	_	_
49	J.	_	NNP	NNP	_	50	compound	_	_
50	Biol	_	NNP	NNP	_	45	dep	_	_

1	Chem	_	FW	FW	_	0	root	_	_

1	260	_	NNP	NNP	_	3	nsubj	_	_
3	5087-5097	_	VBZ	VBZ	_	0	root	_	_

1	Maximum	_	JJ	JJ	_	2	amod	_	_
2	bundling	_	NN	NN	_	6	nsubjpass	_	_
3	of	_	IN	IN	_	4	case	_	_
4	F-actin	_	NNP	NNP	_	2	nmod	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	observed	_	VBN	VBN	_	0	root	_	_
7	at	_	IN	IN	_	10	case	_	_
8	a	_	DT	DT	_	10	det	_	_
9	molar	_	NN	NN	_	10	compound	_	_
10	ratio	_	NN	NN	_	6	nmod	_	_
11	of	_	IN	IN	_	13	case	_	_
12	55-kDa	_	JJ	JJ	_	13	amod	_	_
13	protein	_	NN	NN	_	10	nmod	_	_
14	to	_	TO	TO	_	15	mark	_	_
15	actin	_	VB	VB	_	6	xcomp	_	_
16	higher	_	JJR	JJR	_	15	dobj	_	_
17	than	_	IN	IN	_	18	case	_	_
18	1:8	_	CD	CD	_	15	nmod	_	_

1	None	_	NN	NN	_	11	nsubj	_	_
2	of	_	IN	IN	_	4	case	_	_
3	the	_	DT	DT	_	4	det	_	_
4	isoforms	_	NNS	NNS	_	1	nmod	_	_
5	of	_	IN	IN	_	9	case	_	_
6	cultured	_	JJ	JJ	_	9	amod	_	_
7	rat	_	NN	NN	_	9	compound	_	_
8	cell	_	NN	NN	_	9	compound	_	_
9	tropomyosin	_	NN	NN	_	4	nmod	_	_
10	significantly	_	RB	RB	_	11	advmod	_	_
11	altered	_	VBD	VBD	_	0	root	_	_
12	the	_	DT	DT	_	14	det	_	_
13	F-actin-bundling	_	JJ	JJ	_	14	amod	_	_
14	activity	_	NN	NN	_	11	dobj	_	_
15	of	_	IN	IN	_	17	case	_	_
16	55-kDa	_	JJ	JJ	_	17	amod	_	_
17	protein	_	NN	NN	_	14	nmod	_	_
18	at	_	IN	IN	_	20	case	_	_
19	this	_	DT	DT	_	20	det	_	_
20	ratio	_	NN	NN	_	11	nmod	_	_
22	whereas	_	IN	IN	_	26	mark	_	_
23	skeletal	_	JJ	JJ	_	25	amod	_	_
24	muscle	_	NN	NN	_	25	compound	_	_
25	tropomyosin	_	NN	NN	_	26	nsubj	_	_
26	inhibited	_	VBD	VBD	_	11	advcl	_	_
27	the	_	DT	DT	_	29	det	_	_
28	bundling	_	JJ	JJ	_	29	amod	_	_
29	activity	_	NN	NN	_	26	dobj	_	_
30	to	_	TO	TO	_	33	case	_	_
31	about	_	RB	RB	_	32	advmod	_	_
32	50	_	CD	CD	_	33	nummod	_	_
33	%	_	NN	NN	_	26	nmod	_	_

1	Also	_	RB	RB	_	8	advmod	_	_
3	cultured	_	JJ	JJ	_	5	amod	_	_
4	cell	_	NN	NN	_	5	compound	_	_
5	tropomyosins	_	NNS	NNS	_	8	nsubj	_	_
6	did	_	VBD	VBD	_	8	aux	_	_
7	not	_	RB	RB	_	8	neg	_	_
8	inhibit	_	VB	VB	_	0	root	_	_
9	binding	_	JJ	JJ	_	8	dobj	_	_
10	of	_	IN	IN	_	12	case	_	_
11	55-kDa	_	JJ	JJ	_	12	amod	_	_
12	protein	_	NN	NN	_	9	nmod	_	_
13	to	_	TO	TO	_	14	case	_	_
14	actin	_	NN	NN	_	8	nmod	_	_
16	whereas	_	IN	IN	_	20	mark	_	_
17	skeletal	_	JJ	JJ	_	19	amod	_	_
18	muscle	_	NN	NN	_	19	compound	_	_
19	tropomyosin	_	NN	NN	_	20	nsubj	_	_
20	inhibited	_	VBD	VBD	_	8	advcl	_	_
21	it	_	PRP	PRP	_	20	dobj	_	_
22	by	_	IN	IN	_	24	case	_	_
23	50	_	CD	CD	_	24	nummod	_	_
24	%	_	NN	NN	_	20	nmod	_	_

1	The	_	DT	DT	_	2	det	_	_
2	effect	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	5	case	_	_
4	55-kDa	_	JJ	JJ	_	5	amod	_	_
5	protein	_	NN	NN	_	2	nmod	_	_
6	on	_	IN	IN	_	7	case	_	_
7	the	_	DT	DT	_	5	nmod	_	_
8	binding	_	VBG	VBG	_	7	amod	_	_
9	of	_	IN	IN	_	10	case	_	_
10	tropomyosin	_	NN	NN	_	7	nmod	_	_
11	to	_	TO	TO	_	12	case	_	_
12	actin	_	NN	NN	_	2	nmod	_	_
13	varied	_	VBN	VBN	_	2	acl	_	_
14	with	_	IN	IN	_	17	case	_	_
15	the	_	DT	DT	_	17	det	_	_
16	isoform	_	NN	NN	_	17	compound	_	_
17	type	_	NN	NN	_	13	nmod	_	_
18	of	_	IN	IN	_	19	case	_	_
19	tropomyosin	_	NN	NN	_	17	nmod	_	_

1	Most	_	JJS	JJS	_	20	nsubjpass	_	_
3	80	_	CD	CD	_	4	nummod	_	_
4	%	_	NN	NN	_	1	appos	_	_
6	of	_	IN	IN	_	8	case	_	_
7	the	_	DT	DT	_	8	det	_	_
8	tropomyosins	_	NNS	NNS	_	1	nmod	_	_
9	with	_	IN	IN	_	12	case	_	_
10	low	_	JJ	JJ	_	12	amod	_	_
11	Mr	_	NNP	NNP	_	12	compound	_	_
12	values	_	NNS	NNS	_	8	nmod	_	_
14	Mr	_	NNP	NNP	_	1	appos	_	_
15	32,400	_	CD	CD	_	14	nummod	_	_
16	or	_	CC	CC	_	15	cc	_	_
17	32,000	_	CD	CD	_	15	conj	_	_
19	were	_	VBD	VBD	_	20	auxpass	_	_
20	caused	_	VBN	VBN	_	0	root	_	_
21	to	_	TO	TO	_	22	mark	_	_
22	dissociate	_	VB	VB	_	20	xcomp	_	_
23	from	_	IN	IN	_	24	case	_	_
24	actin	_	NN	NN	_	22	nmod	_	_
25	by	_	IN	IN	_	27	case	_	_
26	55-kDa	_	JJ	JJ	_	27	amod	_	_
27	protein	_	NN	NN	_	22	nmod	_	_
29	but	_	CC	CC	_	20	cc	_	_
30	only	_	RB	RB	_	31	advmod	_	_
31	20	_	CD	CD	_	32	nummod	_	_
32	%	_	NN	NN	_	46	nsubjpass	_	_
33	of	_	IN	IN	_	34	case	_	_
34	tropomyosins	_	NNS	NNS	_	32	nmod	_	_
35	with	_	IN	IN	_	38	case	_	_
36	high	_	JJ	JJ	_	38	amod	_	_
37	Mr	_	NNP	NNP	_	38	compound	_	_
38	values	_	NNS	NNS	_	34	nmod	_	_
40	Mr	_	NNP	NNP	_	32	appos	_	_
41	40,000	_	CD	CD	_	40	nummod	_	_
42	or	_	CC	CC	_	41	cc	_	_
43	36,500	_	CD	CD	_	41	conj	_	_
45	was	_	VBD	VBD	_	46	auxpass	_	_
46	dissociated	_	VBN	VBN	_	20	conj	_	_
47	from	_	IN	IN	_	48	case	_	_
48	actin	_	NN	NN	_	46	nmod	_	_
49	in	_	IN	IN	_	51	case	_	_
50	these	_	DT	DT	_	51	det	_	_
51	conditions	_	NNS	NNS	_	48	nmod	_	_

1	Immunofluorescence	_	NNP	NNP	_	3	nsubj	_	_
2	has	_	VBZ	VBZ	_	3	aux	_	_
3	shown	_	VBN	VBN	_	0	root	_	_
4	that	_	IN	IN	_	17	mark	_	_
6	while	_	IN	IN	_	9	mark	_	_
7	tropomyosin	_	NN	NN	_	9	nsubj	_	_
8	was	_	VBD	VBD	_	9	cop	_	_
9	localized	_	JJ	JJ	_	17	advcl	_	_
10	in	_	IN	IN	_	12	case	_	_
11	stress	_	NN	NN	_	12	compound	_	_
12	fibers	_	NNS	NNS	_	9	nmod	_	_
14	55-kDa	_	JJ	JJ	_	15	amod	_	_
15	protein	_	NN	NN	_	17	nsubjpass	_	_
16	was	_	VBD	VBD	_	17	auxpass	_	_
17	found	_	VBN	VBN	_	3	ccomp	_	_
18	in	_	IN	IN	_	19	case	_	_
19	microspikes	_	NNS	NNS	_	17	nmod	_	_
20	as	_	RB	RB	_	19	cc	_	_
21	well	_	RB	RB	_	20	mwe	_	_
22	as	_	IN	IN	_	20	mwe	_	_
23	stress	_	NN	NN	_	24	compound	_	_
24	fibers	_	NNS	NNS	_	19	conj	_	_
26	both	_	DT	DT	_	28	dep	_	_
27	of	_	IN	IN	_	28	case	_	_
28	which	_	WDT	WDT	_	30	nsubjpass	_	_
29	are	_	VBP	VBP	_	30	auxpass	_	_
30	known	_	VBN	VBN	_	24	acl:relcl	_	_
31	to	_	TO	TO	_	32	mark	_	_
32	contain	_	VB	VB	_	30	xcomp	_	_
33	bundles	_	NNS	NNS	_	32	dobj	_	_
34	of	_	IN	IN	_	35	case	_	_
35	microfilaments	_	NNS	NNS	_	33	nmod	_	_

1	Therefore	_	RB	RB	_	4	advmod	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	suggest	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	15	mark	_	_
6	55-kDa	_	JJ	JJ	_	7	amod	_	_
7	protein	_	NN	NN	_	15	nsubj	_	_
8	together	_	RB	RB	_	13	advmod	_	_
9	with	_	IN	IN	_	13	case	_	_
10	the	_	DT	DT	_	13	det	_	_
11	multiple	_	JJ	JJ	_	13	amod	_	_
12	tropomyosin	_	NN	NN	_	13	compound	_	_
13	isoforms	_	NNS	NNS	_	7	nmod	_	_
14	may	_	MD	MD	_	15	aux	_	_
15	regulate	_	VB	VB	_	4	ccomp	_	_
16	the	_	DT	DT	_	17	det	_	_
17	formation	_	NN	NN	_	15	dobj	_	_
18	of	_	IN	IN	_	20	case	_	_
19	two	_	CD	CD	_	20	nummod	_	_
20	types	_	NNS	NNS	_	17	nmod	_	_
21	of	_	IN	IN	_	23	case	_	_
22	actin-filament	_	JJ	JJ	_	23	amod	_	_
23	bundles	_	NNS	NNS	_	20	nmod	_	_
25	bundles	_	NNS	NNS	_	23	appos	_	_
26	containing	_	VBG	VBG	_	25	acl	_	_
27	tropomyosin	_	NN	NN	_	26	dobj	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	those	_	DT	DT	_	27	conj	_	_
30	without	_	IN	IN	_	31	case	_	_
31	tropomyosin	_	NN	NN	_	26	nmod	_	_

1	Structures	_	NNS	NNS	_	4	nsubj	_	_
2	of	_	IN	IN	_	3	case	_	_
3	glycosphingolipids	_	NNS	NNS	_	1	nmod	_	_
4	isolated	_	VBD	VBD	_	0	root	_	_
5	from	_	IN	IN	_	8	case	_	_
6	human	_	JJ	JJ	_	8	amod	_	_
7	embryonal_carcinoma	_	NN	NN	_	8	compound	_	_
8	cells	_	NNS	NNS	_	4	nmod	_	_

1	The	_	DT	DT	_	2	det	_	_
2	presence	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	4	case	_	_
4	mono	_	NN	NN	_	2	nmod	_	_
6	and	_	CC	CC	_	4	cc	_	_
7	disialosyl_glycolipids	_	NN	NN	_	4	conj	_	_
8	with	_	IN	IN	_	12	case	_	_
9	blood	_	NN	NN	_	12	compound	_	_
10	group	_	NN	NN	_	12	compound	_	_
11	type_1	_	JJ	JJ	_	12	amod	_	_
12	sequence	_	NN	NN	_	2	nmod	_	_

1	Structures	_	NNS	NNS	_	4	nsubj	_	_
2	of	_	IN	IN	_	3	case	_	_
3	glycolipids	_	NNS	NNS	_	1	nmod	_	_
4	present	_	VBP	VBP	_	13	ccomp	_	_
5	in	_	IN	IN	_	10	case	_	_
6	the	_	DT	DT	_	10	det	_	_
7	human	_	JJ	JJ	_	10	amod	_	_
8	embryonal_carcinoma	_	NN	NN	_	10	compound	_	_
9	cell	_	NN	NN	_	10	compound	_	_
10	PA1	_	NN	NN	_	4	nmod	_	_
12	were	_	VBD	VBD	_	13	auxpass	_	_
13	elucidated	_	VBN	VBN	_	0	root	_	_
14	by	_	IN	IN	_	17	case	_	_
15	fast	_	JJ	JJ	_	17	amod	_	_
16	atom	_	NN	NN	_	17	compound	_	_
17	bombardment-mass	_	NNS	NNS	_	13	nmod	_	_
18	spectrometry	_	NN	NN	_	13	nsubjpass	_	_
20	methylation	_	NN	NN	_	21	compound	_	_
21	analysis	_	NN	NN	_	18	appos	_	_
23	and	_	CC	CC	_	18	cc	_	_
24	exo	_	JJ	JJ	_	28	amod	_	_
26	and	_	CC	CC	_	24	cc	_	_
27	endoglycosidase	_	JJ	JJ	_	24	conj	_	_
28	digestion	_	NN	NN	_	18	conj	_	_

1	PA1	_	NNP	NNP	_	2	compound	_	_
2	cells	_	NNS	NNS	_	3	nsubj	_	_
3	contain	_	VBP	VBP	_	0	root	_	_
4	globotriaosylceramide	_	JJ	JJ	_	11	amod	_	_
6	sialosylgangliotriaosylceramide	_	JJ	JJ	_	4	conj	_	_
8	sialylated	_	JJ	JJ	_	4	conj	_	_
9	and	_	CC	CC	_	4	cc	_	_
10	nonsialylated	_	JJ	JJ	_	4	conj	_	_
11	lacto-N-neotetraosylceramide	_	NN	NN	_	3	dobj	_	_
13	and	_	CC	CC	_	11	cc	_	_
14	the	_	DT	DT	_	16	det	_	_
15	following	_	JJ	JJ	_	16	amod	_	_
16	glycolipids	_	NNS	NNS	_	11	conj	_	_
17	with	_	IN	IN	_	23	case	_	_
18	a	_	DT	DT	_	23	det	_	_
19	blood	_	NN	NN	_	23	compound	_	_
20	group	_	NN	NN	_	23	compound	_	_
21	type	_	NN	NN	_	23	compound	_	_
22	1	_	CD	CD	_	23	nummod	_	_
23	sequence	_	NN	NN	_	16	nmod	_	_
26	formula	_	VB	VB	_	3	dep	_	_
28	see	_	VB	VB	_	26	dep	_	_
29	text	_	NN	NN	_	28	dobj	_	_
31	The	_	DT	DT	_	34	det	_	_
32	two	_	CD	CD	_	34	nummod	_	_
33	former	_	JJ	JJ	_	34	amod	_	_
34	glycolipids	_	NNS	NNS	_	40	nsubj	_	_
36	lacto-N-tetraosylceramide	_	JJ	JJ	_	34	amod	_	_
37	and	_	CC	CC	_	36	cc	_	_
38	sialosyllacto-N-tetraosylceramide	_	JJ	JJ	_	36	conj	_	_
40	reacted	_	VBD	VBD	_	3	parataxis	_	_
41	with	_	IN	IN	_	43	case	_	_
42	monoclonal	_	JJ	JJ	_	43	amod	_	_
43	antibodies	_	NNS	NNS	_	40	nmod	_	_
45	K21	_	NNP	NNP	_	43	conj	_	_
46	and	_	CC	CC	_	43	cc	_	_
47	K4	_	NNP	NNP	_	43	conj	_	_
49	respectively	_	RB	RB	_	40	advmod	_	_

1	K21	_	NNP	NNP	_	4	compound	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	K4	_	NNP	NNP	_	1	conj	_	_
4	antigens	_	NNS	NNS	_	24	nsubj	_	_
5	are	_	VBP	VBP	_	24	cop	_	_
6	present	_	JJ	JJ	_	24	xcomp	_	_
7	in	_	IN	IN	_	8	case	_	_
8	many	_	JJ	JJ	_	24	nmod	_	_
9	of	_	IN	IN	_	13	case	_	_
10	the	_	DT	DT	_	13	det	_	_
11	human	_	JJ	JJ	_	13	amod	_	_
12	embryonal_carcinoma	_	NN	NN	_	13	compound	_	_
13	cells	_	NNS	NNS	_	8	nmod	_	_
14	but	_	CC	CC	_	15	cc	_	_
15	not	_	RB	RB	_	8	cc	_	_
16	in	_	IN	IN	_	18	case	_	_
17	a	_	DT	DT	_	18	det	_	_
18	variety	_	NN	NN	_	8	conj	_	_
19	of	_	IN	IN	_	22	case	_	_
20	other	_	JJ	JJ	_	22	amod	_	_
21	cell	_	NN	NN	_	22	compound	_	_
22	lines	_	NNS	NNS	_	18	nmod	_	_
24	suggesting	_	VBG	VBG	_	0	root	_	_
25	that	_	DT	DT	_	31	det	_	_
26	sialylated	_	JJ	JJ	_	31	amod	_	_
27	but	_	CC	CC	_	28	cc	_	_
28	not	_	RB	RB	_	26	cc	_	_
29	fucosylated	_	JJ	JJ	_	26	conj	_	_
30	blood	_	NN	NN	_	31	compound	_	_
31	group	_	NN	NN	_	24	dobj	_	_
32	type_1	_	JJ	JJ	_	33	amod	_	_
33	sequences	_	NNS	NNS	_	36	nsubj	_	_
34	are	_	VBP	VBP	_	36	cop	_	_
35	characteristic	_	JJ	JJ	_	36	amod	_	_
36	markers	_	NNS	NNS	_	31	acl:relcl	_	_
37	for	_	IN	IN	_	40	case	_	_
38	human	_	JJ	JJ	_	40	amod	_	_
39	embryonal_carcinoma	_	NN	NN	_	40	compound	_	_
40	cells	_	NNS	NNS	_	36	nmod	_	_
41	and	_	CC	CC	_	36	cc	_	_
42	malignant_teratocarcinomas	_	VBZ	VBZ	_	36	conj	_	_

1	Aluminum	_	NNP	NNP	_	2	nsubj	_	_
2	ions	_	VBZ	VBZ	_	0	root	_	_
3	stimulate	_	VB	VB	_	2	xcomp	_	_
4	mitosis	_	NNS	NNS	_	3	dobj	_	_
5	in	_	IN	IN	_	7	case	_	_
6	murine	_	JJ	JJ	_	7	amod	_	_
7	cells	_	NNS	NNS	_	3	nmod	_	_
8	in	_	IN	IN	_	10	case	_	_
9	tissue	_	NN	NN	_	10	compound	_	_
10	culture	_	NN	NN	_	7	nmod	_	_

1	Addition	_	JJ	JJ	_	16	amod	_	_
2	of	_	IN	IN	_	3	case	_	_
3	aluminum	_	NN	NN	_	1	nmod	_	_
4	to	_	TO	TO	_	7	case	_	_
5	the	_	DT	DT	_	7	det	_	_
6	culture	_	NN	NN	_	7	compound	_	_
7	medium	_	NN	NN	_	1	nmod	_	_
8	of	_	IN	IN	_	9	case	_	_
9	Nakano	_	NNP	NNP	_	7	nmod	_	_
10	mouse	_	NN	NN	_	16	compound	_	_
11	lens	_	NN	NN	_	16	compound	_	_
12	epithelial	_	NN	NN	_	16	compound	_	_
14	NMLE	_	NNP	NNP	_	16	appos	_	_
16	cells	_	NNS	NNS	_	21	nsubj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	Swiss	_	JJ	JJ	_	20	amod	_	_
19	3T3K	_	CD	CD	_	18	dep	_	_
20	cells	_	NNS	NNS	_	16	conj	_	_
21	induced	_	VBN	VBN	_	0	root	_	_
22	both	_	DT	DT	_	24	det	_	_
23	3H-thymidine	_	JJ	JJ	_	24	amod	_	_
24	incorporation	_	NN	NN	_	21	dobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	mitosis	_	NNS	NNS	_	24	conj	_	_

1	This	_	DT	DT	_	4	nsubj	_	_
2	is	_	VBZ	VBZ	_	4	cop	_	_
3	in	_	IN	IN	_	4	case	_	_
4	contrast	_	NN	NN	_	0	root	_	_
5	to	_	TO	TO	_	8	case	_	_
6	other	_	JJ	JJ	_	8	amod	_	_
7	metal	_	NN	NN	_	8	compound	_	_
8	ions	_	NNS	NNS	_	4	nmod	_	_
9	such	_	JJ	JJ	_	11	case	_	_
10	as	_	IN	IN	_	9	mwe	_	_
11	vanadium	_	NN	NN	_	8	nmod	_	_
13	which	_	WDT	WDT	_	25	nsubj	_	_
15	at	_	IN	IN	_	16	case	_	_
16	concentrations	_	NNS	NNS	_	25	nmod	_	_
17	high	_	JJ	JJ	_	16	amod	_	_
18	enough	_	RB	RB	_	17	advmod	_	_
19	to	_	TO	TO	_	20	mark	_	_
20	increase	_	VB	VB	_	17	xcomp	_	_
21	3H-thymidine	_	JJ	JJ	_	22	amod	_	_
22	incorporation	_	NN	NN	_	20	dobj	_	_
24	actually	_	RB	RB	_	25	advmod	_	_
25	inhibits	_	VBZ	VBZ	_	11	acl:relcl	_	_
26	mitosis	_	NNS	NNS	_	25	dobj	_	_
28	Jones	_	NNP	NNP	_	26	appos	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	Reid	_	NNP	NNP	_	28	conj	_	_
32	J	_	NNP	NNP	_	35	compound	_	_
33	Cell	_	NNP	NNP	_	35	compound	_	_
34	Physiol	_	NNP	NNP	_	35	compound	_	_
35	121:199	_	NNP	NNP	_	28	dep	_	_
37	1984	_	CD	CD	_	28	dep	_	_

1	Aluminum	_	NNP	NNP	_	2	compound	_	_
2	concentrations	_	NNS	NNS	_	11	nsubj	_	_
3	between	_	IN	IN	_	5	case	_	_
4	20	_	CD	CD	_	5	nummod	_	_
5	microM	_	NN	NN	_	2	nmod	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	50	_	CD	CD	_	8	nummod	_	_
8	microM	_	NN	NN	_	5	conj	_	_
9	were	_	VBD	VBD	_	11	cop	_	_
10	most	_	RBS	RBS	_	11	advmod	_	_
11	effective	_	JJ	JJ	_	0	root	_	_

1	The	_	DT	DT	_	3	det	_	_
2	3T3	_	CD	CD	_	3	nummod	_	_
3	cells	_	NNS	NNS	_	4	nsubj	_	_
4	respond	_	VBP	VBP	_	0	root	_	_
5	to	_	TO	TO	_	6	case	_	_
6	aluminum	_	NN	NN	_	4	nmod	_	_
7	with	_	IN	IN	_	10	case	_	_
8	a	_	DT	DT	_	10	det	_	_
9	7.6-fold	_	JJ	JJ	_	10	amod	_	_
10	increase	_	NN	NN	_	4	nmod	_	_
12	and	_	CC	CC	_	4	cc	_	_
13	NMLE	_	NNP	NNP	_	14	compound	_	_
14	cells	_	NNS	NNS	_	15	nsubj	_	_
15	respond	_	VBP	VBP	_	4	conj	_	_
16	with	_	IN	IN	_	19	case	_	_
17	a	_	DT	DT	_	19	det	_	_
18	21-fold	_	JJ	JJ	_	19	amod	_	_
19	increase	_	NN	NN	_	15	nmod	_	_
20	in	_	IN	IN	_	22	case	_	_
21	3H-thymidine	_	JJ	JJ	_	22	amod	_	_
22	incorporation	_	NN	NN	_	19	nmod	_	_

1	DNA	_	NNP	NNP	_	2	compound	_	_
2	synthesis	_	NNP	NNP	_	8	nsubjpass	_	_
3	in	_	IN	IN	_	5	case	_	_
4	NMLE	_	JJ	JJ	_	5	amod	_	_
5	cells	_	NNS	NNS	_	2	nmod	_	_
6	was	_	VBD	VBD	_	8	auxpass	_	_
7	also	_	RB	RB	_	8	advmod	_	_
8	found	_	VBN	VBN	_	0	root	_	_
9	to	_	TO	TO	_	12	mark	_	_
10	be	_	VB	VB	_	12	auxpass	_	_
11	synergistically	_	RB	RB	_	12	advmod	_	_
12	stimulated	_	VBN	VBN	_	8	xcomp	_	_
13	by	_	IN	IN	_	17	case	_	_
14	aluminum	_	NN	NN	_	17	compound	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	low	_	JJ	JJ	_	14	conj	_	_
17	concentrations	_	NNS	NNS	_	12	nmod	_	_
18	of	_	IN	IN	_	19	case	_	_
19	insulin	_	NN	NN	_	17	nmod	_	_
21	4.5	_	CD	CD	_	19	dep	_	_
22	X	_	NNP	NNP	_	21	dep	_	_
23	10	_	CD	CD	_	22	nummod	_	_
25	-8	_	CD	CD	_	22	appos	_	_
27	M	_	NNP	NNP	_	22	dep	_	_

1	A	_	DT	DT	_	3	det	_	_
2	3.25-hr	_	JJ	JJ	_	3	amod	_	_
3	incubation	_	NN	NN	_	9	nsubj	_	_
4	with	_	IN	IN	_	7	case	_	_
5	50	_	CD	CD	_	7	nummod	_	_
6	microM	_	NN	NN	_	7	compound	_	_
7	aluminum	_	NN	NN	_	3	nmod	_	_
8	was	_	VBD	VBD	_	9	cop	_	_
9	sufficient	_	JJ	JJ	_	0	root	_	_
10	to	_	TO	TO	_	11	mark	_	_
11	induce	_	VB	VB	_	9	xcomp	_	_
12	50	_	CD	CD	_	13	nummod	_	_
13	%	_	NN	NN	_	11	dobj	_	_
14	of	_	IN	IN	_	17	case	_	_
15	maximum	_	JJ	JJ	_	17	amod	_	_
16	3H-thymidine	_	JJ	JJ	_	17	amod	_	_
17	incorporation	_	NN	NN	_	13	nmod	_	_
18	during	_	IN	IN	_	21	case	_	_
19	the	_	DT	DT	_	21	det	_	_
20	40-hr	_	JJ	JJ	_	21	amod	_	_
21	assay	_	NN	NN	_	11	nmod	_	_

1	Aluminum-stimulated_3H-thymidine	_	JJ	JJ	_	2	amod	_	_
2	incorporation	_	NN	NN	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	inhibited	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	6	case	_	_
6	hydroxyurea	_	NN	NN	_	4	nmod	_	_
8	and	_	CC	CC	_	4	cc	_	_
9	aluminum	_	NN	NN	_	10	nsubj	_	_
10	causes	_	VBZ	VBZ	_	4	conj	_	_
11	an	_	DT	DT	_	12	det	_	_
12	increase	_	NN	NN	_	10	dobj	_	_
13	in	_	IN	IN	_	15	case	_	_
14	cell	_	NN	NN	_	15	compound	_	_
15	number	_	NN	NN	_	12	nmod	_	_

1	Also	_	RB	RB	_	16	advmod	_	_
3	by	_	IN	IN	_	6	case	_	_
4	sedimentation	_	NN	NN	_	6	compound	_	_
5	equilibrium	_	NN	NN	_	6	compound	_	_
6	analysis	_	NN	NN	_	16	nmod	_	_
7	of	_	IN	IN	_	9	case	_	_
8	the	_	DT	DT	_	9	det	_	_
9	product	_	NN	NN	_	6	nmod	_	_
10	of	_	IN	IN	_	13	case	_	_
11	aluminum-stimulated	_	JJ	JJ	_	13	amod	_	_
12	DNA	_	NN	NN	_	13	compound	_	_
13	synthesis	_	NN	NN	_	9	nmod	_	_
14	it	_	PRP	PRP	_	16	nsubjpass	_	_
15	was	_	VBD	VBD	_	16	auxpass	_	_
16	found	_	VBN	VBN	_	0	root	_	_
17	that	_	IN	IN	_	24	mark	_	_
18	a	_	DT	DT	_	20	det	_	_
19	single	_	JJ	JJ	_	20	amod	_	_
20	copy	_	NN	NN	_	24	nsubjpass	_	_
21	of	_	IN	IN	_	22	case	_	_
22	DNA	_	NNP	NNP	_	20	nmod	_	_
23	was	_	VBD	VBD	_	24	auxpass	_	_
24	synthesized	_	VBN	VBN	_	16	ccomp	_	_
25	following	_	VBG	VBG	_	26	case	_	_
26	addition	_	NN	NN	_	24	nmod	_	_
27	of	_	IN	IN	_	28	case	_	_
28	aluminum	_	NN	NN	_	26	nmod	_	_
29	to	_	TO	TO	_	31	case	_	_
30	quiescent	_	JJ	JJ	_	31	amod	_	_
31	cells	_	NNS	NNS	_	28	nmod	_	_

1	These	_	DT	DT	_	2	det	_	_
2	facts	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	6	mark	_	_
5	aluminum	_	NN	NN	_	6	nsubj	_	_
6	induces	_	VBZ	VBZ	_	3	ccomp	_	_
7	both	_	DT	DT	_	10	det	_	_
8	S-phase	_	JJ	JJ	_	10	amod	_	_
9	DNA	_	NN	NN	_	10	compound	_	_
10	synthesis	_	NN	NN	_	6	dobj	_	_
11	and	_	CC	CC	_	6	cc	_	_
12	mitosis	_	VBZ	VBZ	_	6	conj	_	_

1	However	_	RB	RB	_	16	advmod	_	_
3	only	_	RB	RB	_	4	advmod	_	_
4	48	_	CD	CD	_	5	nummod	_	_
5	%	_	NN	NN	_	16	nsubj	_	_
6	of	_	IN	IN	_	9	case	_	_
7	the	_	DT	DT	_	9	det	_	_
8	NMLE	_	JJ	JJ	_	9	amod	_	_
9	cells	_	NNS	NNS	_	5	nmod	_	_
10	found	_	VBN	VBN	_	9	acl	_	_
11	to	_	TO	TO	_	13	mark	_	_
12	be	_	VB	VB	_	13	auxpass	_	_
13	labeled	_	VBN	VBN	_	10	xcomp	_	_
14	with	_	IN	IN	_	15	case	_	_
15	DNA	_	NNP	NNP	_	13	nmod	_	_
16	went	_	VBD	VBD	_	0	root	_	_
17	on	_	RP	RP	_	16	compound:prt	_	_
18	to	_	TO	TO	_	19	case	_	_
19	divide	_	NN	NN	_	16	nmod	_	_

1	In	_	IN	IN	_	2	case	_	_
2	contrast	_	NN	NN	_	25	nmod	_	_
4	although	_	IN	IN	_	13	mark	_	_
5	only	_	RB	RB	_	8	advmod	_	_
6	a	_	DT	DT	_	8	det	_	_
7	small	_	JJ	JJ	_	8	amod	_	_
8	percentage	_	NN	NN	_	13	nsubjpass	_	_
9	of	_	IN	IN	_	11	case	_	_
10	3T3	_	CD	CD	_	11	nummod	_	_
11	cells	_	NNS	NNS	_	8	nmod	_	_
12	were	_	VBD	VBD	_	13	auxpass	_	_
13	found	_	VBN	VBN	_	25	advcl	_	_
14	to	_	TO	TO	_	16	mark	_	_
15	be	_	VB	VB	_	16	auxpass	_	_
16	labeled	_	VBN	VBN	_	13	xcomp	_	_
17	after	_	IN	IN	_	19	case	_	_
18	aluminum	_	NN	NN	_	19	compound	_	_
19	treatment	_	NN	NN	_	16	nmod	_	_
21	all	_	DT	DT	_	25	nsubj	_	_
22	of	_	IN	IN	_	24	case	_	_
23	these	_	DT	DT	_	24	det	_	_
24	cells	_	NNS	NNS	_	21	nmod	_	_
25	appeared	_	VBD	VBD	_	0	root	_	_
26	to	_	TO	TO	_	27	mark	_	_
27	go	_	VB	VB	_	25	xcomp	_	_
28	through	_	IN	IN	_	29	case	_	_
29	mitosis	_	NNS	NNS	_	27	nmod	_	_

1	-LSB-	_	JJ	JJ	_	3	amod	_	_
2	Colony-forming	_	JJ	JJ	_	3	amod	_	_
3	capacity	_	NN	NN	_	0	root	_	_
4	of	_	IN	IN	_	7	case	_	_
5	bone	_	NN	NN	_	7	compound	_	_
6	marrow	_	NN	NN	_	7	compound	_	_
7	cells	_	NNS	NNS	_	3	nmod	_	_
8	in	_	IN	IN	_	9	case	_	_
9	children	_	NNS	NNS	_	3	nmod	_	_
10	with	_	IN	IN	_	13	case	_	_
11	myeloblastic	_	JJ	JJ	_	13	amod	_	_
12	leukemia	_	NN	NN	_	13	compound	_	_
13	-RSB-	_	NNS	NNS	_	9	nmod	_	_

1	-LSB-	_	NNP	NNP	_	2	compound	_	_
2	AL	_	NNP	NNP	_	0	root	_	_
4	and	_	NNP	NNP	_	13	compound	_	_
5	AA-amyloidosis	_	NNP	NNP	_	13	compound	_	_
7	the	_	DT	DT	_	8	det	_	_
8	status	_	NN	NN	_	13	dep	_	_
9	of	_	IN	IN	_	11	case	_	_
10	the	_	DT	DT	_	11	det	_	_
11	problem	_	NN	NN	_	8	nmod	_	_
13	-RSB-	_	NNP	NNP	_	2	dep	_	_

1	Alcohol	_	NN	NN	_	4	compound	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	alcohol	_	NN	NN	_	1	conj	_	_
4	problems	_	NNS	NNS	_	0	root	_	_
5	research	_	NN	NN	_	4	dep	_	_

1	3	_	CD	CD	_	0	root	_	_

1	Nordic	_	CD	CD	_	2	nummod	_	_
2	countries	_	NNS	NNS	_	0	root	_	_

1	-LSB-	_	NNP	NNP	_	2	compound	_	_
2	Factors	_	NNP	NNP	_	9	nsubj	_	_
3	determining	_	VBG	VBG	_	2	acl	_	_
4	the	_	DT	DT	_	5	det	_	_
5	adherence	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	8	case	_	_
7	S.	_	NNP	NNP	_	8	compound	_	_
8	_	_	NNP	NNP	_	5	nmod	_	_
9	pyogenes	_	VBZ	VBZ	_	0	root	_	_
10	to	_	TO	TO	_	14	case	_	_
11	human	_	JJ	JJ	_	14	amod	_	_
12	epithelial	_	JJ	JJ	_	14	amod	_	_
13	cells	_	NNS	NNS	_	14	compound	_	_
14	-RSB-	_	NNS	NNS	_	9	nmod	_	_

1	Study	_	NNP	NNP	_	0	root	_	_
2	of	_	IN	IN	_	3	case	_	_
3	haemopoiesis	_	NNS	NNS	_	1	nmod	_	_
4	in	_	IN	IN	_	10	case	_	_
5	the	_	DT	DT	_	10	det	_	_
6	human	_	JJ	JJ	_	10	amod	_	_
7	embryonal	_	JJ	JJ	_	10	amod	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	foetal	_	JJ	JJ	_	7	conj	_	_
10	liver	_	NN	NN	_	1	nmod	_	_

1	Effects	_	NNPS	NNPS	_	0	root	_	_
2	of	_	IN	IN	_	4	case	_	_
3	crude	_	JJ	JJ	_	4	amod	_	_
4	drugs	_	NNS	NNS	_	1	nmod	_	_
5	on	_	IN	IN	_	8	case	_	_
6	various	_	JJ	JJ	_	8	amod	_	_
7	digestive	_	NN	NN	_	8	compound	_	_
8	enzymes	_	NNS	NNS	_	1	nmod	_	_
9	in	_	IN	IN	_	10	case	_	_
10	vitro	_	NN	NN	_	1	acl	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	in	_	IN	IN	_	13	case	_	_
13	vivo	_	NN	NN	_	10	conj	_	_

1	-LSB-	_	NNP	NNP	_	2	compound	_	_
2	Progress	_	NNP	NNP	_	0	root	_	_
3	in	_	IN	IN	_	5	case	_	_
4	chemotherapeutic	_	JJ	JJ	_	5	amod	_	_
5	agents	_	NNS	NNS	_	2	nmod	_	_
7	beta-lactam	_	JJ	JJ	_	8	amod	_	_
8	antibiotics	_	NNS	NNS	_	2	dep	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	beta-lactamase	_	JJ	JJ	_	12	amod	_	_
11	inhibitors	_	NNS	NNS	_	12	compound	_	_
12	-RSB-	_	NNS	NNS	_	8	conj	_	_

1	-LSB-	_	NNP	NNP	_	2	compound	_	_
2	Ingestion	_	NNP	NNP	_	8	nsubj	_	_
3	of	_	IN	IN	_	4	case	_	_
4	tiaprofenic_acid	_	NN	NN	_	2	nmod	_	_
6	Surgam	_	NNP	NNP	_	2	appos	_	_
8	associated	_	VBN	VBN	_	0	root	_	_
9	with	_	IN	IN	_	11	case	_	_
10	an	_	DT	DT	_	11	det	_	_
11	outbreak	_	NN	NN	_	8	nmod	_	_
12	of	_	IN	IN	_	14	case	_	_
13	acute_pancreatitis	_	JJ	JJ	_	14	amod	_	_
14	-RSB-	_	NNS	NNS	_	11	nmod	_	_

1	-LSB-	_	NNP	NNP	_	0	root	_	_
2	In	_	IN	IN	_	4	case	_	_
3	vitro	_	JJ	JJ	_	4	amod	_	_
4	effect	_	NN	NN	_	1	nmod	_	_
5	of	_	IN	IN	_	6	case	_	_
6	native	_	NN	NN	_	4	nmod	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	recombinant	_	JJ	JJ	_	10	amod	_	_
9	human	_	JJ	JJ	_	10	amod	_	_
10	interferon-beta	_	NN	NN	_	6	conj	_	_
11	or	_	CC	CC	_	4	cc	_	_
13	gamma	_	NN	NN	_	4	conj	_	_
14	on	_	IN	IN	_	15	case	_	_
15	adenovirus_infection	_	NN	NN	_	13	nmod	_	_
17	measured	_	VBN	VBN	_	15	acl	_	_
18	by	_	IN	IN	_	21	case	_	_
19	enzyme	_	JJ	JJ	_	21	amod	_	_
20	immunoassay	_	NN	NN	_	21	compound	_	_
21	-RSB-	_	NNS	NNS	_	17	nmod	_	_

1	-LSB-	_	NNP	NNP	_	2	compound	_	_
2	Munchausen	_	NNP	NNP	_	5	nmod:poss	_	_
3	's	_	POS	POS	_	2	case	_	_
4	_	_	JJ	JJ	_	5	amod	_	_
5	syndrome	_	NN	NN	_	6	nsubj	_	_
6	-RSB-	_	VBZ	VBZ	_	0	root	_	_

1	3-Carbethoxypsoralen-DNA	_	JJ	JJ	_	2	amod	_	_
2	photolesions	_	NNS	NNS	_	0	root	_	_
4	identification	_	NN	NN	_	7	compound	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	quantitative	_	JJ	JJ	_	4	conj	_	_
7	detection	_	NN	NN	_	2	dep	_	_
8	in	_	IN	IN	_	12	case	_	_
9	yeast	_	NN	NN	_	12	compound	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	mammalian	_	JJ	JJ	_	9	conj	_	_
12	cells	_	NNS	NNS	_	7	nmod	_	_
13	of	_	IN	IN	_	17	case	_	_
14	the	_	DT	DT	_	17	det	_	_
15	two	_	CD	CD	_	17	nummod	_	_
16	cis-syn	_	JJ	JJ	_	17	amod	_	_
17	diastereoisomers	_	NNS	NNS	_	12	nmod	_	_
18	formed	_	VBN	VBN	_	17	acl	_	_
19	with	_	IN	IN	_	20	case	_	_
20	thymidine	_	NN	NN	_	18	nmod	_	_

1	Rapid	_	NNP	NNP	_	2	compound	_	_
2	detection	_	NNP	NNP	_	7	nsubj	_	_
3	of	_	IN	IN	_	4	case	_	_
4	respiratory_syncytial_virus	_	NNS	NNS	_	2	nmod	_	_
5	in	_	IN	IN	_	6	case	_	_
6	nasopharyngeal	_	NN	NN	_	4	nmod	_	_
7	aspirates	_	VBZ	VBZ	_	0	root	_	_
8	by	_	IN	IN	_	12	case	_	_
9	a	_	DT	DT	_	12	det	_	_
10	commercial	_	JJ	JJ	_	12	amod	_	_
11	enzyme	_	NN	NN	_	12	compound	_	_
12	immunoassay	_	NN	NN	_	7	nmod	_	_

1	A	_	DT	DT	_	4	det	_	_
2	commercial	_	JJ	JJ	_	4	amod	_	_
3	enzyme	_	NN	NN	_	4	compound	_	_
4	immunoassay	_	NN	NN	_	21	nsubjpass	_	_
6	EIA	_	NNP	NNP	_	4	appos	_	_
8	for	_	IN	IN	_	11	case	_	_
9	the	_	DT	DT	_	11	det	_	_
10	rapid	_	JJ	JJ	_	11	amod	_	_
11	detection	_	NN	NN	_	4	nmod	_	_
12	of	_	IN	IN	_	13	case	_	_
13	respiratory_syncytial_virus	_	NNS	NNS	_	11	nmod	_	_
15	RSV	_	NNP	NNP	_	13	appos	_	_
17	in	_	IN	IN	_	19	case	_	_
18	respiratory	_	JJ	JJ	_	19	amod	_	_
19	secretions	_	NNS	NNS	_	13	nmod	_	_
20	was	_	VBD	VBD	_	21	auxpass	_	_
21	evaluated	_	VBN	VBN	_	0	root	_	_
22	by	_	IN	IN	_	23	case	_	_
23	comparison	_	NN	NN	_	21	nmod	_	_
24	with	_	IN	IN	_	27	case	_	_
25	both	_	DT	DT	_	27	det	_	_
26	virus	_	NN	NN	_	27	compound	_	_
27	isolation	_	NN	NN	_	23	nmod	_	_
28	in	_	IN	IN	_	37	mark	_	_
29	HEp-2	_	NN	NN	_	30	compound	_	_
30	cells	_	NNS	NNS	_	37	nsubj	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	indirect	_	JJ	JJ	_	33	amod	_	_
33	immunofluorescence	_	NN	NN	_	30	conj	_	_
35	IFA	_	NNP	NNP	_	33	appos	_	_
37	staining	_	VBG	VBG	_	21	advcl	_	_
38	of	_	IN	IN	_	41	case	_	_
39	exfoliated	_	JJ	JJ	_	41	amod	_	_
40	respiratory	_	NN	NN	_	41	compound	_	_
41	cells	_	NNS	NNS	_	37	nmod	_	_

1	Initial	_	JJ	JJ	_	2	amod	_	_
2	examination	_	NN	NN	_	14	nsubj	_	_
3	of	_	IN	IN	_	6	case	_	_
4	80	_	CD	CD	_	6	nummod	_	_
5	nasopharyngeal	_	JJ	JJ	_	6	amod	_	_
6	aspirates	_	NNS	NNS	_	2	nmod	_	_
7	collected	_	VBN	VBN	_	6	acl	_	_
8	from	_	IN	IN	_	9	case	_	_
9	infants	_	NNS	NNS	_	7	nmod	_	_
10	with	_	IN	IN	_	13	case	_	_
11	acute	_	JJ	JJ	_	13	amod	_	_
12	respiratory	_	JJ	JJ	_	13	amod	_	_
13	illness	_	NN	NN	_	9	nmod	_	_
14	showed	_	VBD	VBD	_	0	root	_	_
15	that	_	IN	IN	_	20	mark	_	_
16	the	_	DT	DT	_	18	det	_	_
17	RSV	_	NNP	NNP	_	18	compound	_	_
18	EIA	_	NNP	NNP	_	20	nsubj	_	_
19	was	_	VBD	VBD	_	20	cop	_	_
20	positive	_	JJ	JJ	_	14	ccomp	_	_
21	for	_	IN	IN	_	22	case	_	_
22	21	_	CD	CD	_	20	nmod	_	_
23	of	_	IN	IN	_	25	case	_	_
24	24	_	CD	CD	_	25	nummod	_	_
25	specimens	_	NNS	NNS	_	22	nmod	_	_
26	positive	_	JJ	JJ	_	25	amod	_	_
27	by	_	IN	IN	_	29	case	_	_
28	virus	_	NN	NN	_	29	compound	_	_
29	isolation	_	NN	NN	_	26	nmod	_	_
30	or	_	CC	CC	_	29	cc	_	_
31	IFA	_	NNP	NNP	_	29	conj	_	_
33	87.5	_	CD	CD	_	34	nummod	_	_
34	%	_	NN	NN	_	26	dep	_	_
35	sensitivity	_	NN	NN	_	34	dep	_	_
37	and	_	CC	CC	_	26	cc	_	_
38	negative	_	JJ	JJ	_	26	conj	_	_
39	for	_	IN	IN	_	40	case	_	_
40	53	_	CD	CD	_	38	nmod	_	_
41	of	_	IN	IN	_	43	case	_	_
42	56	_	CD	CD	_	43	nummod	_	_
43	specimens	_	NNS	NNS	_	40	nmod	_	_
44	negative	_	JJ	JJ	_	25	advmod	_	_
45	by	_	IN	IN	_	47	case	_	_
46	virus	_	NN	NN	_	47	compound	_	_
47	isolation	_	NN	NN	_	44	nmod	_	_
48	and	_	CC	CC	_	47	cc	_	_
49	IFA	_	NNP	NNP	_	47	conj	_	_
51	95	_	CD	CD	_	52	nummod	_	_
52	%	_	NN	NN	_	25	dep	_	_
53	specificity	_	NN	NN	_	52	dep	_	_

1	The	_	DT	DT	_	2	det	_	_
2	EIA	_	NNP	NNP	_	3	nsubj	_	_
3	appears	_	VBZ	VBZ	_	0	root	_	_
4	to	_	TO	TO	_	11	mark	_	_
5	be	_	VB	VB	_	11	cop	_	_
6	an	_	DT	DT	_	11	det	_	_
7	acceptable	_	JJ	JJ	_	11	amod	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	more	_	RBR	RBR	_	10	advmod	_	_
10	rapid	_	JJ	JJ	_	7	conj	_	_
11	test	_	NN	NN	_	3	xcomp	_	_
12	than	_	IN	IN	_	14	case	_	_
13	virus	_	NN	NN	_	14	compound	_	_
14	isolation	_	NN	NN	_	11	nmod	_	_
15	for	_	IN	IN	_	17	case	_	_
16	the	_	DT	DT	_	17	det	_	_
17	detection	_	NN	NN	_	14	nmod	_	_
18	of	_	IN	IN	_	19	case	_	_
19	RSV	_	NNP	NNP	_	17	nmod	_	_
21	especially	_	RB	RB	_	23	advmod	_	_
22	for	_	IN	IN	_	23	case	_	_
23	laboratories	_	NNS	NNS	_	11	nmod	_	_
24	in	_	IN	IN	_	25	case	_	_
25	which	_	WDT	WDT	_	33	nmod	_	_
26	prompt	_	JJ	JJ	_	27	amod	_	_
27	inoculation	_	NN	NN	_	33	nsubj	_	_
28	of	_	IN	IN	_	29	case	_	_
29	specimens	_	NNS	NNS	_	27	nmod	_	_
30	is	_	VBZ	VBZ	_	33	cop	_	_
31	not	_	RB	RB	_	33	neg	_	_
32	always	_	RB	RB	_	33	advmod	_	_
33	possible	_	JJ	JJ	_	23	acl:relcl	_	_

1	IFA	_	NNP	NNP	_	9	nsubjpass	_	_
2	staining	_	VBG	VBG	_	1	acl	_	_
3	with	_	IN	IN	_	7	case	_	_
4	commercial	_	JJ	JJ	_	7	amod	_	_
5	bovine	_	JJ	JJ	_	7	amod	_	_
6	anti-RSV	_	JJ	JJ	_	7	amod	_	_
7	serum	_	NN	NN	_	2	nmod	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	found	_	VBN	VBN	_	0	root	_	_
10	to	_	TO	TO	_	17	mark	_	_
11	be	_	VB	VB	_	17	cop	_	_
12	the	_	DT	DT	_	17	det	_	_
13	most	_	RBS	RBS	_	14	advmod	_	_
14	sensitive	_	JJ	JJ	_	17	amod	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	rapid	_	JJ	JJ	_	14	conj	_	_
17	test	_	NN	NN	_	9	xcomp	_	_
18	for	_	IN	IN	_	20	case	_	_
19	the	_	DT	DT	_	20	det	_	_
20	detection	_	NN	NN	_	17	nmod	_	_
21	of	_	IN	IN	_	22	case	_	_
22	RSV	_	NNP	NNP	_	20	nmod	_	_

1	However	_	RB	RB	_	17	advmod	_	_
3	three	_	CD	CD	_	17	nsubjpass	_	_
4	of	_	IN	IN	_	6	case	_	_
5	four	_	CD	CD	_	6	nummod	_	_
6	specimens	_	NNS	NNS	_	3	nmod	_	_
7	positive	_	JJ	JJ	_	6	amod	_	_
8	by	_	IN	IN	_	9	case	_	_
9	IFA	_	NNP	NNP	_	7	nmod	_	_
10	and	_	CC	CC	_	7	cc	_	_
11	negative	_	JJ	JJ	_	7	conj	_	_
12	by	_	IN	IN	_	14	case	_	_
13	virus	_	NN	NN	_	14	compound	_	_
14	isolation	_	NN	NN	_	11	nmod	_	_
15	were	_	VBD	VBD	_	17	auxpass	_	_
16	not	_	RB	RB	_	17	neg	_	_
17	cultured	_	VBN	VBN	_	0	root	_	_
18	under	_	IN	IN	_	20	case	_	_
19	optimal	_	JJ	JJ	_	20	amod	_	_
20	conditions	_	NNS	NNS	_	17	nmod	_	_

1	In	_	IN	IN	_	2	case	_	_
2	addition	_	NN	NN	_	7	nmod	_	_
4	the	_	DT	DT	_	6	det	_	_
5	IFA	_	NNP	NNP	_	6	compound	_	_
6	test	_	NN	NN	_	7	nsubj	_	_
7	requires	_	VBZ	VBZ	_	0	root	_	_
8	a	_	DT	DT	_	11	det	_	_
9	highly	_	RB	RB	_	10	advmod	_	_
10	trained	_	JJ	JJ	_	11	amod	_	_
11	technologist	_	NN	NN	_	7	dobj	_	_
12	to	_	TO	TO	_	13	mark	_	_
13	interpret	_	VB	VB	_	7	xcomp	_	_
14	the	_	DT	DT	_	16	det	_	_
15	staining	_	VBG	VBG	_	16	amod	_	_
16	results	_	NNS	NNS	_	13	dobj	_	_

1	Treatment	_	NNP	NNP	_	0	root	_	_
2	of	_	IN	IN	_	3	case	_	_
3	depression	_	NN	NN	_	1	nmod	_	_
4	in	_	IN	IN	_	6	case	_	_
5	chronic	_	JJ	JJ	_	6	amod	_	_
6	cocaine	_	NN	NN	_	1	nmod	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	phencyclidine	_	NN	NN	_	9	compound	_	_
9	abuse	_	NN	NN	_	6	conj	_	_
10	with	_	IN	IN	_	11	case	_	_
11	desipramine	_	NN	NN	_	6	nmod	_	_

1	An	_	DT	DT	_	4	det	_	_
2	open	_	JJ	JJ	_	4	amod	_	_
3	field	_	NN	NN	_	4	compound	_	_
4	trial	_	NN	NN	_	6	nsubjpass	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	conducted	_	VBN	VBN	_	0	root	_	_
7	comparing	_	VBG	VBG	_	6	xcomp	_	_
8	desipramine	_	NN	NN	_	7	dobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	an	_	DT	DT	_	12	det	_	_
11	active	_	JJ	JJ	_	12	amod	_	_
12	placebo	_	NN	NN	_	8	conj	_	_
13	in	_	IN	IN	_	19	case	_	_
14	separate	_	JJ	JJ	_	19	amod	_	_
15	populations_of_chronic_cocaine_and_phencyclidine	_	NN	NN	_	19	compound	_	_
17	PCP	_	NNP	NNP	_	19	appos	_	_
19	abusers	_	NNS	NNS	_	7	nmod	_	_
21	who	_	WP	WP	_	22	nsubj	_	_
22	discontinued	_	VBN	VBN	_	19	acl:relcl	_	_
23	their	_	PRP$	PRP$	_	24	nmod:poss	_	_
24	abuse	_	NN	NN	_	22	dobj	_	_

1	Subjects	_	NNS	NNS	_	5	nsubj	_	_
2	who	_	WP	WP	_	3	nsubj	_	_
3	received	_	VBD	VBD	_	1	acl:relcl	_	_
4	desipramine	_	JJ	JJ	_	3	xcomp	_	_
5	showed	_	VBD	VBD	_	0	root	_	_
6	a	_	DT	DT	_	7	det	_	_
7	decrease	_	NN	NN	_	5	dobj	_	_
8	in	_	IN	IN	_	10	case	_	_
9	depressive	_	JJ	JJ	_	10	amod	_	_
10	symptoms	_	NNS	NNS	_	7	nmod	_	_
11	after	_	IN	IN	_	15	case	_	_
12	a	_	DT	DT	_	15	det	_	_
13	20-40	_	CD	CD	_	15	nummod	_	_
14	day	_	NN	NN	_	15	compound	_	_
15	period	_	NN	NN	_	10	nmod	_	_
16	regardless	_	RB	RB	_	5	advmod	_	_
17	of	_	IN	IN	_	20	mark	_	_
18	whether	_	IN	IN	_	20	mark	_	_
19	they	_	PRP	PRP	_	20	nsubj	_	_
20	abused	_	VBD	VBD	_	16	advcl	_	_
21	PCP	_	NNP	NNP	_	20	dobj	_	_
22	or	_	CC	CC	_	21	cc	_	_
23	cocaine	_	NN	NN	_	21	conj	_	_

1	Cutaneous	_	JJ	JJ	_	3	amod	_	_
2	secondary	_	JJ	JJ	_	3	amod	_	_
3	syphilis	_	NNS	NNS	_	0	root	_	_
5	preliminary	_	JJ	JJ	_	7	amod	_	_
6	immunohistopathologic	_	JJ	JJ	_	7	amod	_	_
7	support	_	NN	NN	_	3	dep	_	_
8	for	_	IN	IN	_	10	case	_	_
9	a	_	DT	DT	_	10	det	_	_
10	role	_	NN	NN	_	7	nmod	_	_
11	for	_	IN	IN	_	13	case	_	_
12	immune	_	JJ	JJ	_	13	amod	_	_
13	complexes	_	NNS	NNS	_	10	nmod	_	_
14	in	_	IN	IN	_	16	case	_	_
15	lesion	_	NN	NN	_	16	compound	_	_
16	pathogenesis	_	NNS	NNS	_	13	nmod	_	_

1	A	_	DT	DT	_	5	det	_	_
2	circulating	_	CD	CD	_	5	nummod	_	_
3	immune	_	JJ	JJ	_	5	amod	_	_
4	complex-mediated	_	JJ	JJ	_	5	amod	_	_
5	pathogenesis	_	NNS	NNS	_	13	nsubjpass	_	_
6	for	_	IN	IN	_	7	case	_	_
7	lesions	_	NNS	NNS	_	5	nmod	_	_
8	of	_	IN	IN	_	10	case	_	_
9	secondary	_	JJ	JJ	_	10	amod	_	_
10	syphilis	_	NNS	NNS	_	7	nmod	_	_
11	has	_	VBZ	VBZ	_	13	aux	_	_
12	been	_	VBN	VBN	_	13	auxpass	_	_
13	postulated	_	VBN	VBN	_	0	root	_	_

1	Textbook	_	NN	NN	_	2	compound	_	_
2	descriptions	_	NNS	NNS	_	9	nsubj	_	_
3	of	_	IN	IN	_	7	case	_	_
4	a	_	DT	DT	_	7	det	_	_
5	lymphoplasmacytic	_	JJ	JJ	_	7	amod	_	_
6	histopathologic	_	JJ	JJ	_	7	amod	_	_
7	picture	_	NN	NN	_	2	nmod	_	_
8	have	_	VBP	VBP	_	9	aux	_	_
9	contradicted	_	VBN	VBN	_	0	root	_	_
10	a	_	DT	DT	_	11	det	_	_
11	role	_	NN	NN	_	9	dobj	_	_
12	for	_	IN	IN	_	13	mark	_	_
13	circulating	_	VBG	VBG	_	9	advcl	_	_
14	immune	_	JJ	JJ	_	15	amod	_	_
15	complexes	_	NNS	NNS	_	13	dobj	_	_
16	in	_	IN	IN	_	18	case	_	_
17	lesion	_	NN	NN	_	18	compound	_	_
18	pathogenesis	_	NNS	NNS	_	13	nmod	_	_

1	Four	_	CD	CD	_	2	nummod	_	_
2	patients	_	NNS	NNS	_	10	nsubjpass	_	_
3	with	_	IN	IN	_	5	case	_	_
4	early	_	JJ	JJ	_	5	amod	_	_
5	cutaneous_lesions	_	NNS	NNS	_	2	nmod	_	_
6	of	_	IN	IN	_	8	case	_	_
7	secondary	_	JJ	JJ	_	8	amod	_	_
8	syphilis	_	NNS	NNS	_	5	nmod	_	_
9	were	_	VBD	VBD	_	10	auxpass	_	_
10	studied	_	VBN	VBN	_	0	root	_	_

1	All	_	DT	DT	_	3	det	_	_
2	four	_	CD	CD	_	3	nummod	_	_
3	patients	_	NNS	NNS	_	4	nsubj	_	_
4	had	_	VBD	VBD	_	0	root	_	_
5	serum	_	JJ	JJ	_	7	amod	_	_
6	Raji	_	NNP	NNP	_	7	compound	_	_
7	cell	_	NN	NN	_	4	dobj	_	_
8	and/or	_	CC	CC	_	4	cc	_	_
9	Clq	_	VB	VB	_	4	conj	_	_
10	binding	_	JJ	JJ	_	12	amod	_	_
11	assay	_	NN	NN	_	12	compound	_	_
12	evidence	_	NN	NN	_	9	dobj	_	_
13	for	_	IN	IN	_	14	mark	_	_
14	circulating	_	VBG	VBG	_	9	advcl	_	_
15	immune	_	JJ	JJ	_	16	amod	_	_
16	complexes	_	NNS	NNS	_	14	dobj	_	_

1	Three	_	CD	CD	_	2	nummod	_	_
2	patients	_	NNS	NNS	_	3	nsubj	_	_
3	showed	_	VBD	VBD	_	0	root	_	_
4	a	_	DT	DT	_	7	det	_	_
5	neutrophilic	_	JJ	JJ	_	7	amod	_	_
6	vascular	_	NN	NN	_	7	compound	_	_
7	reaction	_	NN	NN	_	3	dobj	_	_
8	on	_	IN	IN	_	10	case	_	_
9	histologic	_	JJ	JJ	_	10	amod	_	_
10	study	_	NN	NN	_	3	nmod	_	_
11	of	_	IN	IN	_	13	case	_	_
12	early	_	JJ	JJ	_	13	amod	_	_
13	lesions	_	NNS	NNS	_	10	nmod	_	_

1	The	_	DT	DT	_	2	det	_	_
2	patients	_	NNS	NNS	_	4	nsubj	_	_
3	studied	_	VBN	VBN	_	2	acl	_	_
4	had	_	VBD	VBD	_	0	root	_	_
5	immunofluorescence	_	JJ	JJ	_	7	amod	_	_
6	microscopic	_	JJ	JJ	_	7	amod	_	_
7	evidence	_	NN	NN	_	4	dobj	_	_
8	of	_	IN	IN	_	10	case	_	_
9	immunoreactant	_	JJ	JJ	_	10	amod	_	_
10	deposition	_	NN	NN	_	7	nmod	_	_
11	in	_	IN	IN	_	14	case	_	_
12	dermal	_	JJ	JJ	_	14	amod	_	_
13	blood	_	NN	NN	_	14	compound	_	_
14	vessels	_	NNS	NNS	_	4	nmod	_	_
16	4	_	CD	CD	_	17	nummod	_	_
17	hours	_	NNS	NNS	_	14	appos	_	_
19	and/or	_	CC	CC	_	4	cc	_	_
20	a	_	DT	DT	_	23	det	_	_
21	neutrophilic	_	JJ	JJ	_	23	amod	_	_
22	vascular	_	NN	NN	_	23	compound	_	_
23	reaction	_	NN	NN	_	4	conj	_	_
25	24	_	CD	CD	_	26	nummod	_	_
26	hours	_	NNS	NNS	_	23	appos	_	_
28	after	_	IN	IN	_	31	case	_	_
29	intradermal	_	JJ	JJ	_	31	amod	_	_
30	histamine	_	NN	NN	_	31	compound	_	_
31	injection	_	NN	NN	_	23	nmod	_	_

1	Dieterle	_	JJ	JJ	_	2	amod	_	_
2	staining	_	NN	NN	_	9	nsubj	_	_
3	of	_	IN	IN	_	5	case	_	_
4	lesional	_	JJ	JJ	_	5	amod	_	_
5	tissue	_	NN	NN	_	2	nmod	_	_
6	from	_	IN	IN	_	8	case	_	_
7	all	_	DT	DT	_	8	det	_	_
8	patients	_	NNS	NNS	_	5	nmod	_	_
9	showed	_	VBD	VBD	_	0	root	_	_
10	the	_	DT	DT	_	11	det	_	_
11	presence	_	NN	NN	_	9	dobj	_	_
12	of	_	IN	IN	_	14	case	_	_
13	treponemal	_	JJ	JJ	_	14	amod	_	_
14	organisms	_	NNS	NNS	_	11	nmod	_	_
15	in	_	IN	IN	_	18	case	_	_
16	dermal	_	JJ	JJ	_	18	amod	_	_
17	blood	_	NN	NN	_	18	compound	_	_
18	vessels	_	NNS	NNS	_	9	nmod	_	_

1	This	_	DT	DT	_	4	det	_	_
2	new	_	JJ	JJ	_	4	amod	_	_
3	preliminary	_	JJ	JJ	_	4	amod	_	_
4	evidence	_	NN	NN	_	5	nsubj	_	_
5	adds	_	VBZ	VBZ	_	0	root	_	_
6	some	_	DT	DT	_	7	det	_	_
7	support	_	NN	NN	_	5	dobj	_	_
8	to	_	TO	TO	_	13	case	_	_
9	a	_	DT	DT	_	13	det	_	_
10	circulating	_	CD	CD	_	13	nummod	_	_
11	immune	_	JJ	JJ	_	13	amod	_	_
12	complex-mediated	_	JJ	JJ	_	13	amod	_	_
13	pathogenesis	_	NNS	NNS	_	5	nmod	_	_
14	of	_	IN	IN	_	15	case	_	_
15	cutaneous_lesions	_	NNS	NNS	_	13	nmod	_	_
16	in	_	IN	IN	_	19	case	_	_
17	human	_	JJ	JJ	_	19	amod	_	_
18	secondary	_	JJ	JJ	_	19	amod	_	_
19	syphilis	_	NNS	NNS	_	15	nmod	_	_

1	Murine	_	JJ	JJ	_	4	amod	_	_
2	IgA	_	JJ	JJ	_	4	amod	_	_
3	binding	_	VBG	VBG	_	4	amod	_	_
4	factors	_	NNS	NNS	_	0	root	_	_
6	IgA-BF	_	NNP	NNP	_	4	appos	_	_
8	suppressing	_	VBG	VBG	_	4	acl	_	_
9	IgA	_	NNP	NNP	_	10	compound	_	_
10	production	_	NN	NN	_	8	dobj	_	_
12	characterization	_	NN	NN	_	15	compound	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	target	_	NN	NN	_	12	conj	_	_
15	specificity	_	NN	NN	_	4	dep	_	_
16	of	_	IN	IN	_	17	case	_	_
17	IgA-BF	_	NNP	NNP	_	15	nmod	_	_

1	Chemical	_	NNP	NNP	_	4	compound	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	functional	_	NNP	NNP	_	1	conj	_	_
4	properties	_	NNS	NNS	_	39	nsubjpass	_	_
5	of	_	IN	IN	_	8	case	_	_
6	IgA	_	NNP	NNP	_	8	compound	_	_
7	binding	_	JJ	JJ	_	8	amod	_	_
8	factor	_	NN	NN	_	4	nmod	_	_
10	s	_	PRP	PRP	_	8	dep	_	_
13	IgA-BF	_	NNP	NNP	_	8	appos	_	_
15	from	_	IN	IN	_	21	case	_	_
16	both	_	DT	DT	_	21	cc:preconj	_	_
17	murine	_	JJ	JJ	_	21	amod	_	_
18	Con	_	NN	NN	_	21	compound	_	_
19	A-activated	_	JJ	JJ	_	21	amod	_	_
20	spleen	_	NN	NN	_	21	compound	_	_
21	cells	_	NNS	NNS	_	4	nmod	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	Fc	_	NN	NN	_	34	compound	_	_
24	gamma	_	NN	NN	_	34	compound	_	_
25	R	_	NN	NN	_	34	compound	_	_
26	+	_	NNS	NNS	_	34	compound	_	_
28	Fc	_	JJ	JJ	_	29	dep	_	_
29	alpha	_	NN	NN	_	34	amod	_	_
30	R	_	NN	NN	_	34	compound	_	_
31	+	_	NNP	NNP	_	34	compound	_	_
32	T	_	NNP	NNP	_	34	compound	_	_
33	hybridoma	_	NN	NN	_	34	compound	_	_
34	cells	_	NNS	NNS	_	21	conj	_	_
36	T2D4	_	NNP	NNP	_	21	appos	_	_
38	were	_	VBD	VBD	_	39	auxpass	_	_
39	studied	_	VBN	VBN	_	0	root	_	_

1	IgA-BF	_	NNP	NNP	_	2	nsubj	_	_
2	produced	_	VBD	VBD	_	0	root	_	_
3	from	_	IN	IN	_	5	case	_	_
4	the	_	DT	DT	_	5	det	_	_
5	cells	_	NNS	NNS	_	2	nmod	_	_
6	after	_	IN	IN	_	11	mark	_	_
7	preculture	_	NN	NN	_	11	nsubjpass	_	_
8	with	_	IN	IN	_	9	case	_	_
9	IgA	_	NNP	NNP	_	7	nmod	_	_
10	were	_	VBD	VBD	_	11	auxpass	_	_
11	purified	_	VBN	VBN	_	2	advcl	_	_
12	with	_	IN	IN	_	13	case	_	_
13	IgA-Sepharose	_	NNP	NNP	_	11	nmod	_	_

1	Purified	_	NNP	NNP	_	2	compound	_	_
2	IgA-BF	_	NNP	NNP	_	3	nsubj	_	_
3	inhibited	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	16	det	_	_
5	binding	_	JJ	JJ	_	16	amod	_	_
6	of	_	IN	IN	_	7	case	_	_
7	IgA	_	NNP	NNP	_	5	nmod	_	_
8	to	_	TO	TO	_	10	case	_	_
9	Fc	_	JJ	JJ	_	10	dep	_	_
10	alpha	_	NN	NN	_	5	advcl	_	_
11	R	_	NN	NN	_	16	compound	_	_
12	+	_	NNP	NNP	_	16	compound	_	_
13	L5178Y	_	NNP	NNP	_	16	compound	_	_
14	T	_	NNP	NNP	_	16	compound	_	_
15	lymphoma	_	NN	NN	_	16	compound	_	_
16	cells	_	NNS	NNS	_	33	nsubj	_	_
18	and	_	CC	CC	_	16	cc	_	_
19	class-specifically	_	NN	NN	_	16	conj	_	_
20	suppressed	_	VBN	VBN	_	19	acl	_	_
21	in	_	IN	IN	_	24	case	_	_
22	vitro	_	NNP	NNP	_	24	compound	_	_
23	IgA	_	NNP	NNP	_	24	compound	_	_
24	synthesis	_	NNP	NNP	_	20	nmod	_	_
25	of	_	IN	IN	_	28	case	_	_
26	the	_	DT	DT	_	28	det	_	_
27	pokeweed	_	JJ	JJ	_	28	amod	_	_
28	mitogen	_	NN	NN	_	24	nmod	_	_
30	PWM	_	NNP	NNP	_	28	appos	_	_
33	stimulated	_	VBN	VBN	_	3	ccomp	_	_
34	murine	_	JJ	JJ	_	36	amod	_	_
35	spleen	_	NN	NN	_	36	compound	_	_
36	cells	_	NNS	NNS	_	33	dobj	_	_

1	Both	_	DT	DT	_	4	cc:preconj	_	_
2	IgA-specific	_	NNP	NNP	_	4	compound	_	_
3	suppressive	_	NN	NN	_	4	compound	_	_
4	activity	_	NN	NN	_	16	nsubjpass	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	IgA	_	NN	NN	_	8	compound	_	_
7	binding	_	VBG	VBG	_	8	amod	_	_
8	activity	_	NN	NN	_	4	conj	_	_
9	of	_	IN	IN	_	11	case	_	_
10	the	_	DT	DT	_	11	det	_	_
11	factor	_	NN	NN	_	4	nmod	_	_
13	s	_	PRP	PRP	_	11	dep	_	_
15	were	_	VBD	VBD	_	16	auxpass	_	_
16	co-fractionated	_	VBN	VBN	_	0	root	_	_
17	between	_	IN	IN	_	18	case	_	_
18	BSA	_	NNP	NNP	_	16	nmod	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	OVA	_	NNP	NNP	_	18	conj	_	_
21	in	_	IN	IN	_	24	case	_	_
22	gel	_	NN	NN	_	24	compound	_	_
23	filtration	_	NN	NN	_	24	compound	_	_
24	analysis	_	NN	NN	_	16	nmod	_	_

1	SDS-PAGE	_	NN	NN	_	2	compound	_	_
2	analysis	_	NN	NN	_	12	nsubj	_	_
3	of	_	IN	IN	_	4	case	_	_
4	IgA-BF	_	NNP	NNP	_	2	nmod	_	_
5	biosynthetically	_	RB	RB	_	6	advmod	_	_
6	labeled	_	VBN	VBN	_	4	acl	_	_
7	with	_	IN	IN	_	11	case	_	_
8	-LSB-	_	NN	NN	_	11	compound	_	_
9	35S	_	CD	CD	_	11	nummod	_	_
10	-RSB-	_	NN	NN	_	11	compound	_	_
11	methionine	_	NN	NN	_	6	nmod	_	_
12	showed	_	VBD	VBD	_	0	root	_	_
13	a	_	DT	DT	_	15	det	_	_
14	specific	_	JJ	JJ	_	15	amod	_	_
15	band	_	NN	NN	_	12	dobj	_	_
16	on	_	IN	IN	_	17	case	_	_
17	56,000	_	NNP	NNP	_	12	nmod	_	_

1	Suppressive	_	JJ	JJ	_	2	amod	_	_
2	activity	_	NN	NN	_	6	nsubjpass	_	_
3	of	_	IN	IN	_	4	case	_	_
4	IgA-BF	_	NNP	NNP	_	2	nmod	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	absorbed	_	VBN	VBN	_	0	root	_	_
7	with	_	IN	IN	_	8	case	_	_
8	lentil-lectin-Sepharose	_	NN	NN	_	6	nmod	_	_
9	and	_	CC	CC	_	6	cc	_	_
10	was	_	VBD	VBD	_	11	auxpass	_	_
11	eluted	_	VBN	VBN	_	6	conj	_	_
12	with	_	IN	IN	_	15	case	_	_
13	0.2	_	CD	CD	_	15	nummod	_	_
14	M	_	NNP	NNP	_	15	compound	_	_
15	alpha-methyl-D-mannoside	_	NN	NN	_	11	nmod	_	_

1	The	_	DT	DT	_	3	det	_	_
2	suppressive	_	JJ	JJ	_	3	amod	_	_
3	activity	_	NN	NN	_	20	nsubjpass	_	_
4	obtained	_	VBN	VBN	_	3	acl	_	_
5	from	_	IN	IN	_	7	case	_	_
6	T2D4	_	CD	CD	_	7	nummod	_	_
7	cells	_	NNS	NNS	_	4	nmod	_	_
9	H-2k	_	NNP	NNP	_	7	appos	_	_
11	and	_	CC	CC	_	7	cc	_	_
12	BALB/c	_	JJ	JJ	_	13	amod	_	_
13	Con	_	NN	NN	_	7	conj	_	_
14	A	_	DT	DT	_	15	det	_	_
15	blasts	_	NNS	NNS	_	13	dep	_	_
17	H-2d	_	NNP	NNP	_	3	appos	_	_
19	was	_	VBD	VBD	_	20	auxpass	_	_
20	absorbed	_	VBN	VBN	_	0	root	_	_
21	with	_	IN	IN	_	24	case	_	_
22	the	_	DT	DT	_	24	det	_	_
23	corresponding	_	JJ	JJ	_	24	amod	_	_
24	anti-H-2	_	NN	NN	_	20	nmod	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	anti-I-A	_	JJ	JJ	_	27	amod	_	_
27	column	_	NN	NN	_	24	conj	_	_
28	and	_	CC	CC	_	20	cc	_	_
29	recovered	_	VBN	VBN	_	20	conj	_	_
30	in	_	IN	IN	_	32	case	_	_
31	the	_	DT	DT	_	32	det	_	_
32	acid-eluate	_	NN	NN	_	29	nmod	_	_

1	The	_	DT	DT	_	2	det	_	_
2	activity	_	NN	NN	_	5	nsubjpass	_	_
3	was	_	VBD	VBD	_	5	auxpass	_	_
4	not	_	RB	RB	_	5	neg	_	_
5	absorbed	_	VBN	VBN	_	0	root	_	_
6	with	_	IN	IN	_	10	case	_	_
7	the	_	DT	DT	_	10	det	_	_
8	unrelated	_	JJ	JJ	_	10	amod	_	_
9	anti-H-2	_	JJ	JJ	_	10	amod	_	_
10	column	_	NN	NN	_	5	nmod	_	_

1	Despite	_	IN	IN	_	3	case	_	_
2	the	_	DT	DT	_	3	det	_	_
3	presence	_	NN	NN	_	14	nmod	_	_
4	of	_	IN	IN	_	6	case	_	_
5	MHC	_	NNP	NNP	_	6	compound	_	_
6	products	_	NNS	NNS	_	3	nmod	_	_
8	IgA-BF	_	NNP	NNP	_	14	nsubj	_	_
9	from	_	IN	IN	_	12	case	_	_
10	both	_	DT	DT	_	12	det	_	_
11	cell	_	NN	NN	_	12	compound	_	_
12	sources	_	NNS	NNS	_	8	nmod	_	_
13	equally	_	RB	RB	_	14	advmod	_	_
14	suppressed	_	VBD	VBD	_	0	root	_	_
15	IgA-specific	_	JJ	JJ	_	16	amod	_	_
16	responses	_	NNS	NNS	_	14	dobj	_	_
17	of	_	IN	IN	_	18	case	_	_
18	BALB/c	_	NNP	NNP	_	16	nmod	_	_
20	H-2d	_	NNP	NNP	_	18	appos	_	_
23	C3H/He	_	NNS	NNS	_	18	conj	_	_
25	H-2k	_	NNP	NNP	_	23	appos	_	_
28	and	_	CC	CC	_	18	cc	_	_
29	C57BL/10	_	JJ	JJ	_	34	amod	_	_
31	H-2b	_	JJ	JJ	_	29	dep	_	_
33	spleen	_	NN	NN	_	34	compound	_	_
34	cells	_	NNS	NNS	_	18	conj	_	_

1	They	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	suppressed	_	VBD	VBD	_	0	root	_	_
4	IgA	_	NNP	NNP	_	5	compound	_	_
5	production	_	NN	NN	_	3	dobj	_	_
6	as	_	RB	RB	_	5	cc	_	_
7	well	_	RB	RB	_	6	mwe	_	_
8	as	_	IN	IN	_	6	mwe	_	_
9	IgA	_	NNP	NNP	_	10	compound	_	_
10	synthesis	_	NNP	NNP	_	5	conj	_	_
11	of	_	IN	IN	_	13	case	_	_
12	PWM-stimulated	_	JJ	JJ	_	13	amod	_	_
13	culture	_	NN	NN	_	10	nmod	_	_
14	of	_	IN	IN	_	18	case	_	_
15	human	_	JJ	JJ	_	18	amod	_	_
16	peripheral	_	JJ	JJ	_	18	amod	_	_
17	blood	_	NN	NN	_	18	compound	_	_
18	lymphocytes	_	NNS	NNS	_	13	nmod	_	_
19	without	_	IN	IN	_	20	mark	_	_
20	affecting	_	VBG	VBG	_	3	advcl	_	_
21	IgM	_	NNP	NNP	_	24	compound	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	IgG	_	NNP	NNP	_	21	conj	_	_
24	responses	_	NNS	NNS	_	20	dobj	_	_

1	Suppression	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	7	case	_	_
3	murine	_	NN	NN	_	7	compound	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	human	_	JJ	JJ	_	3	conj	_	_
6	IgA	_	NN	NN	_	7	compound	_	_
7	responses	_	NNS	NNS	_	1	nmod	_	_
8	both	_	DT	DT	_	14	nsubjpass	_	_
9	in	_	IN	IN	_	10	case	_	_
10	mouse	_	NN	NN	_	8	nmod	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	human	_	NN	NN	_	10	conj	_	_
13	were	_	VBD	VBD	_	14	auxpass	_	_
14	mediated	_	VBN	VBN	_	1	dep	_	_
15	by	_	IN	IN	_	17	case	_	_
16	the	_	DT	DT	_	17	det	_	_
17	molecules	_	NNS	NNS	_	14	nmod	_	_
18	having	_	VBG	VBG	_	17	acl	_	_
19	the	_	DT	DT	_	22	det	_	_
20	same	_	JJ	JJ	_	22	amod	_	_
21	Ia	_	NNP	NNP	_	22	compound	_	_
22	products	_	NNS	NNS	_	18	dobj	_	_
24	suggesting	_	VBG	VBG	_	1	acl	_	_
25	that	_	IN	IN	_	27	mark	_	_
26	there	_	EX	EX	_	27	expl	_	_
27	is	_	VBZ	VBZ	_	24	ccomp	_	_
28	no	_	DT	DT	_	29	neg	_	_
29	MHC	_	NNP	NNP	_	27	nsubj	_	_
31	as	_	RB	RB	_	29	cc	_	_
32	well	_	RB	RB	_	31	mwe	_	_
33	as	_	IN	IN	_	31	mwe	_	_
34	species	_	NN	NN	_	35	compound	_	_
35	restriction	_	NN	NN	_	29	conj	_	_
37	for	_	IN	IN	_	39	case	_	_
38	the	_	DT	DT	_	39	det	_	_
39	interaction	_	NN	NN	_	29	nmod	_	_
40	between	_	IN	IN	_	41	case	_	_
41	IgA-BF	_	NNP	NNP	_	1	nmod	_	_
42	and	_	CC	CC	_	41	cc	_	_
43	their	_	PRP$	PRP$	_	45	nmod:poss	_	_
44	target	_	NN	NN	_	45	compound	_	_
45	cells	_	NNS	NNS	_	41	conj	_	_

1	IgA-specific	_	NNP	NNP	_	3	compound	_	_
2	suppressive	_	NN	NN	_	3	compound	_	_
3	activity	_	NN	NN	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	absorbed	_	VBN	VBN	_	0	root	_	_
6	with	_	IN	IN	_	10	case	_	_
7	human	_	JJ	JJ	_	10	amod	_	_
8	B	_	NNP	NNP	_	10	compound	_	_
9	blastoid	_	NN	NN	_	10	compound	_	_
10	cells	_	NNS	NNS	_	5	nmod	_	_
11	bearing	_	VBG	VBG	_	10	acl	_	_
12	surface	_	NN	NN	_	13	compound	_	_
13	IgA	_	NN	NN	_	11	dobj	_	_
15	Dakiki	_	NNP	NNP	_	13	appos	_	_
17	but	_	CC	CC	_	18	cc	_	_
18	not	_	RB	RB	_	10	cc	_	_
19	with	_	IN	IN	_	46	mark	_	_
20	those	_	DT	DT	_	23	det	_	_
21	bearing	_	NN	NN	_	23	compound	_	_
22	surface	_	NN	NN	_	23	compound	_	_
23	IgG	_	NN	NN	_	46	nsubj	_	_
25	CESS	_	NNP	NNP	_	23	appos	_	_
27	or	_	CC	CC	_	23	cc	_	_
28	murine	_	JJ	JJ	_	34	amod	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	human	_	JJ	JJ	_	28	conj	_	_
31	T	_	NNP	NNP	_	34	compound	_	_
32	cell	_	NN	NN	_	34	compound	_	_
33	line	_	NN	NN	_	34	compound	_	_
34	cells	_	NNS	NNS	_	23	conj	_	_
36	BW5147	_	NNP	NNP	_	34	dep	_	_
38	L5178Y	_	CD	CD	_	36	appos	_	_
40	HPB-ALL	_	CD	CD	_	38	nummod	_	_
42	and	_	CC	CC	_	38	cc	_	_
43	MOLT4	_	CD	CD	_	38	conj	_	_
46	indicating	_	VBG	VBG	_	10	conj	_	_
47	that	_	DT	DT	_	49	det	_	_
48	IgA-BF	_	JJ	JJ	_	49	amod	_	_
49	interact	_	NN	NN	_	46	dobj	_	_
50	with	_	IN	IN	_	53	mark	_	_
51	B	_	NNP	NNP	_	52	compound	_	_
52	cells	_	NNS	NNS	_	53	nsubj	_	_
53	bearing	_	VBG	VBG	_	46	advcl	_	_
54	IgA	_	NNP	NNP	_	53	dobj	_	_
55	to	_	TO	TO	_	56	mark	_	_
56	suppress	_	VB	VB	_	53	xcomp	_	_
57	their	_	PRP$	PRP$	_	58	nmod:poss	_	_
58	differentiation	_	NN	NN	_	56	dobj	_	_

1	-LSB-	_	NNP	NNP	_	2	compound	_	_
2	Radiotherapy	_	NNP	NNP	_	16	nsubj	_	_
3	in	_	IN	IN	_	4	case	_	_
4	Ewing_sarcoma	_	NNP	NNP	_	2	nmod	_	_
6	current	_	JJ	JJ	_	7	amod	_	_
7	results	_	NNS	NNS	_	4	dep	_	_
8	of	_	IN	IN	_	11	case	_	_
9	the	_	DT	DT	_	11	det	_	_
10	German	_	JJ	JJ	_	11	amod	_	_
11	Society	_	NN	NN	_	7	nmod	_	_
12	of	_	IN	IN	_	15	case	_	_
13	Pediatric	_	NNP	NNP	_	15	compound	_	_
14	Oncology	_	NNP	NNP	_	15	compound	_	_
15	studies	_	NNS	NNS	_	11	nmod	_	_
16	CESS	_	VBZ	VBZ	_	0	root	_	_
17	81	_	CD	CD	_	16	dobj	_	_
18	and	_	CC	CC	_	16	cc	_	_
19	CESS	_	VBZ	VBZ	_	16	conj	_	_
20	86	_	CD	CD	_	21	nummod	_	_
21	-RSB-	_	NNS	NNS	_	19	dobj	_	_

1	In	_	IN	IN	_	2	case	_	_
2	CESS	_	NNP	NNP	_	10	nmod	_	_
3	81	_	CD	CD	_	2	nummod	_	_
4	the	_	DT	DT	_	5	det	_	_
5	rate	_	NN	NN	_	10	nsubj	_	_
6	of	_	IN	IN	_	8	case	_	_
7	local	_	JJ	JJ	_	8	amod	_	_
8	recurrences	_	NNS	NNS	_	5	nmod	_	_
9	was	_	VBD	VBD	_	10	cop	_	_
10	high	_	JJ	JJ	_	0	root	_	_
11	particularly	_	RB	RB	_	10	advmod	_	_
12	in	_	IN	IN	_	13	case	_	_
13	patients	_	NNS	NNS	_	10	nmod	_	_
14	with	_	IN	IN	_	15	case	_	_
15	radiation	_	NN	NN	_	13	nmod	_	_
16	for	_	IN	IN	_	18	case	_	_
17	local	_	JJ	JJ	_	18	amod	_	_
18	control	_	NN	NN	_	15	nmod	_	_

1	To	_	TO	TO	_	2	mark	_	_
2	improve	_	VB	VB	_	13	csubj	_	_
3	the	_	DT	DT	_	4	det	_	_
4	safety	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	7	case	_	_
6	local	_	JJ	JJ	_	7	amod	_	_
7	control	_	NN	NN	_	4	nmod	_	_
9	in	_	IN	IN	_	12	case	_	_
10	the	_	DT	DT	_	12	det	_	_
11	follow-up	_	NN	NN	_	12	compound	_	_
12	study	_	NN	NN	_	2	nmod	_	_
13	CESS	_	VBZ	VBZ	_	0	root	_	_
14	86	_	CD	CD	_	15	nummod	_	_
15	chemotherapy	_	NN	NN	_	21	nsubjpass	_	_
16	for	_	IN	IN	_	19	case	_	_
17	high	_	JJ	JJ	_	19	amod	_	_
18	risk	_	NN	NN	_	19	compound	_	_
19	patients	_	NNS	NNS	_	15	nmod	_	_
20	was	_	VBD	VBD	_	21	auxpass	_	_
21	intensified	_	VBN	VBN	_	13	ccomp	_	_

1	The	_	DT	DT	_	2	det	_	_
2	combination	_	NN	NN	_	9	nsubjpass	_	_
3	of	_	IN	IN	_	4	case	_	_
4	surgery	_	NN	NN	_	2	nmod	_	_
5	with	_	IN	IN	_	7	case	_	_
6	postoperative	_	JJ	JJ	_	7	amod	_	_
7	radiation	_	NN	NN	_	4	nmod	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	favoured	_	VBN	VBN	_	0	root	_	_
10	when	_	WRB	WRB	_	16	advmod	_	_
11	possible	_	JJ	JJ	_	14	amod	_	_
13	local	_	JJ	JJ	_	14	amod	_	_
14	control	_	NN	NN	_	16	nsubjpass	_	_
15	was	_	VBD	VBD	_	16	auxpass	_	_
16	brought	_	VBN	VBN	_	9	advcl	_	_
17	forward	_	RP	RP	_	16	compound:prt	_	_
18	from	_	IN	IN	_	19	case	_	_
19	week	_	NN	NN	_	16	nmod	_	_
20	18	_	CD	CD	_	19	nummod	_	_
21	to	_	TO	TO	_	22	case	_	_
22	week	_	NN	NN	_	16	nmod	_	_
23	9	_	CD	CD	_	22	nummod	_	_
25	the	_	DT	DT	_	26	det	_	_
26	doses	_	NNS	NNS	_	31	nsubjpass	_	_
27	of	_	IN	IN	_	29	case	_	_
28	postoperative	_	JJ	JJ	_	29	amod	_	_
29	radiotherapy	_	NN	NN	_	26	nmod	_	_
30	was	_	VBD	VBD	_	31	auxpass	_	_
31	increased	_	VBN	VBN	_	9	ccomp	_	_
32	from	_	IN	IN	_	36	case	_	_
33	36	_	CD	CD	_	35	compound	_	_
34	to	_	TO	TO	_	35	dep	_	_
35	46	_	CD	CD	_	36	nummod	_	_
36	Gy	_	NNS	NNS	_	31	nmod	_	_
38	and	_	CC	CC	_	9	cc	_	_
39	a	_	DT	DT	_	42	det	_	_
40	radiation	_	NN	NN	_	42	compound	_	_
41	planning	_	VBG	VBG	_	42	amod	_	_
42	center	_	NN	NN	_	44	nsubjpass	_	_
43	was	_	VBD	VBD	_	44	auxpass	_	_
44	established	_	VBN	VBN	_	9	conj	_	_
45	for	_	IN	IN	_	47	case	_	_
46	centralized	_	JJ	JJ	_	47	amod	_	_
47	planning	_	NN	NN	_	44	nmod	_	_
48	of	_	IN	IN	_	49	case	_	_
49	radiotherapy	_	NN	NN	_	47	nmod	_	_
50	on	_	IN	IN	_	52	case	_	_
51	the	_	DT	DT	_	52	det	_	_
52	basis	_	NN	NN	_	44	nmod	_	_
53	of	_	IN	IN	_	55	case	_	_
54	tumor	_	NN	NN	_	55	compound	_	_
55	extension	_	NN	NN	_	52	nmod	_	_
56	at	_	IN	IN	_	57	case	_	_
57	diagnosis	_	NN	NN	_	44	nmod	_	_

1	In	_	IN	IN	_	2	case	_	_
2	addition	_	NN	NN	_	7	nmod	_	_
3	patients	_	NNS	NNS	_	7	nsubjpass	_	_
4	with	_	IN	IN	_	5	case	_	_
5	radiation	_	NN	NN	_	3	nmod	_	_
6	were	_	VBD	VBD	_	7	auxpass	_	_
7	randomized	_	VBN	VBN	_	0	root	_	_
8	for	_	IN	IN	_	10	case	_	_
9	conventional	_	JJ	JJ	_	10	amod	_	_
10	fractionation	_	NN	NN	_	7	nmod	_	_
11	or	_	CC	CC	_	10	cc	_	_
12	a	_	DT	DT	_	13	det	_	_
13	scheme	_	NN	NN	_	10	conj	_	_
14	of	_	IN	IN	_	18	case	_	_
15	accelerated	_	VBN	VBN	_	18	amod	_	_
16	split	_	NN	NN	_	18	compound	_	_
17	course	_	NN	NN	_	18	compound	_	_
18	hyperfractionation	_	NN	NN	_	13	nmod	_	_
19	with	_	IN	IN	_	21	case	_	_
20	simultaneous	_	JJ	JJ	_	21	amod	_	_
21	chemotherapy	_	NN	NN	_	18	nmod	_	_

1	Preliminary	_	JJ	JJ	_	2	amod	_	_
2	results	_	NNS	NNS	_	7	nsubj	_	_
3	of	_	IN	IN	_	5	case	_	_
4	76	_	CD	CD	_	5	nummod	_	_
5	CESS	_	NNS	NNS	_	2	nmod	_	_
6	86	_	RB	RB	_	7	advmod	_	_
7	patients	_	VBZ	VBZ	_	0	root	_	_
9	incl	_	NN	NN	_	7	dobj	_	_

1	pilot	_	IN	IN	_	2	case	_	_
2	phase	_	NN	NN	_	25	nmod	_	_
5	show	_	VBP	VBP	_	2	acl:relcl	_	_
6	a	_	DT	DT	_	8	det	_	_
7	lowered	_	VBN	VBN	_	8	amod	_	_
8	rate	_	NN	NN	_	5	dobj	_	_
9	of	_	IN	IN	_	11	case	_	_
10	local	_	JJ	JJ	_	11	amod	_	_
11	recurrences	_	NNS	NNS	_	8	nmod	_	_
12	compared	_	VBN	VBN	_	14	case	_	_
13	to	_	TO	TO	_	14	case	_	_
14	CESS	_	NNP	NNP	_	8	acl	_	_
15	81	_	CD	CD	_	14	nummod	_	_
17	6	_	CD	CD	_	18	compound	_	_
18	%	_	NN	NN	_	20	amod	_	_
19	local	_	JJ	JJ	_	20	amod	_	_
20	recurrences	_	NNS	NNS	_	25	nsubj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	15	_	CD	CD	_	23	compound	_	_
23	%	_	NN	NN	_	20	conj	_	_
24	local	_	JJ	JJ	_	23	amod	_	_
25	recurrences	_	VBZ	VBZ	_	0	root	_	_
26	in	_	IN	IN	_	27	case	_	_
27	patients	_	NNS	NNS	_	25	nmod	_	_
28	with	_	IN	IN	_	29	case	_	_
29	radiation	_	NN	NN	_	27	nmod	_	_

1	With	_	IN	IN	_	2	case	_	_
2	selection	_	NN	NN	_	17	nmod	_	_
3	of	_	IN	IN	_	4	case	_	_
4	patients	_	NNS	NNS	_	2	nmod	_	_
5	with	_	IN	IN	_	9	case	_	_
6	small	_	JJ	JJ	_	9	amod	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	chemoresponsive	_	JJ	JJ	_	6	conj	_	_
9	tumors	_	NNS	NNS	_	4	nmod	_	_
10	for	_	IN	IN	_	11	case	_	_
11	radiotherapy	_	NN	NN	_	9	nmod	_	_
12	no	_	RB	RB	_	13	neg	_	_
13	longer	_	RB	RB	_	4	advmod	_	_
14	a	_	DT	DT	_	15	det	_	_
15	disadvantage	_	NN	NN	_	17	nsubjpass	_	_
16	was	_	VBD	VBD	_	17	auxpass	_	_
17	seen	_	VBN	VBN	_	0	root	_	_
18	for	_	IN	IN	_	19	case	_	_
19	patients	_	NNS	NNS	_	17	nmod	_	_
20	with	_	IN	IN	_	22	mark	_	_
21	radiotherapy	_	RB	RB	_	22	advmod	_	_
22	concerning	_	VBG	VBG	_	17	advcl	_	_
23	the	_	DT	DT	_	24	det	_	_
24	safety	_	NN	NN	_	22	dobj	_	_
25	of	_	IN	IN	_	27	case	_	_
26	local	_	JJ	JJ	_	27	amod	_	_
27	control	_	NN	NN	_	24	nmod	_	_

1	NaF-induced	_	JJ	JJ	_	4	amod	_	_
2	Ca2	_	JJ	JJ	_	4	amod	_	_
3	+	_	JJ	JJ	_	4	amod	_	_
4	mobilization	_	NN	NN	_	6	nsubj	_	_
5	is	_	VBZ	VBZ	_	6	cop	_	_
6	dependent	_	JJ	JJ	_	0	root	_	_
7	upon	_	IN	IN	_	10	case	_	_
8	the	_	DT	DT	_	10	det	_	_
9	culture	_	NN	NN	_	10	compound	_	_
10	density	_	NN	NN	_	6	nmod	_	_
11	in	_	IN	IN	_	16	case	_	_
12	a	_	DT	DT	_	16	det	_	_
13	parathyroid_hormone-responsive	_	JJ	JJ	_	16	amod	_	_
14	osteoblast-like	_	JJ	JJ	_	16	amod	_	_
15	cell	_	NN	NN	_	16	compound	_	_
16	line	_	NN	NN	_	10	nmod	_	_

1	The	_	DT	DT	_	2	det	_	_
2	effect	_	NN	NN	_	19	nsubjpass	_	_
3	of	_	IN	IN	_	11	case	_	_
4	NaF	_	JJ	JJ	_	11	amod	_	_
5	on	_	IN	IN	_	8	case	_	_
6	cytosolic	_	JJ	JJ	_	8	amod	_	_
7	free	_	JJ	JJ	_	8	amod	_	_
8	Ca2	_	NNS	NNS	_	4	nmod	_	_
9	+	_	NN	NN	_	11	compound	_	_
10	concentrations	_	NNS	NNS	_	11	compound	_	_
11	-LSB-	_	NN	NN	_	2	nmod	_	_
13	Ca2	_	JJ	JJ	_	16	amod	_	_
14	+	_	NNP	NNP	_	16	compound	_	_
15	-RSB-	_	NNP	NNP	_	16	compound	_	_
16	i	_	NNP	NNP	_	11	appos	_	_
18	was	_	VBD	VBD	_	19	auxpass	_	_
19	examined	_	VBN	VBN	_	0	root	_	_
20	in	_	IN	IN	_	25	case	_	_
21	a	_	DT	DT	_	25	det	_	_
22	clonal	_	JJ	JJ	_	25	amod	_	_
23	osteoblast-like	_	JJ	JJ	_	25	amod	_	_
24	cell	_	NN	NN	_	25	compound	_	_
25	line	_	NN	NN	_	19	nmod	_	_
27	MOB	_	NNP	NNP	_	25	appos	_	_
28	3-4	_	CD	CD	_	27	nummod	_	_
30	loaded	_	VBN	VBN	_	25	acl	_	_
31	with	_	IN	IN	_	32	case	_	_
32	Fura_2	_	NNS	NNS	_	30	nmod	_	_

1	MOB	_	VBG	VBG	_	0	root	_	_
2	3-4	_	CD	CD	_	3	nummod	_	_
3	cells	_	NNS	NNS	_	1	dobj	_	_
4	in	_	IN	IN	_	7	case	_	_
5	a	_	DT	DT	_	7	det	_	_
6	sparse	_	JJ	JJ	_	7	amod	_	_
7	culture	_	NN	NN	_	3	nmod	_	_
9	which	_	WDT	WDT	_	10	nsubj	_	_
10	exhibited	_	VBD	VBD	_	7	acl:relcl	_	_
11	neither	_	DT	DT	_	16	det	_	_
12	alkaline_phosphatase	_	JJ	JJ	_	16	amod	_	_
14	ALP	_	NNP	NNP	_	16	appos	_	_
16	activity	_	NN	NN	_	10	dobj	_	_
17	nor	_	CC	CC	_	16	cc	_	_
18	the	_	DT	DT	_	19	det	_	_
19	response	_	NN	NN	_	16	conj	_	_
20	to	_	TO	TO	_	21	case	_	_
21	parathyroid_hormone	_	NN	NN	_	10	nmod	_	_
23	PTH	_	NNP	NNP	_	21	appos	_	_
26	responded	_	VBD	VBD	_	1	dep	_	_
27	to	_	TO	TO	_	28	mark	_	_
28	NaF	_	VB	VB	_	26	xcomp	_	_
30	0.1-10	_	CD	CD	_	31	nummod	_	_
31	mM	_	NN	NN	_	28	dobj	_	_
33	to	_	TO	TO	_	34	mark	_	_
34	increase	_	VB	VB	_	28	xcomp	_	_
35	-LSB-	_	JJ	JJ	_	36	amod	_	_
36	Ca2	_	NNS	NNS	_	34	dobj	_	_
37	+	_	NNP	NNP	_	40	compound	_	_
38	-RSB-	_	NNP	NNP	_	40	compound	_	_
39	i	_	FW	FW	_	40	compound	_	_
40	transiently	_	NNP	NNP	_	1	nsubj	_	_

1	In	_	IN	IN	_	2	case	_	_
2	contrast	_	NN	NN	_	22	nmod	_	_
4	the	_	DT	DT	_	5	det	_	_
5	cells	_	NNS	NNS	_	22	nsubj	_	_
6	in	_	IN	IN	_	9	case	_	_
7	a	_	DT	DT	_	9	det	_	_
8	dense	_	JJ	JJ	_	9	amod	_	_
9	culture	_	NN	NN	_	5	nmod	_	_
11	which	_	WDT	WDT	_	12	nsubj	_	_
12	exhibited	_	VBD	VBD	_	5	acl:relcl	_	_
13	both	_	DT	DT	_	15	det	_	_
14	ALP	_	NNP	NNP	_	15	compound	_	_
15	activity	_	NN	NN	_	12	dobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	the	_	DT	DT	_	18	det	_	_
18	response	_	NN	NN	_	15	conj	_	_
19	to	_	TO	TO	_	20	case	_	_
20	PTH	_	NNP	NNP	_	12	nmod	_	_
22	responded	_	VBD	VBD	_	0	root	_	_
23	to	_	TO	TO	_	24	case	_	_
24	NaF	_	NNP	NNP	_	22	nmod	_	_
26	above	_	IN	IN	_	28	case	_	_
27	4	_	CD	CD	_	28	nummod	_	_
28	mM	_	NN	NN	_	24	nmod	_	_
30	to	_	TO	TO	_	31	mark	_	_
31	increase	_	VB	VB	_	22	xcomp	_	_
32	-LSB-	_	NNP	NNP	_	36	compound	_	_
33	Ca2	_	NNP	NNP	_	36	compound	_	_
34	+	_	NNP	NNP	_	36	compound	_	_
35	-RSB-	_	NNP	NNP	_	36	compound	_	_
36	i	_	NNP	NNP	_	31	dobj	_	_
37	slowly	_	RB	RB	_	31	advmod	_	_

1	-LSB-	_	NNP	NNP	_	5	compound	_	_
2	Ca2	_	NNP	NNP	_	5	compound	_	_
3	+	_	NNP	NNP	_	5	compound	_	_
4	-RSB-	_	NNP	NNP	_	5	compound	_	_
5	i	_	NNP	NNP	_	12	nsubj	_	_
6	in	_	IN	IN	_	7	case	_	_
7	osteoblasts	_	NNS	NNS	_	5	nmod	_	_
8	in	_	IN	IN	_	10	case	_	_
9	primary	_	JJ	JJ	_	10	amod	_	_
10	culture	_	NN	NN	_	7	nmod	_	_
11	slowly	_	RB	RB	_	12	advmod	_	_
12	increased	_	VBD	VBD	_	0	root	_	_
13	in	_	IN	IN	_	14	case	_	_
14	response	_	NN	NN	_	12	nmod	_	_
15	to	_	TO	TO	_	17	case	_	_
16	both	_	DT	DT	_	17	det	_	_
17	NaF	_	NN	NN	_	12	nmod	_	_
19	above	_	IN	IN	_	21	case	_	_
20	4	_	CD	CD	_	21	nummod	_	_
21	mM	_	NN	NN	_	17	nmod	_	_
23	and	_	CC	CC	_	17	cc	_	_
24	PTH	_	NNP	NNP	_	17	conj	_	_
26	3	_	CD	CD	_	27	compound	_	_
27	U/ml	_	CD	CD	_	17	dep	_	_

1	Thus	_	RB	RB	_	16	advmod	_	_
3	the	_	DT	DT	_	4	det	_	_
4	sensitivity	_	NN	NN	_	16	nsubj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	the	_	DT	DT	_	7	det	_	_
7	response	_	NN	NN	_	4	conj	_	_
8	of	_	IN	IN	_	9	mark	_	_
9	MOB	_	VBG	VBG	_	7	acl	_	_
10	3-4	_	CD	CD	_	11	nummod	_	_
11	cells	_	NNS	NNS	_	9	dobj	_	_
12	to	_	TO	TO	_	13	case	_	_
13	NaF	_	NNP	NNP	_	9	nmod	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	PTH	_	NNP	NNP	_	13	conj	_	_
16	varied	_	VBD	VBD	_	0	root	_	_
17	with	_	IN	IN	_	20	case	_	_
18	the	_	DT	DT	_	20	det	_	_
19	culture	_	NN	NN	_	20	compound	_	_
20	density	_	NN	NN	_	16	nmod	_	_
22	and	_	CC	CC	_	16	cc	_	_
23	high	_	JJ	JJ	_	25	amod	_	_
24	culture	_	NN	NN	_	25	compound	_	_
25	density	_	NN	NN	_	26	nsubj	_	_
26	matured	_	VBN	VBN	_	16	conj	_	_
27	the	_	DT	DT	_	28	det	_	_
28	cells	_	NNS	NNS	_	26	dobj	_	_
29	like	_	IN	IN	_	30	case	_	_
30	osteoblasts	_	NNS	NNS	_	26	nmod	_	_
31	in	_	IN	IN	_	33	case	_	_
32	primary	_	JJ	JJ	_	33	amod	_	_
33	culture	_	NN	NN	_	26	nmod	_	_

1	These	_	DT	DT	_	5	det	_	_
2	NaF-induced	_	JJ	JJ	_	5	amod	_	_
3	Ca2	_	JJ	JJ	_	5	amod	_	_
4	+	_	NN	NN	_	5	compound	_	_
5	mobilizations	_	NNS	NNS	_	8	nsubj	_	_
6	were	_	VBD	VBD	_	8	cop	_	_
7	not	_	RB	RB	_	8	neg	_	_
8	dependent	_	JJ	JJ	_	0	root	_	_
9	upon	_	IN	IN	_	12	case	_	_
10	external	_	JJ	JJ	_	12	amod	_	_
11	Ca2	_	JJ	JJ	_	12	amod	_	_
12	+	_	NNS	NNS	_	8	nmod	_	_
13	and	_	CC	CC	_	8	cc	_	_
14	were	_	VBD	VBD	_	15	auxpass	_	_
15	enhanced	_	VBN	VBN	_	8	conj	_	_
16	by	_	IN	IN	_	18	case	_	_
17	Al3	_	NNP	NNP	_	18	compound	_	_
18	+	_	NNP	NNP	_	15	nmod	_	_
20	1	_	CD	CD	_	21	nummod	_	_
21	microM	_	NN	NN	_	18	appos	_	_
24	whereas	_	IN	IN	_	31	mark	_	_
25	the	_	DT	DT	_	29	det	_	_
26	PTH-induced	_	JJ	JJ	_	29	amod	_	_
27	Ca2	_	JJ	JJ	_	29	amod	_	_
28	+	_	NN	NN	_	29	compound	_	_
29	mobilizations	_	NNS	NNS	_	31	nsubj	_	_
30	were	_	VBD	VBD	_	31	cop	_	_
31	due	_	JJ	JJ	_	15	advcl	_	_
32	to	_	TO	TO	_	35	case	_	_
33	Ca2	_	JJ	JJ	_	35	amod	_	_
34	+	_	JJ	JJ	_	35	amod	_	_
35	influx	_	NN	NN	_	31	nmod	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	18	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	maturation	_	NN	NN	_	18	nsubj	_	_
7	of	_	IN	IN	_	10	case	_	_
8	MOB	_	CD	CD	_	10	nummod	_	_
9	3-4	_	CD	CD	_	10	nummod	_	_
10	cells	_	NNS	NNS	_	6	nmod	_	_
12	dependent	_	JJ	JJ	_	6	amod	_	_
13	upon	_	IN	IN	_	16	case	_	_
14	the	_	DT	DT	_	16	det	_	_
15	culture	_	NN	NN	_	16	compound	_	_
16	density	_	NN	NN	_	12	nmod	_	_
18	modulates	_	VBZ	VBZ	_	3	ccomp	_	_
19	intracellular	_	NN	NN	_	22	compound	_	_
20	signal	_	NN	NN	_	22	compound	_	_
21	transduction	_	NN	NN	_	22	compound	_	_
22	pathways	_	NNS	NNS	_	18	dobj	_	_
23	and	_	CC	CC	_	18	cc	_	_
24	thereby	_	RB	RB	_	25	advmod	_	_
25	alters	_	VBZ	VBZ	_	18	conj	_	_
26	the	_	DT	DT	_	30	det	_	_
27	NaF-induced	_	JJ	JJ	_	30	amod	_	_
28	Ca2	_	JJ	JJ	_	30	amod	_	_
29	+	_	JJ	JJ	_	30	amod	_	_
30	mobilization	_	NN	NN	_	25	dobj	_	_
32	and	_	CC	CC	_	18	cc	_	_
33	that	_	IN	IN	_	39	mark	_	_
34	the	_	DT	DT	_	36	det	_	_
35	culture	_	NN	NN	_	36	compound	_	_
36	density	_	NN	NN	_	39	nsubjpass	_	_
37	must	_	MD	MD	_	39	aux	_	_
38	be	_	VB	VB	_	39	auxpass	_	_
39	taken	_	VBN	VBN	_	18	conj	_	_
40	into	_	IN	IN	_	41	case	_	_
41	consideration	_	NN	NN	_	39	nmod	_	_
42	in	_	IN	IN	_	43	mark	_	_
43	studying	_	VBG	VBG	_	39	advcl	_	_
44	Ca2	_	JJ	JJ	_	46	amod	_	_
45	+	_	JJ	JJ	_	46	amod	_	_
46	mobilization	_	NN	NN	_	43	dobj	_	_
47	in	_	IN	IN	_	52	case	_	_
48	such	_	PDT	PDT	_	52	dep	_	_
49	an	_	DT	DT	_	52	det	_	_
50	osteoblast-like	_	JJ	JJ	_	52	amod	_	_
51	cells	_	NNS	NNS	_	52	compound	_	_
52	line	_	NN	NN	_	43	nmod	_	_
53	as	_	IN	IN	_	57	case	_	_
54	MOB	_	NN	NN	_	57	compound	_	_
55	3-4	_	CD	CD	_	57	nummod	_	_
56	cell	_	NN	NN	_	57	compound	_	_
57	line	_	NN	NN	_	52	nmod	_	_

1	Changes	_	NNS	NNS	_	6	nsubj	_	_
2	in	_	IN	IN	_	5	case	_	_
3	neurofilament	_	JJ	JJ	_	5	amod	_	_
4	gene	_	NN	NN	_	5	compound	_	_
5	expression	_	NN	NN	_	1	nmod	_	_
6	occur	_	VBP	VBP	_	0	root	_	_
7	after	_	IN	IN	_	8	case	_	_
8	axotomy	_	NN	NN	_	6	nmod	_	_
9	of	_	IN	IN	_	13	case	_	_
10	dorsal	_	JJ	JJ	_	13	amod	_	_
11	root	_	NN	NN	_	13	compound	_	_
12	ganglion	_	NN	NN	_	13	compound	_	_
13	neurons	_	NNS	NNS	_	8	nmod	_	_
15	an	_	DT	DT	_	19	det	_	_
16	in	_	IN	IN	_	17	dep	_	_
17	situ	_	JJ	JJ	_	19	amod	_	_
18	hybridization	_	NN	NN	_	19	compound	_	_
19	study	_	NN	NN	_	13	dep	_	_

1	Neurofilaments	_	NNS	NNS	_	7	nsubj	_	_
3	NFs	_	NNP	NNP	_	1	appos	_	_
5	are	_	VBP	VBP	_	7	cop	_	_
6	predominant	_	JJ	JJ	_	7	amod	_	_
7	elements	_	NNS	NNS	_	0	root	_	_
8	in	_	IN	IN	_	11	case	_	_
9	large	_	JJ	JJ	_	11	amod	_	_
10	myelinated	_	JJ	JJ	_	11	amod	_	_
11	axons	_	NNS	NNS	_	7	nmod	_	_
13	where	_	WRB	WRB	_	16	advmod	_	_
14	they	_	PRP	PRP	_	16	nsubjpass	_	_
15	are	_	VBP	VBP	_	16	auxpass	_	_
16	thought	_	VBN	VBN	_	11	acl:relcl	_	_
17	to	_	TO	TO	_	18	mark	_	_
18	serve	_	VB	VB	_	16	xcomp	_	_
19	the	_	DT	DT	_	21	det	_	_
20	important	_	JJ	JJ	_	21	amod	_	_
21	function	_	NN	NN	_	18	dobj	_	_
22	of	_	IN	IN	_	23	mark	_	_
23	maintaining	_	VBG	VBG	_	21	acl	_	_
24	axonal	_	JJ	JJ	_	25	amod	_	_
25	caliber	_	NN	NN	_	23	dobj	_	_

1	Previous	_	JJ	JJ	_	2	amod	_	_
2	studies	_	NNS	NNS	_	4	nsubj	_	_
3	have	_	VBP	VBP	_	4	aux	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	13	mark	_	_
6	changes	_	NNS	NNS	_	13	nsubj	_	_
7	in	_	IN	IN	_	9	case	_	_
8	NF	_	NNP	NNP	_	9	compound	_	_
9	synthesis	_	NNP	NNP	_	6	nmod	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	axonal	_	JJ	JJ	_	12	amod	_	_
12	transport	_	NN	NN	_	9	conj	_	_
13	occur	_	VBP	VBP	_	4	ccomp	_	_
14	after	_	IN	IN	_	20	mark	_	_
15	axonal	_	JJ	JJ	_	16	amod	_	_
16	injury	_	NN	NN	_	20	nsubj	_	_
17	in	_	IN	IN	_	19	case	_	_
18	rat	_	NN	NN	_	19	compound	_	_
19	dorsal	_	NN	NN	_	16	nmod	_	_
20	root	_	VBP	VBP	_	13	advcl	_	_
21	ganglion	_	JJ	JJ	_	25	amod	_	_
23	DRG	_	NNP	NNP	_	25	appos	_	_
25	cells	_	NNS	NNS	_	20	dobj	_	_

1	The	_	DT	DT	_	3	det	_	_
2	resulting	_	VBG	VBG	_	3	amod	_	_
3	reduction	_	NN	NN	_	12	nsubjpass	_	_
4	in	_	IN	IN	_	7	case	_	_
5	the	_	DT	DT	_	7	det	_	_
6	NF	_	NNP	NNP	_	7	compound	_	_
7	supply	_	NN	NN	_	3	nmod	_	_
8	to	_	TO	TO	_	10	case	_	_
9	DRG	_	NNP	NNP	_	10	compound	_	_
10	axons	_	NNS	NNS	_	7	nmod	_	_
11	is	_	VBZ	VBZ	_	12	auxpass	_	_
12	thought	_	VBN	VBN	_	0	root	_	_
13	to	_	TO	TO	_	16	mark	_	_
14	be	_	VB	VB	_	16	cop	_	_
15	largely	_	RB	RB	_	16	advmod	_	_
16	responsible	_	JJ	JJ	_	12	xcomp	_	_
17	for	_	IN	IN	_	20	case	_	_
18	the	_	DT	DT	_	20	det	_	_
19	observed	_	JJ	JJ	_	20	amod	_	_
20	decrease	_	NN	NN	_	16	nmod	_	_
21	in	_	IN	IN	_	23	case	_	_
22	axonal	_	JJ	JJ	_	23	amod	_	_
23	diameter	_	NN	NN	_	20	nmod	_	_
24	in	_	IN	IN	_	28	case	_	_
25	the	_	DT	DT	_	28	det	_	_
26	proximal	_	JJ	JJ	_	28	amod	_	_
27	axonal	_	JJ	JJ	_	28	amod	_	_
28	stump	_	NN	NN	_	23	nmod	_	_
29	after	_	IN	IN	_	31	case	_	_
30	an	_	DT	DT	_	31	det	_	_
31	injury	_	NN	NN	_	16	nmod	_	_

1	In	_	IN	IN	_	4	case	_	_
2	the	_	DT	DT	_	4	det	_	_
3	present	_	JJ	JJ	_	4	amod	_	_
4	study	_	NN	NN	_	7	nmod	_	_
6	we	_	PRP	PRP	_	7	nsubj	_	_
7	test	_	VBP	VBP	_	0	root	_	_
8	the	_	DT	DT	_	9	det	_	_
9	hypothesis	_	NNS	NNS	_	7	dobj	_	_
10	that	_	IN	IN	_	17	mark	_	_
11	a	_	DT	DT	_	16	det	_	_
12	change	_	NN	NN	_	16	dep	_	_
13	in	_	IN	IN	_	14	case	_	_
14	NF	_	NNP	NNP	_	12	nmod	_	_
15	gene	_	NN	NN	_	16	compound	_	_
16	expression	_	NN	NN	_	17	nsubj	_	_
17	precedes	_	VBZ	VBZ	_	7	ccomp	_	_
18	the	_	DT	DT	_	19	det	_	_
19	changes	_	NNS	NNS	_	17	dobj	_	_
20	in	_	IN	IN	_	21	case	_	_
21	synthesis	_	NN	NN	_	19	nmod	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	transport	_	NN	NN	_	21	conj	_	_
24	of	_	IN	IN	_	26	case	_	_
25	NF	_	NNP	NNP	_	26	compound	_	_
26	proteins	_	NNS	NNS	_	19	nmod	_	_

1	To	_	TO	TO	_	2	mark	_	_
2	address	_	VB	VB	_	27	advcl	_	_
3	this	_	DT	DT	_	4	det	_	_
4	hypothesis	_	NNS	NNS	_	2	dobj	_	_
6	the	_	DT	DT	_	7	det	_	_
7	levels	_	NNS	NNS	_	27	nsubjpass	_	_
8	of	_	IN	IN	_	9	case	_	_
9	mRNA	_	NN	NN	_	7	nmod	_	_
10	encoding	_	VBG	VBG	_	9	acl	_	_
11	the	_	DT	DT	_	17	det	_	_
12	68-kilodalton	_	JJ	JJ	_	17	amod	_	_
14	kd	_	NN	NN	_	17	appos	_	_
16	neurofilament	_	NN	NN	_	17	compound	_	_
17	protein	_	NN	NN	_	10	dobj	_	_
19	NF68	_	NNP	NNP	_	17	appos	_	_
21	in	_	IN	IN	_	25	case	_	_
22	adult	_	JJ	JJ	_	25	amod	_	_
23	rat	_	NN	NN	_	25	compound	_	_
24	DRG	_	NN	NN	_	25	compound	_	_
25	neurons	_	NNS	NNS	_	10	nmod	_	_
26	were	_	VBD	VBD	_	27	auxpass	_	_
27	assessed	_	VBN	VBN	_	0	root	_	_
28	at	_	IN	IN	_	30	case	_	_
29	different	_	JJ	JJ	_	30	amod	_	_
30	times	_	NNS	NNS	_	27	nmod	_	_
31	after	_	IN	IN	_	33	case	_	_
32	peripheral	_	JJ	JJ	_	33	amod	_	_
33	axotomy	_	NN	NN	_	27	nmod	_	_
34	using	_	VBG	VBG	_	33	acl	_	_
35	in	_	IN	IN	_	37	case	_	_
36	situ	_	JJ	JJ	_	37	amod	_	_
37	hybridization	_	NN	NN	_	34	nmod	_	_

1	For	_	IN	IN	_	3	case	_	_
2	these	_	DT	DT	_	3	det	_	_
3	studies	_	NNS	NNS	_	5	nmod	_	_
4	we	_	PRP	PRP	_	5	nsubj	_	_
5	used	_	VBD	VBD	_	0	root	_	_
6	a	_	DT	DT	_	9	det	_	_
7	35S-labeled	_	JJ	JJ	_	9	amod	_	_
8	cDNA	_	NN	NN	_	9	compound	_	_
9	probe	_	NN	NN	_	5	dobj	_	_
10	to	_	TO	TO	_	11	case	_	_
11	NF68	_	NNP	NNP	_	5	nmod	_	_

1	The	_	DT	DT	_	2	det	_	_
2	levels	_	NNS	NNS	_	30	nsubjpass	_	_
3	of	_	IN	IN	_	5	case	_	_
4	NF68	_	NNP	NNP	_	5	compound	_	_
5	mRNA	_	NNP	NNP	_	2	nmod	_	_
6	in	_	IN	IN	_	8	case	_	_
7	sensory	_	JJ	JJ	_	8	amod	_	_
8	neurons	_	NNS	NNS	_	5	nmod	_	_
9	located	_	VBN	VBN	_	8	acl	_	_
10	in	_	IN	IN	_	12	case	_	_
11	ipsilateral	_	NN	NN	_	12	nmod:npmod	_	_
12	fourth	_	JJ	JJ	_	9	nmod	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	fifth	_	JJ	JJ	_	16	amod	_	_
15	lumbar	_	NN	NN	_	16	compound	_	_
16	DRG	_	NN	NN	_	12	conj	_	_
17	at	_	IN	IN	_	18	case	_	_
18	1	_	CD	CD	_	12	nmod	_	_
20	7	_	CD	CD	_	18	conj	_	_
22	and	_	CC	CC	_	18	cc	_	_
23	14	_	CD	CD	_	24	nummod	_	_
24	days	_	NNS	NNS	_	18	conj	_	_
25	after	_	IN	IN	_	28	case	_	_
26	sciatic	_	JJ	JJ	_	28	amod	_	_
27	nerve	_	NN	NN	_	28	compound	_	_
28	crush	_	NN	NN	_	9	nmod	_	_
29	were	_	VBD	VBD	_	30	auxpass	_	_
30	compared	_	VBN	VBN	_	0	root	_	_
31	to	_	TO	TO	_	32	case	_	_
32	those	_	DT	DT	_	30	nmod	_	_
33	in	_	IN	IN	_	36	case	_	_
34	normal	_	JJ	JJ	_	36	amod	_	_
35	DRG	_	NNP	NNP	_	36	compound	_	_
36	neurons	_	NNS	NNS	_	32	nmod	_	_
37	using	_	VBG	VBG	_	30	xcomp	_	_
38	quantitative	_	JJ	JJ	_	39	amod	_	_
39	autoradiography	_	NN	NN	_	37	dobj	_	_

1	In	_	IN	IN	_	4	case	_	_
2	large	_	JJ	JJ	_	4	amod	_	_
3	DRG	_	NNP	NNP	_	4	compound	_	_
4	neurons	_	NNS	NNS	_	20	nmod	_	_
6	greater	_	JJR	JJR	_	8	advmod	_	_
7	than	_	IN	IN	_	8	advmod	_	_
8	1000	_	$	$	_	4	dep	_	_
9	micron	_	CD	CD	_	10	compound	_	_
10	2	_	CD	CD	_	8	nummod	_	_
13	the	_	DT	DT	_	14	det	_	_
14	levels	_	NNS	NNS	_	20	nsubjpass	_	_
15	of	_	IN	IN	_	17	case	_	_
16	NF68	_	NNP	NNP	_	17	compound	_	_
17	mRNA	_	NNP	NNP	_	14	nmod	_	_
18	were	_	VBD	VBD	_	20	auxpass	_	_
19	significantly	_	RB	RB	_	20	advmod	_	_
20	reduced	_	VBN	VBN	_	0	root	_	_
21	relative	_	JJ	JJ	_	20	advmod	_	_
22	to	_	TO	TO	_	23	case	_	_
23	normal	_	JJ	JJ	_	21	advcl	_	_
24	at	_	IN	IN	_	25	case	_	_
25	1	_	CD	CD	_	20	nmod	_	_
27	7	_	CD	CD	_	25	conj	_	_
29	and	_	CC	CC	_	25	cc	_	_
30	14	_	CD	CD	_	31	nummod	_	_
31	days	_	NNS	NNS	_	25	conj	_	_
32	after	_	IN	IN	_	33	case	_	_
33	axotomy	_	NN	NN	_	20	nmod	_	_

1	Medium-sized	_	JJ	JJ	_	2	amod	_	_
2	cells	_	NNS	NNS	_	8	nsubj	_	_
4	601-1000	_	NNP	NNP	_	2	appos	_	_
5	micron	_	CD	CD	_	6	compound	_	_
6	2	_	CD	CD	_	4	nummod	_	_
8	exhibited	_	VBD	VBD	_	0	root	_	_
9	a	_	DT	DT	_	10	det	_	_
10	reduction	_	NN	NN	_	8	dobj	_	_
11	only	_	RB	RB	_	8	advmod	_	_
12	at	_	IN	IN	_	14	case	_	_
13	14	_	CD	CD	_	14	nummod	_	_
14	days	_	NNS	NNS	_	8	nmod	_	_
15	postinjury	_	RB	RB	_	8	advmod	_	_
17	and	_	CC	CC	_	8	cc	_	_
18	small-sized	_	JJ	JJ	_	19	amod	_	_
19	cells	_	NNS	NNS	_	23	nsubj	_	_
20	were	_	VBD	VBD	_	23	cop	_	_
21	not	_	RB	RB	_	23	neg	_	_
22	significantly	_	RB	RB	_	23	advmod	_	_
23	affected	_	JJ	JJ	_	8	conj	_	_

1	These	_	DT	DT	_	2	det	_	_
2	findings	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	16	mark	_	_
5	larger	_	JJR	JJR	_	7	amod	_	_
6	DRG	_	NNP	NNP	_	7	compound	_	_
7	neurons	_	NNS	NNS	_	16	nsubj	_	_
8	which	_	WDT	WDT	_	9	nsubj	_	_
9	give	_	VBP	VBP	_	7	acl:relcl	_	_
10	rise	_	NN	NN	_	9	dobj	_	_
11	to	_	TO	TO	_	15	case	_	_
12	large	_	JJ	JJ	_	15	amod	_	_
13	myelinated	_	JJ	JJ	_	15	amod	_	_
14	sensory	_	JJ	JJ	_	15	amod	_	_
15	axons	_	NNS	NNS	_	9	nmod	_	_
16	exhibit	_	VB	VB	_	3	ccomp	_	_
17	a	_	DT	DT	_	22	det	_	_
18	change	_	NN	NN	_	22	dep	_	_
19	in	_	IN	IN	_	20	case	_	_
20	NF	_	NNP	NNP	_	18	nmod	_	_
21	gene	_	NN	NN	_	22	compound	_	_
22	expression	_	NN	NN	_	16	dobj	_	_
23	after	_	IN	IN	_	25	case	_	_
24	axonal	_	JJ	JJ	_	25	amod	_	_
25	injury	_	NN	NN	_	22	nmod	_	_

1	The	_	DT	DT	_	3	det	_	_
2	observed	_	JJ	JJ	_	3	amod	_	_
3	changes	_	NNS	NNS	_	9	nsubj	_	_
4	in	_	IN	IN	_	7	case	_	_
5	NF68	_	NNP	NNP	_	7	compound	_	_
6	mRNA	_	NN	NN	_	7	compound	_	_
7	levels	_	NNS	NNS	_	3	nmod	_	_
8	temporally	_	RB	RB	_	9	advmod	_	_
9	precede	_	VB	VB	_	0	root	_	_
10	changes	_	NNS	NNS	_	9	dobj	_	_
11	in	_	IN	IN	_	13	case	_	_
12	NF	_	NNP	NNP	_	13	compound	_	_
13	synthesis	_	NNP	NNP	_	9	nmod	_	_
14	and	_	CC	CC	_	9	cc	_	_
15	transport	_	VB	VB	_	9	conj	_	_
16	in	_	IN	IN	_	19	case	_	_
17	injured	_	JJ	JJ	_	19	amod	_	_
18	DRG	_	NNP	NNP	_	19	compound	_	_
19	cells	_	NNS	NNS	_	15	nmod	_	_

1	Thus	_	RB	RB	_	13	advmod	_	_
3	a	_	DT	DT	_	8	det	_	_
4	change	_	NN	NN	_	8	dep	_	_
5	in	_	IN	IN	_	6	case	_	_
6	NF	_	NNP	NNP	_	4	nmod	_	_
7	gene	_	NN	NN	_	8	compound	_	_
8	expression	_	NN	NN	_	13	nsubj	_	_
9	may	_	MD	MD	_	13	aux	_	_
10	be	_	VB	VB	_	13	cop	_	_
11	an	_	DT	DT	_	13	det	_	_
12	important	_	JJ	JJ	_	13	amod	_	_
13	component	_	NN	NN	_	0	root	_	_
14	of	_	IN	IN	_	18	case	_	_
15	an	_	DT	DT	_	18	det	_	_
16	effective	_	JJ	JJ	_	17	amod	_	_
17	regenerative	_	JJ	JJ	_	18	amod	_	_
18	response	_	NN	NN	_	13	nmod	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	a	_	DT	DT	_	22	det	_	_
21	critical	_	JJ	JJ	_	22	amod	_	_
22	step	_	NN	NN	_	18	conj	_	_
23	at	_	IN	IN	_	24	case	_	_
24	which	_	WDT	WDT	_	28	nmod	_	_
25	axonal	_	JJ	JJ	_	26	amod	_	_
26	caliber	_	NN	NN	_	28	nsubjpass	_	_
27	is	_	VBZ	VBZ	_	28	auxpass	_	_
28	regulated	_	VBN	VBN	_	22	acl:relcl	_	_
29	in	_	IN	IN	_	31	case	_	_
30	injured	_	JJ	JJ	_	31	amod	_	_
31	neurons	_	NNS	NNS	_	28	nmod	_	_

1	Platelet-derived	_	JJ	JJ	_	3	amod	_	_
2	growth	_	NN	NN	_	3	compound	_	_
3	factor	_	NN	NN	_	6	nsubj	_	_
4	does	_	VBZ	VBZ	_	6	aux	_	_
5	not	_	RB	RB	_	6	neg	_	_
6	induce	_	VB	VB	_	0	root	_	_
7	c-fos	_	NNS	NNS	_	6	dobj	_	_
8	in	_	IN	IN	_	11	case	_	_
9	NIH	_	NNP	NNP	_	11	compound	_	_
10	3T3	_	CD	CD	_	11	nummod	_	_
11	cells	_	NNS	NNS	_	7	nmod	_	_
12	expressing	_	VBG	VBG	_	6	xcomp	_	_
13	the	_	DT	DT	_	15	det	_	_
14	EJ-ras	_	NNP	NNP	_	15	compound	_	_
15	oncogene	_	NN	NN	_	12	dobj	_	_

1	Platelet-derived	_	JJ	JJ	_	3	amod	_	_
2	growth	_	NN	NN	_	3	compound	_	_
3	factor	_	NN	NN	_	18	nsubj	_	_
5	PDGF	_	NNP	NNP	_	3	appos	_	_
8	the	_	DT	DT	_	11	det	_	_
9	calcium	_	NN	NN	_	11	compound	_	_
10	ionophore	_	NN	NN	_	11	compound	_	_
11	A23187	_	NN	NN	_	3	appos	_	_
13	and	_	CC	CC	_	3	cc	_	_
14	the	_	DT	DT	_	17	det	_	_
15	tumor	_	NN	NN	_	17	compound	_	_
16	promoter	_	NN	NN	_	17	compound	_	_
17	phorbol_myristate_acetate	_	NN	NN	_	3	conj	_	_
18	stimulated	_	VBN	VBN	_	0	root	_	_
19	c-fos	_	JJ	JJ	_	21	amod	_	_
20	mRNA	_	NN	NN	_	21	compound	_	_
21	levels	_	NNS	NNS	_	18	dobj	_	_
22	in	_	IN	IN	_	26	case	_	_
23	control	_	JJ	JJ	_	26	amod	_	_
24	NIH	_	NNP	NNP	_	26	compound	_	_
25	3T3	_	CD	CD	_	26	nummod	_	_
26	cells	_	NNS	NNS	_	21	nmod	_	_

1	However	_	RB	RB	_	20	advmod	_	_
3	NIH	_	NNP	NNP	_	5	compound	_	_
4	3T3	_	CD	CD	_	5	nummod	_	_
5	cells	_	NNS	NNS	_	20	nsubj	_	_
6	transformed	_	VBN	VBN	_	5	acl	_	_
7	by	_	IN	IN	_	10	case	_	_
8	EJ-ras	_	NNP	NNP	_	10	compound	_	_
9	DNA	_	NNP	NNP	_	10	compound	_	_
10	transfection	_	NN	NN	_	6	nmod	_	_
12	which	_	WDT	WDT	_	14	nsubj	_	_
13	have	_	VBP	VBP	_	14	aux	_	_
14	diminished	_	VBN	VBN	_	5	acl:relcl	_	_
15	PDGF-stimulated	_	JJ	JJ	_	18	amod	_	_
16	phospholipase	_	NN	NN	_	18	compound	_	_
17	C	_	NNP	NNP	_	18	compound	_	_
18	activity	_	NN	NN	_	14	xcomp	_	_
20	showed	_	VBD	VBD	_	0	root	_	_
21	a	_	DT	DT	_	24	det	_	_
22	95	_	CD	CD	_	23	compound	_	_
23	%	_	NN	NN	_	24	amod	_	_
24	reduction	_	NN	NN	_	20	dobj	_	_
25	in	_	IN	IN	_	29	case	_	_
26	PDGF-stimulated	_	JJ	JJ	_	29	amod	_	_
27	c-fos	_	JJ	JJ	_	29	amod	_	_
28	mRNA	_	NN	NN	_	29	compound	_	_
29	levels	_	NNS	NNS	_	24	nmod	_	_

1	The	_	DT	DT	_	2	det	_	_
2	responses	_	NNS	NNS	_	9	nsubj	_	_
3	to	_	TO	TO	_	4	case	_	_
4	A23187	_	NN	NN	_	2	nmod	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	phorbol_myristate_acetate	_	NN	NN	_	4	conj	_	_
7	were	_	VBD	VBD	_	9	cop	_	_
8	also	_	RB	RB	_	9	advmod	_	_
9	attenuated	_	JJ	JJ	_	0	root	_	_
11	but	_	CC	CC	_	9	cc	_	_
12	not	_	RB	RB	_	14	neg	_	_
13	as	_	RB	RB	_	14	advmod	_	_
14	severely	_	RB	RB	_	9	conj	_	_
15	as	_	IN	IN	_	18	case	_	_
16	the	_	DT	DT	_	18	det	_	_
17	PDGF-mediated	_	JJ	JJ	_	18	amod	_	_
18	induction	_	NN	NN	_	9	nmod	_	_

1	The	_	DT	DT	_	2	det	_	_
2	reduction	_	NN	NN	_	9	nsubj	_	_
3	in	_	IN	IN	_	6	case	_	_
4	PDGF-stimulated	_	JJ	JJ	_	6	amod	_	_
5	c-fos	_	JJ	JJ	_	6	amod	_	_
6	induction	_	NN	NN	_	2	nmod	_	_
7	did	_	VBD	VBD	_	9	aux	_	_
8	not	_	RB	RB	_	9	neg	_	_
9	appear	_	VB	VB	_	0	root	_	_
10	to	_	TO	TO	_	14	mark	_	_
11	be	_	VB	VB	_	14	cop	_	_
12	a	_	DT	DT	_	14	det	_	_
13	general	_	JJ	JJ	_	14	amod	_	_
14	result	_	NN	NN	_	9	xcomp	_	_
15	of	_	IN	IN	_	17	case	_	_
16	cellular	_	JJ	JJ	_	17	amod	_	_
17	transformation	_	NN	NN	_	14	nmod	_	_
19	since	_	IN	IN	_	24	mark	_	_
20	src-transformed	_	JJ	JJ	_	23	amod	_	_
21	NIH	_	NNP	NNP	_	23	compound	_	_
22	3T3	_	NNP	NNP	_	23	compound	_	_
23	cells	_	NNS	NNS	_	24	nsubj	_	_
24	displayed	_	VBD	VBD	_	14	advcl	_	_
25	a	_	DT	DT	_	29	det	_	_
26	strong	_	JJ	JJ	_	29	amod	_	_
27	PDGF-stimulated	_	JJ	JJ	_	29	amod	_	_
28	c-fos	_	JJ	JJ	_	29	amod	_	_
29	induction	_	NN	NN	_	24	dobj	_	_

1	Despite	_	IN	IN	_	3	case	_	_
2	the	_	DT	DT	_	3	det	_	_
3	reduction	_	NN	NN	_	12	nmod	_	_
4	in	_	IN	IN	_	7	case	_	_
5	PDGF-stimulated	_	JJ	JJ	_	7	amod	_	_
6	c-fos	_	JJ	JJ	_	7	amod	_	_
7	induction	_	NN	NN	_	3	nmod	_	_
9	EJ-ras-transformed	_	JJ	JJ	_	10	amod	_	_
10	cells	_	NNS	NNS	_	12	nsubj	_	_
11	still	_	RB	RB	_	12	advmod	_	_
12	responded	_	VBD	VBD	_	0	root	_	_
13	mitogenically	_	RB	RB	_	12	advmod	_	_
14	to	_	TO	TO	_	15	case	_	_
15	PDGF	_	NNP	NNP	_	12	nmod	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	14	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	magnitude	_	NN	NN	_	14	nsubjpass	_	_
7	of	_	IN	IN	_	9	case	_	_
8	c-fos	_	JJ	JJ	_	9	amod	_	_
9	induction	_	NN	NN	_	6	nmod	_	_
10	can	_	MD	MD	_	14	aux	_	_
11	not	_	RB	RB	_	14	neg	_	_
12	be	_	VB	VB	_	14	auxpass	_	_
13	directly	_	RB	RB	_	14	advmod	_	_
14	correlated	_	VBN	VBN	_	3	ccomp	_	_
15	with	_	IN	IN	_	17	case	_	_
16	PDGF-stimulated	_	JJ	JJ	_	17	amod	_	_
17	mitogenesis	_	NNS	NNS	_	14	nmod	_	_
18	in	_	IN	IN	_	22	case	_	_
19	EJ-ras-transformed	_	JJ	JJ	_	22	amod	_	_
20	NIH	_	NNP	NNP	_	22	compound	_	_
21	3T3	_	CD	CD	_	22	nummod	_	_
22	cells	_	NNS	NNS	_	17	nmod	_	_

1	Inhibition	_	NNP	NNP	_	5	nsubj	_	_
2	of	_	IN	IN	_	3	case	_	_
3	NIH	_	NNP	NNP	_	1	nmod	_	_
4	3T3	_	CD	CD	_	3	nummod	_	_
5	cell	_	VBD	VBD	_	0	root	_	_
6	proliferation	_	NN	NN	_	5	dobj	_	_
7	by	_	IN	IN	_	11	case	_	_
8	a	_	DT	DT	_	11	det	_	_
9	mutant	_	JJ	JJ	_	11	amod	_	_
10	ras	_	NN	NN	_	11	compound	_	_
11	protein	_	NN	NN	_	5	nmod	_	_
12	with	_	IN	IN	_	14	case	_	_
13	preferential	_	JJ	JJ	_	14	amod	_	_
14	affinity	_	NN	NN	_	5	nmod	_	_
15	for	_	IN	IN	_	16	case	_	_
16	GDP	_	NNP	NNP	_	14	nmod	_	_

1	Substitution	_	NNP	NNP	_	4	nsubj	_	_
2	of	_	IN	IN	_	3	case	_	_
3	asparagine_for_serine_at_position_17	_	CD	CD	_	1	nmod	_	_
4	decreased	_	VBD	VBD	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	affinity	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	9	case	_	_
8	rasH	_	JJ	JJ	_	9	amod	_	_
9	p21	_	NNS	NNS	_	6	nmod	_	_
10	for	_	IN	IN	_	11	case	_	_
11	GTP	_	NNP	NNP	_	4	nmod	_	_
12	20	_	CD	CD	_	11	nummod	_	_
14	to	_	TO	TO	_	15	case	_	_
15	40-fold	_	JJ	JJ	_	4	advcl	_	_
16	without	_	IN	IN	_	18	mark	_	_
17	significantly	_	RB	RB	_	18	advmod	_	_
18	affecting	_	VBG	VBG	_	15	advcl	_	_
19	its	_	PRP$	PRP$	_	20	nmod:poss	_	_
20	affinity	_	NN	NN	_	18	dobj	_	_
21	for	_	IN	IN	_	22	case	_	_
22	GDP	_	NNP	NNP	_	18	nmod	_	_

1	Transfection	_	NNP	NNP	_	27	nsubj	_	_
2	of	_	IN	IN	_	5	case	_	_
3	NIH	_	NNP	NNP	_	5	compound	_	_
4	3T3	_	CD	CD	_	5	nummod	_	_
5	cells	_	NNS	NNS	_	1	nmod	_	_
6	with	_	IN	IN	_	10	case	_	_
7	a	_	DT	DT	_	10	det	_	_
8	mammalian	_	JJ	JJ	_	10	amod	_	_
9	expression	_	NN	NN	_	10	compound	_	_
10	vector	_	NN	NN	_	5	nmod	_	_
11	containing	_	VBG	VBG	_	10	acl	_	_
12	the	_	DT	DT	_	15	det	_	_
13	Asn-17	_	NN	NN	_	15	compound	_	_
14	rasH	_	NN	NN	_	15	compound	_	_
15	gene	_	NN	NN	_	11	dobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	a	_	DT	DT	_	19	det	_	_
18	Neor	_	NNP	NNP	_	19	compound	_	_
19	gene	_	NN	NN	_	15	conj	_	_
20	under	_	IN	IN	_	22	case	_	_
21	the	_	DT	DT	_	22	det	_	_
22	control	_	NN	NN	_	11	nmod	_	_
23	of	_	IN	IN	_	26	case	_	_
24	the	_	DT	DT	_	26	det	_	_
25	same	_	JJ	JJ	_	26	amod	_	_
26	promoter	_	NN	NN	_	22	nmod	_	_
27	yielded	_	VBD	VBD	_	0	root	_	_
28	only	_	RB	RB	_	31	advmod	_	_
29	a	_	DT	DT	_	31	det	_	_
30	small	_	JJ	JJ	_	31	amod	_	_
31	fraction	_	NN	NN	_	27	dobj	_	_
32	of	_	IN	IN	_	35	case	_	_
33	the	_	DT	DT	_	35	det	_	_
34	expected	_	JJ	JJ	_	35	amod	_	_
35	number	_	NN	NN	_	31	nmod	_	_
36	of	_	IN	IN	_	38	case	_	_
37	G418-resistant	_	NN	NN	_	38	compound	_	_
38	colonies	_	NNS	NNS	_	35	nmod	_	_
40	indicating	_	VBG	VBG	_	27	advcl	_	_
41	that	_	IN	IN	_	46	mark	_	_
42	expression	_	NN	NN	_	46	nsubj	_	_
43	of	_	IN	IN	_	45	case	_	_
44	Asn-17	_	NN	NN	_	45	compound	_	_
45	p21	_	NNS	NNS	_	42	nmod	_	_
46	inhibited	_	VBD	VBD	_	40	ccomp	_	_
47	cell	_	NN	NN	_	48	compound	_	_
48	proliferation	_	NN	NN	_	46	dobj	_	_

1	The	_	DT	DT	_	3	det	_	_
2	inhibitory	_	JJ	JJ	_	3	amod	_	_
3	effect	_	NN	NN	_	7	nsubj	_	_
4	of	_	IN	IN	_	6	case	_	_
5	Asn-17	_	NN	NN	_	6	compound	_	_
6	p21	_	NNS	NNS	_	3	nmod	_	_
7	required	_	VBD	VBD	_	0	root	_	_
8	its	_	PRP$	PRP$	_	9	nmod:poss	_	_
9	localization	_	NN	NN	_	7	dobj	_	_
10	to	_	TO	TO	_	13	case	_	_
11	the	_	DT	DT	_	13	det	_	_
12	plasma	_	NN	NN	_	13	compound	_	_
13	membrane	_	NN	NN	_	7	nmod	_	_
14	and	_	CC	CC	_	7	cc	_	_
15	was	_	VBD	VBD	_	16	cop	_	_
16	reversed	_	JJ	JJ	_	7	conj	_	_
17	by	_	IN	IN	_	18	case	_	_
18	coexpression	_	NN	NN	_	16	nmod	_	_
19	of	_	IN	IN	_	23	case	_	_
20	an	_	DT	DT	_	23	det	_	_
21	activated	_	VBN	VBN	_	23	amod	_	_
22	ras	_	NN	NN	_	23	compound	_	_
23	gene	_	NN	NN	_	18	nmod	_	_
25	indicating	_	VBG	VBG	_	16	xcomp	_	_
26	that	_	IN	IN	_	30	mark	_	_
27	the	_	DT	DT	_	29	det	_	_
28	mutant	_	JJ	JJ	_	29	amod	_	_
29	p21	_	NNS	NNS	_	30	nsubj	_	_
30	blocked	_	VBD	VBD	_	25	ccomp	_	_
31	the	_	DT	DT	_	34	det	_	_
32	endogenous	_	JJ	JJ	_	34	amod	_	_
33	ras	_	NN	NN	_	34	compound	_	_
34	function	_	NN	NN	_	30	dobj	_	_
35	required	_	VBN	VBN	_	34	acl	_	_
36	for	_	IN	IN	_	37	case	_	_
37	NIH	_	NNP	NNP	_	35	nmod	_	_
38	3T3	_	CD	CD	_	37	nummod	_	_
39	cell	_	NN	NN	_	40	compound	_	_
40	proliferation	_	NN	NN	_	7	dobj	_	_

1	NIH	_	NNP	NNP	_	3	compound	_	_
2	3T3	_	CD	CD	_	3	nummod	_	_
3	cells	_	NNS	NNS	_	15	nsubj	_	_
4	transformed	_	VBN	VBN	_	3	acl	_	_
5	by	_	IN	IN	_	6	case	_	_
6	v-mos	_	NNS	NNS	_	4	nmod	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	v-raf	_	NN	NN	_	6	conj	_	_
10	but	_	IN	IN	_	3	amod	_	_
11	not	_	RB	RB	_	12	neg	_	_
12	v-src	_	JJ	JJ	_	3	amod	_	_
14	were	_	VBD	VBD	_	15	cop	_	_
15	resistant	_	JJ	JJ	_	0	root	_	_
16	to	_	TO	TO	_	17	mark	_	_
17	inhibition	_	VB	VB	_	15	xcomp	_	_
18	by	_	IN	IN	_	20	case	_	_
19	Asn-17	_	NN	NN	_	20	compound	_	_
20	p21	_	NNS	NNS	_	17	nmod	_	_
22	indicating	_	VBG	VBG	_	17	xcomp	_	_
23	that	_	IN	IN	_	32	mark	_	_
24	the	_	DT	DT	_	25	det	_	_
25	requirement	_	NN	NN	_	32	nsubjpass	_	_
26	for	_	IN	IN	_	29	case	_	_
27	normal	_	JJ	JJ	_	29	amod	_	_
28	ras	_	NN	NN	_	29	compound	_	_
29	function	_	NN	NN	_	25	nmod	_	_
30	can	_	MD	MD	_	32	aux	_	_
31	be	_	VB	VB	_	32	auxpass	_	_
32	bypassed	_	VBN	VBN	_	22	ccomp	_	_
33	by	_	IN	IN	_	36	case	_	_
34	these	_	DT	DT	_	36	det	_	_
35	cytoplasmic	_	JJ	JJ	_	36	amod	_	_
36	oncogenes	_	NNS	NNS	_	32	nmod	_	_

1	The	_	DT	DT	_	3	det	_	_
2	Asn-17	_	NN	NN	_	3	compound	_	_
3	mutant	_	NN	NN	_	4	nsubj	_	_
4	represents	_	VBZ	VBZ	_	0	root	_	_
5	a	_	DT	DT	_	7	det	_	_
6	novel	_	NN	NN	_	7	compound	_	_
7	reagent	_	NN	NN	_	4	dobj	_	_
8	for	_	IN	IN	_	10	case	_	_
9	the	_	DT	DT	_	10	det	_	_
10	study	_	NN	NN	_	7	nmod	_	_
11	of	_	IN	IN	_	13	case	_	_
12	ras	_	NN	NN	_	13	compound	_	_
13	function	_	NN	NN	_	10	nmod	_	_
14	by	_	IN	IN	_	15	case	_	_
15	virtue	_	NN	NN	_	4	nmod	_	_
16	of	_	IN	IN	_	18	case	_	_
17	its	_	PRP$	PRP$	_	18	nmod:poss	_	_
18	ability	_	NN	NN	_	15	nmod	_	_
19	to	_	TO	TO	_	20	mark	_	_
20	inhibit	_	VB	VB	_	18	acl	_	_
21	cellular	_	JJ	JJ	_	23	amod	_	_
22	ras	_	NN	NN	_	23	compound	_	_
23	activity	_	NN	NN	_	20	dobj	_	_
24	in	_	IN	IN	_	25	case	_	_
25	vivo	_	NN	NN	_	23	nmod	_	_

1	Since	_	IN	IN	_	6	mark	_	_
2	this	_	DT	DT	_	3	det	_	_
3	phenotype	_	NN	NN	_	6	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	6	auxpass	_	_
5	likely	_	RB	RB	_	6	advmod	_	_
6	associated	_	VBN	VBN	_	22	advcl	_	_
7	with	_	IN	IN	_	10	case	_	_
8	the	_	DT	DT	_	10	det	_	_
9	preferential	_	JJ	JJ	_	10	amod	_	_
10	affinity	_	NN	NN	_	6	nmod	_	_
11	of	_	IN	IN	_	14	case	_	_
12	the	_	DT	DT	_	14	det	_	_
13	mutant	_	JJ	JJ	_	14	amod	_	_
14	protein	_	NN	NN	_	10	nmod	_	_
15	for	_	IN	IN	_	16	case	_	_
16	GDP	_	NNP	NNP	_	14	nmod	_	_
18	analogous	_	JJ	JJ	_	19	amod	_	_
19	mutations	_	NNS	NNS	_	22	nsubj	_	_
20	might	_	MD	MD	_	22	aux	_	_
21	also	_	RB	RB	_	22	advmod	_	_
22	yield	_	VB	VB	_	0	root	_	_
23	inhibitors	_	NNS	NNS	_	22	dobj	_	_
24	of	_	IN	IN	_	26	case	_	_
25	other	_	JJ	JJ	_	26	amod	_	_
26	proteins	_	NNS	NNS	_	23	nmod	_	_
27	whose	_	WP$	WP$	_	28	nmod:poss	_	_
28	activities	_	NNS	NNS	_	30	nsubjpass	_	_
29	are	_	VBP	VBP	_	30	auxpass	_	_
30	regulated	_	VBN	VBN	_	23	acl:relcl	_	_
31	by	_	IN	IN	_	32	case	_	_
32	guanine_nucleotide	_	JJ	JJ	_	30	nmod	_	_
33	binding	_	VBG	VBG	_	32	amod	_	_

1	Human	_	NNP	NNP	_	2	nsubj	_	_
2	myeloid	_	VBD	VBD	_	0	root	_	_
3	differentiation	_	NN	NN	_	4	compound	_	_
4	antigens	_	NNS	NNS	_	5	nsubj	_	_
5	identified	_	VBD	VBD	_	2	ccomp	_	_
6	by	_	IN	IN	_	8	case	_	_
7	monoclonal	_	JJ	JJ	_	8	amod	_	_
8	antibodies	_	NNS	NNS	_	5	nmod	_	_
9	to	_	TO	TO	_	14	case	_	_
10	the	_	DT	DT	_	14	det	_	_
11	myelomonocytic_leukemia	_	JJ	JJ	_	14	amod	_	_
12	cell	_	NN	NN	_	14	compound	_	_
13	line	_	NN	NN	_	14	compound	_	_
14	RC-2A	_	NN	NN	_	5	nmod	_	_

1	Murine	_	JJ	JJ	_	3	amod	_	_
2	monoclonal	_	JJ	JJ	_	3	amod	_	_
3	antibodies	_	NNS	NNS	_	12	nsubjpass	_	_
4	to	_	TO	TO	_	10	case	_	_
5	human	_	JJ	JJ	_	10	amod	_	_
6	myeloid	_	JJ	JJ	_	10	amod	_	_
7	cell	_	NN	NN	_	10	compound	_	_
8	surface	_	NN	NN	_	10	compound	_	_
9	differentiation	_	JJ	JJ	_	10	amod	_	_
10	antigens	_	NNS	NNS	_	3	nmod	_	_
11	were	_	VBD	VBD	_	12	auxpass	_	_
12	prepared	_	VBN	VBN	_	0	root	_	_
13	using	_	VBG	VBG	_	12	xcomp	_	_
14	the	_	DT	DT	_	18	det	_	_
15	myelomonocytic_leukemia	_	JJ	JJ	_	18	amod	_	_
16	cell	_	NN	NN	_	18	compound	_	_
17	line	_	NN	NN	_	18	compound	_	_
18	RC-2A	_	NN	NN	_	13	dobj	_	_
19	as	_	IN	IN	_	20	case	_	_
20	immunogen	_	NN	NN	_	13	nmod	_	_

1	Using	_	VBG	VBG	_	10	advcl	_	_
2	a	_	DT	DT	_	6	det	_	_
3	highly	_	RB	RB	_	4	advmod	_	_
4	sensitive	_	JJ	JJ	_	6	amod	_	_
5	colorimetric	_	JJ	JJ	_	6	amod	_	_
6	assay	_	NN	NN	_	1	dobj	_	_
8	antibodies	_	NNS	NNS	_	10	nsubjpass	_	_
9	were	_	VBD	VBD	_	10	auxpass	_	_
10	selected	_	VBN	VBN	_	0	root	_	_
11	as	_	RB	RB	_	12	advmod	_	_
12	myeloid-associated	_	JJ	JJ	_	10	xcomp	_	_
13	based	_	VBN	VBN	_	33	case	_	_
14	on	_	IN	IN	_	33	case	_	_
15	their	_	PRP$	PRP$	_	33	nmod:poss	_	_
16	binding	_	JJ	JJ	_	33	amod	_	_
17	to	_	TO	TO	_	19	case	_	_
18	RC-2A	_	NN	NN	_	19	compound	_	_
19	cells	_	NNS	NNS	_	16	nmod	_	_
21	but	_	CC	CC	_	19	cc	_	_
22	not	_	RB	RB	_	24	neg	_	_
23	to	_	TO	TO	_	24	case	_	_
24	cells	_	NNS	NNS	_	19	conj	_	_
25	of	_	IN	IN	_	27	case	_	_
26	the	_	DT	DT	_	27	det	_	_
27	autologous	_	NNS	NNS	_	24	nmod	_	_
28	EBV-transformed	_	JJ	JJ	_	33	amod	_	_
29	*	_	NN	NN	_	33	compound	_	_
30	B	_	NNP	NNP	_	33	compound	_	_
31	cell	_	NN	NN	_	33	compound	_	_
32	line	_	NN	NN	_	33	compound	_	_
33	Cess-B	_	NN	NN	_	10	advcl	_	_

1	Antibodies	_	NNS	NNS	_	10	nsubjpass	_	_
2	to	_	TO	TO	_	7	case	_	_
3	five	_	CD	CD	_	7	nummod	_	_
4	distinct	_	JJ	JJ	_	7	amod	_	_
5	cell	_	NN	NN	_	7	compound	_	_
6	surface	_	NN	NN	_	7	compound	_	_
7	antigens	_	NNS	NNS	_	1	nmod	_	_
8	were	_	VBD	VBD	_	10	auxpass	_	_
9	extensively	_	RB	RB	_	10	advmod	_	_
10	characterized	_	VBN	VBN	_	0	root	_	_
11	for	_	IN	IN	_	24	case	_	_
12	their	_	PRP$	PRP$	_	24	nmod:poss	_	_
13	binding	_	JJ	JJ	_	24	amod	_	_
14	to	_	TO	TO	_	19	case	_	_
15	normal	_	JJ	JJ	_	19	amod	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	leukemic	_	JJ	JJ	_	15	conj	_	_
18	hemopoietic	_	JJ	JJ	_	19	amod	_	_
19	cells	_	NNS	NNS	_	13	nmod	_	_
21	and	_	CC	CC	_	19	cc	_	_
22	to	_	TO	TO	_	23	case	_	_
23	tissue	_	NN	NN	_	19	conj	_	_
24	sections	_	NNS	NNS	_	10	nmod	_	_

1	Three	_	CD	CD	_	2	nummod	_	_
2	antibodies	_	NNS	NNS	_	4	nsubj	_	_
3	may	_	MD	MD	_	4	aux	_	_
4	identify	_	VB	VB	_	0	root	_	_
5	antigens	_	NNS	NNS	_	4	dobj	_	_
6	previously	_	RB	RB	_	7	advmod	_	_
7	described	_	VBN	VBN	_	5	acl	_	_
8	in	_	IN	IN	_	13	case	_	_
9	the	_	DT	DT	_	13	det	_	_
10	International	_	NNP	NNP	_	13	compound	_	_
11	Leucocyte	_	NNP	NNP	_	13	compound	_	_
12	Typing	_	NNP	NNP	_	13	compound	_	_
13	Workshops	_	NNP	NNP	_	7	nmod	_	_
15	CD14	_	NNP	NNP	_	5	appos	_	_
17	CD11b	_	NNP	NNP	_	15	dep	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	CD31	_	NNP	NNP	_	17	conj	_	_

1	The	_	DT	DT	_	4	det	_	_
2	other	_	JJ	JJ	_	4	amod	_	_
3	two	_	CD	CD	_	4	nummod	_	_
4	antigens	_	NNS	NNS	_	5	nsubj	_	_
5	appear	_	VBP	VBP	_	0	root	_	_
6	to	_	TO	TO	_	8	mark	_	_
7	be	_	VB	VB	_	8	auxpass	_	_
8	expressed	_	VBN	VBN	_	5	xcomp	_	_
9	at	_	IN	IN	_	11	case	_	_
10	low	_	JJ	JJ	_	11	amod	_	_
11	levels	_	NNS	NNS	_	8	nmod	_	_
12	on	_	IN	IN	_	14	case	_	_
13	the	_	DT	DT	_	14	det	_	_
14	surface	_	NN	NN	_	8	nmod	_	_
15	of	_	IN	IN	_	17	case	_	_
16	RC-2A	_	NN	NN	_	17	compound	_	_
17	cells	_	NNS	NNS	_	14	nmod	_	_
19	and	_	CC	CC	_	5	cc	_	_
20	do	_	VBP	VBP	_	22	aux	_	_
21	not	_	RB	RB	_	22	neg	_	_
22	correspond	_	VB	VB	_	5	conj	_	_
23	to	_	TO	TO	_	26	case	_	_
24	existing	_	VBG	VBG	_	26	amod	_	_
25	CD	_	NN	NN	_	26	compound	_	_
26	groups	_	NNS	NNS	_	22	nmod	_	_

1	One	_	CD	CD	_	6	nsubj	_	_
2	of	_	IN	IN	_	3	case	_	_
3	these	_	DT	DT	_	1	nmod	_	_
4	is	_	VBZ	VBZ	_	6	cop	_	_
5	also	_	RB	RB	_	6	advmod	_	_
6	present	_	JJ	JJ	_	0	root	_	_
7	on	_	IN	IN	_	8	case	_	_
8	monocytes	_	NNS	NNS	_	6	nmod	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	neutrophils	_	NNS	NNS	_	8	conj	_	_

1	Both	_	DT	DT	_	3	nsubj	_	_
2	were	_	VBD	VBD	_	3	cop	_	_
3	present	_	JJ	JJ	_	0	root	_	_
4	on	_	IN	IN	_	7	case	_	_
5	myeloid	_	JJ	JJ	_	7	amod	_	_
6	progenitor	_	NN	NN	_	7	compound	_	_
7	cells	_	NNS	NNS	_	3	nmod	_	_
9	as	_	IN	IN	_	10	mark	_	_
10	judged	_	VBN	VBN	_	3	advcl	_	_
11	by	_	IN	IN	_	13	case	_	_
12	depletion	_	NN	NN	_	13	compound	_	_
13	experiments	_	NNS	NNS	_	10	nmod	_	_
14	with	_	IN	IN	_	15	case	_	_
15	antibody	_	NN	NN	_	10	nmod	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	complement	_	NN	NN	_	15	conj	_	_
19	although	_	IN	IN	_	21	mark	_	_
20	neither	_	DT	DT	_	21	nsubj	_	_
21	bound	_	VBN	VBN	_	10	advcl	_	_
22	appreciably	_	RB	RB	_	21	advmod	_	_
23	to	_	TO	TO	_	25	case	_	_
24	myeloid_leukemic	_	JJ	JJ	_	25	amod	_	_
25	cells	_	NNS	NNS	_	21	nmod	_	_
26	as	_	IN	IN	_	27	mark	_	_
27	judged	_	VBN	VBN	_	21	advcl	_	_
28	by	_	IN	IN	_	30	case	_	_
29	indirect	_	JJ	JJ	_	30	amod	_	_
30	immunofluorescence	_	NN	NN	_	27	nmod	_	_

1	The	_	DT	DT	_	4	det	_	_
2	other	_	JJ	JJ	_	4	amod	_	_
3	three	_	CD	CD	_	4	nummod	_	_
4	antibodies	_	NNS	NNS	_	5	nsubj	_	_
5	bound	_	VBN	VBN	_	0	root	_	_
6	preferentially	_	RB	RB	_	5	advmod	_	_
7	to	_	TO	TO	_	9	case	_	_
8	leukemic	_	JJ	JJ	_	9	amod	_	_
9	specimens	_	NNS	NNS	_	5	nmod	_	_
10	displaying	_	VBG	VBG	_	9	acl	_	_
11	monocytic	_	JJ	JJ	_	12	amod	_	_
12	differentiation	_	NN	NN	_	10	dobj	_	_

1	Four	_	CD	CD	_	7	nsubjpass	_	_
2	of	_	IN	IN	_	4	case	_	_
3	the	_	DT	DT	_	4	det	_	_
4	antibodies	_	NNS	NNS	_	1	nmod	_	_
5	could	_	MD	MD	_	7	aux	_	_
6	be	_	VB	VB	_	7	auxpass	_	_
7	demonstrated	_	VBN	VBN	_	0	root	_	_
8	to	_	TO	TO	_	9	case	_	_
9	bind	_	NN	NN	_	7	nmod	_	_
10	to	_	TO	TO	_	11	case	_	_
11	cells	_	NNS	NNS	_	7	nmod	_	_
12	in	_	IN	IN	_	14	case	_	_
13	frozen	_	JJ	JJ	_	14	amod	_	_
14	sections	_	NNS	NNS	_	11	nmod	_	_
15	of	_	IN	IN	_	19	case	_	_
16	tonsil	_	JJ	JJ	_	19	amod	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	small	_	JJ	JJ	_	16	conj	_	_
19	intestine	_	NN	NN	_	14	nmod	_	_
20	and	_	CC	CC	_	7	cc	_	_
21	all	_	DT	DT	_	22	nsubj	_	_
22	gave	_	VBD	VBD	_	7	conj	_	_
23	distinct	_	JJ	JJ	_	24	amod	_	_
24	patterns	_	NNS	NNS	_	22	dobj	_	_
25	of	_	IN	IN	_	26	case	_	_
26	reactivity	_	NN	NN	_	24	nmod	_	_

1	In	_	IN	IN	_	2	case	_	_
2	particular	_	JJ	JJ	_	6	advcl	_	_
4	these	_	DT	DT	_	5	det	_	_
5	antibodies	_	NNS	NNS	_	6	nsubj	_	_
6	differed	_	VBD	VBD	_	0	root	_	_
7	markedly	_	RB	RB	_	6	advmod	_	_
8	in	_	IN	IN	_	10	case	_	_
9	their	_	PRP$	PRP$	_	10	nmod:poss	_	_
10	binding	_	JJ	JJ	_	7	nmod	_	_
11	to	_	TO	TO	_	12	case	_	_
12	endothelium	_	NN	NN	_	6	nmod	_	_
14	follicular	_	JJ	JJ	_	16	amod	_	_
15	dendritic	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	12	conj	_	_
17	and	_	CC	CC	_	12	cc	_	_
18	various	_	JJ	JJ	_	19	amod	_	_
19	types	_	NNS	NNS	_	12	conj	_	_
20	of	_	IN	IN	_	22	case	_	_
21	tissue	_	NN	NN	_	22	compound	_	_
22	macrophages	_	NNS	NNS	_	19	nmod	_	_

1	These	_	DT	DT	_	2	det	_	_
2	antibodies	_	NNS	NNS	_	5	nsubj	_	_
3	may	_	MD	MD	_	5	aux	_	_
4	be	_	VB	VB	_	5	cop	_	_
5	useful	_	JJ	JJ	_	0	root	_	_
6	in	_	IN	IN	_	8	case	_	_
7	the	_	DT	DT	_	8	det	_	_
8	study	_	NN	NN	_	5	nmod	_	_
9	of	_	IN	IN	_	11	case	_	_
10	the	_	DT	DT	_	11	det	_	_
11	differentiation	_	NN	NN	_	8	nmod	_	_
12	of	_	IN	IN	_	14	case	_	_
13	myeloid	_	JJ	JJ	_	14	amod	_	_
14	cells	_	NNS	NNS	_	11	nmod	_	_
15	and	_	CC	CC	_	8	cc	_	_
16	in	_	IN	IN	_	17	case	_	_
17	studies	_	NNS	NNS	_	8	conj	_	_
18	of	_	IN	IN	_	21	case	_	_
19	immunologically	_	RB	RB	_	20	advmod	_	_
20	mediated	_	JJ	JJ	_	21	amod	_	_
21	disease	_	NN	NN	_	17	nmod	_	_
22	such	_	JJ	JJ	_	25	case	_	_
23	as	_	IN	IN	_	22	mwe	_	_
24	allograft	_	JJ	JJ	_	25	amod	_	_
25	rejection	_	NN	NN	_	21	nmod	_	_

1	Tetanus	_	JJ	JJ	_	2	amod	_	_
2	toxin	_	NN	NN	_	0	root	_	_
3	binding	_	JJ	JJ	_	8	amod	_	_
4	to	_	TO	TO	_	5	case	_	_
5	mouse	_	NN	NN	_	3	nmod	_	_
6	spinal	_	JJ	JJ	_	8	amod	_	_
7	cord	_	NN	NN	_	8	compound	_	_
8	cells	_	NNS	NNS	_	2	dep	_	_
10	an	_	DT	DT	_	11	det	_	_
11	evaluation	_	NN	NN	_	2	dep	_	_
12	of	_	IN	IN	_	14	case	_	_
13	the	_	DT	DT	_	14	det	_	_
14	role	_	NN	NN	_	11	nmod	_	_
15	of	_	IN	IN	_	16	case	_	_
16	gangliosides	_	NNS	NNS	_	14	nmod	_	_
17	in	_	IN	IN	_	19	case	_	_
18	toxin	_	NN	NN	_	19	compound	_	_
19	internalization	_	NN	NN	_	16	nmod	_	_

1	Studies	_	VBN	VBN	_	0	root	_	_
2	on	_	IN	IN	_	14	case	_	_
3	the	_	DT	DT	_	14	det	_	_
4	binding	_	JJ	JJ	_	14	amod	_	_
5	of	_	IN	IN	_	8	case	_	_
6	125I-labelled	_	JJ	JJ	_	8	amod	_	_
7	tetanus	_	NN	NN	_	8	compound	_	_
8	toxin	_	NN	NN	_	4	nmod	_	_
9	to	_	TO	TO	_	10	case	_	_
10	mouse	_	NN	NN	_	8	nmod	_	_
11	spinal	_	JJ	JJ	_	14	amod	_	_
12	cord	_	NN	NN	_	14	compound	_	_
13	cell	_	NN	NN	_	14	compound	_	_
14	cultures	_	NNS	NNS	_	1	nmod	_	_
15	revealed	_	VBD	VBD	_	1	dep	_	_
16	two	_	CD	CD	_	17	nummod	_	_
17	classes	_	NNS	NNS	_	15	dobj	_	_
18	of	_	IN	IN	_	20	case	_	_
19	toxin	_	NN	NN	_	20	compound	_	_
20	acceptor	_	NN	NN	_	17	nmod	_	_
22	one	_	CD	CD	_	20	amod	_	_
23	a	_	DT	DT	_	26	det	_	_
24	high-affinity	_	JJ	JJ	_	26	amod	_	_
25	protease-sensitive	_	JJ	JJ	_	26	amod	_	_
26	site	_	NN	NN	_	1	nsubj	_	_
28	the	_	DT	DT	_	34	det	_	_
29	other	_	JJ	JJ	_	34	amod	_	_
30	a	_	DT	DT	_	31	det	_	_
31	lower	_	JJR	JJR	_	34	amod	_	_
32	affinity	_	RB	RB	_	33	advmod	_	_
33	protease-resistant	_	JJ	JJ	_	34	amod	_	_
34	site	_	NN	NN	_	26	appos	_	_

1	The	_	DT	DT	_	2	det	_	_
2	latter	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	to	_	TO	TO	_	7	mark	_	_
6	be	_	VB	VB	_	7	cop	_	_
7	sialidase-sensitive	_	JJ	JJ	_	4	xcomp	_	_
8	and	_	CC	CC	_	4	cc	_	_
9	may	_	MD	MD	_	10	aux	_	_
10	represent	_	VB	VB	_	4	conj	_	_
11	binding	_	JJ	JJ	_	10	xcomp	_	_
12	to	_	TO	TO	_	13	case	_	_
13	gangliosides	_	NNS	NNS	_	11	nmod	_	_

1	Tetanus	_	JJ	JJ	_	3	amod	_	_
2	toxin	_	NN	NN	_	3	compound	_	_
3	internalization	_	NN	NN	_	9	nsubj	_	_
4	by	_	IN	IN	_	7	case	_	_
5	spinal	_	JJ	JJ	_	7	amod	_	_
6	cord	_	NN	NN	_	7	compound	_	_
7	cells	_	NNS	NNS	_	3	nmod	_	_
8	is	_	VBZ	VBZ	_	9	cop	_	_
9	rapid	_	JJ	JJ	_	0	root	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	coated	_	JJ	JJ	_	12	amod	_	_
12	pits	_	NNS	NNS	_	15	nsubjpass	_	_
13	have	_	VBP	VBP	_	15	aux	_	_
14	been	_	VBN	VBN	_	15	auxpass	_	_
15	implicated	_	VBN	VBN	_	9	conj	_	_
16	in	_	IN	IN	_	18	case	_	_
17	the	_	DT	DT	_	18	det	_	_
18	process	_	NN	NN	_	15	nmod	_	_
20	Parton	_	NNP	NNP	_	22	compound	_	_
21	et	_	FW	FW	_	22	compound	_	_
22	al.	_	NNP	NNP	_	15	xcomp	_	_

1	J.	_	NNP	NNP	_	2	compound	_	_
2	Neurochem	_	NNP	NNP	_	0	root	_	_

1	,	_	NNP	NNP	_	6	nsubj	_	_
2	49	_	CD	CD	_	1	nummod	_	_
4	1987	_	CD	CD	_	1	appos	_	_
6	1057-1068	_	VBZ	VBZ	_	0	root	_	_

1	To	_	TO	TO	_	2	mark	_	_
2	investigate	_	VB	VB	_	14	advcl	_	_
3	the	_	DT	DT	_	4	det	_	_
4	role	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	6	case	_	_
6	gangliosides	_	NNS	NNS	_	4	nmod	_	_
7	in	_	IN	IN	_	10	case	_	_
8	the	_	DT	DT	_	10	det	_	_
9	internalization	_	NN	NN	_	10	compound	_	_
10	process	_	NN	NN	_	6	nmod	_	_
12	trisialoganglioside	_	NN	NN	_	14	nsubjpass	_	_
13	was	_	VBD	VBD	_	14	auxpass	_	_
14	incorporated	_	VBN	VBN	_	0	root	_	_
15	into	_	IN	IN	_	18	case	_	_
16	the	_	DT	DT	_	18	det	_	_
17	plasma	_	NN	NN	_	18	compound	_	_
18	membrane	_	NN	NN	_	14	nmod	_	_
19	of	_	IN	IN	_	22	case	_	_
20	Balb/c	_	NNP	NNP	_	22	compound	_	_
21	3T3	_	CD	CD	_	22	nummod	_	_
22	cells	_	NNS	NNS	_	18	nmod	_	_
23	which	_	WDT	WDT	_	24	nsubj	_	_
24	lack	_	VBP	VBP	_	18	acl:relcl	_	_
25	endogenous	_	JJ	JJ	_	27	amod	_	_
26	toxin-binding	_	JJ	JJ	_	27	amod	_	_
27	activity	_	NN	NN	_	24	dobj	_	_

1	125I-labelled	_	JJ	JJ	_	3	amod	_	_
2	tetanus	_	NN	NN	_	3	compound	_	_
3	toxin	_	NN	NN	_	28	nsubjpass	_	_
4	bound	_	VBN	VBN	_	3	acl	_	_
5	specifically	_	RB	RB	_	7	advmod	_	_
6	to	_	TO	TO	_	7	mark	_	_
7	ganglioside	_	VB	VB	_	4	xcomp	_	_
8	treated	_	JJ	JJ	_	9	amod	_	_
9	cells	_	NNS	NNS	_	7	dobj	_	_
10	at	_	IN	IN	_	12	case	_	_
11	4	_	CD	CD	_	12	nummod	_	_
12	degrees	_	NNS	NNS	_	7	nmod	_	_
13	C.	_	NNP	NNP	_	7	dep	_	_
14	On	_	IN	IN	_	13	mark	_	_
15	warming	_	VBG	VBG	_	13	dep	_	_
16	cells	_	NNS	NNS	_	15	dobj	_	_
17	to	_	TO	TO	_	19	case	_	_
18	37	_	CD	CD	_	19	nummod	_	_
19	degrees	_	NNS	NNS	_	15	nmod	_	_
20	C	_	NNP	NNP	_	15	dobj	_	_
22	a	_	DT	DT	_	23	det	_	_
23	proportion	_	NN	NN	_	20	appos	_	_
24	of	_	IN	IN	_	26	case	_	_
25	bound	_	JJ	JJ	_	26	amod	_	_
26	toxin	_	NN	NN	_	23	nmod	_	_
27	was	_	VBD	VBD	_	28	auxpass	_	_
28	degraded	_	VBN	VBN	_	0	root	_	_
29	indicating	_	VBG	VBG	_	28	xcomp	_	_
30	that	_	IN	IN	_	36	mark	_	_
31	some	_	DT	DT	_	32	det	_	_
32	internalization	_	NN	NN	_	36	nsubj	_	_
33	of	_	IN	IN	_	34	case	_	_
34	toxin	_	NN	NN	_	32	nmod	_	_
35	had	_	VBD	VBD	_	36	aux	_	_
36	occurred	_	VBN	VBN	_	29	ccomp	_	_

1	The	_	DT	DT	_	2	det	_	_
2	mechanism	_	NN	NN	_	6	nsubjpass	_	_
3	of	_	IN	IN	_	4	case	_	_
4	internalization	_	NN	NN	_	2	nmod	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	studied	_	VBN	VBN	_	0	root	_	_
7	using	_	VBG	VBG	_	6	xcomp	_	_
8	tetanus	_	NN	NN	_	9	compound	_	_
9	toxin	_	NN	NN	_	7	dobj	_	_
10	adsorbed	_	VBN	VBN	_	9	acl	_	_
11	to	_	TO	TO	_	13	case	_	_
12	colloidal	_	JJ	JJ	_	13	amod	_	_
13	gold	_	NN	NN	_	10	nmod	_	_

1	At	_	IN	IN	_	3	case	_	_
2	4	_	CD	CD	_	3	nummod	_	_
3	degrees	_	NNS	NNS	_	8	nmod	_	_
4	C	_	NNP	NNP	_	3	appos	_	_
6	toxin-gold	_	JJ	JJ	_	8	nsubjpass	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	concentrated	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	14	case	_	_
10	non-coated	_	JJ	JJ	_	14	amod	_	_
11	cell	_	NN	NN	_	14	compound	_	_
12	surface	_	NN	NN	_	14	compound	_	_
13	membrane	_	JJ	JJ	_	14	amod	_	_
14	invaginations	_	NNS	NNS	_	8	nmod	_	_

1	On	_	IN	IN	_	3	case	_	_
2	warming	_	VBG	VBG	_	3	amod	_	_
3	cells	_	NNS	NNS	_	12	nmod	_	_
4	to	_	TO	TO	_	6	case	_	_
5	37	_	CD	CD	_	6	nummod	_	_
6	degrees	_	NNS	NNS	_	3	nmod	_	_
7	C	_	NNP	NNP	_	6	appos	_	_
9	toxin	_	NN	NN	_	10	compound	_	_
10	gold	_	NN	NN	_	12	nsubjpass	_	_
11	was	_	VBD	VBD	_	12	auxpass	_	_
12	internalized	_	VBN	VBN	_	0	root	_	_
13	via	_	IN	IN	_	15	case	_	_
14	non-coated	_	JJ	JJ	_	15	amod	_	_
15	vesicles	_	NNS	NNS	_	12	nmod	_	_
16	and	_	CC	CC	_	12	cc	_	_
17	accumulated	_	VBN	VBN	_	12	conj	_	_
18	within	_	IN	IN	_	20	case	_	_
19	multivesicular	_	NN	NN	_	20	compound	_	_
20	bodies	_	NNS	NNS	_	17	nmod	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	lysosomes	_	NNS	NNS	_	20	conj	_	_

1	The	_	DT	DT	_	3	det	_	_
2	relative	_	JJ	JJ	_	3	amod	_	_
3	roles	_	NNS	NNS	_	20	nsubjpass	_	_
4	of	_	IN	IN	_	10	case	_	_
5	coated	_	JJ	JJ	_	10	amod	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	non-coated	_	JJ	JJ	_	5	conj	_	_
8	vesicular	_	JJ	JJ	_	10	amod	_	_
9	uptake	_	NN	NN	_	10	compound	_	_
10	systems	_	NNS	NNS	_	3	nmod	_	_
11	in	_	IN	IN	_	13	case	_	_
12	the	_	DT	DT	_	13	det	_	_
13	mechanism	_	NN	NN	_	10	nmod	_	_
14	of	_	IN	IN	_	15	case	_	_
15	action	_	NN	NN	_	13	nmod	_	_
16	of	_	IN	IN	_	18	case	_	_
17	tetanus	_	NN	NN	_	18	compound	_	_
18	toxin	_	NN	NN	_	15	nmod	_	_
19	are	_	VBP	VBP	_	20	auxpass	_	_
20	discussed	_	VBN	VBN	_	0	root	_	_

1	Oncogene	_	NNP	NNP	_	2	nsubj	_	_
2	ras	_	VBP	VBP	_	0	root	_	_
3	p21	_	JJ	JJ	_	8	amod	_	_
5	and	_	CC	CC	_	3	cc	_	_
6	v-src	_	JJ	JJ	_	3	conj	_	_
7	pp60-transformed	_	JJ	JJ	_	8	amod	_	_
8	cells	_	NNS	NNS	_	9	nsubj	_	_
9	exhibit	_	VB	VB	_	2	ccomp	_	_
10	altered	_	VBN	VBN	_	11	amod	_	_
11	expression	_	NN	NN	_	9	dobj	_	_
12	of	_	IN	IN	_	13	case	_	_
13	proteases	_	NNS	NNS	_	11	nmod	_	_

1	To	_	TO	TO	_	2	mark	_	_
2	evaluate	_	VB	VB	_	13	advcl	_	_
3	the	_	DT	DT	_	5	det	_	_
4	proteolytic	_	JJ	JJ	_	5	amod	_	_
5	activities	_	NNS	NNS	_	2	dobj	_	_
6	of	_	IN	IN	_	9	case	_	_
7	oncogene-transfected	_	JJ	JJ	_	9	amod	_	_
8	3T3	_	CD	CD	_	9	nummod	_	_
9	cells	_	NNS	NNS	_	5	nmod	_	_
11	we	_	PRP	PRP	_	13	nsubj	_	_
12	have	_	VBP	VBP	_	13	aux	_	_
13	developed	_	VBN	VBN	_	0	root	_	_
14	a	_	DT	DT	_	18	det	_	_
15	copolymerized	_	JJ	JJ	_	18	amod	_	_
16	substrate	_	JJ	JJ	_	18	amod	_	_
17	electrophoretic	_	JJ	JJ	_	18	amod	_	_
18	assay	_	NN	NN	_	13	dobj	_	_
19	that	_	WDT	WDT	_	20	nsubj	_	_
20	permits	_	VBZ	VBZ	_	18	acl:relcl	_	_
21	the	_	DT	DT	_	22	det	_	_
22	detection	_	NN	NN	_	20	dobj	_	_
23	of	_	IN	IN	_	25	case	_	_
24	picogram	_	NN	NN	_	25	compound	_	_
25	quantities	_	NNS	NNS	_	22	nmod	_	_
26	of	_	IN	IN	_	27	case	_	_
27	proteases	_	NNS	NNS	_	25	nmod	_	_
28	produced	_	VBN	VBN	_	27	acl	_	_
29	by	_	IN	IN	_	30	case	_	_
30	cells	_	NNS	NNS	_	28	nmod	_	_
31	in	_	IN	IN	_	32	case	_	_
32	culture	_	NN	NN	_	30	nmod	_	_

1	Our	_	PRP$	PRP$	_	2	nmod:poss	_	_
2	assay	_	NN	NN	_	3	nsubj	_	_
3	involves	_	VBZ	VBZ	_	0	root	_	_
4	a	_	DT	DT	_	6	det	_	_
5	gelatin	_	NN	NN	_	6	compound	_	_
6	substrate	_	NN	NN	_	3	dobj	_	_
7	copolymerized	_	VBN	VBN	_	6	acl	_	_
8	in	_	IN	IN	_	11	case	_	_
9	a	_	DT	DT	_	11	det	_	_
10	polyacrylamide	_	JJ	JJ	_	11	amod	_	_
11	gel	_	NN	NN	_	7	nmod	_	_

1	Purified	_	JJ	JJ	_	4	amod	_	_
2	cell	_	NN	NN	_	4	compound	_	_
3	membrane	_	NN	NN	_	4	compound	_	_
4	preparations	_	NNS	NNS	_	6	nsubjpass	_	_
5	were	_	VBD	VBD	_	6	auxpass	_	_
6	run	_	VBN	VBN	_	0	root	_	_
7	on	_	IN	IN	_	8	case	_	_
8	gels	_	NNS	NNS	_	6	nmod	_	_
9	and	_	CC	CC	_	6	cc	_	_
10	various	_	JJ	JJ	_	12	amod	_	_
11	protease	_	NN	NN	_	12	compound	_	_
12	activities	_	NNS	NNS	_	14	nsubjpass	_	_
13	were	_	VBD	VBD	_	14	auxpass	_	_
14	detected	_	VBN	VBN	_	6	conj	_	_
15	by	_	IN	IN	_	16	case	_	_
16	amido_black	_	NN	NN	_	14	nmod	_	_

1	Ras-transfected	_	JJ	JJ	_	3	amod	_	_
2	3T3	_	CD	CD	_	3	nummod	_	_
3	cells	_	NNS	NNS	_	4	nsubj	_	_
4	appear	_	VBP	VBP	_	0	root	_	_
5	to	_	TO	TO	_	6	mark	_	_
6	have	_	VB	VB	_	4	xcomp	_	_
7	a	_	DT	DT	_	9	det	_	_
8	soluble	_	JJ	JJ	_	9	amod	_	_
9	metalloprotease	_	NN	NN	_	6	dobj	_	_
10	that	_	WDT	WDT	_	15	nsubjpass	_	_
11	may	_	MD	MD	_	15	aux	_	_
12	be	_	VB	VB	_	15	auxpass	_	_
13	transiently	_	RB	RB	_	15	advmod	_	_
14	membrane	_	RB	RB	_	15	advmod	_	_
15	bound	_	VBN	VBN	_	9	acl:relcl	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	responsible	_	JJ	JJ	_	15	conj	_	_
18	for	_	IN	IN	_	19	case	_	_
19	destruction	_	NN	NN	_	17	nmod	_	_
20	of	_	IN	IN	_	23	case	_	_
21	red	_	JJ	JJ	_	23	amod	_	_
22	blood	_	NN	NN	_	23	compound	_	_
23	cells	_	NNS	NNS	_	19	nmod	_	_
25	RBC	_	NNP	NNP	_	23	appos	_	_

1	Oncogene-transfected	_	JJ	JJ	_	3	amod	_	_
2	NIH-3T3	_	NN	NN	_	3	compound	_	_
3	cells	_	NNS	NNS	_	6	nsubjpass	_	_
4	have	_	VBP	VBP	_	6	aux	_	_
5	been	_	VBN	VBN	_	6	auxpass	_	_
6	demonstrated	_	VBN	VBN	_	0	root	_	_
7	to	_	TO	TO	_	8	mark	_	_
8	have	_	VB	VB	_	6	xcomp	_	_
9	RBC	_	NNP	NNP	_	11	compound	_	_
10	cytolytic	_	JJ	JJ	_	11	amod	_	_
11	activity	_	NN	NN	_	8	dobj	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	previously	_	RB	RB	_	4	advmod	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	that	_	DT	DT	_	8	det	_	_
6	v-src-transfected	_	JJ	JJ	_	8	amod	_	_
7	3T3	_	CD	CD	_	8	nummod	_	_
8	cells	_	NNS	NNS	_	13	nsubj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	their	_	PRP$	PRP$	_	12	nmod:poss	_	_
11	cell	_	NN	NN	_	12	compound	_	_
12	membranes	_	NNS	NNS	_	8	conj	_	_
13	cause	_	VB	VB	_	4	ccomp	_	_
14	RBC	_	NNP	NNP	_	15	compound	_	_
15	cytolysis	_	NNS	NNS	_	13	dobj	_	_
16	which	_	WDT	WDT	_	18	nsubjpass	_	_
17	is	_	VBZ	VBZ	_	18	auxpass	_	_
18	inhibited	_	VBN	VBN	_	15	acl:relcl	_	_
19	by	_	IN	IN	_	23	case	_	_
20	the	_	DT	DT	_	23	det	_	_
21	protease	_	JJ	JJ	_	23	amod	_	_
22	inhibitor	_	NN	NN	_	23	compound	_	_
23	leupeptin	_	NN	NN	_	18	nmod	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	report	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	23	mark	_	_
5	both	_	DT	DT	_	6	dep	_	_
6	H-ras	_	JJ	JJ	_	23	nsubj	_	_
8	and	_	CC	CC	_	6	cc	_	_
9	K-ras-transfected	_	JJ	JJ	_	6	conj	_	_
10	3T3	_	CD	CD	_	11	nummod	_	_
11	cells	_	NNS	NNS	_	17	nsubj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	their	_	PRP$	PRP$	_	15	nmod:poss	_	_
14	cell	_	NN	NN	_	15	compound	_	_
15	membranes	_	NNS	NNS	_	11	conj	_	_
16	are	_	VBP	VBP	_	17	cop	_	_
17	cytolytic	_	JJ	JJ	_	6	acl:relcl	_	_
18	for	_	IN	IN	_	19	case	_	_
19	RBC	_	NNP	NNP	_	17	nmod	_	_
21	but	_	CC	CC	_	17	cc	_	_
22	are	_	VBP	VBP	_	17	conj	_	_
23	inhibited	_	VBD	VBD	_	3	ccomp	_	_
24	by	_	IN	IN	_	28	case	_	_
25	the	_	DT	DT	_	28	det	_	_
26	metalloprotease	_	JJ	JJ	_	28	amod	_	_
27	inhibitor	_	NN	NN	_	28	compound	_	_
28	ethylene_diamine	_	NN	NN	_	23	nmod	_	_
29	tetraacetic_acid	_	VBN	VBN	_	28	acl	_	_

1	Using	_	VBG	VBG	_	9	advcl	_	_
2	the	_	DT	DT	_	5	det	_	_
3	gelatin	_	JJ	JJ	_	5	amod	_	_
4	substrate	_	NN	NN	_	5	compound	_	_
5	gel	_	NN	NN	_	1	dobj	_	_
6	assay	_	RB	RB	_	1	advmod	_	_
8	we	_	PRP	PRP	_	9	nsubj	_	_
9	determined	_	VBD	VBD	_	0	root	_	_
10	that	_	IN	IN	_	16	mark	_	_
11	some	_	DT	DT	_	16	nsubj	_	_
12	of	_	IN	IN	_	14	case	_	_
13	the	_	DT	DT	_	14	det	_	_
14	proteases	_	NNS	NNS	_	11	nmod	_	_
15	were	_	VBD	VBD	_	16	cop	_	_
16	intrinsic	_	JJ	JJ	_	9	ccomp	_	_
17	to	_	TO	TO	_	19	case	_	_
18	the	_	DT	DT	_	19	det	_	_
19	oncogene	_	NN	NN	_	16	nmod	_	_
20	expressing	_	VBG	VBG	_	19	acl	_	_
21	cells	_	NNS	NNS	_	20	dobj	_	_
23	while	_	IN	IN	_	27	mark	_	_
24	other	_	JJ	JJ	_	25	amod	_	_
25	proteases	_	NNS	NNS	_	27	nsubjpass	_	_
26	were	_	VBD	VBD	_	27	auxpass	_	_
27	secreted	_	VBN	VBN	_	16	advcl	_	_
28	into	_	IN	IN	_	32	case	_	_
29	the	_	DT	DT	_	32	det	_	_
30	culture	_	NN	NN	_	32	compound	_	_
31	growth	_	NN	NN	_	32	compound	_	_
32	medium	_	NN	NN	_	27	nmod	_	_

1	Enhancement	_	NNP	NNP	_	0	root	_	_
2	of	_	IN	IN	_	3	case	_	_
3	yield	_	NN	NN	_	1	nmod	_	_
4	of	_	IN	IN	_	9	case	_	_
5	Chlamydia_trachomatis	_	NNP	NNP	_	9	compound	_	_
6	Hela	_	NNP	NNP	_	9	compound	_	_
7	229	_	NNP	NNP	_	9	compound	_	_
8	cell	_	NN	NN	_	9	compound	_	_
9	culture	_	NN	NN	_	1	nmod	_	_

1	Restoration	_	NNP	NNP	_	0	root	_	_
2	of	_	IN	IN	_	7	case	_	_
3	anti-interleukin-1	_	JJ	JJ	_	7	amod	_	_
4	depressed	_	VBN	VBN	_	7	amod	_	_
5	natural	_	JJ	JJ	_	7	amod	_	_
6	killer	_	NN	NN	_	7	compound	_	_
7	activity	_	NN	NN	_	1	nmod	_	_
8	by	_	IN	IN	_	11	case	_	_
9	human	_	JJ	JJ	_	11	amod	_	_
10	recombinant	_	JJ	JJ	_	11	amod	_	_
11	interferon	_	NN	NN	_	7	nmod	_	_
12	alpha	_	NN	NN	_	1	amod	_	_
13	or	_	CC	CC	_	12	cc	_	_
14	gamma	_	NN	NN	_	12	conj	_	_
16	human	_	JJ	JJ	_	18	amod	_	_
17	recombinant	_	JJ	JJ	_	18	amod	_	_
18	interleukin-2	_	NN	NN	_	1	appos	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	indomethacin	_	NN	NN	_	18	conj	_	_

1	The	_	DT	DT	_	2	det	_	_
2	lymphokines	_	NNS	NNS	_	7	nsubjpass	_	_
3	interleukin-2_and_interferon_alpha	_	JJ	JJ	_	2	amod	_	_
4	or	_	CC	CC	_	3	cc	_	_
5	gamma	_	JJ	JJ	_	3	conj	_	_
6	are	_	VBP	VBP	_	7	auxpass	_	_
7	synthesized	_	VBN	VBN	_	0	root	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	secreted	_	VBN	VBN	_	7	conj	_	_
10	by	_	IN	IN	_	13	case	_	_
11	activated	_	VBN	VBN	_	13	amod	_	_
12	mononuclear	_	NN	NN	_	13	compound	_	_
13	cells	_	NNS	NNS	_	7	nmod	_	_
15	MC	_	NNP	NNP	_	13	appos	_	_
17	and	_	CC	CC	_	7	cc	_	_
18	play	_	VB	VB	_	7	conj	_	_
19	a	_	DT	DT	_	21	det	_	_
20	critical	_	JJ	JJ	_	21	amod	_	_
21	role	_	NN	NN	_	18	dobj	_	_
22	in	_	IN	IN	_	25	case	_	_
23	the	_	DT	DT	_	25	det	_	_
24	proliferative	_	JJ	JJ	_	25	amod	_	_
25	expansion	_	NN	NN	_	21	nmod	_	_
26	of	_	IN	IN	_	29	case	_	_
27	T-lymphocyte	_	JJ	JJ	_	29	amod	_	_
28	effector	_	NN	NN	_	29	compound	_	_
29	cells	_	NNS	NNS	_	25	nmod	_	_
30	during	_	IN	IN	_	33	case	_	_
31	the	_	DT	DT	_	33	det	_	_
32	immune	_	JJ	JJ	_	33	amod	_	_
33	response	_	NN	NN	_	18	nmod	_	_

1	The	_	DT	DT	_	2	det	_	_
2	pretreatment	_	NN	NN	_	26	nsubj	_	_
3	of	_	IN	IN	_	8	case	_	_
4	human	_	JJ	JJ	_	8	amod	_	_
5	peripheral	_	JJ	JJ	_	8	amod	_	_
6	blood	_	NN	NN	_	8	compound	_	_
7	mononuclear	_	NN	NN	_	8	compound	_	_
8	cells	_	NNS	NNS	_	2	nmod	_	_
10	PBMC	_	NNP	NNP	_	2	appos	_	_
12	with	_	IN	IN	_	13	case	_	_
13	antibody	_	NN	NN	_	2	nmod	_	_
14	IgG	_	VBN	VBN	_	13	acl	_	_
15	against	_	IN	IN	_	17	case	_	_
16	human	_	JJ	JJ	_	17	amod	_	_
17	interleukin-1	_	NN	NN	_	14	nmod	_	_
19	IL-1	_	NNP	NNP	_	17	appos	_	_
21	from	_	IN	IN	_	24	case	_	_
22	normal	_	JJ	JJ	_	24	amod	_	_
23	rabbit	_	NN	NN	_	24	compound	_	_
24	serum	_	NN	NN	_	14	nmod	_	_
26	inhibited	_	VBD	VBD	_	0	root	_	_
27	their	_	PRP$	PRP$	_	33	nmod:poss	_	_
28	natural	_	JJ	JJ	_	33	amod	_	_
29	killer	_	NN	NN	_	33	compound	_	_
31	NK	_	NNP	NNP	_	33	appos	_	_
33	activity	_	NN	NN	_	26	dobj	_	_
34	against	_	IN	IN	_	36	case	_	_
35	both	_	DT	DT	_	36	det	_	_
36	myeloid	_	NN	NN	_	26	nmod	_	_
38	K562	_	NNP	NNP	_	36	appos	_	_
40	and	_	CC	CC	_	36	cc	_	_
41	lymphoid	_	JJ	JJ	_	46	amod	_	_
43	MOLT-4	_	NNP	NNP	_	41	dep	_	_
45	cell	_	NN	NN	_	46	compound	_	_
46	lines	_	NNS	NNS	_	36	conj	_	_

1	Percent	_	JJ	JJ	_	3	amod	_	_
2	specific	_	JJ	JJ	_	3	amod	_	_
3	lysis	_	NNS	NNS	_	7	nsubj	_	_
4	of	_	IN	IN	_	6	case	_	_
5	tumor	_	NN	NN	_	6	compound	_	_
6	cells	_	NNS	NNS	_	3	nmod	_	_
7	decreased	_	VBD	VBD	_	0	root	_	_
8	by	_	IN	IN	_	9	mark	_	_
9	increasing	_	VBG	VBG	_	7	advcl	_	_
10	the	_	DT	DT	_	11	det	_	_
11	antibody	_	NN	NN	_	9	iobj	_	_
12	anti-IL-1	_	JJ	JJ	_	13	amod	_	_
13	dose	_	NN	NN	_	9	dobj	_	_
14	in	_	IN	IN	_	18	case	_	_
15	an	_	DT	DT	_	18	det	_	_
16	almost	_	RB	RB	_	18	advmod	_	_
17	linear	_	JJ	JJ	_	18	amod	_	_
18	fashion	_	NN	NN	_	13	nmod	_	_

1	When	_	WRB	WRB	_	6	advmod	_	_
2	the	_	DT	DT	_	4	det	_	_
3	effector	_	NN	NN	_	4	compound	_	_
4	cells	_	NNS	NNS	_	6	nsubjpass	_	_
5	were	_	VBD	VBD	_	6	auxpass	_	_
6	pretreated	_	VBN	VBN	_	35	advcl	_	_
7	with	_	IN	IN	_	10	case	_	_
8	human	_	JJ	JJ	_	10	amod	_	_
9	recombinant	_	JJ	JJ	_	10	amod	_	_
10	interleukin-2	_	NN	NN	_	6	nmod	_	_
12	human	_	JJ	JJ	_	14	amod	_	_
13	interferon	_	NN	NN	_	14	compound	_	_
14	alpha	_	NNS	NNS	_	10	conj	_	_
15	or	_	CC	CC	_	10	cc	_	_
16	gamma	_	NN	NN	_	10	conj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	indomethacin	_	NN	NN	_	16	conj	_	_
19	alone	_	RB	RB	_	10	advmod	_	_
20	or	_	CC	CC	_	10	cc	_	_
21	in	_	IN	IN	_	22	case	_	_
22	combination	_	NN	NN	_	10	conj	_	_
24	the	_	DT	DT	_	26	det	_	_
25	inhibitory	_	JJ	JJ	_	26	amod	_	_
26	effect	_	NN	NN	_	35	nsubj	_	_
27	of	_	IN	IN	_	28	case	_	_
28	antibody	_	NN	NN	_	26	nmod	_	_
29	against	_	IN	IN	_	31	case	_	_
30	human	_	JJ	JJ	_	31	amod	_	_
31	IL-1	_	NN	NN	_	28	nmod	_	_
32	was	_	VBD	VBD	_	35	cop	_	_
33	almost	_	RB	RB	_	35	advmod	_	_
34	totally	_	RB	RB	_	35	advmod	_	_
35	reversed	_	JJ	JJ	_	0	root	_	_

1	Effects	_	NNPS	NNPS	_	5	nsubj	_	_
2	of	_	IN	IN	_	4	case	_	_
3	platelet-activating	_	JJ	JJ	_	4	amod	_	_
4	factor	_	NN	NN	_	1	nmod	_	_
5	antagonist	_	VBP	VBP	_	0	root	_	_
6	SRI	_	NNP	NNP	_	5	dobj	_	_
7	63-441	_	CD	CD	_	6	nummod	_	_
8	on	_	IN	IN	_	9	case	_	_
9	endotoxemia	_	NN	NN	_	6	nmod	_	_
10	in	_	IN	IN	_	11	case	_	_
11	sheep	_	NN	NN	_	9	nmod	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	investigated	_	VBD	VBD	_	0	root	_	_
3	whether	_	IN	IN	_	9	mark	_	_
4	platelet-activating	_	JJ	JJ	_	5	amod	_	_
5	factor	_	NN	NN	_	9	nsubj	_	_
7	PAF	_	NNP	NNP	_	5	appos	_	_
9	mediates	_	VBZ	VBZ	_	2	ccomp	_	_
10	endotoxin-induced	_	JJ	JJ	_	11	amod	_	_
11	systemic	_	JJ	JJ	_	9	dobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	pulmonary	_	JJ	JJ	_	15	amod	_	_
14	vascular	_	NN	NN	_	15	compound	_	_
15	derangements	_	NNS	NNS	_	11	conj	_	_
16	by	_	IN	IN	_	17	mark	_	_
17	studying	_	VBG	VBG	_	9	advcl	_	_
18	the	_	DT	DT	_	19	det	_	_
19	effects	_	NNS	NNS	_	17	dobj	_	_
20	of	_	IN	IN	_	25	case	_	_
21	a	_	DT	DT	_	25	det	_	_
22	selective	_	JJ	JJ	_	25	amod	_	_
23	PAF	_	NNP	NNP	_	25	compound	_	_
24	receptor	_	NN	NN	_	25	compound	_	_
25	antagonist	_	NN	NN	_	19	nmod	_	_
27	SRI	_	NNP	NNP	_	25	appos	_	_
28	63-441	_	CD	CD	_	27	nummod	_	_
30	during	_	IN	IN	_	31	case	_	_
31	endotoxemia	_	NN	NN	_	17	nmod	_	_
32	in	_	IN	IN	_	33	case	_	_
33	sheep	_	NN	NN	_	31	nmod	_	_

(())
1	Arterial	_	NNP	NNP	_	2	compound	_	_
2	PO2	_	NNP	NNP	_	6	nsubj	_	_
4	PaO2	_	NNP	NNP	_	2	appos	_	_
6	decreased	_	VBD	VBD	_	0	root	_	_
7	from	_	IN	IN	_	10	case	_	_
8	341	_	CD	CD	_	9	compound	_	_
9	+	_	CD	CD	_	10	nummod	_	_
10	/	_	NNS	NNS	_	6	nmod	_	_
12	79	_	CD	CD	_	14	compound	_	_
13	to	_	TO	TO	_	14	dep	_	_
14	198	_	CD	CD	_	15	nummod	_	_
15	+	_	NNS	NNS	_	10	dep	_	_
18	97	_	CD	CD	_	10	dep	_	_
20	P	_	NNP	NNP	_	18	appos	_	_
21	less	_	JJR	JJR	_	23	advmod	_	_
22	than	_	IN	IN	_	21	mwe	_	_
23	0.01	_	CD	CD	_	20	nummod	_	_
25	and	_	CC	CC	_	18	cc	_	_
26	202	_	CD	CD	_	27	compound	_	_
27	+	_	CD	CD	_	28	nummod	_	_
28	/	_	NNS	NNS	_	18	conj	_	_
30	161	_	NNP	NNP	_	31	compound	_	_
31	Torr	_	NNP	NNP	_	10	dep	_	_
32	at	_	IN	IN	_	33	amod	_	_
33	0.5	_	CD	CD	_	36	nummod	_	_
34	and	_	CC	CC	_	33	cc	_	_
35	5	_	CD	CD	_	33	conj	_	_
36	h	_	NN	NN	_	31	acl:relcl	_	_
38	respectively	_	RB	RB	_	36	advmod	_	_
40	inspired	_	VBN	VBN	_	10	dep	_	_
41	O2	_	NNP	NNP	_	42	compound	_	_
42	fraction	_	NN	NN	_	44	nsubj	_	_
43	=	_	SYM	SYM	_	44	dep	_	_
44	1.0	_	CD	CD	_	40	ccomp	_	_

1	SRI	_	NNP	NNP	_	5	dep	_	_
2	63-441	_	CD	CD	_	1	nummod	_	_
4	20	_	CD	CD	_	1	nummod	_	_
5	mg.kg-1	_	JJ	JJ	_	0	root	_	_

1	h-1	_	JJ	JJ	_	2	amod	_	_
2	infused	_	NNS	NNS	_	7	nsubj	_	_
3	for	_	IN	IN	_	5	case	_	_
4	5	_	CD	CD	_	5	nummod	_	_
5	h	_	NN	NN	_	7	nmod	_	_
7	blocked	_	VBD	VBD	_	0	root	_	_
8	the	_	DT	DT	_	10	det	_	_
9	early	_	JJ	JJ	_	10	amod	_	_
10	rise	_	NN	NN	_	7	dobj	_	_
11	in	_	IN	IN	_	12	case	_	_
12	Ppa	_	NNP	NNP	_	7	nmod	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	PVR	_	NNP	NNP	_	12	conj	_	_
15	and	_	CC	CC	_	7	cc	_	_
16	fall	_	VBP	VBP	_	7	conj	_	_
17	in	_	IN	IN	_	18	case	_	_
18	PaO2	_	NNS	NNS	_	16	nmod	_	_
20	but	_	CC	CC	_	7	cc	_	_
21	had	_	VBD	VBD	_	7	conj	_	_
22	no	_	DT	DT	_	23	neg	_	_
23	effect	_	NN	NN	_	21	dobj	_	_
24	on	_	IN	IN	_	28	case	_	_
25	the	_	DT	DT	_	28	det	_	_
26	late	_	JJ	JJ	_	28	amod	_	_
27	phase	_	NN	NN	_	28	compound	_	_
28	pulmonary_hypertension	_	NN	NN	_	23	nmod	_	_
29	or	_	CC	CC	_	28	cc	_	_
30	hypoxemia	_	NN	NN	_	28	conj	_	_

1	Endotoxin	_	NNP	NNP	_	2	nsubj	_	_
2	caused	_	VBD	VBD	_	0	root	_	_
3	a	_	DT	DT	_	5	det	_	_
4	gradual	_	JJ	JJ	_	5	amod	_	_
5	decrease	_	NN	NN	_	2	dobj	_	_
6	in	_	IN	IN	_	9	case	_	_
7	mean	_	JJ	JJ	_	9	amod	_	_
8	aortic	_	JJ	JJ	_	9	amod	_	_
9	pressure	_	NN	NN	_	2	nmod	_	_
11	which	_	WDT	WDT	_	13	nsubj	_	_
12	was	_	VBD	VBD	_	13	cop	_	_
13	unaffected	_	JJ	JJ	_	9	acl:relcl	_	_
14	by	_	IN	IN	_	15	case	_	_
15	SRI	_	NNP	NNP	_	13	nmod	_	_
16	63-441	_	CD	CD	_	15	nummod	_	_

1	Infusion	_	NNP	NNP	_	6	nsubj	_	_
2	of	_	IN	IN	_	3	case	_	_
3	SRI	_	NNP	NNP	_	1	nmod	_	_
4	63-441	_	CD	CD	_	3	nummod	_	_
5	alone	_	RB	RB	_	6	advmod	_	_
6	caused	_	VBD	VBD	_	0	root	_	_
7	no	_	DT	DT	_	9	neg	_	_
8	hemodynamic	_	JJ	JJ	_	9	amod	_	_
9	alterations	_	NNS	NNS	_	6	dobj	_	_

1	In	_	IN	IN	_	3	case	_	_
2	follow-up	_	NN	NN	_	3	compound	_	_
3	studies	_	NNS	NNS	_	6	nmod	_	_
5	endotoxin	_	NN	NN	_	6	nsubj	_	_
6	caused	_	VBD	VBD	_	0	root	_	_
7	an	_	DT	DT	_	8	det	_	_
8	increase	_	NN	NN	_	6	dobj	_	_
9	in	_	IN	IN	_	12	case	_	_
10	lung	_	NN	NN	_	12	compound	_	_
11	lymph	_	NN	NN	_	12	compound	_	_
12	flow	_	NN	NN	_	6	nmod	_	_
14	QL	_	NNP	NNP	_	12	appos	_	_
16	from	_	IN	IN	_	19	case	_	_
17	3.8	_	CD	CD	_	18	compound	_	_
18	+	_	CD	CD	_	19	nummod	_	_
19	/	_	NNS	NNS	_	12	nmod	_	_
21	1.1	_	CD	CD	_	23	compound	_	_
22	to	_	TO	TO	_	23	dep	_	_
23	14.1	_	CD	CD	_	24	nummod	_	_
24	+	_	NNS	NNS	_	19	dep	_	_
27	8.0	_	CD	CD	_	12	dep	_	_
29	P	_	NNP	NNP	_	27	appos	_	_
30	less	_	JJR	JJR	_	32	advmod	_	_
31	than	_	IN	IN	_	30	mwe	_	_
32	0.05	_	CD	CD	_	29	nummod	_	_
34	and	_	CC	CC	_	27	cc	_	_
35	12.7	_	CD	CD	_	36	compound	_	_
36	+	_	CD	CD	_	37	nummod	_	_
37	/	_	NNS	NNS	_	27	conj	_	_
39	8.6	_	CD	CD	_	42	nummod	_	_
40	ml/h	_	JJ	JJ	_	42	amod	_	_
41	_	_	JJ	JJ	_	42	amod	_	_
42	at_1	_	NNS	NNS	_	12	dep	_	_
43	and	_	CC	CC	_	42	cc	_	_
44	4	_	CD	CD	_	45	nummod	_	_
45	h	_	NN	NN	_	42	conj	_	_
47	respectively	_	RB	RB	_	12	advmod	_	_

1	SRI	_	NNP	NNP	_	2	compound	_	_
2	63-441	_	NNP	NNP	_	3	nsubj	_	_
3	abolished	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	early	_	JJ	JJ	_	3	dobj	_	_
6	and	_	CC	CC	_	3	cc	_	_
7	attenuated	_	VBD	VBD	_	3	conj	_	_
8	the	_	DT	DT	_	10	det	_	_
9	late	_	JJ	JJ	_	10	amod	_	_
10	increase	_	NN	NN	_	7	dobj	_	_
11	in	_	IN	IN	_	12	case	_	_
12	QL	_	NNP	NNP	_	7	nmod	_	_

2	ABSTRACT	_	NNP	NNP	_	4	compound	_	_
3	TRUNCATED	_	NNP	NNP	_	4	compound	_	_
4	AT	_	NNP	NNP	_	0	root	_	_
5	250	_	CD	CD	_	8	nummod	_	_
6	WORDS	_	NNP	NNP	_	8	compound	_	_
8	Reaction	_	NNP	NNP	_	4	dep	_	_
9	of	_	IN	IN	_	10	case	_	_
10	fibroblasts	_	NNS	NNS	_	8	nmod	_	_
11	to	_	TO	TO	_	15	case	_	_
12	various	_	JJ	JJ	_	15	amod	_	_
13	dental	_	JJ	JJ	_	15	amod	_	_
14	casting	_	NN	NN	_	15	compound	_	_
15	alloys	_	NNS	NNS	_	4	nmod	_	_

1	The	_	DT	DT	_	2	det	_	_
2	cytotoxicity	_	NN	NN	_	17	nsubjpass	_	_
3	of	_	IN	IN	_	5	case	_	_
4	a	_	DT	DT	_	5	det	_	_
5	series	_	NN	NN	_	2	nmod	_	_
6	of	_	IN	IN	_	9	case	_	_
7	dental	_	JJ	JJ	_	9	amod	_	_
8	casting	_	NN	NN	_	9	compound	_	_
9	alloys	_	NNS	NNS	_	5	nmod	_	_
10	in	_	IN	IN	_	15	case	_	_
11	the	_	DT	DT	_	15	det	_	_
12	as-cast	_	JJ	JJ	_	15	amod	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	polished	_	JJ	JJ	_	12	conj	_	_
15	condition	_	NN	NN	_	9	nmod	_	_
16	was	_	VBD	VBD	_	17	auxpass	_	_
17	determined	_	VBN	VBN	_	0	root	_	_
18	with	_	IN	IN	_	21	case	_	_
19	cell	_	NN	NN	_	21	compound	_	_
20	culture	_	NN	NN	_	21	compound	_	_
21	techniques	_	NNS	NNS	_	17	nmod	_	_
22	involving	_	VBG	VBG	_	21	acl	_	_
23	phase	_	NN	NN	_	24	compound	_	_
24	contrast	_	NN	NN	_	22	dobj	_	_
25	microscopy	_	RB	RB	_	22	advmod	_	_
26	to	_	TO	TO	_	27	mark	_	_
27	examine	_	VB	VB	_	22	advcl	_	_
28	cell	_	NN	NN	_	29	compound	_	_
29	morphology	_	NN	NN	_	27	dobj	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	the	_	DT	DT	_	35	det	_	_
32	succinic	_	JJ	JJ	_	35	amod	_	_
33	dehydrogenase	_	JJ	JJ	_	35	amod	_	_
34	histochemical	_	NN	NN	_	35	compound	_	_
35	reaction	_	NN	NN	_	29	conj	_	_
36	to	_	TO	TO	_	37	mark	_	_
37	measure	_	VB	VB	_	27	xcomp	_	_
38	any	_	DT	DT	_	39	det	_	_
39	ring	_	NN	NN	_	37	dobj	_	_
40	of	_	IN	IN	_	41	case	_	_
41	inhibition	_	NN	NN	_	39	nmod	_	_
42	of	_	IN	IN	_	46	case	_	_
43	Balb/c	_	JJ	JJ	_	46	amod	_	_
44	3T3	_	CD	CD	_	46	nummod	_	_
45	cellular	_	JJ	JJ	_	46	amod	_	_
46	respiration	_	NNS	NNS	_	41	nmod	_	_
47	around	_	IN	IN	_	48	case	_	_
48	alloys	_	NNS	NNS	_	46	nmod	_	_

1	Crown	_	NNP	NNP	_	15	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	bridge	_	JJ	JJ	_	5	amod	_	_
4	casting	_	VBG	VBG	_	5	amod	_	_
5	alloys	_	NNS	NNS	_	1	conj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	a	_	DT	DT	_	8	det	_	_
8	nickel	_	NN	NN	_	5	conj	_	_
10	and	_	CC	CC	_	5	cc	_	_
11	a	_	DT	DT	_	13	det	_	_
12	cobalt-base	_	JJ	JJ	_	13	amod	_	_
13	alloy	_	NN	NN	_	5	conj	_	_
14	were	_	VBD	VBD	_	15	cop	_	_
15	biocompatible	_	JJ	JJ	_	0	root	_	_
16	in	_	IN	IN	_	19	case	_	_
17	the	_	DT	DT	_	19	det	_	_
18	polished	_	JJ	JJ	_	19	amod	_	_
19	condition	_	NN	NN	_	15	nmod	_	_
21	but	_	CC	CC	_	15	cc	_	_
22	less	_	JJR	JJR	_	15	conj	_	_
23	so	_	RB	RB	_	15	advmod	_	_
24	in	_	IN	IN	_	27	case	_	_
25	the	_	DT	DT	_	27	det	_	_
26	as-cast	_	JJ	JJ	_	27	amod	_	_
27	condition	_	NN	NN	_	23	nmod	_	_

1	The	_	DT	DT	_	4	det	_	_
2	only	_	JJ	JJ	_	4	amod	_	_
3	two	_	CD	CD	_	4	nummod	_	_
4	exceptions	_	NNS	NNS	_	6	nsubj	_	_
5	were	_	VBD	VBD	_	6	aux	_	_
6	casting	_	VBG	VBG	_	0	root	_	_
7	alloys	_	NNS	NNS	_	6	dobj	_	_
8	containing	_	VBG	VBG	_	6	advcl	_	_
9	50-60	_	CD	CD	_	11	nummod	_	_
10	wt	_	CD	CD	_	11	nummod	_	_
11	%	_	NN	NN	_	8	dobj	_	_
12	Cu	_	VBN	VBN	_	11	acl	_	_

1	Porcelain-fused-to-metal	_	NNP	NNP	_	2	compound	_	_
2	alloys	_	NNS	NNS	_	4	nsubj	_	_
3	were	_	VBD	VBD	_	4	cop	_	_
4	biocompatible	_	JJ	JJ	_	0	root	_	_
5	in	_	IN	IN	_	8	case	_	_
6	either	_	CC	CC	_	8	cc:preconj	_	_
7	the	_	DT	DT	_	8	det	_	_
8	as-cast	_	JJ	JJ	_	4	nmod	_	_
9	or	_	CC	CC	_	8	cc	_	_
10	polished	_	JJ	JJ	_	11	amod	_	_
11	condition	_	NN	NN	_	8	conj	_	_

1	This	_	DT	DT	_	4	det	_	_
2	direct	_	JJ	JJ	_	4	amod	_	_
3	contact	_	NN	NN	_	4	compound	_	_
4	method	_	NN	NN	_	5	nsubj	_	_
5	appeared	_	VBD	VBD	_	0	root	_	_
6	satisfactory	_	JJ	JJ	_	5	xcomp	_	_
7	for	_	IN	IN	_	8	mark	_	_
8	evaluating	_	VBG	VBG	_	5	advcl	_	_
9	biocompatibility	_	NN	NN	_	8	dobj	_	_
10	of	_	IN	IN	_	13	case	_	_
11	dental	_	JJ	JJ	_	13	amod	_	_
12	casting	_	NN	NN	_	13	compound	_	_
13	alloys	_	NNS	NNS	_	9	nmod	_	_
15	especially	_	RB	RB	_	21	advmod	_	_
16	since	_	IN	IN	_	21	mark	_	_
17	these	_	DT	DT	_	18	det	_	_
18	materials	_	NNS	NNS	_	21	nsubj	_	_
19	are	_	VBP	VBP	_	21	cop	_	_
20	in	_	IN	IN	_	21	case	_	_
21	contact	_	NN	NN	_	5	advcl	_	_
22	with	_	IN	IN	_	24	case	_	_
23	gingival	_	JJ	JJ	_	24	amod	_	_
24	tissues	_	NNS	NNS	_	21	nmod	_	_

1	Vitamins	_	VBZ	VBZ	_	0	root	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	coenzymes	_	VBZ	VBZ	_	1	conj	_	_

1	Part	_	NNP	NNP	_	3	compound	_	_
2	H.	_	NNP	NNP	_	3	compound	_	_
3	Clinical	_	NNP	NNP	_	4	nsubj	_	_
4	pharmacokinetics	_	VBZ	VBZ	_	0	root	_	_
5	of	_	IN	IN	_	9	case	_	_
6	a	_	DT	DT	_	9	det	_	_
7	new	_	JJ	JJ	_	9	amod	_	_
8	antiandrogen	_	NN	NN	_	9	compound	_	_
9	Anandron	_	NN	NN	_	4	nmod	_	_
11	RU_23908	_	NNP	NNP	_	9	appos	_	_

1	-LSB-	_	CD	CD	_	2	compound	_	_
2	1	_	CD	CD	_	3	nummod	_	_
3	years	_	NNS	NNS	_	5	nmod:poss	_	_
4	'	_	POS	POS	_	3	case	_	_
5	experience	_	NN	NN	_	0	root	_	_
6	with	_	IN	IN	_	7	case	_	_
7	Novopen	_	NNP	NNP	_	5	nmod	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	Insuject	_	NNP	NNP	_	7	conj	_	_
11	a	_	DT	DT	_	12	det	_	_
12	survey	_	NN	NN	_	5	dep	_	_
13	of	_	IN	IN	_	17	case	_	_
14	50	_	CD	CD	_	17	nummod	_	_
15	insulin-dependent	_	JJ	JJ	_	17	amod	_	_
16	diabetic	_	JJ	JJ	_	17	amod	_	_
17	patients	_	NNS	NNS	_	12	nmod	_	_
18	-RSB-	_	VBN	VBN	_	17	acl	_	_

1	Precision	_	JJ	JJ	_	4	amod	_	_
2	cut	_	NN	NN	_	4	compound	_	_
3	tissue	_	NN	NN	_	4	compound	_	_
4	slices	_	NNS	NNS	_	0	root	_	_
5	in	_	IN	IN	_	6	case	_	_
6	culture	_	NN	NN	_	4	nmod	_	_
8	a	_	DT	DT	_	10	det	_	_
9	new	_	JJ	JJ	_	10	amod	_	_
10	tool	_	NN	NN	_	4	dep	_	_
11	in	_	IN	IN	_	12	case	_	_
12	pharmacology	_	NN	NN	_	10	nmod	_	_

1	Changes	_	NNS	NNS	_	6	nsubj	_	_
2	in	_	IN	IN	_	5	case	_	_
3	guinea_pig	_	VBG	VBG	_	5	amod	_	_
4	lung	_	NN	NN	_	5	compound	_	_
5	beta-adrenoceptor	_	NN	NN	_	1	nmod	_	_
6	function	_	VBP	VBP	_	0	root	_	_
7	by	_	IN	IN	_	8	case	_	_
8	Haemophilus_influenzae	_	NNP	NNP	_	6	nmod	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	its	_	PRP$	PRP$	_	11	nmod:poss	_	_
11	mediation	_	NN	NN	_	8	conj	_	_
12	by	_	IN	IN	_	16	case	_	_
13	specifically	_	RB	RB	_	14	advmod	_	_
14	stimulated	_	VBN	VBN	_	16	amod	_	_
15	pulmonary	_	JJ	JJ	_	16	amod	_	_
16	macrophages	_	NNS	NNS	_	6	nmod	_	_

1	-LSB-	_	NNP	NNP	_	2	compound	_	_
2	Composition	_	NNP	NNP	_	10	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	properties	_	NNS	NNS	_	2	conj	_	_
5	of	_	IN	IN	_	9	case	_	_
6	heparin	_	NN	NN	_	9	compound	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	protamine	_	NN	NN	_	6	conj	_	_
9	complexes	_	NNS	NNS	_	4	nmod	_	_
10	formed	_	VBD	VBD	_	0	root	_	_
11	in	_	IN	IN	_	14	case	_	_
12	the	_	DT	DT	_	14	det	_	_
13	plasma	_	NN	NN	_	14	compound	_	_
14	-RSB-	_	NN	NN	_	10	nmod	_	_

1	Nerve	_	JJ	JJ	_	3	amod	_	_
2	growth	_	NN	NN	_	3	compound	_	_
3	factor	_	NN	NN	_	5	nsubj	_	_
4	rapidly	_	RB	RB	_	5	advmod	_	_
5	stimulates	_	VBZ	VBZ	_	0	root	_	_
6	arachidonate	_	JJ	JJ	_	7	amod	_	_
7	metabolism	_	NN	NN	_	5	dobj	_	_
8	in	_	IN	IN	_	10	case	_	_
9	PC12	_	CD	CD	_	10	nummod	_	_
10	cells	_	NNS	NNS	_	5	nmod	_	_
12	potential	_	JJ	JJ	_	13	amod	_	_
13	involvement	_	NN	NN	_	5	parataxis	_	_
14	in	_	IN	IN	_	17	case	_	_
15	nerve	_	NN	NN	_	17	compound	_	_
16	fiber	_	NN	NN	_	17	compound	_	_
17	growth	_	NN	NN	_	13	nmod	_	_

1	Homogenates	_	NNS	NNS	_	23	nsubj	_	_
2	prepared	_	VBN	VBN	_	1	acl	_	_
3	from	_	IN	IN	_	8	case	_	_
4	pheochromocytoma	_	JJ	JJ	_	8	amod	_	_
6	PC12	_	NNP	NNP	_	8	appos	_	_
8	cells	_	NNS	NNS	_	2	nmod	_	_
9	that	_	WDT	WDT	_	11	nsubj	_	_
10	are	_	VBP	VBP	_	11	aux	_	_
11	extending	_	VBG	VBG	_	1	acl:relcl	_	_
12	nerve	_	NN	NN	_	13	compound	_	_
13	fibers	_	NNS	NNS	_	11	dobj	_	_
14	in	_	IN	IN	_	15	case	_	_
15	response	_	NN	NN	_	13	nmod	_	_
16	to	_	TO	TO	_	19	case	_	_
17	nerve	_	NN	NN	_	19	compound	_	_
18	growth	_	NN	NN	_	19	compound	_	_
19	factor	_	NN	NN	_	11	nmod	_	_
21	NGF	_	NNP	NNP	_	1	appos	_	_
23	have	_	VBP	VBP	_	0	root	_	_
24	an	_	DT	DT	_	26	det	_	_
25	increased	_	JJ	JJ	_	26	amod	_	_
26	capacity	_	NN	NN	_	23	dobj	_	_
27	to	_	TO	TO	_	28	mark	_	_
28	metabolize	_	VB	VB	_	26	acl	_	_
29	exogenous	_	JJ	JJ	_	30	amod	_	_
30	arachidonate	_	NN	NN	_	28	dobj	_	_
31	compared	_	VBN	VBN	_	33	case	_	_
32	with	_	IN	IN	_	33	case	_	_
33	homogenates	_	NNS	NNS	_	28	advcl	_	_
34	prepared	_	VBN	VBN	_	33	acl	_	_
35	from	_	IN	IN	_	36	case	_	_
36	cells	_	NNS	NNS	_	34	nmod	_	_
37	untreated	_	JJ	JJ	_	36	amod	_	_
38	with	_	IN	IN	_	39	case	_	_
39	NGF	_	NNP	NNP	_	37	nmod	_	_

1	These	_	DT	DT	_	2	det	_	_
2	changes	_	NNS	NNS	_	6	nsubj	_	_
3	are	_	VBP	VBP	_	6	cop	_	_
4	not	_	RB	RB	_	6	neg	_	_
5	a	_	DT	DT	_	6	det	_	_
6	consequence	_	NN	NN	_	0	root	_	_
7	of	_	IN	IN	_	9	case	_	_
8	cell	_	NN	NN	_	9	compound	_	_
9	attachment	_	NN	NN	_	6	nmod	_	_
11	since	_	IN	IN	_	15	mark	_	_
12	they	_	PRP	PRP	_	15	nsubjpass	_	_
13	are	_	VBP	VBP	_	15	auxpass	_	_
14	also	_	RB	RB	_	15	advmod	_	_
15	seen	_	VBN	VBN	_	6	advcl	_	_
16	in	_	IN	IN	_	19	case	_	_
17	NGF-treated	_	JJ	JJ	_	19	amod	_	_
18	PC12	_	NN	NN	_	19	compound	_	_
19	cells	_	NNS	NNS	_	15	nmod	_	_
20	grown	_	VBN	VBN	_	19	acl	_	_
21	in	_	IN	IN	_	22	case	_	_
22	suspension	_	NN	NN	_	20	nmod	_	_
23	and	_	CC	CC	_	15	cc	_	_
24	are	_	VBP	VBP	_	26	auxpass	_	_
25	not	_	RB	RB	_	26	neg	_	_
26	found	_	VBN	VBN	_	15	conj	_	_
27	in	_	IN	IN	_	29	case	_	_
28	attached	_	JJ	JJ	_	29	amod	_	_
29	cells	_	NNS	NNS	_	26	nmod	_	_
30	grown	_	VBN	VBN	_	29	acl	_	_
31	in	_	IN	IN	_	33	case	_	_
32	the	_	DT	DT	_	33	det	_	_
33	absence	_	NN	NN	_	30	nmod	_	_
34	of	_	IN	IN	_	35	case	_	_
35	NGF	_	NNP	NNP	_	33	nmod	_	_

1	This	_	DT	DT	_	3	det	_	_
2	NGF-stimulated	_	JJ	JJ	_	3	amod	_	_
3	increase	_	NN	NN	_	8	nsubj	_	_
4	in	_	IN	IN	_	7	case	_	_
5	arachidonate	_	JJ	JJ	_	7	amod	_	_
6	metabolic	_	JJ	JJ	_	7	amod	_	_
7	capacity	_	NN	NN	_	3	nmod	_	_
8	occurs	_	VBZ	VBZ	_	0	root	_	_
9	rapidly	_	RB	RB	_	10	advmod	_	_
10	and	_	CC	CC	_	8	advmod	_	_
11	before	_	IN	IN	_	13	case	_	_
12	the	_	DT	DT	_	13	det	_	_
13	extension	_	NN	NN	_	10	conj	_	_
14	of	_	IN	IN	_	16	case	_	_
15	nerve	_	NN	NN	_	16	compound	_	_
16	fibers	_	NNS	NNS	_	13	nmod	_	_

1	In	_	IN	IN	_	2	case	_	_
2	contrast	_	NN	NN	_	11	nmod	_	_
3	to	_	TO	TO	_	4	case	_	_
4	NGF	_	NNP	NNP	_	2	nmod	_	_
6	epidermal	_	JJ	JJ	_	8	amod	_	_
7	growth	_	NN	NN	_	8	compound	_	_
8	factor	_	NN	NN	_	11	nsubj	_	_
9	does	_	VBZ	VBZ	_	11	aux	_	_
10	not	_	RB	RB	_	11	neg	_	_
11	alter	_	VB	VB	_	0	root	_	_
12	the	_	DT	DT	_	13	det	_	_
13	metabolism	_	NN	NN	_	11	dobj	_	_
14	of	_	IN	IN	_	16	case	_	_
15	exogenous	_	JJ	JJ	_	16	amod	_	_
16	arachidonate	_	NN	NN	_	13	nmod	_	_
17	by	_	IN	IN	_	19	case	_	_
18	PC12	_	CD	CD	_	19	nummod	_	_
19	cells	_	NNS	NNS	_	11	nmod	_	_

1	Radioimmunoassay	_	NNP	NNP	_	7	nsubj	_	_
2	of	_	IN	IN	_	3	case	_	_
3	medium	_	NN	NN	_	1	nmod	_	_
4	from	_	IN	IN	_	6	case	_	_
5	PC12	_	CD	CD	_	6	nummod	_	_
6	cultures	_	NNS	NNS	_	3	nmod	_	_
7	indicates	_	VBZ	VBZ	_	0	root	_	_
8	that	_	IN	IN	_	11	mark	_	_
9	intact	_	JJ	JJ	_	10	amod	_	_
10	cells	_	NNS	NNS	_	11	nsubj	_	_
11	produce	_	VBP	VBP	_	7	ccomp	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	release	_	VBP	VBP	_	11	conj	_	_
14	increased	_	VBN	VBN	_	15	amod	_	_
15	amounts	_	NNS	NNS	_	11	dobj	_	_
16	of	_	IN	IN	_	17	case	_	_
17	prostaglandin	_	NN	NN	_	15	nmod	_	_
19	PGE	_	NNP	NNP	_	17	appos	_	_
21	in	_	IN	IN	_	22	case	_	_
22	response	_	NN	NN	_	17	nmod	_	_
23	to	_	TO	TO	_	24	mark	_	_
24	NGF	_	VB	VB	_	11	advcl	_	_

1	Drugs	_	NNS	NNS	_	14	nsubj	_	_
2	that	_	WDT	WDT	_	3	nsubj	_	_
3	inhibit	_	VBP	VBP	_	1	acl:relcl	_	_
4	arachidonate	_	JJ	JJ	_	5	amod	_	_
5	liberation	_	NN	NN	_	3	dobj	_	_
6	from	_	IN	IN	_	8	case	_	_
7	membrane	_	JJ	JJ	_	8	amod	_	_
8	phospholipids	_	NNS	NNS	_	3	nmod	_	_
10	mepacrine	_	JJ	JJ	_	1	dep	_	_
11	or	_	CC	CC	_	10	cc	_	_
12	4-bromphenacyl_bromide	_	JJ	JJ	_	10	conj	_	_
14	block	_	VB	VB	_	0	root	_	_
15	NGF-stimulated	_	JJ	JJ	_	18	amod	_	_
16	nerve	_	NN	NN	_	18	compound	_	_
17	fiber	_	NN	NN	_	18	compound	_	_
18	growth	_	NN	NN	_	14	dobj	_	_
19	by	_	IN	IN	_	21	case	_	_
20	PC12	_	CD	CD	_	21	nummod	_	_
21	cells	_	NNS	NNS	_	14	nmod	_	_

1	Selective	_	JJ	JJ	_	2	amod	_	_
2	inhibitors	_	NNS	NNS	_	13	nsubj	_	_
3	of	_	IN	IN	_	5	case	_	_
4	cyclooxygenase	_	JJ	JJ	_	5	amod	_	_
5	metabolism	_	NN	NN	_	2	nmod	_	_
6	of	_	IN	IN	_	7	case	_	_
7	arachidonate	_	NN	NN	_	5	nmod	_	_
9	indomethacin	_	NN	NN	_	7	dep	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	aspirin	_	NN	NN	_	9	conj	_	_
13	fail	_	VBP	VBP	_	0	root	_	_
14	to	_	TO	TO	_	15	mark	_	_
15	block	_	VB	VB	_	13	xcomp	_	_
16	growth	_	NN	NN	_	15	dobj	_	_
18	but	_	CC	CC	_	13	cc	_	_
19	inhibitors	_	NNS	NNS	_	33	nsubj	_	_
20	of	_	IN	IN	_	22	case	_	_
21	lipoxygenase	_	JJ	JJ	_	22	amod	_	_
22	metabolism	_	NN	NN	_	19	nmod	_	_
24	baicalein	_	NN	NN	_	22	dep	_	_
26	BW755	_	NNP	NNP	_	24	conj	_	_
28	and	_	CC	CC	_	24	cc	_	_
29	eicosatetraynoic_acid	_	NN	NN	_	24	conj	_	_
31	are	_	VBP	VBP	_	33	cop	_	_
32	potent	_	JJ	JJ	_	33	amod	_	_
33	blockers	_	NNS	NNS	_	13	conj	_	_

1	In	_	IN	IN	_	2	case	_	_
2	cultures	_	NNS	NNS	_	30	nmod	_	_
3	of	_	IN	IN	_	7	case	_	_
4	dorsal	_	JJ	JJ	_	7	amod	_	_
5	root	_	NN	NN	_	7	compound	_	_
6	ganglion	_	NN	NN	_	7	compound	_	_
7	neurons	_	NNS	NNS	_	2	nmod	_	_
9	inhibitors	_	NNS	NNS	_	30	nsubj	_	_
10	of	_	IN	IN	_	12	case	_	_
11	arachidonate	_	JJ	JJ	_	12	amod	_	_
12	release	_	NN	NN	_	9	nmod	_	_
14	mepacrine	_	JJ	JJ	_	16	amod	_	_
16	4-bromphenacyl_bromide	_	JJ	JJ	_	12	dep	_	_
18	or	_	CC	CC	_	12	cc	_	_
19	its	_	PRP$	PRP$	_	21	nmod:poss	_	_
20	subsequent	_	JJ	JJ	_	21	amod	_	_
21	metabolism	_	NN	NN	_	12	conj	_	_
22	by	_	IN	IN	_	23	case	_	_
23	lipoxygenases	_	NNS	NNS	_	21	nmod	_	_
25	nordihydroquaiaretic_acid	_	JJ	JJ	_	27	amod	_	_
27	eicosatetraynoic_acid	_	JJ	JJ	_	9	dep	_	_
29	also	_	RB	RB	_	30	advmod	_	_
30	prevent	_	VB	VB	_	0	root	_	_
31	the	_	DT	DT	_	34	det	_	_
32	early	_	JJ	JJ	_	34	amod	_	_
33	morphological	_	JJ	JJ	_	34	amod	_	_
34	events	_	NNS	NNS	_	30	dobj	_	_
35	of	_	IN	IN	_	38	case	_	_
36	nerve	_	NN	NN	_	38	compound	_	_
37	fiber	_	NN	NN	_	38	compound	_	_
38	growth	_	NN	NN	_	34	nmod	_	_

1	Our	_	PRP$	PRP$	_	2	nmod:poss	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	NGF	_	NNP	NNP	_	9	nsubj	_	_
6	rapidly	_	RB	RB	_	9	advmod	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	specifically	_	RB	RB	_	6	conj	_	_
9	increases	_	VBZ	VBZ	_	3	ccomp	_	_
10	the	_	DT	DT	_	11	det	_	_
11	capacity	_	NN	NN	_	9	dobj	_	_
12	of	_	IN	IN	_	14	case	_	_
13	PC12	_	CD	CD	_	14	nummod	_	_
14	cells	_	NNS	NNS	_	11	nmod	_	_
15	to	_	TO	TO	_	16	mark	_	_
16	synthesize	_	VB	VB	_	11	acl	_	_
17	arachidonate	_	JJ	JJ	_	18	amod	_	_
18	metabolites	_	NNS	NNS	_	16	dobj	_	_
20	and	_	CC	CC	_	9	cc	_	_
21	that	_	IN	IN	_	26	mark	_	_
22	arachidonate	_	JJ	JJ	_	23	amod	_	_
23	metabolism	_	NN	NN	_	26	nsubj	_	_
24	may	_	MD	MD	_	26	aux	_	_
25	be	_	VB	VB	_	26	cop	_	_
26	important	_	JJ	JJ	_	9	conj	_	_
27	in	_	IN	IN	_	30	case	_	_
28	nerve	_	NN	NN	_	30	compound	_	_
29	fiber	_	NN	NN	_	30	compound	_	_
30	growth	_	NN	NN	_	26	nmod	_	_
31	by	_	IN	IN	_	34	case	_	_
32	both	_	DT	DT	_	34	det	_	_
33	PC12	_	CD	CD	_	34	nummod	_	_
34	cells	_	NNS	NNS	_	26	nmod	_	_
35	and	_	CC	CC	_	34	cc	_	_
36	dorsal	_	JJ	JJ	_	39	amod	_	_
37	root	_	NN	NN	_	39	compound	_	_
38	ganglion	_	NN	NN	_	39	compound	_	_
39	neurons	_	NNS	NNS	_	34	conj	_	_

1	The	_	DT	DT	_	3	det	_	_
2	receptor	_	NN	NN	_	3	compound	_	_
3	model	_	NN	NN	_	0	root	_	_
4	for	_	IN	IN	_	5	case	_	_
5	transport	_	NN	NN	_	3	nmod	_	_
6	of	_	IN	IN	_	7	case	_	_
7	cholesterol	_	NN	NN	_	3	nmod	_	_
8	in	_	IN	IN	_	9	case	_	_
9	plasma	_	NN	NN	_	3	nmod	_	_

1	Number	_	NNP	NNP	_	0	root	_	_
2	of	_	IN	IN	_	3	case	_	_
3	comorbidities	_	NNS	NNS	_	1	nmod	_	_
4	as	_	IN	IN	_	6	case	_	_
5	a	_	DT	DT	_	6	det	_	_
6	predictor	_	NN	NN	_	3	nmod	_	_
7	of	_	IN	IN	_	8	case	_	_
8	nosocomial_infection_acquisition	_	NN	NN	_	1	nmod	_	_

1	Infection	_	NNP	NNP	_	3	compound	_	_
2	control	_	NN	NN	_	3	compound	_	_
3	programs	_	NNS	NNS	_	6	nsubjpass	_	_
4	are	_	VBP	VBP	_	6	auxpass	_	_
5	primarily	_	RB	RB	_	6	advmod	_	_
6	oriented	_	VBN	VBN	_	0	root	_	_
7	toward	_	IN	IN	_	8	mark	_	_
8	chronicling	_	VBG	VBG	_	6	advcl	_	_
9	the	_	DT	DT	_	10	det	_	_
10	incidence	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	12	case	_	_
12	nosocomial_infections	_	NNS	NNS	_	10	nmod	_	_
14	NI	_	NNP	NNP	_	12	appos	_	_

1	Intervention	_	NN	NN	_	2	compound	_	_
2	programs	_	NNS	NNS	_	9	nsubjpass	_	_
3	oriented	_	VBN	VBN	_	2	amod	_	_
4	toward	_	IN	IN	_	5	mark	_	_
5	preventing	_	VBG	VBG	_	3	advcl	_	_
6	infection	_	NN	NN	_	5	dobj	_	_
7	would	_	MD	MD	_	9	aux	_	_
8	be	_	VB	VB	_	9	auxpass	_	_
9	facilitated	_	VBN	VBN	_	0	root	_	_
10	by	_	IN	IN	_	11	mark	_	_
11	identifying	_	VBG	VBG	_	9	advcl	_	_
12	patients	_	NNS	NNS	_	11	dobj	_	_
13	at	_	IN	IN	_	15	case	_	_
14	greatest	_	JJS	JJS	_	15	amod	_	_
15	risk	_	NN	NN	_	11	nmod	_	_
16	of	_	IN	IN	_	18	case	_	_
17	NI	_	NNP	NNP	_	18	compound	_	_
18	acquisition	_	NN	NN	_	15	nmod	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	studied	_	VBD	VBD	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	number	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	6	case	_	_
6	comorbidities	_	NNS	NNS	_	4	nmod	_	_
7	as	_	IN	IN	_	10	case	_	_
8	a	_	DT	DT	_	10	det	_	_
9	risk	_	NN	NN	_	10	compound	_	_
10	predictor	_	NN	NN	_	6	nmod	_	_
11	for	_	IN	IN	_	12	case	_	_
12	NIs	_	NNP	NNP	_	10	nmod	_	_
13	in	_	IN	IN	_	14	case	_	_
14	patients	_	NNS	NNS	_	2	nmod	_	_
15	admitted	_	VBN	VBN	_	14	acl	_	_
16	to	_	TO	TO	_	21	case	_	_
17	the	_	DT	DT	_	21	det	_	_
18	medical	_	JJ	JJ	_	21	amod	_	_
19	intensive	_	JJ	JJ	_	21	amod	_	_
20	care	_	NN	NN	_	21	compound	_	_
21	unit	_	NN	NN	_	15	nmod	_	_
23	ICU	_	NNP	NNP	_	21	appos	_	_
25	for	_	IN	IN	_	29	case	_	_
26	three	_	CD	CD	_	29	nummod	_	_
27	or	_	CC	CC	_	26	cc	_	_
28	more	_	JJR	JJR	_	26	conj	_	_
29	days	_	NNS	NNS	_	21	nmod	_	_

1	In	_	IN	IN	_	3	case	_	_
2	148	_	CD	CD	_	3	nummod	_	_
3	patients	_	NNS	NNS	_	6	nmod	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	found	_	VBD	VBD	_	0	root	_	_
7	by	_	IN	IN	_	9	case	_	_
8	regression	_	NN	NN	_	9	compound	_	_
9	analysis	_	NN	NN	_	6	nmod	_	_
10	that	_	IN	IN	_	15	mark	_	_
11	the	_	DT	DT	_	12	det	_	_
12	number	_	NN	NN	_	15	nsubj	_	_
13	of	_	IN	IN	_	14	case	_	_
14	comorbidities	_	NNS	NNS	_	12	nmod	_	_
15	varied	_	VBD	VBD	_	6	ccomp	_	_
16	directly	_	RB	RB	_	15	advmod	_	_
17	with	_	IN	IN	_	19	case	_	_
18	the	_	DT	DT	_	19	det	_	_
19	development	_	NN	NN	_	15	nmod	_	_
20	of	_	IN	IN	_	21	case	_	_
21	nosocomial_infections	_	NNS	NNS	_	19	nmod	_	_
23	as	_	RB	RB	_	19	cc	_	_
24	well	_	RB	RB	_	23	mwe	_	_
25	as	_	IN	IN	_	23	mwe	_	_
26	with	_	IN	IN	_	28	case	_	_
27	the	_	DT	DT	_	28	det	_	_
28	appearance	_	NN	NN	_	19	conj	_	_
29	of	_	IN	IN	_	31	case	_	_
30	new	_	JJ	JJ	_	31	amod	_	_
31	complications	_	NNS	NNS	_	28	nmod	_	_
32	and	_	CC	CC	_	28	cc	_	_
33	length	_	NN	NN	_	28	conj	_	_
34	of	_	IN	IN	_	36	case	_	_
35	ICU	_	NNP	NNP	_	36	compound	_	_
36	stay	_	NN	NN	_	33	nmod	_	_

1	Diagnosis-related	_	JJ	JJ	_	2	amod	_	_
2	groups	_	NNS	NNS	_	6	nsubj	_	_
3	did	_	VBD	VBD	_	6	aux	_	_
4	not	_	RB	RB	_	6	neg	_	_
5	adequately	_	RB	RB	_	6	advmod	_	_
6	account	_	NN	NN	_	0	root	_	_
7	for	_	IN	IN	_	9	case	_	_
8	the	_	DT	DT	_	9	det	_	_
9	variance	_	NN	NN	_	6	nmod	_	_
10	in	_	IN	IN	_	11	case	_	_
11	comorbidities	_	NNS	NNS	_	9	nmod	_	_
12	observed	_	VBN	VBN	_	11	acl	_	_

1	Infection	_	NNP	NNP	_	2	nsubj	_	_
2	control	_	VBP	VBP	_	0	root	_	_
3	practices	_	NNS	NNS	_	2	dobj	_	_
4	for	_	IN	IN	_	5	mark	_	_
5	preventing	_	VBG	VBG	_	2	advcl	_	_
6	respiratory_syncytial_virus_infections	_	NNS	NNS	_	5	dobj	_	_

1	Amyloidosis	_	NNS	NNS	_	0	root	_	_
2	in	_	IN	IN	_	6	case	_	_
3	Beh	_	NNP	NNP	_	4	compound	_	_
4	et	_	NNP	NNP	_	6	nmod:poss	_	_
5	's	_	POS	POS	_	4	case	_	_
6	disease	_	NN	NN	_	1	nmod	_	_

1	Evaluation	_	NNP	NNP	_	11	nsubj	_	_
2	of	_	IN	IN	_	4	case	_	_
3	the	_	DT	DT	_	4	det	_	_
4	variety	_	NN	NN	_	1	nmod	_	_
5	of	_	IN	IN	_	7	case	_	_
6	plasmid	_	JJ	JJ	_	7	amod	_	_
7	profiles	_	NNS	NNS	_	4	nmod	_	_
8	in	_	IN	IN	_	10	case	_	_
9	S	_	NNP	NNP	_	10	compound	_	_
10	epidermidis	_	NNS	NNS	_	7	nmod	_	_
11	isolates	_	VBZ	VBZ	_	0	root	_	_
12	from	_	IN	IN	_	14	case	_	_
13	hospital	_	NN	NN	_	14	compound	_	_
14	patients	_	NNS	NNS	_	11	nmod	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	staff	_	NN	NN	_	14	conj	_	_

1	Plasmid	_	JJ	JJ	_	2	amod	_	_
2	profiling	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	used	_	VBN	VBN	_	0	root	_	_
5	to	_	TO	TO	_	6	mark	_	_
6	determine	_	VB	VB	_	4	xcomp	_	_
7	the	_	DT	DT	_	8	det	_	_
8	variability	_	NN	NN	_	12	nsubj	_	_
9	of	_	IN	IN	_	11	case	_	_
10	normal	_	JJ	JJ	_	11	amod	_	_
11	flora	_	NNS	NNS	_	8	nmod	_	_
12	isolates	_	VBZ	VBZ	_	6	ccomp	_	_
13	of	_	IN	IN	_	14	case	_	_
14	Staphylococcus_epidermidis	_	NNP	NNP	_	12	nmod	_	_
15	in	_	IN	IN	_	18	mark	_	_
16	order	_	NN	NN	_	15	mwe	_	_
17	to	_	TO	TO	_	18	mark	_	_
18	evaluate	_	VB	VB	_	12	advcl	_	_
19	the	_	DT	DT	_	20	det	_	_
20	usefulness	_	NN	NN	_	18	dobj	_	_
21	of	_	IN	IN	_	23	case	_	_
22	plasmid	_	JJ	JJ	_	23	amod	_	_
23	profiling	_	NN	NN	_	20	nmod	_	_
24	for	_	IN	IN	_	25	mark	_	_
25	identifying	_	VBG	VBG	_	18	advcl	_	_
26	pathogens	_	NNS	NNS	_	25	dobj	_	_

1	Fifteen	_	JJ	JJ	_	4	amod	_	_
2	hospital	_	NN	NN	_	4	compound	_	_
3	staff	_	NN	NN	_	4	compound	_	_
4	members	_	NNS	NNS	_	8	nsubj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	patients	_	NNS	NNS	_	4	conj	_	_
7	repeatedly	_	RB	RB	_	8	advmod	_	_
8	had	_	VBD	VBD	_	0	root	_	_
9	cultures	_	NNS	NNS	_	8	dobj	_	_
10	taken	_	VBN	VBN	_	9	acl	_	_
11	from	_	IN	IN	_	13	case	_	_
12	the	_	DT	DT	_	13	det	_	_
13	hands	_	NNS	NNS	_	10	nmod	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	nares	_	NNS	NNS	_	13	conj	_	_
17	and	_	CC	CC	_	8	cc	_	_
18	multiple	_	JJ	JJ	_	19	amod	_	_
19	isolates	_	NNS	NNS	_	21	nsubjpass	_	_
20	were	_	VBD	VBD	_	21	auxpass	_	_
21	examined	_	VBN	VBN	_	8	conj	_	_
22	for	_	IN	IN	_	24	case	_	_
23	plasmid	_	JJ	JJ	_	24	amod	_	_
24	profiles	_	NNS	NNS	_	21	nmod	_	_

1	S	_	NNP	NNP	_	2	compound	_	_
2	epidermidis	_	NNS	NNS	_	12	nsubjpass	_	_
3	isolated	_	VBN	VBN	_	2	acl	_	_
4	from	_	IN	IN	_	6	case	_	_
5	the	_	DT	DT	_	6	det	_	_
6	nares	_	NNS	NNS	_	3	nmod	_	_
7	of	_	IN	IN	_	9	case	_	_
8	15	_	CD	CD	_	9	nummod	_	_
9	neonates	_	NNS	NNS	_	6	nmod	_	_
10	were	_	VBD	VBD	_	12	auxpass	_	_
11	also	_	RB	RB	_	12	advmod	_	_
12	examined	_	VBN	VBN	_	0	root	_	_

1	The	_	DT	DT	_	3	det	_	_
2	total	_	JJ	JJ	_	3	amod	_	_
3	number	_	NN	NN	_	6	nsubj	_	_
4	of	_	IN	IN	_	5	case	_	_
5	isolates	_	NNP	NNP	_	3	nmod	_	_
6	examined	_	VBD	VBD	_	0	root	_	_
7	for	_	IN	IN	_	11	mark	_	_
8	plasmid	_	JJ	JJ	_	9	amod	_	_
9	profiles	_	NNS	NNS	_	11	nsubj	_	_
10	was	_	VBD	VBD	_	11	cop	_	_
11	726	_	CD	CD	_	6	advcl	_	_

1	Repetition	_	NNP	NNP	_	5	nsubj	_	_
2	of	_	IN	IN	_	3	case	_	_
3	profiles	_	NNS	NNS	_	1	nmod	_	_
4	was	_	VBD	VBD	_	5	cop	_	_
5	common	_	JJ	JJ	_	0	root	_	_
6	among	_	IN	IN	_	9	case	_	_
7	the	_	DT	DT	_	9	det	_	_
8	different	_	JJ	JJ	_	9	amod	_	_
9	isolates	_	NN	NN	_	5	nmod	_	_
10	from	_	IN	IN	_	13	case	_	_
11	a	_	DT	DT	_	13	det	_	_
12	single	_	JJ	JJ	_	13	amod	_	_
13	sampling	_	NN	NN	_	5	nmod	_	_
15	one	_	CD	CD	_	16	nummod	_	_
16	swab	_	NN	NN	_	13	appos	_	_

1	The	_	DT	DT	_	2	det	_	_
2	frequency	_	NN	NN	_	10	nsubj	_	_
3	of	_	IN	IN	_	6	case	_	_
4	re-isolating	_	JJ	JJ	_	6	amod	_	_
5	similar	_	JJ	JJ	_	6	amod	_	_
6	profiles	_	NNS	NNS	_	2	nmod	_	_
7	on	_	IN	IN	_	9	case	_	_
8	different	_	JJ	JJ	_	9	amod	_	_
9	days	_	NNS	NNS	_	6	nmod	_	_
10	varied	_	VBD	VBD	_	0	root	_	_
11	from	_	IN	IN	_	16	case	_	_
12	7	_	CD	CD	_	16	compound	_	_
13	%	_	NN	NN	_	16	dep	_	_
14	to	_	TO	TO	_	16	dep	_	_
15	13	_	CD	CD	_	16	compound	_	_
16	%	_	NN	NN	_	10	nmod	_	_

1	Simultaneous	_	JJ	JJ	_	2	amod	_	_
2	isolation	_	NN	NN	_	14	nsubj	_	_
3	of	_	IN	IN	_	5	case	_	_
4	similar	_	JJ	JJ	_	5	amod	_	_
5	profiles	_	NNS	NNS	_	2	nmod	_	_
6	from	_	IN	IN	_	7	case	_	_
7	nares	_	NNS	NNS	_	5	nmod	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	hands	_	NNS	NNS	_	7	conj	_	_
10	on	_	IN	IN	_	13	case	_	_
11	the	_	DT	DT	_	13	det	_	_
12	same	_	JJ	JJ	_	13	amod	_	_
13	individual	_	NN	NN	_	7	nmod	_	_
14	varied	_	VBD	VBD	_	0	root	_	_
15	from	_	IN	IN	_	17	case	_	_
16	0	_	CD	CD	_	17	nummod	_	_
17	%	_	NN	NN	_	14	nmod	_	_
18	to	_	TO	TO	_	20	case	_	_
19	11	_	CD	CD	_	20	nummod	_	_
20	%	_	NN	NN	_	14	nmod	_	_
22	the	_	DT	DT	_	23	det	_	_
23	percentage	_	NN	NN	_	20	appos	_	_
24	being	_	VBG	VBG	_	25	cop	_	_
25	lower	_	JJR	JJR	_	14	xcomp	_	_
26	for	_	IN	IN	_	27	case	_	_
27	personnel	_	NNS	NNS	_	25	nmod	_	_

1	Isolation	_	NNP	NNP	_	10	nsubj	_	_
2	of	_	IN	IN	_	6	case	_	_
3	the	_	DT	DT	_	6	det	_	_
4	same	_	JJ	JJ	_	6	amod	_	_
5	plasmid	_	JJ	JJ	_	6	amod	_	_
6	profile	_	NN	NN	_	1	nmod	_	_
7	from	_	IN	IN	_	9	case	_	_
8	different	_	JJ	JJ	_	9	amod	_	_
9	individuals	_	NNS	NNS	_	6	nmod	_	_
10	occurred	_	VBD	VBD	_	0	root	_	_
11	only	_	RB	RB	_	12	advmod	_	_
12	twice	_	RB	RB	_	10	advmod	_	_
13	and	_	CC	CC	_	10	cc	_	_
14	resulted	_	VBD	VBD	_	10	conj	_	_
15	in	_	IN	IN	_	18	case	_	_
16	an	_	DT	DT	_	18	det	_	_
17	assignment	_	NN	NN	_	18	compound	_	_
18	probability	_	NN	NN	_	14	nmod	_	_
19	of	_	IN	IN	_	20	case	_	_
20	Pa	_	NNP	NNP	_	18	nmod	_	_
21	=	_	SYM	SYM	_	22	dep	_	_
22	0.002	_	CD	CD	_	20	acl:relcl	_	_
23	for	_	IN	IN	_	24	case	_	_
24	isolates	_	NNP	NNP	_	14	nmod	_	_
25	obtained	_	VBN	VBN	_	24	acl	_	_
26	from	_	IN	IN	_	28	case	_	_
27	different	_	JJ	JJ	_	28	amod	_	_
28	individuals	_	NNS	NNS	_	25	nmod	_	_

1	Significantly	_	RB	RB	_	3	advmod	_	_
2	more	_	RBR	RBR	_	3	advmod	_	_
3	isolates	_	JJ	JJ	_	6	dep	_	_
4	from	_	IN	IN	_	5	case	_	_
5	nares	_	NNS	NNS	_	3	nmod	_	_
6	contained	_	VBD	VBD	_	0	root	_	_
7	plasmids	_	NNS	NNS	_	6	nsubj	_	_
9	97	_	CD	CD	_	10	nummod	_	_
10	%	_	NN	NN	_	7	appos	_	_
12	compared	_	VBN	VBN	_	14	case	_	_
13	with	_	IN	IN	_	14	case	_	_
14	isolates	_	NNP	NNP	_	6	nmod	_	_
15	from	_	IN	IN	_	16	case	_	_
16	hands	_	NNS	NNS	_	14	nmod	_	_
18	89	_	CD	CD	_	19	nummod	_	_
19	%	_	NN	NN	_	16	appos	_	_

1	Patients	_	NNS	NNS	_	15	nsubjpass	_	_
2	who	_	WP	WP	_	3	nsubj	_	_
3	had	_	VBD	VBD	_	1	acl:relcl	_	_
4	two	_	CD	CD	_	7	nummod	_	_
5	or	_	CC	CC	_	4	cc	_	_
6	more	_	JJR	JJR	_	4	conj	_	_
7	isolates	_	NNS	NNS	_	3	dobj	_	_
8	of	_	IN	IN	_	10	case	_	_
9	coagulase-negative	_	JJ	JJ	_	10	amod	_	_
10	staphylococci	_	NNS	NNS	_	7	nmod	_	_
11	with	_	IN	IN	_	13	case	_	_
12	similar	_	JJ	JJ	_	13	amod	_	_
13	profiles	_	NNS	NNS	_	3	nmod	_	_
14	were	_	VBD	VBD	_	15	auxpass	_	_
15	judged	_	VBN	VBN	_	0	root	_	_
17	clinically	_	RB	RB	_	15	advmod	_	_
19	to	_	TO	TO	_	20	mark	_	_
20	have	_	VB	VB	_	15	xcomp	_	_
21	infections	_	NNS	NNS	_	20	dobj	_	_
22	in	_	IN	IN	_	23	case	_	_
23	12	_	CD	CD	_	21	nmod	_	_
24	of	_	IN	IN	_	26	case	_	_
25	13	_	CD	CD	_	26	nummod	_	_
26	cases	_	NNS	NNS	_	21	nmod	_	_

1	However	_	RB	RB	_	26	advmod	_	_
3	the	_	DT	DT	_	4	det	_	_
4	likelihood	_	NN	NN	_	26	nsubj	_	_
5	of	_	IN	IN	_	6	mark	_	_
6	re-isolating	_	VBG	VBG	_	4	acl	_	_
7	an	_	DT	DT	_	10	det	_	_
8	S	_	NNP	NNP	_	10	compound	_	_
9	epidermidis	_	NNS	NNS	_	10	compound	_	_
10	strain	_	NN	NN	_	6	dobj	_	_
11	with	_	IN	IN	_	15	case	_	_
12	a	_	DT	DT	_	15	det	_	_
13	similar	_	JJ	JJ	_	15	amod	_	_
14	plasmid	_	JJ	JJ	_	15	amod	_	_
15	profile	_	NN	NN	_	6	nmod	_	_
16	twice	_	RB	RB	_	20	advmod	_	_
17	from	_	IN	IN	_	20	case	_	_
18	the	_	DT	DT	_	20	det	_	_
19	same	_	JJ	JJ	_	20	amod	_	_
20	person	_	NN	NN	_	6	nmod	_	_
21	at	_	IN	IN	_	23	case	_	_
22	different	_	JJ	JJ	_	23	amod	_	_
23	times	_	NNS	NNS	_	20	nmod	_	_
24	was	_	VBD	VBD	_	26	cop	_	_
25	sufficiently	_	RB	RB	_	26	advmod	_	_
26	high	_	JJ	JJ	_	0	root	_	_
27	to	_	TO	TO	_	28	mark	_	_
28	prevent	_	VB	VB	_	26	xcomp	_	_
29	plasmid	_	JJ	JJ	_	30	amod	_	_
30	profiling	_	NN	NN	_	28	dobj	_	_
31	from	_	IN	IN	_	33	mark	_	_
32	being	_	VBG	VBG	_	33	auxpass	_	_
33	used	_	VBN	VBN	_	28	advcl	_	_
34	as	_	IN	IN	_	37	case	_	_
35	an	_	DT	DT	_	37	det	_	_
36	absolute	_	JJ	JJ	_	37	amod	_	_
37	criterion	_	NN	NN	_	33	nmod	_	_
38	for	_	IN	IN	_	39	case	_	_
39	infection	_	NN	NN	_	37	nmod	_	_

1	Successful	_	JJ	JJ	_	3	amod	_	_
2	systemic	_	JJ	JJ	_	3	amod	_	_
3	fibrinolysis	_	NNS	NNS	_	7	nsubj	_	_
4	in	_	IN	IN	_	6	case	_	_
5	permanent	_	JJ	JJ	_	6	amod	_	_
6	hemodialysis	_	NNS	NNS	_	3	nmod	_	_
7	catheter	_	VBZ	VBZ	_	0	root	_	_
8	obstruction	_	NN	NN	_	7	dobj	_	_

1	A	_	DT	DT	_	4	det	_	_
2	-LSB-	_	JJ	JJ	_	4	amod	_	_
3	3H	_	CD	CD	_	4	nummod	_	_
4	-RSB-	_	NNS	NNS	_	5	nsubj	_	_
5	amine	_	VBP	VBP	_	0	root	_	_
6	congener	_	NN	NN	_	5	dobj	_	_
7	of	_	IN	IN	_	8	case	_	_
8	1,3-dipropyl-8-phenylxanthine	_	CD	CD	_	6	nmod	_	_

1	A	_	DT	DT	_	3	det	_	_
2	new	_	JJ	JJ	_	3	amod	_	_
3	radioligand	_	NN	NN	_	6	nsubj	_	_
4	for	_	IN	IN	_	5	case	_	_
5	A2	_	NNP	NNP	_	3	nmod	_	_
6	adenosine	_	VBP	VBP	_	0	root	_	_
7	receptors	_	NNS	NNS	_	6	dobj	_	_
8	of	_	IN	IN	_	10	case	_	_
9	human	_	JJ	JJ	_	10	amod	_	_
10	platelets	_	NNS	NNS	_	7	nmod	_	_

1	A	_	DT	DT	_	4	det	_	_
2	xanthine	_	JJ	JJ	_	4	amod	_	_
3	amine	_	NN	NN	_	4	compound	_	_
4	congener	_	NN	NN	_	17	nsubj	_	_
6	XAC	_	NNP	NNP	_	4	appos	_	_
9	an	_	DT	DT	_	11	det	_	_
10	amine-functionalized	_	JJ	JJ	_	11	amod	_	_
11	derivative	_	NN	NN	_	4	appos	_	_
12	of	_	IN	IN	_	13	case	_	_
13	1,3-dipropyl-8-phenylxanthine	_	CD	CD	_	11	nmod	_	_
15	is	_	VBZ	VBZ	_	17	cop	_	_
16	an	_	DT	DT	_	17	det	_	_
17	antagonist	_	NN	NN	_	0	root	_	_
18	ligand	_	VBN	VBN	_	17	acl	_	_
19	for	_	IN	IN	_	22	case	_	_
20	A2	_	CD	CD	_	22	nummod	_	_
21	adenosine	_	JJ	JJ	_	22	amod	_	_
22	receptors	_	NNS	NNS	_	18	nmod	_	_
23	of	_	IN	IN	_	25	case	_	_
24	human	_	JJ	JJ	_	25	amod	_	_
25	platelets	_	NNS	NNS	_	22	nmod	_	_

1	XAC	_	NNP	NNP	_	2	compound	_	_
2	inhibited	_	NNP	NNP	_	6	nmod:poss	_	_
3	5	_	CD	CD	_	2	nummod	_	_
4	'	_	POS	POS	_	2	case	_	_
5	-	_	JJ	JJ	_	6	amod	_	_
6	N-ethylcarboxamidoadenosine	_	NN	NN	_	0	root	_	_
8	NECA	_	NNP	NNP	_	6	appos	_	_
11	induced	_	VBN	VBN	_	6	acl	_	_
12	stimulation	_	NN	NN	_	11	dobj	_	_
13	of	_	IN	IN	_	16	case	_	_
14	adenylate	_	JJ	JJ	_	16	amod	_	_
15	cyclase	_	NN	NN	_	16	compound	_	_
16	activity	_	NN	NN	_	12	nmod	_	_
17	with	_	IN	IN	_	19	case	_	_
18	a	_	DT	DT	_	19	det	_	_
19	KB	_	NNP	NNP	_	11	nmod	_	_
20	of	_	IN	IN	_	22	case	_	_
21	24	_	CD	CD	_	22	nummod	_	_
22	nM	_	NN	NN	_	6	nmod	_	_

1	-LSB-	_	CD	CD	_	2	compound	_	_
2	3H	_	CD	CD	_	37	nsubj	_	_
3	-RSB-	_	NNP	NNP	_	6	compound	_	_
4	XAC	_	NNP	NNP	_	6	compound	_	_
5	exhibits	_	NNS	NNS	_	6	compound	_	_
6	saturable	_	NN	NN	_	2	dep	_	_
8	specific	_	JJ	JJ	_	15	amod	_	_
9	binding	_	JJ	JJ	_	15	amod	_	_
10	with	_	IN	IN	_	12	case	_	_
11	a	_	DT	DT	_	12	det	_	_
12	Kd	_	NN	NN	_	9	nmod	_	_
13	of	_	IN	IN	_	14	case	_	_
14	12	_	CD	CD	_	12	nmod	_	_
15	nM	_	NN	NN	_	2	conj	_	_
16	and	_	CC	CC	_	2	cc	_	_
17	a	_	DT	DT	_	30	det	_	_
18	Bmax	_	JJ	JJ	_	30	amod	_	_
19	of	_	IN	IN	_	22	case	_	_
20	1.1	_	CD	CD	_	22	nummod	_	_
21	pmol/mg	_	VBG	VBG	_	22	amod	_	_
22	protein	_	NN	NN	_	18	nmod	_	_
23	at	_	IN	IN	_	25	case	_	_
24	37	_	CD	CD	_	25	nummod	_	_
25	degrees	_	NNS	NNS	_	22	nmod	_	_
26	C.	_	NNP	NNP	_	30	compound	_	_
27	-LSB-	_	JJ	JJ	_	30	amod	_	_
28	3H	_	CD	CD	_	29	compound	_	_
29	-RSB-	_	CD	CD	_	30	nummod	_	_
30	XAC	_	NN	NN	_	2	conj	_	_
31	binding	_	VBG	VBG	_	30	amod	_	_
32	in	_	IN	IN	_	33	case	_	_
33	platelets	_	NNS	NNS	_	30	nmod	_	_
34	is	_	VBZ	VBZ	_	37	cop	_	_
35	the	_	DT	DT	_	37	det	_	_
36	first	_	JJ	JJ	_	37	amod	_	_
37	example	_	NN	NN	_	0	root	_	_
38	of	_	IN	IN	_	39	mark	_	_
39	labeling	_	VBG	VBG	_	37	acl	_	_
40	of	_	IN	IN	_	43	case	_	_
41	A2	_	CD	CD	_	43	nummod	_	_
42	adenosine	_	JJ	JJ	_	43	amod	_	_
43	receptors	_	NNS	NNS	_	39	nmod	_	_
44	in	_	IN	IN	_	45	case	_	_
45	which	_	WDT	WDT	_	57	nmod	_	_
46	the	_	DT	DT	_	47	det	_	_
47	potencies	_	NNS	NNS	_	57	nsubj	_	_
48	of	_	IN	IN	_	50	case	_	_
49	adenosine	_	JJ	JJ	_	50	amod	_	_
50	agonists	_	NNS	NNS	_	47	nmod	_	_
51	and	_	CC	CC	_	50	cc	_	_
52	antagonists	_	NNS	NNS	_	50	conj	_	_
53	in	_	IN	IN	_	54	mark	_	_
54	inhibiting	_	VBG	VBG	_	50	acl	_	_
55	binding	_	JJ	JJ	_	54	xcomp	_	_
56	are	_	VBP	VBP	_	57	cop	_	_
57	commensurate	_	JJ	JJ	_	43	acl:relcl	_	_
58	with	_	IN	IN	_	60	case	_	_
59	their	_	PRP$	PRP$	_	60	nmod:poss	_	_
60	potencies	_	NNS	NNS	_	57	nmod	_	_
61	at	_	IN	IN	_	63	case	_	_
62	these	_	DT	DT	_	63	det	_	_
63	receptors	_	NNS	NNS	_	57	nmod	_	_
64	in	_	IN	IN	_	66	case	_	_
65	functional	_	JJ	JJ	_	66	amod	_	_
66	studies	_	NNS	NNS	_	63	nmod	_	_

1	Furthermore	_	RB	RB	_	10	advmod	_	_
3	-LSB-	_	NNP	NNP	_	6	compound	_	_
4	3H	_	NNP	NNP	_	6	compound	_	_
5	-RSB-	_	NNP	NNP	_	6	compound	_	_
6	XAC	_	NNP	NNP	_	10	nsubj	_	_
7	is	_	VBZ	VBZ	_	10	cop	_	_
8	the	_	DT	DT	_	10	det	_	_
9	first	_	JJ	JJ	_	10	amod	_	_
10	antagonist	_	NN	NN	_	0	root	_	_
11	radioligand	_	VBN	VBN	_	10	acl	_	_
12	with	_	IN	IN	_	14	case	_	_
13	high	_	JJ	JJ	_	14	amod	_	_
14	affinity	_	NN	NN	_	11	nmod	_	_
15	at	_	IN	IN	_	18	case	_	_
16	A2	_	CD	CD	_	18	nummod	_	_
17	adenosine	_	JJ	JJ	_	18	amod	_	_
18	receptors	_	NNS	NNS	_	11	nmod	_	_

1	-LSB-	_	NNP	NNP	_	2	compound	_	_
2	Interest	_	NNP	NNP	_	9	nsubj	_	_
3	in	_	IN	IN	_	5	case	_	_
4	practical	_	JJ	JJ	_	5	amod	_	_
5	exercises	_	NNS	NNS	_	2	nmod	_	_
6	in	_	IN	IN	_	7	case	_	_
7	resuscitation	_	NN	NN	_	5	nmod	_	_
8	is	_	VBZ	VBZ	_	9	aux	_	_
9	slacking	_	VBG	VBG	_	0	root	_	_
10	off	_	RP	RP	_	9	compound:prt	_	_

1	Interview	_	VB	VB	_	0	root	_	_
2	by	_	IN	IN	_	5	case	_	_
3	K.	_	NNP	NNP	_	5	compound	_	_
4	Venner	_	NNP	NNP	_	5	compound	_	_
5	-RSB-	_	NNP	NNP	_	1	nmod	_	_

1	Krogius	_	NNS	NNS	_	0	root	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	Roux-Goldthwait	_	JJ	JJ	_	4	amod	_	_
4	operations	_	NNS	NNS	_	1	conj	_	_
5	for	_	IN	IN	_	7	case	_	_
6	recurrent	_	JJ	JJ	_	7	amod	_	_
7	patellar_dislocation	_	NN	NN	_	1	nmod	_	_

1	-LSB-	_	JJ	JJ	_	4	amod	_	_
2	Liver	_	NNP	NNP	_	4	compound	_	_
3	function	_	NN	NN	_	4	compound	_	_
4	tests	_	NNS	NNS	_	0	root	_	_
6	metabolic	_	JJ	JJ	_	9	amod	_	_
7	detoxication	_	NN	NN	_	9	compound	_	_
8	test	_	NN	NN	_	9	compound	_	_
9	-RSB-	_	NNS	NNS	_	4	dep	_	_

1	Beta-leucine	_	JJ	JJ	_	5	amod	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	the	_	DT	DT	_	1	conj	_	_
4	beta-keto	_	JJ	JJ	_	5	amod	_	_
5	pathway	_	NN	NN	_	0	root	_	_
6	of	_	IN	IN	_	8	case	_	_
7	leucine	_	JJ	JJ	_	8	amod	_	_
8	metabolism	_	NN	NN	_	5	nmod	_	_

1	Treatment	_	NNP	NNP	_	0	root	_	_
2	of	_	IN	IN	_	3	case	_	_
3	chronic_pancreatitis	_	NNS	NNS	_	1	nmod	_	_
5	current	_	JJ	JJ	_	6	amod	_	_
6	status	_	NN	NN	_	1	dep	_	_

1	Clinical	_	NNP	NNP	_	2	nsubj	_	_
2	review	_	VBP	VBP	_	0	root	_	_

1	Client	_	JJ	JJ	_	2	amod	_	_
2	perceptions	_	NNS	NNS	_	0	root	_	_
3	of	_	IN	IN	_	5	case	_	_
4	nursing	_	NN	NN	_	5	compound	_	_
5	practice	_	NN	NN	_	2	nmod	_	_

1	LHRH	_	VB	VB	_	0	root	_	_
2	agonist	_	NN	NN	_	1	dobj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	contraception	_	NN	NN	_	2	conj	_	_

1	-LSB-	_	VB	VB	_	0	root	_	_
2	The	_	DT	DT	_	3	det	_	_
3	effect	_	NN	NN	_	1	dobj	_	_
4	of	_	IN	IN	_	6	case	_	_
5	quaternary	_	JJ	JJ	_	6	amod	_	_
6	derivatives	_	NNS	NNS	_	3	nmod	_	_
7	of	_	IN	IN	_	8	case	_	_
8	scopolamine	_	NN	NN	_	6	nmod	_	_
10	cimetropium	_	NN	NN	_	11	compound	_	_
11	bromide	_	NN	NN	_	8	appos	_	_
13	on	_	IN	IN	_	16	case	_	_
14	intestinal	_	JJ	JJ	_	16	amod	_	_
15	motility	_	NN	NN	_	16	compound	_	_
16	-RSB-	_	NNS	NNS	_	8	nmod	_	_

1	Immobilization	_	NNP	NNP	_	0	root	_	_
2	of	_	IN	IN	_	3	case	_	_
3	enzymes	_	NNS	NNS	_	1	nmod	_	_
5	an	_	DT	DT	_	6	det	_	_
6	approach	_	NN	NN	_	1	dep	_	_
7	to	_	TO	TO	_	9	case	_	_
8	fundamental	_	JJ	JJ	_	9	amod	_	_
9	studies	_	NNS	NNS	_	6	nmod	_	_
10	in	_	IN	IN	_	11	case	_	_
11	biochemistry	_	NN	NN	_	9	nmod	_	_

1	P-450	_	NN	NN	_	2	compound	_	_
2	cytochromes	_	NNS	NNS	_	0	root	_	_
4	structure	_	NN	NN	_	2	dep	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	function	_	NN	NN	_	4	conj	_	_

1	The	_	DT	DT	_	2	det	_	_
2	behavior	_	NN	NN	_	8	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	significance	_	NN	NN	_	2	conj	_	_
5	of	_	IN	IN	_	7	case	_	_
6	slow-binding	_	JJ	JJ	_	7	amod	_	_
7	enzyme	_	NN	NN	_	2	nmod	_	_
8	inhibitors	_	VBZ	VBZ	_	0	root	_	_

1	Serum	_	CD	CD	_	5	nummod	_	_
2	phosphate	_	JJ	JJ	_	5	amod	_	_
4	parathyroid	_	JJ	JJ	_	5	amod	_	_
5	hormone	_	NN	NN	_	0	root	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	vitamin_D	_	NN	NN	_	8	compound	_	_
8	metabolites	_	NNS	NNS	_	5	conj	_	_
9	in	_	IN	IN	_	10	case	_	_
10	patients	_	NNS	NNS	_	5	nmod	_	_
11	with	_	IN	IN	_	12	case	_	_
12	chronic_renal_failure	_	NN	NN	_	10	nmod	_	_
14	effect	_	NN	NN	_	5	dep	_	_
15	of	_	IN	IN	_	17	case	_	_
16	aluminum_hydroxide	_	JJ	JJ	_	17	amod	_	_
17	administration	_	NN	NN	_	14	nmod	_	_

1	Patients	_	NNS	NNS	_	4	nsubj	_	_
2	with	_	IN	IN	_	3	case	_	_
3	chronic_renal_failure	_	NN	NN	_	1	nmod	_	_
4	showed	_	VBD	VBD	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	existence	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	9	case	_	_
8	phosphate	_	JJ	JJ	_	9	amod	_	_
9	retention	_	NN	NN	_	6	nmod	_	_
11	secondary_hyperparathyroidism	_	NN	NN	_	6	conj	_	_
13	and	_	CC	CC	_	6	cc	_	_
14	reduced	_	VBN	VBN	_	15	amod	_	_
15	production	_	NN	NN	_	6	conj	_	_
16	of	_	IN	IN	_	17	case	_	_
17	1,25	_	CD	CD	_	15	nmod	_	_
20	OH	_	NNP	NNP	_	15	dep	_	_
22	2D	_	CD	CD	_	20	dep	_	_

1	In	_	IN	IN	_	4	mark	_	_
2	order	_	NN	NN	_	1	mwe	_	_
3	to	_	TO	TO	_	4	mark	_	_
4	determine	_	VB	VB	_	26	advcl	_	_
5	the	_	DT	DT	_	6	det	_	_
6	effect	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	8	case	_	_
8	correction	_	NN	NN	_	6	nmod	_	_
9	of	_	IN	IN	_	10	case	_	_
10	hyperphosphatemia	_	NN	NN	_	8	nmod	_	_
11	on	_	IN	IN	_	15	case	_	_
12	secondary_hyperparathyroidism	_	NN	NN	_	15	compound	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	vitamin_D	_	JJ	JJ	_	12	conj	_	_
15	metabolism	_	NN	NN	_	4	nmod	_	_
16	in	_	IN	IN	_	18	case	_	_
17	those	_	DT	DT	_	18	det	_	_
18	patients	_	NNS	NNS	_	15	nmod	_	_
20	7	_	CD	CD	_	22	nummod	_	_
21	nondialyzed	_	JJ	JJ	_	22	amod	_	_
22	patients	_	NNS	NNS	_	26	nsubjpass	_	_
23	with	_	IN	IN	_	24	case	_	_
24	chronic_renal_failure	_	NN	NN	_	22	nmod	_	_
25	were	_	VBD	VBD	_	26	auxpass	_	_
26	treated	_	VBN	VBN	_	0	root	_	_
27	with	_	IN	IN	_	29	case	_	_
28	large	_	JJ	JJ	_	29	amod	_	_
29	doses	_	NNS	NNS	_	26	nmod	_	_
30	of	_	IN	IN	_	35	case	_	_
31	A1	_	NNP	NNP	_	35	compound	_	_
33	OH	_	NNP	NNP	_	35	appos	_	_
35	3	_	NNP	NNP	_	29	nmod	_	_
37	15-18	_	CD	CD	_	38	nummod	_	_
38	g/day	_	NN	NN	_	35	appos	_	_
40	to	_	TO	TO	_	41	mark	_	_
41	correct	_	VB	VB	_	26	xcomp	_	_
42	their	_	PRP$	PRP$	_	44	nmod:poss	_	_
43	high	_	JJ	JJ	_	44	amod	_	_
44	levels	_	NNS	NNS	_	41	dobj	_	_
45	of	_	IN	IN	_	47	case	_	_
46	serum	_	NN	NN	_	47	compound	_	_
47	phosphate	_	NN	NN	_	44	nmod	_	_

1	After	_	IN	IN	_	2	case	_	_
2	treatment	_	NN	NN	_	12	nmod	_	_
3	with	_	IN	IN	_	8	case	_	_
4	A1	_	NNP	NNP	_	8	compound	_	_
6	OH	_	NNP	NNP	_	8	appos	_	_
8	3	_	NNP	NNP	_	2	nmod	_	_
10	serum	_	NN	NN	_	11	compound	_	_
11	phosphate	_	NN	NN	_	12	nsubj	_	_
12	fell	_	VBD	VBD	_	0	root	_	_
13	significantly	_	RB	RB	_	12	advmod	_	_
15	p	_	NNP	NNP	_	13	dep	_	_
16	less	_	JJR	JJR	_	18	advmod	_	_
17	than	_	IN	IN	_	16	mwe	_	_
18	0.005	_	CD	CD	_	15	nummod	_	_
20	from	_	IN	IN	_	22	case	_	_
21	6.3	_	CD	CD	_	22	compound	_	_
22	+	_	CD	CD	_	12	nmod	_	_
24	-	_	CD	CD	_	25	compound	_	_
25	1.3	_	CD	CD	_	22	dep	_	_
27	mean	_	JJ	JJ	_	29	amod	_	_
28	+	_	JJ	JJ	_	29	amod	_	_
29	/	_	NNS	NNS	_	25	appos	_	_
31	SD	_	NNP	NNP	_	29	dep	_	_
33	to	_	TO	TO	_	35	case	_	_
34	3.7	_	CD	CD	_	35	nummod	_	_
35	+	_	NNS	NNS	_	25	nmod	_	_
38	0.5	_	CD	CD	_	39	compound	_	_
39	mg/dl	_	JJ	JJ	_	22	amod	_	_

1	Serum	_	RB	RB	_	2	advmod	_	_
2	parathyroid	_	VBD	VBD	_	0	root	_	_
3	hormone	_	NN	NN	_	4	compound	_	_
4	decreased	_	NNS	NNS	_	2	dobj	_	_
5	significantly	_	RB	RB	_	2	advmod	_	_
7	p	_	NNP	NNP	_	2	dep	_	_
8	less	_	JJR	JJR	_	10	advmod	_	_
9	than	_	IN	IN	_	8	mwe	_	_
10	0.02	_	CD	CD	_	7	nummod	_	_
12	from	_	IN	IN	_	13	case	_	_
13	2.87	_	CD	CD	_	2	nmod	_	_
14	+	_	VBG	VBG	_	15	amod	_	_
15	/	_	NNS	NNS	_	2	nsubj	_	_
17	1.64	_	CD	CD	_	19	compound	_	_
18	to	_	TO	TO	_	19	dep	_	_
19	1.85	_	CD	CD	_	20	nummod	_	_
20	+	_	NNS	NNS	_	15	dep	_	_
23	1.26	_	CD	CD	_	24	nummod	_	_
24	ngEq/ml	_	NN	NN	_	15	dep	_	_

1	Serum	_	NNP	NNP	_	0	root	_	_
2	1,25	_	CD	CD	_	1	nummod	_	_
5	OH	_	NNP	NNP	_	1	dep	_	_
7	2D	_	CD	CD	_	9	nsubj	_	_
8	was	_	VBD	VBD	_	9	cop	_	_
9	low	_	JJ	JJ	_	5	acl:relcl	_	_
10	compared	_	VBN	VBN	_	15	case	_	_
11	to	_	TO	TO	_	15	case	_	_
12	the	_	DT	DT	_	15	det	_	_
13	normal	_	JJ	JJ	_	15	amod	_	_
14	mean	_	JJ	JJ	_	15	amod	_	_
15	level	_	NN	NN	_	9	advcl	_	_
16	before	_	IN	IN	_	17	case	_	_
17	A1	_	NNP	NNP	_	15	nmod	_	_
19	OH	_	NNP	NNP	_	17	appos	_	_
21	3	_	CD	CD	_	22	nummod	_	_
22	administration	_	NN	NN	_	17	dep	_	_
23	and	_	CC	CC	_	9	cc	_	_
24	decreased	_	VBD	VBD	_	9	conj	_	_
25	significantly	_	RB	RB	_	24	advmod	_	_
27	p	_	RB	RB	_	28	dep	_	_
28	greater	_	JJR	JJR	_	25	dep	_	_
29	than	_	IN	IN	_	30	case	_	_
30	0.02	_	CD	CD	_	28	nmod	_	_
32	from	_	IN	IN	_	34	case	_	_
33	19.4	_	CD	CD	_	34	compound	_	_
34	+	_	CD	CD	_	24	nmod	_	_
37	6.1	_	CD	CD	_	39	compound	_	_
38	to	_	TO	TO	_	39	dep	_	_
39	11.4	_	CD	CD	_	1	dep	_	_
40	+	_	NNP	NNP	_	41	compound	_	_
41	/	_	NNP	NNP	_	39	dep	_	_
43	4.3	_	CD	CD	_	44	nummod	_	_
44	pg/ml	_	NN	NN	_	1	dep	_	_
45	after	_	IN	IN	_	47	case	_	_
46	the	_	DT	DT	_	47	det	_	_
47	treatment	_	NN	NN	_	44	nmod	_	_

1	Aluminum	_	NNP	NNP	_	2	compound	_	_
2	levels	_	NNS	NNS	_	3	nsubj	_	_
3	increased	_	VBD	VBD	_	0	root	_	_
4	significantly	_	RB	RB	_	3	advmod	_	_
6	p	_	RB	RB	_	7	dep	_	_
7	greater	_	JJR	JJR	_	4	dep	_	_
8	than	_	IN	IN	_	9	case	_	_
9	0.02	_	CD	CD	_	7	nmod	_	_
11	from	_	IN	IN	_	14	case	_	_
12	1.7	_	CD	CD	_	14	nummod	_	_
13	+	_	JJ	JJ	_	14	amod	_	_
14	/	_	NNS	NNS	_	3	nmod	_	_
16	1.0	_	CD	CD	_	18	compound	_	_
17	to	_	TO	TO	_	18	dep	_	_
18	3.6	_	CD	CD	_	19	nummod	_	_
19	+	_	NNS	NNS	_	14	dep	_	_
22	1.5	_	CD	CD	_	23	nummod	_	_
23	micrograms/dl	_	NN	NN	_	14	dep	_	_

1	Serum	_	JJ	JJ	_	2	amod	_	_
2	calcium	_	NN	NN	_	0	root	_	_
4	calcitonin	_	NN	NN	_	2	conj	_	_
6	and	_	CC	CC	_	2	cc	_	_
7	25	_	CD	CD	_	2	conj	_	_
10	OH	_	NNP	NNP	_	12	compound	_	_
12	D	_	NNP	NNP	_	13	nsubj	_	_
13	showed	_	VBD	VBD	_	2	parataxis	_	_
14	no	_	DT	DT	_	16	neg	_	_
15	significant	_	JJ	JJ	_	16	amod	_	_
16	change	_	NN	NN	_	13	dobj	_	_

1	Our	_	PRP$	PRP$	_	2	nmod:poss	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	suggested	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	16	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	suppression	_	NN	NN	_	16	dep	_	_
7	of	_	IN	IN	_	8	case	_	_
8	secondary_hyperparathyroidism	_	NN	NN	_	6	nmod	_	_
9	by	_	IN	IN	_	10	case	_	_
10	A1	_	NNP	NNP	_	8	nmod	_	_
12	OH	_	NNP	NNP	_	6	appos	_	_
14	3	_	CD	CD	_	16	nummod	_	_
15	treatment	_	NN	NN	_	16	compound	_	_
16	results	_	NNS	NNS	_	3	dep	_	_
17	in	_	IN	IN	_	19	case	_	_
18	a	_	DT	DT	_	19	det	_	_
19	decrease	_	NN	NN	_	16	nmod	_	_
20	of	_	IN	IN	_	28	case	_	_
21	the	_	DT	DT	_	28	det	_	_
22	1,25	_	CD	CD	_	23	compound	_	_
23	-	_	CD	CD	_	28	nummod	_	_
25	OH	_	NNP	NNP	_	28	appos	_	_
27	2D	_	NNP	NNP	_	28	compound	_	_
28	level	_	NN	NN	_	19	nmod	_	_
29	in	_	IN	IN	_	30	case	_	_
30	patients	_	NNS	NNS	_	28	nmod	_	_
31	with	_	IN	IN	_	32	case	_	_
32	chronic_renal_failure	_	NN	NN	_	30	nmod	_	_
34	even	_	RB	RB	_	40	advmod	_	_
35	though	_	IN	IN	_	40	mark	_	_
36	their	_	PRP$	PRP$	_	37	nmod:poss	_	_
37	hyperphosphatemia	_	NN	NN	_	40	nsubjpass	_	_
38	has	_	VBZ	VBZ	_	40	aux	_	_
39	been	_	VBN	VBN	_	40	auxpass	_	_
40	corrected	_	VBN	VBN	_	3	advcl	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	speculate	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	7	mark	_	_
4	aluminum	_	NN	NN	_	5	compound	_	_
5	loading	_	NN	NN	_	7	nsubj	_	_
6	might	_	MD	MD	_	7	aux	_	_
7	play	_	VB	VB	_	2	ccomp	_	_
8	a	_	DT	DT	_	9	det	_	_
9	role	_	NN	NN	_	7	dobj	_	_
10	in	_	IN	IN	_	11	mark	_	_
11	diminishing	_	VBG	VBG	_	7	advcl	_	_
12	the	_	DT	DT	_	13	det	_	_
13	secretion	_	NN	NN	_	11	dobj	_	_
14	of	_	IN	IN	_	16	case	_	_
15	parathyroid	_	JJ	JJ	_	16	amod	_	_
16	hormone	_	NN	NN	_	13	nmod	_	_
17	and	_	CC	CC	_	13	cc	_	_
18	the	_	DT	DT	_	19	det	_	_
19	production	_	NN	NN	_	13	conj	_	_
20	of	_	IN	IN	_	21	case	_	_
21	1,25	_	CD	CD	_	19	nmod	_	_
24	OH	_	NNP	NNP	_	19	dep	_	_
26	2D	_	CD	CD	_	24	dep	_	_
27	in	_	IN	IN	_	28	case	_	_
28	humans	_	NNS	NNS	_	11	nmod	_	_

1	From	_	VB	VB	_	0	root	_	_
3	patient	_	JJ	JJ	_	1	xcomp	_	_
5	to	_	TO	TO	_	7	case	_	_
7	customer	_	NN	NN	_	3	nmod	_	_

1	A	_	DT	DT	_	3	det	_	_
2	dangerous	_	JJ	JJ	_	3	amod	_	_
3	trend	_	NN	NN	_	0	root	_	_
4	in	_	IN	IN	_	5	case	_	_
5	healthcare	_	NN	NN	_	3	nmod	_	_

1	-LSB-	_	NNP	NNP	_	2	compound	_	_
2	Effects	_	NNPS	NNPS	_	13	nsubj	_	_
3	of	_	IN	IN	_	4	case	_	_
4	verapamil	_	NN	NN	_	2	nmod	_	_
5	on	_	IN	IN	_	6	case	_	_
6	recovery	_	NN	NN	_	4	nmod	_	_
7	of	_	IN	IN	_	10	case	_	_
8	postischemic	_	JJ	JJ	_	10	amod	_	_
9	cardiac	_	JJ	JJ	_	10	amod	_	_
10	function	_	NN	NN	_	6	nmod	_	_
11	under	_	IN	IN	_	12	case	_	_
12	2	_	CD	CD	_	10	nmod	_	_
13	MAC	_	VBD	VBD	_	0	root	_	_
14	enflurane	_	JJ	JJ	_	17	amod	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	isoflurane	_	JJ	JJ	_	14	conj	_	_
17	anesthesia	_	NN	NN	_	13	dobj	_	_
18	in	_	IN	IN	_	23	case	_	_
19	the	_	DT	DT	_	23	det	_	_
20	isolated	_	VBN	VBN	_	23	amod	_	_
21	rat	_	NN	NN	_	23	compound	_	_
22	heart	_	NN	NN	_	23	compound	_	_
23	-RSB-	_	NN	NN	_	13	nmod	_	_

1	Mechanisms	_	NN	NN	_	4	compound	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	time	_	NN	NN	_	1	conj	_	_
4	course	_	NN	NN	_	0	root	_	_
5	of	_	IN	IN	_	7	case	_	_
6	beta_1_adrenoceptor	_	JJ	JJ	_	7	amod	_	_
7	desensitisation	_	NN	NN	_	4	nmod	_	_
8	in	_	IN	IN	_	11	case	_	_
9	mammalian	_	JJ	JJ	_	11	amod	_	_
10	cardiac	_	JJ	JJ	_	11	amod	_	_
11	myocytes	_	NNS	NNS	_	4	nmod	_	_

1	To	_	TO	TO	_	2	mark	_	_
2	study	_	VB	VB	_	27	csubjpass	_	_
3	the	_	DT	DT	_	4	det	_	_
4	mechanisms	_	NNS	NNS	_	2	dobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	time	_	NN	NN	_	7	compound	_	_
7	course	_	NN	NN	_	4	conj	_	_
8	of	_	IN	IN	_	10	case	_	_
9	beta1_adrenoceptor	_	JJ	JJ	_	10	amod	_	_
10	desensitisation	_	NN	NN	_	4	nmod	_	_
11	in	_	IN	IN	_	18	case	_	_
12	mammalian	_	JJ	JJ	_	18	amod	_	_
13	heart	_	NN	NN	_	18	compound	_	_
14	tissue	_	NN	NN	_	18	compound	_	_
15	neonatal	_	NN	NN	_	18	compound	_	_
16	rat	_	NN	NN	_	18	compound	_	_
17	cardiac	_	JJ	JJ	_	18	amod	_	_
18	myocytes	_	NNS	NNS	_	10	nmod	_	_
20	greater	_	JJR	JJR	_	22	advmod	_	_
21	than	_	IN	IN	_	22	advmod	_	_
22	90	_	CD	CD	_	23	nummod	_	_
23	%	_	NN	NN	_	24	nmod:npmod	_	_
24	pure	_	JJ	JJ	_	10	dep	_	_
26	were	_	VBD	VBD	_	27	auxpass	_	_
27	cultured	_	VBN	VBN	_	0	root	_	_
28	in	_	IN	IN	_	31	case	_	_
29	serum	_	JJ	JJ	_	31	amod	_	_
30	free	_	JJ	JJ	_	31	amod	_	_
31	medium	_	NN	NN	_	27	nmod	_	_

1	Cells	_	NNS	NNS	_	3	nsubjpass	_	_
2	were	_	VBD	VBD	_	3	auxpass	_	_
3	exposed	_	VBN	VBN	_	0	root	_	_
4	to	_	TO	TO	_	10	case	_	_
5	1	_	CD	CD	_	10	nummod	_	_
6	mumol	_	JJ	JJ	_	10	amod	_	_
7	X	_	NNP	NNP	_	10	compound	_	_
8	litre-1	_	JJ	JJ	_	10	amod	_	_
10	-	_	NNS	NNS	_	3	nmod	_	_
13	isoprenaline	_	NN	NN	_	10	dep	_	_
14	for	_	IN	IN	_	16	case	_	_
15	30	_	CD	CD	_	16	nummod	_	_
16	min	_	NN	NN	_	13	nmod	_	_
18	4	_	CD	CD	_	19	nummod	_	_
19	h	_	NN	NN	_	16	conj	_	_
21	and	_	CC	CC	_	16	cc	_	_
22	16	_	CD	CD	_	23	nummod	_	_
23	h	_	NN	NN	_	16	conj	_	_

1	In	_	IN	IN	_	3	case	_	_
2	myocyte	_	JJ	JJ	_	3	amod	_	_
3	membranes	_	NNS	NNS	_	12	nmod	_	_
4	mean	_	NN	NN	_	12	nsubj	_	_
6	SEM	_	NNP	NNP	_	4	appos	_	_
9	125I-iodocyanopindolol	_	JJ	JJ	_	10	amod	_	_
10	binding	_	JJ	JJ	_	4	amod	_	_
11	was	_	VBD	VBD	_	12	cop	_	_
12	167	_	CD	CD	_	0	root	_	_
14	46	_	CD	CD	_	12	appos	_	_
16	pmol	_	JJ	JJ	_	17	amod	_	_
17	X	_	NNP	NNP	_	12	dep	_	_
18	litre-1	_	CD	CD	_	17	nummod	_	_
20	n	_	VBN	VBN	_	12	dep	_	_
21	=	_	SYM	SYM	_	22	dep	_	_
22	5	_	CD	CD	_	20	ccomp	_	_
24	and	_	CC	CC	_	12	cc	_	_
25	did	_	VBD	VBD	_	27	aux	_	_
26	not	_	RB	RB	_	27	neg	_	_
27	differ	_	VB	VB	_	12	conj	_	_
28	at	_	IN	IN	_	30	case	_	_
29	30	_	CD	CD	_	30	nummod	_	_
30	min	_	NN	NN	_	27	nmod	_	_
32	4	_	CD	CD	_	33	nummod	_	_
33	h	_	NN	NN	_	30	conj	_	_
35	or	_	CC	CC	_	30	cc	_	_
36	16	_	CD	CD	_	37	nummod	_	_
37	h	_	NN	NN	_	30	conj	_	_
38	in	_	IN	IN	_	39	case	_	_
39	control	_	NN	NN	_	37	nmod	_	_
40	compared	_	VBN	VBN	_	43	case	_	_
41	with	_	IN	IN	_	43	case	_	_
43	-	_	NNP	NNP	_	27	advcl	_	_
46	isoprenaline	_	NN	NN	_	43	dep	_	_
47	treated	_	VBN	VBN	_	46	acl	_	_
48	cells	_	NNS	NNS	_	47	dobj	_	_

1	The	_	DT	DT	_	3	det	_	_
2	maximum	_	JJ	JJ	_	3	amod	_	_
3	number	_	NN	NN	_	8	nsubj	_	_
4	of	_	IN	IN	_	6	case	_	_
5	binding	_	JJ	JJ	_	6	amod	_	_
6	sites	_	NNS	NNS	_	3	nmod	_	_
7	was	_	VBD	VBD	_	8	cop	_	_
8	84	_	CD	CD	_	34	dep	_	_
10	32	_	CD	CD	_	8	appos	_	_
12	fmol	_	NNP	NNP	_	13	compound	_	_
13	X	_	NNP	NNP	_	14	nsubj	_	_
14	mg	_	VBP	VBP	_	8	acl:relcl	_	_
15	protein-1	_	NN	NN	_	14	dobj	_	_
16	and	_	CC	CC	_	14	cc	_	_
17	was	_	VBD	VBD	_	18	cop	_	_
18	unchanged	_	JJ	JJ	_	14	conj	_	_
19	at	_	IN	IN	_	21	case	_	_
20	30	_	CD	CD	_	21	nummod	_	_
21	min	_	NN	NN	_	18	nmod	_	_
23	but	_	CC	CC	_	8	cc	_	_
25	-	_	NNP	NNP	_	30	nsubj	_	_
28	isoprenaline	_	NN	NN	_	25	dep	_	_
29	stimulated	_	VBN	VBN	_	28	acl	_	_
30	adenylate	_	VBP	VBP	_	8	conj	_	_
31	cyclase	_	JJ	JJ	_	32	amod	_	_
32	activity	_	NN	NN	_	30	dobj	_	_
33	significantly	_	RB	RB	_	30	advmod	_	_
34	decreased	_	VBD	VBD	_	0	root	_	_
35	from	_	IN	IN	_	36	case	_	_
36	221	_	CD	CD	_	34	nmod	_	_
38	62	_	CD	CD	_	36	appos	_	_
40	to	_	TO	TO	_	41	case	_	_
41	103	_	CD	CD	_	34	nmod	_	_
43	37	_	CD	CD	_	34	dep	_	_
45	pmol	_	JJ	JJ	_	48	amod	_	_
46	X	_	NNP	NNP	_	48	compound	_	_
47	mg	_	NN	NN	_	48	compound	_	_
48	protein-1	_	NNS	NNS	_	34	nsubj	_	_
49	30	_	CD	CD	_	50	compound	_	_
50	min-1	_	JJ	JJ	_	48	amod	_	_

2	-	_	NNP	NNP	_	11	dep	_	_
5	Isoprenaline	_	JJ	JJ	_	7	amod	_	_
6	competition	_	NN	NN	_	7	compound	_	_
7	curves	_	NNS	NNS	_	11	nsubj	_	_
8	at	_	IN	IN	_	10	case	_	_
9	30	_	CD	CD	_	10	nummod	_	_
10	min	_	NN	NN	_	7	nmod	_	_
11	showed	_	VBD	VBD	_	0	root	_	_
12	a	_	DT	DT	_	14	det	_	_
13	significant	_	JJ	JJ	_	14	amod	_	_
14	increase	_	NN	NN	_	11	dobj	_	_
15	in	_	IN	IN	_	17	case	_	_
16	the	_	DT	DT	_	17	det	_	_
17	proportion	_	NN	NN	_	11	nmod	_	_
18	of	_	IN	IN	_	22	case	_	_
19	low	_	JJ	JJ	_	22	amod	_	_
20	affinity	_	RB	RB	_	21	advmod	_	_
21	binding	_	JJ	JJ	_	22	amod	_	_
22	sites	_	NNS	NNS	_	17	nmod	_	_
23	from	_	IN	IN	_	28	case	_	_
24	46	_	CD	CD	_	28	compound	_	_
25	%	_	NN	NN	_	28	dep	_	_
26	to	_	TO	TO	_	28	dep	_	_
27	62	_	CD	CD	_	28	compound	_	_
28	%	_	NN	NN	_	11	nmod	_	_
30	n	_	VBN	VBN	_	11	dep	_	_
31	=	_	SYM	SYM	_	32	dep	_	_
32	5	_	CD	CD	_	30	ccomp	_	_

1	By	_	IN	IN	_	3	case	_	_
2	4	_	CD	CD	_	3	nummod	_	_
3	h	_	NN	NN	_	12	nmod	_	_
4	the	_	DT	DT	_	6	det	_	_
5	maximum	_	JJ	JJ	_	6	amod	_	_
6	number	_	NN	NN	_	12	nsubjpass	_	_
7	of	_	IN	IN	_	9	case	_	_
8	binding	_	JJ	JJ	_	9	amod	_	_
9	sites	_	NNS	NNS	_	6	nmod	_	_
10	was	_	VBD	VBD	_	12	auxpass	_	_
11	significantly	_	RB	RB	_	12	advmod	_	_
12	decreased	_	VBN	VBN	_	0	root	_	_
13	by	_	IN	IN	_	15	case	_	_
14	54	_	CD	CD	_	15	nummod	_	_
15	%	_	NN	NN	_	12	nmod	_	_
17	adenylate	_	JJ	JJ	_	19	amod	_	_
18	cyclase	_	NN	NN	_	19	compound	_	_
19	activity	_	NN	NN	_	20	nsubj	_	_
20	remained	_	VBD	VBD	_	12	dep	_	_
21	depressed	_	JJ	JJ	_	20	xcomp	_	_
23	and	_	CC	CC	_	12	cc	_	_
24	agonist	_	NN	NN	_	26	nsubj	_	_
25	affinity	_	RB	RB	_	26	advmod	_	_
26	decreased	_	VBD	VBD	_	12	conj	_	_
27	threefold	_	RB	RB	_	26	advmod	_	_
28	in	_	IN	IN	_	31	case	_	_
29	the	_	DT	DT	_	31	det	_	_
31	-	_	NN	NN	_	26	nmod	_	_
34	isoprenaline	_	NN	NN	_	31	dep	_	_
35	treated	_	VBN	VBN	_	34	acl	_	_
36	cells	_	NNS	NNS	_	35	dobj	_	_

1	At	_	IN	IN	_	3	case	_	_
2	16	_	CD	CD	_	3	nummod	_	_
3	h	_	NN	NN	_	9	nmod	_	_
5	-	_	NNP	NNP	_	3	appos	_	_
8	isoprenaline	_	NN	NN	_	9	nsubj	_	_
9	treated	_	VBD	VBD	_	0	root	_	_
10	cells	_	NNS	NNS	_	11	nsubj	_	_
11	showed	_	VBD	VBD	_	9	ccomp	_	_
12	alterations	_	NNS	NNS	_	11	iobj	_	_
13	similar	_	JJ	JJ	_	38	amod	_	_
14	to	_	TO	TO	_	18	case	_	_
15	the	_	DT	DT	_	18	det	_	_
16	4	_	CD	CD	_	18	nummod	_	_
17	h	_	NN	NN	_	18	compound	_	_
18	values	_	NNS	NNS	_	13	nmod	_	_
19	in	_	IN	IN	_	22	case	_	_
20	the	_	DT	DT	_	22	det	_	_
21	maximum	_	JJ	JJ	_	22	amod	_	_
22	number	_	NN	NN	_	18	nmod	_	_
23	of	_	IN	IN	_	25	case	_	_
24	binding	_	JJ	JJ	_	25	amod	_	_
25	sites	_	NNS	NNS	_	22	nmod	_	_
27	adenylate	_	JJ	JJ	_	29	amod	_	_
28	cyclase	_	NN	NN	_	29	compound	_	_
29	activity	_	NN	NN	_	25	appos	_	_
31	and	_	CC	CC	_	13	cc	_	_
32	affinity	_	JJ	JJ	_	13	conj	_	_
33	for	_	IN	IN	_	32	nmod	_	_
35	-	_	NNP	NNP	_	32	dep	_	_
38	isoprenaline	_	NN	NN	_	11	dobj	_	_

2	-	_	NNP	NNP	_	10	dep	_	_
5	Isoprenaline	_	NNP	NNP	_	10	nsubj	_	_
6	stimulated	_	VBN	VBN	_	5	acl	_	_
7	adenylate	_	JJ	JJ	_	9	amod	_	_
8	cyclase	_	NN	NN	_	9	compound	_	_
9	activity	_	NN	NN	_	6	dobj	_	_
10	took	_	VBD	VBD	_	0	root	_	_
11	72	_	CD	CD	_	12	nummod	_	_
12	h	_	NN	NN	_	10	dobj	_	_
13	to	_	TO	TO	_	14	mark	_	_
14	recover	_	VB	VB	_	10	advcl	_	_
15	after	_	IN	IN	_	16	case	_	_
16	desensitisation	_	NN	NN	_	14	nmod	_	_

1	Overnight	_	JJ	JJ	_	2	amod	_	_
2	ultracentrifugation	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	5	case	_	_
4	the	_	DT	DT	_	5	det	_	_
5	cytosol	_	NN	NN	_	2	nmod	_	_
6	showed	_	VBD	VBD	_	0	root	_	_
7	a	_	DT	DT	_	11	det	_	_
8	significant	_	JJ	JJ	_	11	amod	_	_
9	40	_	CD	CD	_	10	compound	_	_
10	%	_	NN	NN	_	11	amod	_	_
11	increase	_	NN	NN	_	6	dobj	_	_
12	in	_	IN	IN	_	15	case	_	_
13	beta	_	JJ	JJ	_	15	amod	_	_
14	adrenoceptor	_	NN	NN	_	15	compound	_	_
15	density	_	NN	NN	_	11	nmod	_	_
16	in	_	IN	IN	_	17	case	_	_
17	cells	_	NNS	NNS	_	6	nmod	_	_
18	exposed	_	VBN	VBN	_	17	acl	_	_
19	to	_	TO	TO	_	21	case	_	_
21	-	_	NNP	NNP	_	18	nmod	_	_
24	isoprenaline	_	NN	NN	_	21	dep	_	_
25	for	_	IN	IN	_	27	case	_	_
26	4	_	CD	CD	_	27	nummod	_	_
27	h	_	NN	NN	_	24	nmod	_	_
29	n	_	VBN	VBN	_	24	dep	_	_
30	=	_	SYM	SYM	_	31	dep	_	_
31	5	_	CD	CD	_	29	ccomp	_	_
34	suggesting	_	VBG	VBG	_	24	acl	_	_
35	receptor	_	NN	NN	_	36	compound	_	_
36	internalisation	_	NN	NN	_	34	dobj	_	_

2	ABSTRACT	_	NNP	NNP	_	4	compound	_	_
3	TRUNCATED	_	NNP	NNP	_	4	compound	_	_
4	AT	_	NNP	NNP	_	9	dep	_	_
5	250	_	CD	CD	_	6	nummod	_	_
6	WORDS	_	NNS	NNS	_	4	dep	_	_
8	Comparative	_	JJ	JJ	_	9	amod	_	_
9	trial	_	NN	NN	_	11	nsubj	_	_
10	of	_	IN	IN	_	9	acl	_	_
11	shampoos	_	VBZ	VBZ	_	0	root	_	_
12	for	_	IN	IN	_	13	case	_	_
13	treatment	_	NN	NN	_	11	nmod	_	_
14	of	_	IN	IN	_	15	case	_	_
15	head_infestation	_	NN	NN	_	13	nmod	_	_

1	-LSB-	_	NNP	NNP	_	2	compound	_	_
2	AIDS	_	NNP	NNP	_	0	root	_	_
4	a	_	DT	DT	_	5	det	_	_
5	threat	_	NN	NN	_	2	dep	_	_
6	to	_	TO	TO	_	9	case	_	_
7	public	_	JJ	JJ	_	9	amod	_	_
8	health	_	NN	NN	_	9	compound	_	_
9	-RSB-	_	NNS	NNS	_	5	nmod	_	_

1	Availability	_	NNP	NNP	_	6	nsubj	_	_
2	to	_	TO	TO	_	3	case	_	_
3	patients	_	NNS	NNS	_	1	nmod	_	_
4	of	_	IN	IN	_	5	case	_	_
5	health	_	NN	NN	_	3	nmod	_	_
6	care	_	VBP	VBP	_	0	root	_	_
7	providers	_	NNS	NNS	_	10	nmod:poss	_	_
8	'	_	POS	POS	_	7	case	_	_
9	fee	_	NN	NN	_	10	compound	_	_
10	schedules	_	NNS	NNS	_	6	dobj	_	_

1	The	_	DT	DT	_	2	det	_	_
2	stereochemistry	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	5	case	_	_
4	the	_	DT	DT	_	5	det	_	_
5	reactions	_	NNS	NNS	_	2	nmod	_	_
6	of	_	IN	IN	_	7	case	_	_
7	lipoxygenases	_	NNS	NNS	_	2	nmod	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	their	_	PRP$	PRP$	_	10	nmod:poss	_	_
10	metabolites	_	NNS	NNS	_	7	conj	_	_

1	Proposed	_	JJ	JJ	_	2	amod	_	_
2	nomenclature	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	7	case	_	_
4	lipoxygenases	_	JJ	JJ	_	7	amod	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	related	_	VBN	VBN	_	4	conj	_	_
7	enzymes	_	NNS	NNS	_	2	nmod	_	_

1	AIDS	_	NNP	NNP	_	6	nsubj	_	_
2	complicated	_	VBN	VBN	_	1	acl	_	_
3	by	_	IN	IN	_	4	case	_	_
4	syphilis	_	NNS	NNS	_	2	nmod	_	_
5	can	_	MD	MD	_	6	aux	_	_
6	mimic	_	VB	VB	_	0	root	_	_
7	uveitis	_	NNS	NNS	_	6	dobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	Crohn	_	NNP	NNP	_	12	nmod:poss	_	_
10	's	_	POS	POS	_	9	case	_	_
11	_	_	JJ	JJ	_	12	amod	_	_
12	disease	_	NN	NN	_	7	conj	_	_

1	Case	_	NNP	NNP	_	2	nsubj	_	_
2	report	_	VBP	VBP	_	0	root	_	_

1	Brightness-sense	_	JJ	JJ	_	0	root	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	optic_nerve_disease	_	JJ	JJ	_	1	conj	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	describe	_	VBP	VBP	_	0	root	_	_
3	a	_	DT	DT	_	5	det	_	_
4	simple	_	JJ	JJ	_	5	amod	_	_
5	device	_	NN	NN	_	2	dobj	_	_
6	used	_	VBN	VBN	_	5	acl	_	_
7	to	_	TO	TO	_	8	mark	_	_
8	compare	_	VB	VB	_	6	xcomp	_	_
9	the	_	DT	DT	_	10	det	_	_
10	sense	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	12	case	_	_
12	brightness	_	NNS	NNS	_	10	nmod	_	_
13	in	_	IN	IN	_	16	case	_	_
14	the	_	DT	DT	_	16	det	_	_
15	two	_	CD	CD	_	16	nummod	_	_
16	eyes	_	NNS	NNS	_	12	nmod	_	_

1	An	_	DT	DT	_	2	det	_	_
2	investigation	_	NN	NN	_	23	nsubj	_	_
3	of	_	IN	IN	_	4	case	_	_
4	brightness-sense	_	NN	NN	_	2	nmod	_	_
5	with	_	IN	IN	_	7	case	_	_
6	this	_	DT	DT	_	7	det	_	_
7	device	_	NN	NN	_	4	nmod	_	_
8	in	_	IN	IN	_	10	case	_	_
9	normal	_	JJ	JJ	_	10	amod	_	_
10	persons	_	NNS	NNS	_	7	nmod	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	patients	_	NNS	NNS	_	10	conj	_	_
13	with	_	IN	IN	_	18	case	_	_
14	optic_nerve_disease	_	NN	NN	_	18	compound	_	_
16	maculopathies	_	NNS	NNS	_	18	dep	_	_
18	cataract	_	NN	NN	_	10	nmod	_	_
20	and	_	CC	CC	_	18	cc	_	_
21	factitious	_	NN	NN	_	22	compound	_	_
22	visual_impairment	_	NN	NN	_	18	conj	_	_
23	shows	_	VBZ	VBZ	_	0	root	_	_
24	that	_	IN	IN	_	28	mark	_	_
25	brightness	_	JJ	JJ	_	26	amod	_	_
26	testing	_	NN	NN	_	28	nsubj	_	_
27	can	_	MD	MD	_	28	aux	_	_
28	provide	_	VB	VB	_	23	ccomp	_	_
29	useful	_	JJ	JJ	_	30	amod	_	_
30	information	_	NN	NN	_	28	dobj	_	_
31	supplementary	_	JJ	JJ	_	30	amod	_	_
32	and	_	CC	CC	_	31	cc	_	_
33	complementary	_	JJ	JJ	_	31	conj	_	_
34	to	_	TO	TO	_	36	case	_	_
35	conventional	_	JJ	JJ	_	36	amod	_	_
36	clinical	_	JJ	JJ	_	28	nmod	_	_
37	and	_	CC	CC	_	36	cc	_	_
38	laboratory	_	NN	NN	_	39	compound	_	_
39	investigations	_	NNS	NNS	_	36	conj	_	_

1	Impairment	_	NNP	NNP	_	7	nsubj	_	_
2	of	_	IN	IN	_	3	case	_	_
3	brightness-sense	_	NN	NN	_	1	nmod	_	_
4	was	_	VBD	VBD	_	7	cop	_	_
5	a	_	DT	DT	_	7	det	_	_
6	consistent	_	JJ	JJ	_	7	amod	_	_
7	finding	_	NN	NN	_	0	root	_	_
8	among	_	IN	IN	_	9	case	_	_
9	patients	_	NNS	NNS	_	7	nmod	_	_
10	with	_	IN	IN	_	11	case	_	_
11	optic_neuropathies	_	NNS	NNS	_	9	nmod	_	_
12	and	_	CC	CC	_	7	cc	_	_
14	in	_	IN	IN	_	16	case	_	_
15	some	_	DT	DT	_	16	det	_	_
16	cases	_	NNS	NNS	_	20	nmod	_	_
18	brightness	_	JJ	JJ	_	19	amod	_	_
19	testing	_	NN	NN	_	20	nsubj	_	_
20	appeared	_	VBD	VBD	_	7	conj	_	_
21	to	_	TO	TO	_	24	mark	_	_
22	be	_	VB	VB	_	24	cop	_	_
23	more	_	RBR	RBR	_	24	advmod	_	_
24	sensitive	_	JJ	JJ	_	20	xcomp	_	_
25	than	_	IN	IN	_	27	case	_	_
26	other	_	JJ	JJ	_	27	amod	_	_
27	techniques	_	NNS	NNS	_	24	nmod	_	_
28	in	_	IN	IN	_	29	mark	_	_
29	establishing	_	VBG	VBG	_	24	advcl	_	_
30	the	_	DT	DT	_	31	det	_	_
31	presence	_	NN	NN	_	29	dobj	_	_
32	of	_	IN	IN	_	33	case	_	_
33	disease	_	NN	NN	_	31	nmod	_	_

1	Brightness-sense	_	NNP	NNP	_	4	nsubjpass	_	_
2	was	_	VBD	VBD	_	4	auxpass	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	used	_	VBN	VBN	_	0	root	_	_
5	to	_	TO	TO	_	6	mark	_	_
6	monitor	_	VB	VB	_	4	xcomp	_	_
7	the	_	DT	DT	_	8	det	_	_
8	course	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	13	case	_	_
10	the	_	DT	DT	_	11	det	_	_
11	patient	_	NN	NN	_	13	nmod:poss	_	_
12	's	_	POS	POS	_	11	case	_	_
13	illness	_	NN	NN	_	8	nmod	_	_

1	Abnormalities	_	NNS	NNS	_	4	nsubjpass	_	_
2	were	_	VBD	VBD	_	4	auxpass	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	found	_	VBN	VBN	_	0	root	_	_
5	among	_	IN	IN	_	7	case	_	_
6	some	_	DT	DT	_	7	det	_	_
7	patients	_	NNS	NNS	_	4	nmod	_	_
8	with	_	IN	IN	_	10	case	_	_
9	unilateral	_	JJ	JJ	_	10	amod	_	_
10	maculopathies	_	NNS	NNS	_	7	nmod	_	_
12	but	_	CC	CC	_	4	cc	_	_
13	significant	_	JJ	JJ	_	15	amod	_	_
14	intereye	_	NN	NN	_	15	compound	_	_
15	differences	_	NNS	NNS	_	20	nsubjpass	_	_
16	in	_	IN	IN	_	17	case	_	_
17	brightness-sense	_	NN	NN	_	15	nmod	_	_
18	were	_	VBD	VBD	_	20	auxpass	_	_
19	not	_	RB	RB	_	20	neg	_	_
20	encountered	_	VBN	VBN	_	4	conj	_	_
21	among	_	IN	IN	_	23	case	_	_
22	normal	_	JJ	JJ	_	23	amod	_	_
23	persons	_	NNS	NNS	_	20	nmod	_	_
24	or	_	CC	CC	_	23	cc	_	_
25	patients	_	NNS	NNS	_	23	conj	_	_
26	with	_	IN	IN	_	27	case	_	_
27	cataracts	_	NNS	NNS	_	20	nmod	_	_

1	Patients	_	NNS	NNS	_	5	nsubj	_	_
2	with	_	IN	IN	_	4	case	_	_
3	factitious	_	JJ	JJ	_	4	amod	_	_
4	visual_loss	_	NNS	NNS	_	1	nmod	_	_
5	gave	_	VBD	VBD	_	0	root	_	_
6	variable	_	JJ	JJ	_	7	amod	_	_
7	responses	_	NNS	NNS	_	5	dobj	_	_
9	and	_	CC	CC	_	5	cc	_	_
10	the	_	DT	DT	_	11	det	_	_
11	nature	_	NN	NN	_	17	nsubjpass	_	_
12	of	_	IN	IN	_	14	case	_	_
13	their	_	PRP$	PRP$	_	14	nmod:poss	_	_
14	disorder	_	NN	NN	_	11	nmod	_	_
15	could	_	MD	MD	_	17	aux	_	_
16	be	_	VB	VB	_	17	auxpass	_	_
17	identified	_	VBN	VBN	_	5	conj	_	_
18	by	_	IN	IN	_	20	case	_	_
19	the	_	DT	DT	_	20	det	_	_
20	inconsistency	_	NN	NN	_	17	nmod	_	_
21	of	_	IN	IN	_	23	case	_	_
22	their	_	PRP$	PRP$	_	23	nmod:poss	_	_
23	responses	_	NNS	NNS	_	20	nmod	_	_

1	Leukotrienes	_	NNS	NNS	_	0	root	_	_
2	in	_	IN	IN	_	3	case	_	_
3	aqueous_humor	_	NN	NN	_	1	nmod	_	_
4	of	_	IN	IN	_	5	case	_	_
5	patients	_	NNS	NNS	_	1	nmod	_	_
6	with	_	IN	IN	_	7	case	_	_
7	uveitis	_	NNS	NNS	_	5	nmod	_	_

1	Evidence	_	NN	NN	_	6	nsubj	_	_
2	that	_	DT	DT	_	3	det	_	_
3	myoglobin	_	NN	NN	_	1	dep	_	_
4	does	_	VBZ	VBZ	_	6	aux	_	_
5	not	_	RB	RB	_	6	neg	_	_
6	support	_	VB	VB	_	0	root	_	_
7	heart	_	NN	NN	_	8	compound	_	_
8	performance	_	NN	NN	_	6	dobj	_	_
9	at	_	IN	IN	_	11	case	_	_
10	maximal	_	JJ	JJ	_	11	amod	_	_
11	levels	_	NNS	NNS	_	6	nmod	_	_
12	of	_	IN	IN	_	14	case	_	_
13	oxygen	_	NN	NN	_	14	compound	_	_
14	demand	_	NN	NN	_	11	nmod	_	_

1	Studies	_	NNS	NNS	_	0	root	_	_
2	on	_	IN	IN	_	5	case	_	_
3	the	_	DT	DT	_	5	det	_	_
4	uptake	_	JJ	JJ	_	5	amod	_	_
5	mechanism	_	NN	NN	_	1	nmod	_	_
6	of	_	IN	IN	_	7	case	_	_
7	liposomes	_	NNS	NNS	_	1	nmod	_	_
8	by	_	IN	IN	_	11	case	_	_
9	perfused	_	JJ	JJ	_	11	amod	_	_
10	rat	_	NN	NN	_	11	compound	_	_
11	liver	_	NN	NN	_	7	nmod	_	_

1	II	_	NNP	NNP	_	0	root	_	_

1	An	_	DT	DT	_	3	det	_	_
2	indispensable	_	JJ	JJ	_	3	amod	_	_
3	factor	_	NN	NN	_	6	nsubj	_	_
4	for	_	IN	IN	_	5	case	_	_
5	liver	_	NN	NN	_	3	nmod	_	_
6	uptake	_	VBP	VBP	_	0	root	_	_
7	in	_	IN	IN	_	8	case	_	_
8	serum	_	NN	NN	_	6	nmod	_	_

1	Aztreonam	_	NNP	NNP	_	0	root	_	_
3	absence	_	NN	NN	_	1	dep	_	_
4	of	_	IN	IN	_	5	case	_	_
5	neuromuscular	_	NN	NN	_	3	nmod	_	_
6	blocking	_	VBG	VBG	_	5	acl	_	_
7	activity	_	NN	NN	_	6	dobj	_	_

1	Marketing	_	NNP	NNP	_	0	root	_	_
2	your	_	PRP$	PRP$	_	3	nmod:poss	_	_
3	hospital	_	NN	NN	_	1	dep	_	_

1	Contact	_	NN	NN	_	2	compound	_	_
2	ultrasonography	_	NN	NN	_	8	nsubj	_	_
3	in	_	IN	IN	_	5	case	_	_
4	the	_	DT	DT	_	5	det	_	_
5	detection	_	NN	NN	_	2	nmod	_	_
6	of	_	IN	IN	_	7	case	_	_
7	liver	_	NN	NN	_	5	nmod	_	_
8	metastases	_	VBZ	VBZ	_	0	root	_	_
9	from	_	IN	IN	_	10	case	_	_
10	colorectal_cancer	_	NN	NN	_	8	nmod	_	_
12	an	_	DT	DT	_	15	det	_	_
13	in	_	IN	IN	_	14	dep	_	_
14	vitro	_	NN	NN	_	15	amod	_	_
15	study	_	NN	NN	_	10	dep	_	_

1	A	_	DT	DT	_	4	det	_	_
2	modified	_	VBN	VBN	_	4	amod	_	_
3	saturation-recovery	_	JJ	JJ	_	4	amod	_	_
4	approximation	_	NN	NN	_	9	nsubj	_	_
5	for	_	IN	IN	_	8	case	_	_
6	multiple	_	JJ	JJ	_	8	amod	_	_
7	spin-echo	_	JJ	JJ	_	8	amod	_	_
8	pulse	_	NN	NN	_	4	nmod	_	_
9	sequences	_	VBZ	VBZ	_	0	root	_	_

1	In	_	IN	IN	_	3	mark	_	_
2	equations	_	NNS	NNS	_	3	nsubj	_	_
3	describing	_	VBG	VBG	_	14	advcl	_	_
4	multiple	_	JJ	JJ	_	7	amod	_	_
5	spin-echo	_	JJ	JJ	_	7	amod	_	_
6	pulse	_	NN	NN	_	7	compound	_	_
7	sequences	_	NNS	NNS	_	3	dobj	_	_
9	the	_	DT	DT	_	11	det	_	_
10	T1	_	NNP	NNP	_	11	compound	_	_
11	dependence	_	NN	NN	_	14	nsubjpass	_	_
12	is	_	VBZ	VBZ	_	14	auxpass	_	_
13	often	_	RB	RB	_	14	advmod	_	_
14	approximated	_	VBN	VBN	_	0	root	_	_
15	by	_	IN	IN	_	18	case	_	_
16	a	_	DT	DT	_	18	det	_	_
17	saturation-recovery	_	JJ	JJ	_	18	amod	_	_
18	expression	_	NN	NN	_	14	nmod	_	_
20	which	_	WDT	WDT	_	22	nsubj	_	_
21	is	_	VBZ	VBZ	_	22	cop	_	_
22	valid	_	JJ	JJ	_	18	acl:relcl	_	_
23	only	_	RB	RB	_	22	advmod	_	_
24	when	_	WRB	WRB	_	31	advmod	_	_
25	the	_	DT	DT	_	28	det	_	_
26	repetition	_	NN	NN	_	28	compound	_	_
27	time	_	NN	NN	_	28	compound	_	_
28	TR	_	NNP	NNP	_	31	nsubj	_	_
29	is	_	VBZ	VBZ	_	31	cop	_	_
30	much	_	RB	RB	_	31	advmod	_	_
31	greater	_	JJR	JJR	_	22	advcl	_	_
32	than	_	IN	IN	_	34	case	_	_
33	the	_	DT	DT	_	34	det	_	_
34	time	_	NN	NN	_	31	nmod	_	_
35	required	_	VBN	VBN	_	34	acl	_	_
36	for	_	IN	IN	_	38	case	_	_
37	the	_	DT	DT	_	38	det	_	_
38	echoes	_	NNS	NNS	_	35	nmod	_	_

1	A	_	DT	DT	_	3	det	_	_
2	slight	_	JJ	JJ	_	3	amod	_	_
3	modification	_	NN	NN	_	8	nsubj	_	_
4	of	_	IN	IN	_	6	case	_	_
5	this	_	DT	DT	_	6	det	_	_
6	approximation	_	NN	NN	_	3	nmod	_	_
7	greatly	_	RB	RB	_	8	advmod	_	_
8	increases	_	VBZ	VBZ	_	0	root	_	_
9	its	_	PRP$	PRP$	_	10	nmod:poss	_	_
10	accuracy	_	NN	NN	_	8	dobj	_	_
11	for	_	IN	IN	_	14	case	_	_
12	small	_	JJ	JJ	_	14	amod	_	_
13	TR	_	NNP	NNP	_	14	compound	_	_
14	values	_	NNS	NNS	_	8	nmod	_	_

1	-LSB-	_	JJ	JJ	_	2	amod	_	_
2	Diagnosis	_	NN	NN	_	9	nsubj	_	_
3	of	_	IN	IN	_	4	case	_	_
4	lymphoma	_	NN	NN	_	2	nmod	_	_
5	of	_	IN	IN	_	8	case	_	_
6	the	_	DT	DT	_	8	det	_	_
7	small	_	JJ	JJ	_	8	amod	_	_
8	intestine	_	NN	NN	_	4	nmod	_	_
9	-RSB-	_	VBZ	VBZ	_	0	root	_	_

1	A	_	DT	DT	_	4	det	_	_
2	human	_	JJ	JJ	_	4	amod	_	_
3	monoclonal	_	JJ	JJ	_	4	amod	_	_
4	antibody	_	NN	NN	_	5	nsubj	_	_
5	produced	_	VBD	VBD	_	0	root	_	_
6	by	_	IN	IN	_	9	case	_	_
7	in	_	IN	IN	_	8	dep	_	_
8	vitro	_	NN	NN	_	9	amod	_	_
9	sensitization	_	NN	NN	_	5	nmod	_	_
10	of	_	IN	IN	_	12	case	_	_
11	human	_	JJ	JJ	_	12	amod	_	_
12	lymphocytes	_	NNS	NNS	_	9	nmod	_	_
13	with	_	IN	IN	_	15	case	_	_
14	an	_	DT	DT	_	15	det	_	_
15	antigen	_	NN	NN	_	5	nmod	_	_
16	from	_	IN	IN	_	17	case	_	_
17	urine	_	NN	NN	_	15	nmod	_	_
18	of	_	IN	IN	_	21	case	_	_
19	a	_	DT	DT	_	21	det	_	_
20	sarcoma	_	NN	NN	_	21	compound	_	_
21	patient	_	NN	NN	_	17	nmod	_	_

1	Population-dependent	_	JJ	JJ	_	2	amod	_	_
2	requirements	_	NNS	NNS	_	0	root	_	_
3	of	_	IN	IN	_	4	case	_	_
4	vitamin_B12	_	NNS	NNS	_	2	nmod	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	metabolically	_	RB	RB	_	7	advmod	_	_
7	related	_	VBN	VBN	_	8	amod	_	_
8	substances	_	NNS	NNS	_	4	conj	_	_
9	of	_	IN	IN	_	13	case	_	_
10	several	_	JJ	JJ	_	13	amod	_	_
11	mouse	_	NN	NN	_	13	compound	_	_
12	cell	_	NN	NN	_	13	compound	_	_
13	types	_	NNS	NNS	_	2	nmod	_	_
14	in	_	IN	IN	_	18	case	_	_
15	serum-free	_	JJ	JJ	_	18	amod	_	_
17	albumin-fortified	_	JJ	JJ	_	18	amod	_	_
18	medium	_	NN	NN	_	2	nmod	_	_

1	Mouse	_	NNP	NNP	_	3	compound	_	_
2	FM3A	_	NNP	NNP	_	3	compound	_	_
3	cells	_	NNS	NNS	_	4	nsubj	_	_
4	propagated	_	VBD	VBD	_	0	root	_	_
5	well	_	RB	RB	_	4	advmod	_	_
6	in	_	IN	IN	_	8	case	_	_
7	serum-free	_	JJ	JJ	_	8	amod	_	_
8	medium	_	NN	NN	_	4	nmod	_	_
9	containing	_	VBG	VBG	_	4	xcomp	_	_
10	0.5	_	CD	CD	_	11	compound	_	_
11	%	_	NN	NN	_	13	amod	_	_
12	serum	_	NN	NN	_	13	compound	_	_
13	albumin	_	NN	NN	_	9	dobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	1	_	CD	CD	_	16	nummod	_	_
16	microgram	_	NN	NN	_	13	conj	_	_
17	of	_	IN	IN	_	18	case	_	_
18	insulin/ml	_	NN	NN	_	16	nmod	_	_

1	The	_	DT	DT	_	6	det	_	_
2	vitamin_B12	_	NNP	NNP	_	6	compound	_	_
4	B12	_	NNP	NNP	_	6	appos	_	_
6	requirement	_	NN	NN	_	10	nsubj	_	_
7	of	_	IN	IN	_	9	case	_	_
8	the	_	DT	DT	_	9	det	_	_
9	cells	_	NNS	NNS	_	6	nmod	_	_
10	depended	_	VBD	VBD	_	0	root	_	_
11	on	_	IN	IN	_	14	case	_	_
12	the	_	DT	DT	_	14	det	_	_
13	population	_	NN	NN	_	14	compound	_	_
14	density	_	NN	NN	_	10	nmod	_	_

1	This	_	DT	DT	_	2	det	_	_
2	requirement	_	NN	NN	_	3	nsubj	_	_
3	disappeared	_	VBD	VBD	_	0	root	_	_
4	when	_	WRB	WRB	_	11	advmod	_	_
5	a	_	DT	DT	_	9	det	_	_
6	sufficiently	_	RB	RB	_	7	advmod	_	_
7	large	_	JJ	JJ	_	9	amod	_	_
8	cell	_	NN	NN	_	9	compound	_	_
9	population	_	NN	NN	_	11	nsubj	_	_
10	was	_	VBD	VBD	_	11	cop	_	_
11	present	_	JJ	JJ	_	3	advcl	_	_

1	A	_	DT	DT	_	2	det	_	_
2	combination	_	NN	NN	_	13	nsubj	_	_
3	of	_	IN	IN	_	5	case	_	_
4	1-100	_	CD	CD	_	5	nummod	_	_
5	ng	_	NN	NN	_	2	nmod	_	_
6	of	_	IN	IN	_	7	case	_	_
7	B12/ml	_	NNS	NNS	_	5	nmod	_	_
8	and	_	CC	CC	_	5	cc	_	_
9	4	_	CD	CD	_	10	nummod	_	_
10	micrograms	_	NNS	NNS	_	5	conj	_	_
11	of	_	IN	IN	_	12	case	_	_
12	hypoxanthine/ml	_	NN	NN	_	10	nmod	_	_
13	resulted	_	VBD	VBD	_	0	root	_	_
14	in	_	IN	IN	_	17	case	_	_
15	a	_	DT	DT	_	17	det	_	_
16	synergistic	_	JJ	JJ	_	17	amod	_	_
17	increase	_	NN	NN	_	13	nmod	_	_
18	in	_	IN	IN	_	20	case	_	_
19	cell	_	NN	NN	_	20	compound	_	_
20	growth	_	NN	NN	_	17	nmod	_	_
21	at	_	IN	IN	_	24	case	_	_
22	low	_	JJ	JJ	_	24	amod	_	_
23	cell	_	NN	NN	_	24	compound	_	_
24	densities	_	NNS	NNS	_	13	nmod	_	_

1	A	_	DT	DT	_	4	det	_	_
2	similar	_	JJ	JJ	_	4	amod	_	_
3	growth	_	NN	NN	_	4	compound	_	_
4	response	_	NN	NN	_	6	nsubjpass	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	obtained	_	VBN	VBN	_	0	root	_	_
7	when	_	WRB	WRB	_	13	advmod	_	_
8	the	_	DT	DT	_	11	det	_	_
9	B12	_	NNP	NNP	_	11	compound	_	_
10	plus	_	NN	NN	_	11	compound	_	_
11	hypoxanthine	_	NN	NN	_	13	nsubjpass	_	_
12	was	_	VBD	VBD	_	13	auxpass	_	_
13	replaced	_	VBN	VBN	_	6	advcl	_	_
14	by	_	IN	IN	_	16	case	_	_
15	4	_	CD	CD	_	16	nummod	_	_
16	micrograms	_	NNS	NNS	_	13	nmod	_	_
17	of	_	IN	IN	_	18	case	_	_
18	hypoxanthine/ml	_	NN	NN	_	16	nmod	_	_
19	in	_	IN	IN	_	20	case	_	_
20	combination	_	NN	NN	_	18	nmod	_	_
21	with	_	IN	IN	_	23	case	_	_
22	100	_	CD	CD	_	23	nummod	_	_
23	ng	_	NN	NN	_	13	nmod	_	_
24	of	_	IN	IN	_	25	case	_	_
25	thymidine/ml	_	NN	NN	_	23	nmod	_	_
27	1	_	CD	CD	_	28	nummod	_	_
28	microgram	_	NN	NN	_	23	conj	_	_
29	of	_	IN	IN	_	32	case	_	_
30	folic_acid	_	JJ	JJ	_	32	amod	_	_
31	/	_	JJ	JJ	_	32	amod	_	_
32	ml	_	NN	NN	_	28	nmod	_	_
33	or	_	CC	CC	_	23	cc	_	_
34	1	_	CD	CD	_	35	nummod	_	_
35	microgram	_	NN	NN	_	23	conj	_	_
36	of	_	IN	IN	_	39	case	_	_
37	folinic_acid	_	JJ	JJ	_	39	amod	_	_
38	/	_	JJ	JJ	_	39	amod	_	_
39	ml	_	NN	NN	_	35	nmod	_	_
41	even	_	RB	RB	_	51	advmod	_	_
42	though	_	IN	IN	_	51	mark	_	_
43	1	_	CD	CD	_	44	nummod	_	_
44	microgram	_	NN	NN	_	51	nsubj	_	_
45	of	_	IN	IN	_	48	case	_	_
46	folic_acid	_	JJ	JJ	_	48	amod	_	_
47	/	_	JJ	JJ	_	48	amod	_	_
48	ml	_	NN	NN	_	44	nmod	_	_
49	already	_	RB	RB	_	51	advmod	_	_
50	was	_	VBD	VBD	_	51	cop	_	_
51	present	_	JJ	JJ	_	13	advcl	_	_
52	in	_	IN	IN	_	54	case	_	_
53	the	_	DT	DT	_	54	det	_	_
54	medium	_	NN	NN	_	51	nmod	_	_

1	Experiments	_	NNS	NNS	_	6	nsubj	_	_
2	on	_	IN	IN	_	5	case	_	_
3	single	_	JJ	JJ	_	5	amod	_	_
4	cell	_	NN	NN	_	5	compound	_	_
5	inoculation	_	NN	NN	_	1	nmod	_	_
6	showed	_	VBD	VBD	_	0	root	_	_
7	that	_	IN	IN	_	21	mark	_	_
8	colony	_	NN	NN	_	9	compound	_	_
9	size	_	NN	NN	_	21	nsubj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	the	_	DT	DT	_	12	det	_	_
12	yield	_	NN	NN	_	9	conj	_	_
13	of	_	IN	IN	_	14	case	_	_
14	cells	_	NNS	NNS	_	12	nmod	_	_
15	grown	_	VBN	VBN	_	14	acl	_	_
16	in	_	IN	IN	_	18	case	_	_
17	B12-supplemented	_	NN	NN	_	18	compound	_	_
18	medium	_	NN	NN	_	15	nmod	_	_
19	were	_	VBD	VBD	_	21	cop	_	_
20	much	_	RB	RB	_	21	advmod	_	_
21	larger	_	JJR	JJR	_	6	ccomp	_	_
22	than	_	IN	IN	_	23	case	_	_
23	those	_	DT	DT	_	21	nmod	_	_
24	for	_	IN	IN	_	25	case	_	_
25	cells	_	NNS	NNS	_	23	nmod	_	_
26	grown	_	VBN	VBN	_	25	acl	_	_
27	in	_	IN	IN	_	29	case	_	_
28	B12-free	_	NN	NN	_	29	compound	_	_
29	medium	_	NN	NN	_	26	nmod	_	_

1	A	_	DT	DT	_	6	det	_	_
2	more	_	RBR	RBR	_	3	advmod	_	_
3	critical	_	JJ	JJ	_	6	amod	_	_
4	population-dependent	_	JJ	JJ	_	6	amod	_	_
5	B12	_	NN	NN	_	6	compound	_	_
6	requirement	_	NN	NN	_	8	nsubjpass	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	demonstrated	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	11	case	_	_
10	mouse	_	NNP	NNP	_	11	compound	_	_
11	Ehrlich	_	NNP	NNP	_	8	nmod	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	L	_	NNP	NNP	_	14	compound	_	_
14	cells	_	NNS	NNS	_	11	conj	_	_
15	and	_	CC	CC	_	11	cc	_	_
16	their	_	PRP$	PRP$	_	17	nmod:poss	_	_
17	hybrids	_	NNS	NNS	_	11	conj	_	_

1	At	_	IN	IN	_	5	case	_	_
2	less	_	JJR	JJR	_	4	advmod	_	_
3	than	_	IN	IN	_	2	mwe	_	_
4	100	_	CD	CD	_	5	nummod	_	_
5	cells	_	NNS	NNS	_	7	nmod	_	_
6	there	_	EX	EX	_	7	expl	_	_
7	was	_	VBD	VBD	_	0	root	_	_
8	no	_	DT	DT	_	9	neg	_	_
9	propagation	_	NN	NN	_	7	nsubj	_	_
10	in	_	IN	IN	_	12	case	_	_
11	serum-free	_	JJ	JJ	_	12	amod	_	_
12	medium	_	NN	NN	_	9	nmod	_	_
13	lacking	_	VBG	VBG	_	12	acl	_	_
14	B12	_	NNP	NNP	_	13	dobj	_	_
16	folinic_acid	_	JJ	JJ	_	14	amod	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	thymidine	_	JJ	JJ	_	16	conj	_	_
20	whereas	_	IN	IN	_	27	mark	_	_
22	a	_	DT	DT	_	25	det	_	_
23	satisfactory	_	JJ	JJ	_	25	amod	_	_
24	growth	_	NN	NN	_	25	compound	_	_
25	response	_	NN	NN	_	27	nsubjpass	_	_
26	was	_	VBD	VBD	_	27	auxpass	_	_
27	obtained	_	VBN	VBN	_	13	advcl	_	_
28	in	_	IN	IN	_	29	case	_	_
29	medium	_	NN	NN	_	27	nmod	_	_
30	supplemented	_	VBN	VBN	_	29	acl	_	_
31	with	_	IN	IN	_	33	case	_	_
32	these	_	DT	DT	_	33	det	_	_
33	substances	_	NNS	NNS	_	30	nmod	_	_

1	Human	_	JJ	JJ	_	4	amod	_	_
2	monoclonal	_	JJ	JJ	_	4	amod	_	_
3	anti-nuclear	_	JJ	JJ	_	4	amod	_	_
4	antibodies	_	NNS	NNS	_	5	nsubj	_	_
5	produced	_	VBD	VBD	_	0	root	_	_
6	by	_	IN	IN	_	8	case	_	_
7	human-mouse	_	JJ	JJ	_	8	amod	_	_
8	heterohybridomas	_	NNS	NNS	_	5	nmod	_	_

1	To	_	TO	TO	_	2	mark	_	_
2	obtain	_	VB	VB	_	11	advcl	_	_
3	human	_	JJ	JJ	_	6	amod	_	_
4	monoclonal	_	JJ	JJ	_	6	amod	_	_
5	anticentromere	_	NN	NN	_	6	compound	_	_
6	antibodies	_	NNS	NNS	_	2	dobj	_	_
8	mouse	_	NN	NN	_	9	compound	_	_
9	myelomas	_	NNS	NNS	_	11	nsubjpass	_	_
10	were	_	VBD	VBD	_	11	auxpass	_	_
11	fused	_	VBN	VBN	_	0	root	_	_
12	with	_	IN	IN	_	15	case	_	_
13	unfractionated	_	JJ	JJ	_	15	amod	_	_
14	mononuclear	_	NN	NN	_	15	compound	_	_
15	cells	_	NNS	NNS	_	11	nmod	_	_
16	from	_	IN	IN	_	19	case	_	_
17	the	_	DT	DT	_	19	det	_	_
18	peripheral	_	JJ	JJ	_	19	amod	_	_
19	blood	_	NN	NN	_	11	nmod	_	_
20	of	_	IN	IN	_	22	case	_	_
21	a	_	DT	DT	_	22	det	_	_
22	patient	_	NN	NN	_	19	nmod	_	_
23	diagnosed	_	VBN	VBN	_	22	acl	_	_
24	as	_	IN	IN	_	25	mark	_	_
25	having	_	VBG	VBG	_	23	advcl	_	_
26	the	_	DT	DT	_	28	det	_	_
27	CREST	_	JJ	JJ	_	28	amod	_	_
28	variant	_	NN	NN	_	25	dobj	_	_
29	of	_	IN	IN	_	30	case	_	_
30	scleroderma	_	NN	NN	_	28	nmod	_	_
32	with	_	IN	IN	_	35	case	_	_
33	only	_	JJ	JJ	_	35	amod	_	_
34	anticentromere	_	NN	NN	_	35	compound	_	_
35	antibodies	_	NNS	NNS	_	23	nmod	_	_

1	After	_	IN	IN	_	4	case	_	_
2	a	_	DT	DT	_	4	det	_	_
3	single	_	JJ	JJ	_	4	amod	_	_
4	fusion	_	NN	NN	_	24	nmod	_	_
5	an	_	DT	DT	_	6	det	_	_
6	heterohybridoma	_	NN	NN	_	24	nsubjpass	_	_
7	secreting	_	VBG	VBG	_	6	acl	_	_
8	a	_	DT	DT	_	11	det	_	_
9	human	_	JJ	JJ	_	11	amod	_	_
10	antibody	_	NN	NN	_	11	compound	_	_
11	specific	_	NN	NN	_	7	dobj	_	_
12	for	_	IN	IN	_	14	case	_	_
13	nuclear	_	JJ	JJ	_	14	amod	_	_
14	antigens	_	NNS	NNS	_	11	nmod	_	_
16	as	_	IN	IN	_	6	amod	_	_
17	detected	_	JJ	JJ	_	6	amod	_	_
18	by	_	IN	IN	_	21	case	_	_
19	indirect	_	JJ	JJ	_	21	amod	_	_
20	immunofluorescence	_	NN	NN	_	21	compound	_	_
21	staining	_	NN	NN	_	17	nmod	_	_
23	was	_	VBD	VBD	_	24	auxpass	_	_
24	isolated	_	VBN	VBN	_	0	root	_	_

1	The	_	DT	DT	_	3	det	_	_
2	monoclonal	_	JJ	JJ	_	3	amod	_	_
3	antibody	_	NN	NN	_	13	nsubj	_	_
4	secreted	_	VBN	VBN	_	3	acl	_	_
5	by	_	IN	IN	_	7	case	_	_
6	the	_	DT	DT	_	7	det	_	_
7	clone	_	NN	NN	_	4	nmod	_	_
8	was	_	VBD	VBD	_	13	cop	_	_
9	of	_	IN	IN	_	13	case	_	_
10	the	_	DT	DT	_	13	det	_	_
11	human	_	JJ	JJ	_	13	amod	_	_
12	IgM	_	NNP	NNP	_	13	compound	_	_
13	class	_	NN	NN	_	0	root	_	_

1	Indirect	_	JJ	JJ	_	3	amod	_	_
2	immunofluorescence	_	NN	NN	_	3	compound	_	_
3	staining	_	NN	NN	_	10	nsubj	_	_
4	of	_	IN	IN	_	6	case	_	_
5	the	_	DT	DT	_	6	det	_	_
6	antibody	_	NN	NN	_	3	nmod	_	_
7	on	_	IN	IN	_	9	case	_	_
8	HEp-2	_	NN	NN	_	9	compound	_	_
9	cells	_	NNS	NNS	_	6	nmod	_	_
10	showed	_	VBD	VBD	_	0	root	_	_
11	multiple	_	JJ	JJ	_	13	amod	_	_
12	nuclear	_	JJ	JJ	_	13	amod	_	_
13	dots	_	NNS	NNS	_	19	nsubj	_	_
14	or	_	CC	CC	_	13	cc	_	_
15	a	_	DT	DT	_	18	det	_	_
16	discrete	_	JJ	JJ	_	18	amod	_	_
17	speckled	_	JJ	JJ	_	18	amod	_	_
18	pattern	_	NN	NN	_	13	conj	_	_
19	resembling	_	VBG	VBG	_	10	dep	_	_
20	that	_	DT	DT	_	19	xcomp	_	_
21	of	_	IN	IN	_	24	case	_	_
22	an	_	DT	DT	_	24	det	_	_
23	anticentromere	_	JJ	JJ	_	24	amod	_	_
24	antibody	_	NN	NN	_	20	nmod	_	_

1	Immunoblot	_	JJ	JJ	_	2	amod	_	_
2	analysis	_	NN	NN	_	3	nsubj	_	_
3	showed	_	VBD	VBD	_	0	root	_	_
4	antibody	_	NN	NN	_	3	dobj	_	_
5	binding	_	JJ	JJ	_	4	amod	_	_
6	to	_	TO	TO	_	10	case	_	_
7	a	_	DT	DT	_	10	det	_	_
8	33	_	CD	CD	_	10	nummod	_	_
9	kD	_	NN	NN	_	10	compound	_	_
10	antigen	_	NN	NN	_	5	nmod	_	_
11	derived	_	VBN	VBN	_	10	acl	_	_
12	from	_	IN	IN	_	16	case	_	_
13	the	_	DT	DT	_	16	det	_	_
14	nuclear	_	JJ	JJ	_	16	amod	_	_
15	protein	_	NN	NN	_	16	compound	_	_
16	fraction	_	NN	NN	_	11	nmod	_	_

1	Enzyme-immunoassay	_	JJ	JJ	_	2	amod	_	_
2	results	_	NNS	NNS	_	4	nsubj	_	_
3	clearly	_	RB	RB	_	4	advmod	_	_
4	showed	_	VBD	VBD	_	0	root	_	_
5	that	_	IN	IN	_	8	mark	_	_
6	the	_	DT	DT	_	7	det	_	_
7	antibody	_	NN	NN	_	8	nsubj	_	_
8	reacted	_	VBD	VBD	_	4	ccomp	_	_
9	with	_	IN	IN	_	13	case	_	_
10	the	_	DT	DT	_	13	det	_	_
11	chromosomal	_	JJ	JJ	_	13	amod	_	_
12	protein	_	NN	NN	_	13	compound	_	_
13	fraction	_	NN	NN	_	8	nmod	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	not	_	RB	RB	_	18	neg	_	_
16	calf	_	NN	NN	_	18	compound	_	_
17	thymus	_	NN	NN	_	18	compound	_	_
18	DNA	_	NN	NN	_	13	conj	_	_

1	Cellular	_	NNP	NNP	_	2	compound	_	_
2	localization	_	NNP	NNP	_	0	root	_	_
3	of	_	IN	IN	_	6	case	_	_
4	the	_	DT	DT	_	6	det	_	_
5	Ro/SS-A	_	JJ	JJ	_	6	amod	_	_
6	antigen	_	NN	NN	_	2	nmod	_	_

1	The	_	DT	DT	_	3	det	_	_
2	cellular	_	JJ	JJ	_	3	amod	_	_
3	localization	_	NN	NN	_	9	nsubjpass	_	_
4	of	_	IN	IN	_	7	case	_	_
5	the	_	DT	DT	_	7	det	_	_
6	Ro/SS-A	_	JJ	JJ	_	7	amod	_	_
7	antigen	_	NN	NN	_	3	nmod	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	defined	_	VBN	VBN	_	0	root	_	_
10	using	_	VBG	VBG	_	9	xcomp	_	_
11	indirect	_	JJ	JJ	_	12	amod	_	_
12	immunofluorescence	_	NN	NN	_	10	dobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	eight	_	CD	CD	_	18	nummod	_	_
15	monospecific	_	JJ	JJ	_	18	amod	_	_
16	anti-	_	JJ	JJ	_	18	amod	_	_
17	Ro/SS-A	_	JJ	JJ	_	18	amod	_	_
18	antisera	_	NN	NN	_	12	conj	_	_
19	which	_	WDT	WDT	_	21	nsubjpass	_	_
20	were	_	VBD	VBD	_	21	auxpass	_	_
21	identified	_	VBN	VBN	_	18	acl:relcl	_	_
22	by	_	IN	IN	_	23	case	_	_
23	immunoblotting	_	NN	NN	_	21	nmod	_	_

1	Several	_	JJ	JJ	_	3	amod	_	_
2	mammalian	_	JJ	JJ	_	3	amod	_	_
3	tissues	_	NNS	NNS	_	5	nsubjpass	_	_
4	were	_	VBD	VBD	_	5	auxpass	_	_
5	used	_	VBN	VBN	_	0	root	_	_
6	as	_	IN	IN	_	7	case	_	_
7	substrates	_	NNS	NNS	_	5	nmod	_	_

1	The	_	DT	DT	_	3	det	_	_
2	Ro/SS-A	_	JJ	JJ	_	3	amod	_	_
3	antigen	_	NN	NN	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	located	_	VBN	VBN	_	0	root	_	_
6	mainly	_	RB	RB	_	5	advmod	_	_
7	in	_	IN	IN	_	9	case	_	_
8	the	_	DT	DT	_	9	det	_	_
9	nucleus	_	NN	NN	_	5	nmod	_	_
10	of	_	IN	IN	_	12	case	_	_
11	dog	_	NN	NN	_	12	compound	_	_
12	liver	_	NN	NN	_	9	nmod	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	Hep-2-cells	_	NN	NN	_	12	conj	_	_
16	and	_	CC	CC	_	5	cc	_	_
17	anti-Ro	_	JJ	JJ	_	18	amod	_	_
18	sera	_	NN	NN	_	20	nsubj	_	_
19	had	_	VBD	VBD	_	20	aux	_	_
20	produced	_	VBN	VBN	_	5	conj	_	_
21	a	_	DT	DT	_	24	det	_	_
22	speckled	_	JJ	JJ	_	24	amod	_	_
23	staining	_	NN	NN	_	24	compound	_	_
24	pattern	_	NN	NN	_	20	dobj	_	_

1	Cytoplasmic	_	JJ	JJ	_	2	amod	_	_
2	fluorescence	_	NN	NN	_	3	nsubj	_	_
3	appeared	_	VBD	VBD	_	0	root	_	_
4	only	_	RB	RB	_	3	advmod	_	_
5	in	_	IN	IN	_	7	case	_	_
6	one	_	CD	CD	_	7	nummod	_	_
7	serum	_	NN	NN	_	3	nmod	_	_

1	IgG	_	NNP	NNP	_	5	nsubj	_	_
2	was	_	VBD	VBD	_	5	cop	_	_
3	the	_	DT	DT	_	5	det	_	_
4	predominant	_	JJ	JJ	_	5	amod	_	_
5	immunoglobulin	_	NN	NN	_	0	root	_	_
6	with	_	IN	IN	_	8	case	_	_
7	anti-Ro/SS-A	_	JJ	JJ	_	8	amod	_	_
8	activity	_	NN	NN	_	5	nmod	_	_
10	five	_	CD	CD	_	11	nummod	_	_
11	sera	_	NN	NN	_	13	nsubj	_	_
12	had	_	VBD	VBD	_	13	aux	_	_
13	complement	_	VBN	VBN	_	5	parataxis	_	_
14	fixing	_	VBG	VBG	_	13	xcomp	_	_
15	activity	_	NN	NN	_	14	dobj	_	_

1	The	_	DT	DT	_	4	det	_	_
2	sera	_	JJ	JJ	_	4	amod	_	_
3	absorption	_	NN	NN	_	4	compound	_	_
4	studies	_	NNS	NNS	_	18	nsubj	_	_
5	with	_	IN	IN	_	9	case	_	_
6	partially	_	RB	RB	_	7	advmod	_	_
7	purified	_	JJ	JJ	_	9	amod	_	_
8	Ro/SS-A	_	JJ	JJ	_	9	amod	_	_
9	antigen	_	NN	NN	_	4	nmod	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	the	_	DT	DT	_	12	det	_	_
12	negativation	_	NN	NN	_	9	conj	_	_
13	of	_	IN	IN	_	16	case	_	_
14	the	_	DT	DT	_	16	det	_	_
15	ANA	_	NNP	NNP	_	16	compound	_	_
16	tests	_	NNS	NNS	_	12	nmod	_	_
17	had	_	VBD	VBD	_	18	aux	_	_
18	confirmed	_	VBN	VBN	_	0	root	_	_
19	the	_	DT	DT	_	20	det	_	_
20	specificity	_	NN	NN	_	18	dobj	_	_
21	of	_	IN	IN	_	23	case	_	_
22	our	_	PRP$	PRP$	_	23	nmod:poss	_	_
23	findings	_	NNS	NNS	_	20	nmod	_	_

1	Preferential	_	JJ	JJ	_	2	amod	_	_
2	association	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	5	case	_	_
4	acidic	_	JJ	JJ	_	5	amod	_	_
5	actin	_	NN	NN	_	2	nmod	_	_
6	with	_	IN	IN	_	7	case	_	_
7	nuclei	_	NNS	NNS	_	2	nmod	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	nuclear	_	JJ	JJ	_	10	amod	_	_
10	matrix	_	NN	NN	_	7	conj	_	_
11	from	_	IN	IN	_	15	case	_	_
12	mouse	_	NN	NN	_	15	compound	_	_
13	leukemia	_	NN	NN	_	15	compound	_	_
14	L5178Y	_	NN	NN	_	15	compound	_	_
15	cells	_	NNS	NNS	_	2	nmod	_	_

1	Nuclear	_	JJ	JJ	_	2	amod	_	_
2	matrix	_	NN	NN	_	9	nsubj	_	_
3	prepared	_	VBN	VBN	_	2	acl	_	_
4	from	_	IN	IN	_	8	case	_	_
5	mouse	_	NN	NN	_	8	compound	_	_
6	leukemia	_	NN	NN	_	8	compound	_	_
7	L5178Y	_	NN	NN	_	8	compound	_	_
8	cells	_	NNS	NNS	_	3	nmod	_	_
9	contained	_	VBD	VBD	_	0	root	_	_
10	not	_	RB	RB	_	11	neg	_	_
11	only	_	JJ	JJ	_	16	cc:preconj	_	_
12	the	_	DT	DT	_	16	det	_	_
13	two	_	CD	CD	_	16	nummod	_	_
14	common	_	JJ	JJ	_	16	amod	_	_
15	actin	_	NN	NN	_	16	compound	_	_
16	isomers	_	NNS	NNS	_	9	dobj	_	_
18	beta	_	NN	NN	_	21	compound	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	gamma	_	NN	NN	_	18	conj	_	_
21	actins	_	NNS	NNS	_	16	appos	_	_
23	but	_	CC	CC	_	16	cc	_	_
24	also	_	RB	RB	_	28	advmod	_	_
25	two	_	CD	CD	_	28	nummod	_	_
26	additional	_	JJ	JJ	_	28	amod	_	_
27	acidic	_	JJ	JJ	_	28	amod	_	_
28	species	_	NNS	NNS	_	16	conj	_	_
29	of	_	IN	IN	_	30	case	_	_
30	actin	_	NN	NN	_	28	nmod	_	_
32	pI	_	VB	VB	_	28	dep	_	_
33	5.1	_	CD	CD	_	32	dobj	_	_
34	and	_	CC	CC	_	33	cc	_	_
35	5.3	_	CD	CD	_	33	conj	_	_

1	An	_	DT	DT	_	3	det	_	_
2	anti-actin	_	JJ	JJ	_	3	amod	_	_
3	antibody	_	NN	NN	_	4	nsubj	_	_
4	recognized	_	VBD	VBD	_	0	root	_	_
5	these	_	DT	DT	_	7	det	_	_
6	acidic	_	JJ	JJ	_	7	amod	_	_
7	species	_	NN	NN	_	4	dobj	_	_
8	as	_	RB	RB	_	7	cc	_	_
9	well	_	RB	RB	_	8	mwe	_	_
10	as	_	IN	IN	_	8	mwe	_	_
11	beta	_	NN	NN	_	14	compound	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	gamma	_	NN	NN	_	11	conj	_	_
14	actins	_	NNS	NNS	_	7	conj	_	_
15	on	_	IN	IN	_	18	case	_	_
16	a	_	DT	DT	_	18	det	_	_
17	nitrocellulose	_	JJ	JJ	_	18	amod	_	_
18	filter	_	NN	NN	_	4	nmod	_	_
19	following	_	VBG	VBG	_	20	case	_	_
20	western	_	JJ	JJ	_	18	nmod	_	_
21	blotting	_	VBG	VBG	_	20	amod	_	_
22	of	_	IN	IN	_	24	case	_	_
23	two-dimensional	_	JJ	JJ	_	24	amod	_	_
24	electrophoresis	_	NNS	NNS	_	20	nmod	_	_

1	These	_	DT	DT	_	3	det	_	_
2	acidic	_	JJ	JJ	_	3	amod	_	_
3	species	_	NN	NN	_	5	nsubjpass	_	_
4	were	_	VBD	VBD	_	5	auxpass	_	_
5	co-purified	_	VBN	VBN	_	0	root	_	_
6	with	_	IN	IN	_	10	case	_	_
7	beta	_	NN	NN	_	10	compound	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	gamma	_	NN	NN	_	7	conj	_	_
10	actins	_	NNS	NNS	_	5	nmod	_	_
11	using	_	VBG	VBG	_	5	xcomp	_	_
12	DNase_I-Sepharose	_	JJ	JJ	_	14	amod	_	_
13	affinity	_	NN	NN	_	14	compound	_	_
14	chromatography	_	NN	NN	_	11	dobj	_	_
15	on	_	IN	IN	_	18	case	_	_
16	the	_	DT	DT	_	18	det	_	_
17	nuclear	_	JJ	JJ	_	18	amod	_	_
18	matrix	_	NN	NN	_	11	nmod	_	_

1	Limited	_	JJ	JJ	_	2	amod	_	_
2	digestion	_	NN	NN	_	12	nsubj	_	_
3	of	_	IN	IN	_	6	case	_	_
4	the	_	DT	DT	_	6	det	_	_
5	acidic	_	JJ	JJ	_	6	amod	_	_
6	actin	_	NN	NN	_	2	nmod	_	_
7	with	_	IN	IN	_	9	case	_	_
8	protease	_	JJ	JJ	_	9	amod	_	_
9	V8	_	NN	NN	_	6	nmod	_	_
10	or	_	CC	CC	_	9	cc	_	_
11	trypsin	_	NN	NN	_	9	conj	_	_
12	gave	_	VBD	VBD	_	0	root	_	_
13	very	_	RB	RB	_	14	advmod	_	_
14	similar	_	JJ	JJ	_	16	amod	_	_
15	peptide	_	JJ	JJ	_	16	amod	_	_
16	fragments	_	NNS	NNS	_	12	dobj	_	_
17	as	_	IN	IN	_	18	mark	_	_
18	did	_	VBD	VBD	_	12	advcl	_	_
19	digestion	_	NN	NN	_	18	dobj	_	_
20	of	_	IN	IN	_	24	case	_	_
21	beta	_	NN	NN	_	24	compound	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	gamma	_	NN	NN	_	21	conj	_	_
24	actins	_	NNS	NNS	_	19	nmod	_	_

1	These	_	DT	DT	_	3	det	_	_
2	acidic	_	JJ	JJ	_	3	amod	_	_
3	actins	_	NNS	NNS	_	5	nsubjpass	_	_
4	were	_	VBD	VBD	_	5	auxpass	_	_
5	found	_	VBN	VBN	_	0	root	_	_
6	to	_	TO	TO	_	8	mark	_	_
7	be	_	VB	VB	_	8	auxpass	_	_
8	distributed	_	VBN	VBN	_	5	xcomp	_	_
9	in	_	IN	IN	_	12	case	_	_
10	the	_	DT	DT	_	12	det	_	_
11	nuclear	_	JJ	JJ	_	12	amod	_	_
12	fraction	_	NN	NN	_	8	nmod	_	_
14	but	_	CC	CC	_	5	cc	_	_
15	were	_	VBD	VBD	_	17	cop	_	_
16	scarcely	_	RB	RB	_	17	advmod	_	_
17	detectable	_	JJ	JJ	_	5	conj	_	_
18	in	_	IN	IN	_	21	case	_	_
19	the	_	DT	DT	_	21	det	_	_
20	cytoplasmic	_	JJ	JJ	_	21	amod	_	_
21	fraction	_	NN	NN	_	17	nmod	_	_

1	One	_	CD	CD	_	11	nsubjpass	_	_
2	of	_	IN	IN	_	5	case	_	_
3	the	_	DT	DT	_	5	det	_	_
4	acidic	_	JJ	JJ	_	5	amod	_	_
5	actins	_	NNS	NNS	_	1	nmod	_	_
7	pI	_	CD	CD	_	8	compound	_	_
8	5.3	_	CD	CD	_	5	dep	_	_
10	was	_	VBD	VBD	_	11	auxpass	_	_
11	found	_	VBN	VBN	_	0	root	_	_
12	in	_	IN	IN	_	15	case	_	_
13	all	_	DT	DT	_	15	det	_	_
14	subnuclear	_	NN	NN	_	15	compound	_	_
15	fractions	_	NNS	NNS	_	11	nmod	_	_
17	DNase	_	NNP	NNP	_	18	compound	_	_
18	extract	_	NNP	NNP	_	15	dep	_	_
20	high-salt	_	JJ	JJ	_	21	amod	_	_
21	extract	_	NNS	NNS	_	18	conj	_	_
22	and	_	CC	CC	_	18	cc	_	_
23	nuclear	_	JJ	JJ	_	24	amod	_	_
24	matrix	_	NN	NN	_	18	conj	_	_
27	while	_	IN	IN	_	42	mark	_	_
28	the	_	DT	DT	_	30	det	_	_
29	other	_	JJ	JJ	_	30	amod	_	_
30	species	_	NN	NN	_	42	nsubj	_	_
32	the	_	DT	DT	_	35	det	_	_
33	most	_	RBS	RBS	_	35	advmod	_	_
34	acidic	_	JJ	JJ	_	35	amod	_	_
35	actin	_	NN	NN	_	30	appos	_	_
37	pI	_	CD	CD	_	38	compound	_	_
38	5.1	_	CD	CD	_	35	dep	_	_
41	was	_	VBD	VBD	_	42	cop	_	_
42	localized	_	JJ	JJ	_	11	advcl	_	_
43	predominantly	_	RB	RB	_	42	advmod	_	_
44	in	_	IN	IN	_	47	case	_	_
45	the	_	DT	DT	_	47	det	_	_
46	nuclear	_	JJ	JJ	_	47	amod	_	_
47	matrix	_	NN	NN	_	42	nmod	_	_

1	Distribution	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	4	case	_	_
3	microfilament	_	JJ	JJ	_	4	amod	_	_
4	bundles	_	NNS	NNS	_	1	nmod	_	_
5	during	_	IN	IN	_	6	case	_	_
6	rotation	_	NN	NN	_	1	nmod	_	_
7	of	_	IN	IN	_	9	case	_	_
8	the	_	DT	DT	_	9	det	_	_
9	nucleus	_	NN	NN	_	1	nmod	_	_
10	in	_	IN	IN	_	12	case	_	_
11	3T3	_	CD	CD	_	12	nummod	_	_
12	cells	_	NNS	NNS	_	1	nmod	_	_
13	treated	_	VBN	VBN	_	1	acl	_	_
14	with	_	IN	IN	_	15	case	_	_
15	monensin	_	NN	NN	_	13	nmod	_	_

1	Cytoskeletal	_	JJ	JJ	_	2	amod	_	_
2	aspects	_	NNS	NNS	_	11	nsubjpass	_	_
3	of	_	IN	IN	_	6	case	_	_
4	monensin-treated	_	JJ	JJ	_	6	amod	_	_
5	3T3	_	CD	CD	_	6	nummod	_	_
6	cells	_	NNS	NNS	_	2	nmod	_	_
7	with	_	IN	IN	_	9	case	_	_
8	rotating	_	VBG	VBG	_	9	amod	_	_
9	nuclei	_	NNS	NNS	_	2	nmod	_	_
10	were	_	VBD	VBD	_	11	auxpass	_	_
11	studied	_	VBN	VBN	_	0	root	_	_
12	by	_	IN	IN	_	13	case	_	_
13	immunofluorescence	_	NN	NN	_	11	nmod	_	_

1	The	_	DT	DT	_	2	det	_	_
2	pattern	_	NN	NN	_	8	nsubj	_	_
3	of	_	IN	IN	_	5	case	_	_
4	intermediate	_	JJ	JJ	_	5	amod	_	_
5	filaments	_	NNS	NNS	_	2	nmod	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	microtubules	_	NNS	NNS	_	5	conj	_	_
8	appeared	_	VBD	VBD	_	0	root	_	_
9	unchanged	_	JJ	JJ	_	8	xcomp	_	_
10	when	_	WRB	WRB	_	11	advmod	_	_
11	compared	_	VBN	VBN	_	8	advcl	_	_
12	with	_	IN	IN	_	14	case	_	_
13	control	_	NN	NN	_	14	compound	_	_
14	cells	_	NNS	NNS	_	11	nmod	_	_
15	having	_	VBG	VBG	_	14	acl	_	_
16	a	_	DT	DT	_	18	det	_	_
17	stationary	_	JJ	JJ	_	18	amod	_	_
18	nucleus	_	NN	NN	_	15	dobj	_	_

1	In	_	IN	IN	_	2	case	_	_
2	contrast	_	NN	NN	_	8	nmod	_	_
4	the	_	DT	DT	_	7	det	_	_
5	actin	_	NN	NN	_	7	compound	_	_
6	microfilament	_	NN	NN	_	7	compound	_	_
7	bundles	_	NNS	NNS	_	8	nsubj	_	_
8	appeared	_	VBD	VBD	_	0	root	_	_
9	to	_	TO	TO	_	10	mark	_	_
10	have	_	VB	VB	_	8	xcomp	_	_
11	a	_	DT	DT	_	13	det	_	_
12	consistent	_	JJ	JJ	_	13	amod	_	_
13	distribution	_	NN	NN	_	10	dobj	_	_
14	in	_	IN	IN	_	15	case	_	_
15	cells	_	NNS	NNS	_	13	nmod	_	_
16	with	_	IN	IN	_	18	case	_	_
17	rotating	_	VBG	VBG	_	18	amod	_	_
18	nuclei	_	NNS	NNS	_	15	nmod	_	_

1	Typically	_	RB	RB	_	6	advmod	_	_
3	we	_	PRP	PRP	_	6	nsubj	_	_
4	did	_	VBD	VBD	_	6	aux	_	_
5	not	_	RB	RB	_	6	neg	_	_
6	find	_	VB	VB	_	0	root	_	_
7	long	_	JJ	JJ	_	9	amod	_	_
8	microfilament	_	NN	NN	_	9	compound	_	_
9	bundles	_	NNS	NNS	_	6	dobj	_	_
10	that	_	WDT	WDT	_	11	nsubj	_	_
11	traverse	_	VBP	VBP	_	9	acl:relcl	_	_
12	the	_	DT	DT	_	13	det	_	_
13	length	_	NN	NN	_	11	dobj	_	_
14	of	_	IN	IN	_	16	case	_	_
15	the	_	DT	DT	_	16	det	_	_
16	cytoplasm	_	NN	NN	_	13	nmod	_	_
17	of	_	IN	IN	_	18	case	_	_
18	cells	_	NNS	NNS	_	16	nmod	_	_
19	that	_	WDT	WDT	_	21	nsubjpass	_	_
20	were	_	VBD	VBD	_	21	auxpass	_	_
21	fixed	_	VBN	VBN	_	18	acl:relcl	_	_
22	at	_	IN	IN	_	24	case	_	_
23	the	_	DT	DT	_	24	det	_	_
24	time	_	NN	NN	_	21	nmod	_	_
25	of	_	IN	IN	_	27	case	_	_
26	nuclear	_	JJ	JJ	_	27	amod	_	_
27	rotation	_	NN	NN	_	24	nmod	_	_

1	Instead	_	RB	RB	_	4	advmod	_	_
3	there	_	EX	EX	_	4	expl	_	_
4	was	_	VBD	VBD	_	0	root	_	_
5	a	_	DT	DT	_	7	det	_	_
6	local	_	JJ	JJ	_	7	amod	_	_
7	distribution	_	NN	NN	_	4	nsubj	_	_
8	of	_	IN	IN	_	11	case	_	_
9	short	_	JJ	JJ	_	11	amod	_	_
10	microfilament	_	NN	NN	_	11	compound	_	_
11	bundles	_	NNS	NNS	_	7	nmod	_	_
12	situated	_	VBN	VBN	_	11	dep	_	_
13	ventrally	_	RB	RB	_	12	advmod	_	_
14	to	_	TO	TO	_	16	case	_	_
15	the	_	DT	DT	_	16	det	_	_
16	nucleus	_	NN	NN	_	12	nmod	_	_
17	and	_	CC	CC	_	12	cc	_	_
18	oriented	_	JJ	JJ	_	12	conj	_	_
19	at	_	IN	IN	_	21	case	_	_
20	various	_	JJ	JJ	_	21	amod	_	_
21	angles	_	NNS	NNS	_	18	nmod	_	_
22	to	_	TO	TO	_	23	case	_	_
23	one	_	CD	CD	_	18	nmod	_	_
24	another	_	DT	DT	_	23	dep	_	_
25	and	_	CC	CC	_	23	cc	_	_
26	to	_	TO	TO	_	29	case	_	_
27	the	_	DT	DT	_	29	det	_	_
28	predominant	_	JJ	JJ	_	29	amod	_	_
29	distribution	_	NN	NN	_	23	conj	_	_
30	of	_	IN	IN	_	32	case	_	_
31	microfilament	_	JJ	JJ	_	32	amod	_	_
32	bundles	_	NNS	NNS	_	29	nmod	_	_
33	in	_	IN	IN	_	35	case	_	_
34	the	_	DT	DT	_	35	det	_	_
35	cell	_	NN	NN	_	32	nmod	_	_

1	The	_	DT	DT	_	2	det	_	_
2	observations	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	actin	_	NN	NN	_	7	compound	_	_
7	cytoskeleton	_	NN	NN	_	9	nsubjpass	_	_
8	is	_	VBZ	VBZ	_	9	auxpass	_	_
9	reorganized	_	VBN	VBN	_	3	ccomp	_	_
10	locally	_	RB	RB	_	9	advmod	_	_
11	before	_	IN	IN	_	14	case	_	_
12	or	_	CC	CC	_	11	cc	_	_
13	during	_	IN	IN	_	11	conj	_	_
14	rotation	_	NN	NN	_	9	nmod	_	_
15	of	_	IN	IN	_	17	case	_	_
16	the	_	DT	DT	_	17	det	_	_
17	nucleus	_	NN	NN	_	14	nmod	_	_

1	Metabolism	_	NNP	NNP	_	0	root	_	_
2	of	_	IN	IN	_	3	case	_	_
3	neuropeptides	_	NNS	NNS	_	1	nmod	_	_
4	at	_	IN	IN	_	8	case	_	_
5	brain	_	NN	NN	_	8	compound	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	pituitary	_	NN	NN	_	5	conj	_	_
8	sites	_	NNS	NNS	_	1	nmod	_	_

1	-LSB-	_	NNP	NNP	_	3	compound	_	_
2	Quantitative	_	NNP	NNP	_	3	compound	_	_
3	evaluation	_	NN	NN	_	6	nsubj	_	_
4	of	_	IN	IN	_	5	case	_	_
5	EMG	_	NNP	NNP	_	3	nmod	_	_
6	records	_	VBZ	VBZ	_	0	root	_	_
7	based	_	VBN	VBN	_	12	case	_	_
8	on	_	IN	IN	_	12	case	_	_
9	2	_	CD	CD	_	12	nummod	_	_
10	digital	_	JJ	JJ	_	12	amod	_	_
11	indicators	_	NNS	NNS	_	12	compound	_	_
12	-RSB-	_	NNS	NNS	_	6	advcl	_	_

1	The	_	DT	DT	_	2	det	_	_
2	author	_	NN	NN	_	3	nsubj	_	_
3	presents	_	VBZ	VBZ	_	0	root	_	_
4	a	_	DT	DT	_	6	det	_	_
5	new	_	JJ	JJ	_	6	amod	_	_
6	concept	_	NN	NN	_	3	dobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	the	_	DT	DT	_	9	det	_	_
9	results	_	NNS	NNS	_	6	conj	_	_
10	of	_	IN	IN	_	12	case	_	_
11	simple	_	JJ	JJ	_	12	amod	_	_
12	assessment	_	NN	NN	_	9	nmod	_	_
13	of	_	IN	IN	_	15	case	_	_
14	EMG	_	NNP	NNP	_	15	compound	_	_
15	records	_	NNS	NNS	_	12	nmod	_	_
16	by	_	IN	IN	_	17	case	_	_
17	means	_	NNS	NNS	_	3	nmod	_	_
18	of	_	IN	IN	_	21	case	_	_
19	a	_	DT	DT	_	21	det	_	_
20	universal	_	JJ	JJ	_	21	amod	_	_
21	set	_	NN	NN	_	17	nmod	_	_
22	of	_	IN	IN	_	23	case	_	_
23	parameters	_	NNS	NNS	_	21	nmod	_	_
24	represented	_	VBN	VBN	_	23	acl	_	_
25	by	_	IN	IN	_	28	case	_	_
26	two	_	CD	CD	_	28	nummod	_	_
27	digital	_	JJ	JJ	_	28	amod	_	_
28	indices	_	NNS	NNS	_	24	nmod	_	_
